matchedPattern,context,lineNumber,columnNumber,publicationName
1.85.12.126,...robin Plant Dis 2001 85 1264 1270 10.1094/PDIS.2001.85.12.1264,194,144,3_Biotech_2016_Dec_5_6(1)_8.txt
2.46.2.109,...ses Holzforschung 1992 46 109 115 10.1515/hfsg.1992.46.2.109,594,222,3_Biotech_2016_Dec_4_6(1)_46.txt
EC 1.1.3.2,"oxidase from Pediococcus species (LO, EC 1.1.3.2",457,39,ACS_Cent_Sci_2016_Nov_23_2(11)_843-849.txt
3.3.2.1,3.3.2.1 TNF-α release from particle-stimulated PBM...,67,1,Acta_Biomater_2015_Sep_1_23_38-51.txt
4.4.4.4,"(4.4.4.4.4.4.4.4.6.6.6.6.6.6.6.) (Figs. 4, 5)",178,10,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_29_68(Pt_3)_o866.txt
EC 1.2.1.2,"... cited.NAD+-dependent formate dehydrogenase (FDH, EC 1.2.1.2) widely occur",7,59,Acta_Naturae_2011_Oct-Dec_3(4)_38-54.txt
EC 3.1.1.8,...tyrylcholinesterase (BChE) is a serine hydrolase (EC 3.1.1.8) which can b,9,53,Acta_Naturae_2013_Jan-Mar_5(1)_73-84.txt
1.1.1.42," Isocitrate dehydrogenase (IDH, 1.1.1.42)b	A, B	2.30",50,33,Acta_Trop_2006_Dec_100(3)_246-251.txt
3.4.17.4,...	Hypothetical protein	3.4.2.3; Transferred entry: 3.4.17.4	T2-3.4.23.2	Pepsin B,204,60,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
2.5.2.1,2.5.2.1. Low Temperatur,67,1,Adv_Funct_Mater_2014_May_1_24(20)_2993-3002.txt
6.18.2.227,...an J Cogn Neurosci 2006 18 227 41 10.1162/jocn.2006.18.2.227 16494683,330,180,PMC5270666.txt
1.23.4.382,...Education and Prevention  382 392 10.1521/aeap.2011.23.4.382 21861610,330,249,AIDS_Care_2015_Nov_2_27(sup1)_365-46.txt
6.3.1.131,...cogenomics 2002 3 131 144 11966409 10.1517/14622416.3.1.131,140,127,Algorithms_Mol_Biol_2006_Apr_19_1_6.txt
1.3.3.205,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.3.205Original ArticleMesenchymal Stem Cell Tra...,3,229,Allergy_Asthma_Immunol_Res_2011_Jul_17_3(3)_205-211.txt
1.3.4.236,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.4.236ReviewThe Search for Genetic Variants and...,3,229,Allergy_Asthma_Immunol_Res_2011_Oct_30_3(4)_236-244.txt
2.4.1.12,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.1.12ReviewEpidermal Barrier in Atopic Dermatit...,3,229,Allergy_Asthma_Immunol_Res_2012_Jan_21_4(1)_12-16.txt
4.6.4.276,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.4.276ReviewEpidermal Permeability Barrier Defe...,3,255,Allergy_Asthma_Immunol_Res_2014_Jul_21_6(4)_276-287.txt
4.7.4.622,...list Psychol Aging 1992 7 622 631 10.1037/0882-7974.7.4.622 1466831,298,169,Alzheimers_Res_Ther_2010_Aug_26_2(4)_24.txt
EC 1.13.11.12,"Lipoxygenases (EC 1.13.11.12, EC 1.13.11.34 and EC 1.13.11.33) ar...",6,16,AMB_Express_2012_Mar_26_2_17.txt
EC 3.2.1.91,...BSA) as a standard (Bradford 1976). Exoglucanase (EC 3.2.1.91) activity was measured using 1% Avicel...,40,862,AMB_Express_2012_Mar_15_2_16.txt
EC 3.2.1.37,"...antarel et al. 2009) encompassing β-d-xylosidase (EC 3.2.1.37), β-1,3-xylosidase (EC 3.2.1.-), α-l-a...",12,108,AMB_Express_2013_Sep_11_3_56.txt
EC 3.2.1.37,"...ities have been abbreviated as X: β-d-xylosidase (EC 3.2.1.37). X13: β-1,3-xylosidase (EC 3.2.1.-). ...",51,307,AMB_Express_2013_Sep_11_3_56.txt
2.2.3.1,...2 with proteases of Bacillus strains using Blastp 2.2.3.,203,103,AMB_Express_2016_Jun_30_6_42.txt
EC 5.4.99.2,"...A) mutases (methylmalonyl-CoA CoA-carbonylmutase; EC 5.4.99.2), which are present in the mitochondri...",29,561,Am_J_Clin_Nutr_2011_Jul_94(1)_359S-365S.txt
2.45.1.47,...73Korean Association of Anatomists 10.5115/acb.2012.45.1.47Original ArticleNeurobiologyActivated mic...,3,120,Anat_Cell_Biol_2012_Mar_31_45(1)_47-52.txt
3.46.2.167,...73Korean Association of Anatomists 10.5115/acb.2013.46.2.167Case ReportRight-sided aortic arch with ...,3,120,Anat_Cell_Biol_2013_Jun_30_46(2)_167-170.txt
3.46.3.171,...73Korean Association of Anatomists 10.5115/acb.2013.46.3.171Original ArticleCell BiologyHistological...,3,120,Anat_Cell_Biol_2013_Sep_30_46(3)_171-176.txt
4.47.3.157,...73Korean Association of Anatomists 10.5115/acb.2014.47.3.157Original ArticleCell BiologyDistribution...,3,120,Anat_Cell_Biol_2014_Sep_23_47(3)_157-161.txt
4.47.3.162,...73Korean Association of Anatomists 10.5115/acb.2014.47.3.162Original ArticleCell BiologyEffect of ni...,3,120,Anat_Cell_Biol_2014_Sep_23_47(3)_162-170.txt
5.16.2.402,...al of Radiology  2015 16 2 402 409 10.3348/kjr.2015.16.2.402 25741202,144,278,Anat_Res_Int_2015_Jul_7_2015_384148.txt
3.1.3.2,(EC:3.1.3.2) and alkaline phosphatas,99,5,Anc_Sci_Life_1997_Jul-Sep_17(1)_41-46.txt
2.27.6.608,...n Hospitalaria  2012 27 6 1817 1836 10.3305/nh.2012.27.6.6087 23588429,241,261,Anemia_2015_Jul_5_2015_647930.txt
4.2.1.1,4.2.1.1. Techniqu,85,1,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
3.33.4.381,...nim Behav Process 2007 33 381 391 10.1037/0097-7403.33.4.381 17924787,218,177,Anim_Cogn_2014_Oct_20_17(3)_559-575.txt
3.29.1.5,...he Korean Society of Coloproctology 10.3393/ac.2013.29.1.5EditorialFunctional New Sphincter Ani Reco...,3,126,Ann_Coloproctol_2013_Feb_28_29(1)_5-6.txt
3.29.1.28,...he Korean Society of Coloproctology 10.3393/ac.2013.29.1.28Case ReportRectal Perforation Caused by A...,3,126,Ann_Coloproctol_2013_Feb_28_29(1)_28-30.txt
3.29.6.217,...he Korean Society of Coloproctology 10.3393/ac.2013.29.6.217EditorialWhat Is the Role of Hand-Assist...,3,126,Ann_Coloproctol_2013_Dec_31_29(6)_217-218.txt
4.30.1.2,...he Korean Society of Coloproctology 10.3393/ac.2014.30.1.2EditorialSecond Primary Cancers Following ...,3,126,Ann_Coloproctol_2014_Feb_28_30(1)_2.txt
4.30.3.153,"...he Korean Society of Coloproctology 10.3393/ac.2014.30.3.153Letter to the EditorReply on \"Data on th...",3,126,Ann_Coloproctol_2014_Jun_23_30(3)_153.txt
6.32.2.79,"...he Korean Society of Coloproctology 10.3393/ac.2016.32.2.79Case ReportIncidentally Solitary, Synchro...",3,126,Ann_Coloproctol_2016_Apr_30_32(2)_79-82.txt
4.30.1.35,...he Korean Society of Coloproctology 10.3393/ac.2014.30.1.35Original ArticleRectourethral Fistula: Sy...,3,126,Ann_Coloproctol_2014_Feb_28_30(1)_35-41.txt
2.24.1.32,"...ciety for Investigative Dermatology 10.5021/ad.2012.24.1.32Original ArticleThe Prevalence, Genotype ...",3,152,Ann_Dermatol_2012_Feb_2_24(1)_32-38.txt
2.24.2.235,...ciety for Investigative Dermatology 10.5021/ad.2012.24.2.235Letter to the EditorA Case of Blastic Pl...,3,164,Ann_Dermatol_2012_May_26_24(2)_235-237.txt
2.24.4.426,...ciety for Investigative Dermatology 10.5021/ad.2012.24.4.426Original ArticleRelation of Nickel Aller...,3,164,Ann_Dermatol_2012_Nov_8_24(4)_426-429.txt
4.26.2.246,...ciety for Investigative Dermatology 10.5021/ad.2014.26.2.246Case ReportAcute Generalized Exanthemato...,3,164,Ann_Dermatol_2014_Apr_30_26(2)_246-249.txt
4.26.2.184,"...ciety for Investigative Dermatology 10.5021/ad.2014.26.2.184Original ArticleA Prospective, Long-Term...",3,164,Ann_Dermatol_2014_Apr_30_26(2)_184-188.txt
4.26.3.343,...ciety for Investigative Dermatology 10.5021/ad.2014.26.3.343Original ArticleAssociation of CYP2C9 Ge...,3,164,Ann_Dermatol_2014_Jun_12_26(3)_343-348.txt
5.27.4.439,...ciety for Investigative Dermatology 10.5021/ad.2015.27.4.439Case ReportA Case of Metastatic Gastric ...,3,164,Ann_Dermatol_2015_Aug_29_27(4)_439-441.txt
5.27.6.715,...ciety for Investigative Dermatology 10.5021/ad.2015.27.6.715Original ArticleAntifungal Susceptibilit...,3,164,Ann_Dermatol_2015_Dec_7_27(6)_715-720.txt
4.64.6.102,...c Psych 1993 64 1029 1041 8326466 10.1037/0022-3514.64.6.1029,180,146,Ann_Gen_Psychiatry_2008_Aug_21_7_14.txt
4.10.4.741,...n Inveting Drugs 2001 10 4 741 752 10.1517/13543784.10.4.74,18,140,Ann_Gen_Psychiatry_2010_Apr_22_9(Suppl_1)_S99.txt
2.32.1.99,...an Society for Laboratory Medicine 10.3343/alm.2012.32.1.99Case ReportDiagnostic GeneticsThe First S...,3,120,Ann_Lab_Med_2012_Jan_20_32(1)_99-101.txt
2.32.5.324,...an Society for Laboratory Medicine 10.3343/alm.2012.32.5.324Original ArticleClinical MicrobiologyAba...,3,131,Ann_Lab_Med_2012_Sep_13_32(5)_324-330.txt
6.36.5.441,...ty for Laboratory Medicine 2737470910.3343/alm.2016.36.5.441Original ArticleClinical MicrobiologyAna...,3,139,Ann_Lab_Med_2016_Sep_24_36(5)_441-449.txt
4.34.1.1,...an Society for Laboratory Medicine 10.3343/alm.2014.34.1.1Original ArticleClinical ChemistryAssessme...,3,131,Ann_Lab_Med_2014_Jan_6_34(1)_1-6.txt
4.34.3.256,...an Society for Laboratory Medicine 10.3343/alm.2014.34.3.256Letter to the EditorTransfusion Medicine...,3,131,Ann_Lab_Med_2014_May_8_34(3)_256-258.txt
5.35.1.178,...an Society for Laboratory Medicine 10.3343/alm.2015.35.1.178Letter to the EditorDiagnostic GeneticsI...,3,131,Ann_Lab_Med_2015_Jan_8_35(1)_178-180.txt
5.35.4.429,...an Society for Laboratory Medicine 10.3343/alm.2015.35.4.429Original ArticleDiagnostic ImmunologyAll...,3,131,Ann_Lab_Med_2015_Jul_21_35(4)_429-435.txt
6.36.4.300,...ty for Laboratory Medicine 2713960110.3343/alm.2016.36.4.300Original ArticleClinical ChemistryPlasma...,3,139,Ann_Lab_Med_2016_Jul_25_36(4)_300-305.txt
5.35.4.469,...an Society for Laboratory Medicine 10.3343/alm.2015.35.4.469Letter to the EditorDiagnostic Hematolog...,3,131,Ann_Lab_Med_2015_Jul_21_35(4)_469-471.txt
EC 3.2.1.52,...inases (EC 3.2.1.14) and N-acetylglucosaminidase (EC 3.2.1.52),11,352,Ann_Microbiol_2011_Dec_22_61(4)_801-807.txt
3.18.3.128,...ociety of Pediatric Endocrinology 10.6065/apem.2013.18.3.128Original ArticleGenotype-phenotype corre...,3,187,Ann_Pediatr_Endocrinol_Metab_2013_Sep_30_18(3)_128-134.txt
4.19.3.127,...ociety of Pediatric Endocrinology 10.6065/apem.2014.19.3.127Original ArticleNo influence of parental...,3,187,Ann_Pediatr_Endocrinol_Metab_2014_Sep_30_19(3)_127-134.txt
4.19.4.202,...ociety of Pediatric Endocrinology 10.6065/apem.2014.19.4.202Original ArticleClinical and radiologica...,3,187,Ann_Pediatr_Endocrinol_Metab_2014_Dec_31_19(4)_202-207.txt
5.20.3.119,...ociety of Pediatric Endocrinology 10.6065/apem.2015.20.3.119Review ArticleScreening newborns for met...,3,187,Ann_Pediatr_Endocrinol_Metab_2015_Sep_30_20(3)_119-124.txt
1.35.5.729,...of Rehabilitation Medicine 2250619810.5535/arm.2011.35.5.729Case ReportMyelopathy Caused by Spinal D...,3,150,Ann_Rehabil_Med_2011_Oct_31_35(5)_729-732.txt
1.35.4.579,...of Rehabilitation Medicine 2250617710.5535/arm.2011.35.4.579Case ReportSuppression of Seizure by Cat...,3,150,Ann_Rehabil_Med_2011_Aug_31_35(4)_579-582.txt
2.36.4.573,...Academy of Rehabilitation Medicine 10.5535/arm.2012.36.4.573Case ReportShoulder Joint Infectious Art...,3,142,Ann_Rehabil_Med_2012_Aug_27_36(4)_573-577.txt
3.37.5.750,...Academy of Rehabilitation Medicine 10.5535/arm.2013.37.5.750Case ReportRecurrent Cerebral Infarction...,3,142,Ann_Rehabil_Med_2013_Oct_29_37(5)_750-754.txt
4.38.2.145,...Academy of Rehabilitation Medicine 10.5535/arm.2014.38.2.145Original ArticlePlantar Pressure Distrib...,3,142,Ann_Rehabil_Med_2014_Apr_29_38(2)_145-152.txt
6.40.1.168,...Academy of Rehabilitation Medicine 10.5535/arm.2016.40.1.168Case ReportBilateral Cranial IX and X Ne...,3,142,Ann_Rehabil_Med_2016_Feb_26_40(1)_168-171.txt
6.40.2.288,...Academy of Rehabilitation Medicine 10.5535/arm.2016.40.2.288Original ArticleCharacteristics of Patie...,3,142,Ann_Rehabil_Med_2016_Apr_25_40(2)_288-293.txt
6.40.3.520,...Academy of Rehabilitation Medicine 10.5535/arm.2016.40.3.520Original ArticleUsefulness of a Hanging ...,3,142,Ann_Rehabil_Med_2016_Jun_29_40(3)_520-527.txt
6.40.3.432,...Academy of Rehabilitation Medicine 10.5535/arm.2016.40.3.432Original ArticleCharacteristics of Dysph...,3,142,Ann_Rehabil_Med_2016_Jun_29_40(3)_432-439.txt
6.40.3.447,...Academy of Rehabilitation Medicine 10.5535/arm.2016.40.3.447Original ArticleEMG Activity of Masseter...,3,142,Ann_Rehabil_Med_2016_Jun_29_40(3)_447-456.txt
4.86.1.35,...8-6796The Korean Surgical Society 10.4174/astr.2014.86.1.35Original ArticleSingle port laparoscopic ...,3,144,Ann_Surg_Treat_Res_2014_Jan_1_86(1)_35-38.txt
5.88.3.166,...8-6796The Korean Surgical Society 10.4174/astr.2015.88.3.166Case ReportAn idiopathic gigantomastia C...,3,144,Ann_Surg_Treat_Res_2015_Mar_27_88(3)_166-169.txt
5.89.6.300,...8-6796The Korean Surgical Society 10.4174/astr.2015.89.6.300Original ArticleThe role of preoperative...,3,144,Ann_Surg_Treat_Res_2015_Dec_27_89(6)_300-305.txt
2.3.1.1,"2.3.1.1. Scavenging Activity of the 2,2-Diphenyl-1...",29,1,Antioxidants_(Basel)_2014_Dec_16_3(4)_866-889.txt
4.94.5.463,...2 Phytopathology 2004 94 463 469 10.1094/PHYTO.2004.94.5.463 18943764,334,213,Antonie_Van_Leeuwenhoek_2010_Oct_14_98(3)_359-377.txt
3.80.2.175,...al Chemistry 2003 80 175 183 doi:10.1094/CCHEM.2003.80.2.175,90,156,AoB_Plants_2010_Oct_5_2010_plq016.txt
EC 1.2.1.3,"...tic activity of the aldehyde dehydrogenase (ALDH; EC 1.2.1.3, 1.2.1.4, 1.2.1.5) was measured using t...",162,61,Appl_Microbiol_Biotechnol_2011_Jan_31_89(1)_63-72.txt
1.11.1.10,"The heme-dependent chloroperoxidase (CPO, E.C.1.11.1.10) from Caldariomyces fumago catalyzes in ...",121,47,Appl_Microbiol_Biotechnol_2011_Nov_2_92(3)_467-477.txt
EC 2.4.1.2,"...a et al. 2012). In addition, dextrin dextrinases (EC 2.4.1.2) form isomalto/maltooligosaccharides; h...",12,1378,Appl_Microbiol_Biotechnol_2013_Jan_25_97(1)_181-193.txt
EC 1.14.18.1,Tyrosinase (EC 1.14.18.1)	Melanin formation	Copper	Network for...,44,13,Appl_Microbiol_Biotechnol_2013_Jan_25_97(2)_461-475.txt
EC 1.1.1.175,"...g D-xylose to xylitol, or D-xylose dehydrogenase (EC 1.1.1.175 or EC 1.1.1.179) converting D-xylose ...",12,748,PMC4628093.txt
2.5.1.7,"...P-N-acetylglucosamine 1-carboxyvinyltransferase 1	2.5.1.7	52,809 ± 5883	123,575 ± 11,825	2.3	<0.001",228,78,Appl_Microbiol_Biotechnol_2016_Jul_27_100(24)_10307-10319.txt
2.7.1.45,2-Dehydro-3-deoxygluconokinase	2.7.1.45	953 ± 128	3422 ± 735	3.6	0.07,252,32,Appl_Microbiol_Biotechnol_2016_Jul_27_100(24)_10307-10319.txt
1.3.2.166,...f Cognitive Neuroscience  166 182 10.1162/jocn.1991.3.2.166 23972091,244,216,Appl_Neuropsychol_Adult_2016_May_3_23(3)_1866-195.txt
EC 6.5.1.1,"...heir cofactor specificity. ATP-dependent ligases (EC 6.5.1.1) are typically found in Eukarya, Archae...",18,410,Archaea_2015_Oct_1_2015_170571.txt
EC 2.1.1.13,"...l-THF in turn is utilized by methionine synthase (EC 2.1.1.13, MS) yielding THF and methionine by tr...",32,586,Arch_Biochem_Biophys_2013_Jul_15_535(2)_150-162.txt
1.1.5.3,4	1.1.5.3	Glycerol 3-phosphate dehydrogenase	FAD	NAD...,131,3,Arch_Biochem_Biophys_2013_Jul_15_535(2)_150-162.txt
2.39.1.76,...lastic and Reconstructive Surgeons 10.5999/aps.2012.39.1.76LetterCongratulation for a Giant Leap For...,3,152,Arch_Plast_Surg_2012_Jan_15_39(1)_76.txt
3.40.4.312,...lastic and Reconstructive Surgeons 10.5999/aps.2013.40.4.312Topic: Simulation for Excellence in Micr...,3,152,Arch_Plast_Surg_2013_Jul_17_40(4)_312-319.txt
3.40.5.522,...lastic and Reconstructive Surgeons 10.5999/aps.2013.40.5.522Original ArticleThe Relationship between...,3,152,Arch_Plast_Surg_2013_Sep_13_40(5)_522-529.txt
3.40.6.773,...lastic and Reconstructive Surgeons 10.5999/aps.2013.40.6.773Original ArticleComparative Study of Spi...,3,152,Arch_Plast_Surg_2013_Nov_8_40(6)_773-778.txt
4.41.4.317,...lastic and Reconstructive Surgeons 10.5999/aps.2014.41.4.317Original ArticleCreation of Consistent B...,3,152,Arch_Plast_Surg_2014_Jul_15_41(4)_317-324.txt
4.41.6.748,...lastic and Reconstructive Surgeons 10.5999/aps.2014.41.6.748Original ArticleGynecomastia Surgery Is ...,3,152,Arch_Plast_Surg_2014_Nov_3_41(6)_748-752.txt
4.41.6.716,...lastic and Reconstructive Surgeons 10.5999/aps.2014.41.6.716Original ArticleAn Algorithm to Guide Re...,3,152,Arch_Plast_Surg_2014_Nov_3_41(6)_716-721.txt
5.42.2.245,...lastic and Reconstructive Surgeons 10.5999/aps.2015.42.2.245ImagesA Severe Acute Hypersensitivity Re...,3,152,Arch_Plast_Surg_2015_Mar_16_42(2)_245-247.txt
3.24.1.24,...ractice Pract Nurs 2013 24 24 29 10.12968/pnur.2013.24.1.24,276,138,Arch_Public_Health_2015_Mar_30_73(1)_14.txt
4.50.5.925,...Social Psychology 1995 50 925 935 10.1037/0022-3514.50.5.925,159,277,Arch_Sex_Behav_2012_Oct_14_41(5)_1209-1218.txt
6.6.7.691,...ts Pharmacogenomics 2005 6 691 699 10.2217/14622416.6.7.691 16207146,168,200,Arch_Toxicol_2016_Jan_9_90(12)_3073-3085.txt
2.11.2.111,...r Targets 2007 11 111 122 17227228 10.1517/14728222.11.2.111,132,156,Arthritis_Res_Ther_2008_Jul_24_10(4)_210.txt
1.77.3.224,...Nutr Res 2007 77 224 235 18214024 10.1024/0300-9831.77.3.224,138,160,Arthritis_Res_Ther_2009_Mar_30_11(2)_R49.txt
3.18.4.696,... J Bone Miner Res 2003 18 696 704 10.1359/jbmr.2003.18.4.696 12674330,217,159,Arthritis_Res_Ther_2010_Feb_18_12(1)_R28.txt
2.17.10.174,... Bone Miner Res 2002 17 1744 1751 10.1359/jbmr.2002.17.10.1744 12369777,171,276,Arthritis_Res_Ther_2012_May_2_14(3)_R105.txt
EC 3.5.3.1,Arginase (EC 3.5.3.1) is a hydrolytic enzyme responsible for...,20,11,Arthritis_Res_Ther_2012_May_30_14(3)_R130.txt
2.2.2.5,"...as the reference. The respective values with NFTA 2.2.2.5 were 103%, 87%, 111%, 27%, 90%, 68%, 116%,...",54,711,Asian-Australas_J_Anim_Sci_2014_Nov_27(11)_1615-1622.txt
1.5.4.208,...846Korean Society of Spine Surgery 10.4184/asj.2011.5.4.208Clinical StudyVariations in Practice Patt...,3,101,Asian_Spine_J_2011_Dec_28_5(4)_208-212.txt
2.6.2.131,...846Korean Society of Spine Surgery 10.4184/asj.2012.6.2.131Clinical StudyDoes the Occupational Activ...,3,114,Asian_Spine_J_2012_Jun_31_6(2)_131-135.txt
4.8.3.322,...846Korean Society of Spine Surgery 10.4184/asj.2014.8.3.322Clinical StudyMajor Surgical Treatment of...,3,114,Asian_Spine_J_2014_Jun_9_8(3)_322-330.txt
4.8.4.435,...846Korean Society of Spine Surgery 10.4184/asj.2014.8.4.435Clinical StudySurgery-Related Complicatio...,3,114,Asian_Spine_J_2014_Aug_19_8(4)_435-445.txt
5.9.6.833,...846Korean Society of Spine Surgery 10.4184/asj.2015.9.6.833Clinical StudyOutcomes of Microendoscopic...,3,114,Asian_Spine_J_2015_Dec_8_9(6)_833-840.txt
6.10.1.6,...846Korean Society of Spine Surgery 10.4184/asj.2016.10.1.6Basic StudySimple and Economical Method to...,3,114,Asian_Spine_J_2016_Feb_16_10(1)_6-13.txt
6.10.4.705,...846Korean Society of Spine Surgery 10.4184/asj.2016.10.4.705Clinical StudyQuantitative Anatomy of C7...,3,114,Asian_Spine_J_2016_Aug_16_10(4)_705-710.txt
3.3.1.74,...thma and Clinical Immunology 10.5415/apallergy.2013.3.1.74ErratumErratum: Measurement of Hymenoptera...,3,163,Asia_Pac_Allergy_2013_Jan_30_3(1)_74.txt
3.3.4.257,...thma and Clinical Immunology 10.5415/apallergy.2013.3.4.257Hypothesis & ExperienceNuts 'n' guts: tra...,3,163,Asia_Pac_Allergy_2013_Oct_31_3(4)_257-265.txt
4.4.3.156,...thma and Clinical Immunology 10.5415/apallergy.2014.4.3.156Original ArticleA retrospective study on ...,3,163,Asia_Pac_Allergy_2014_Jul_29_4(3)_156-163.txt
4.4.4.241,...thma and Clinical Immunology 10.5415/apallergy.2014.4.4.241Educational & Teaching MaterialHouse dust...,3,163,Asia_Pac_Allergy_2014_Oct_29_4(4)_241-252.txt
2.13.9.428,... J Cancer Prev 2012 13 4289 4294 10.7314/APJCP.2012.13.9.4289 23167330,178,212,Asia_Pac_Fam_Med_2014_Nov_18_13(1)_13.txt
4.21.2.353,...chology and Aging 2006 21 353 371 10.1037/0882-7974.21.2.353 16768580,194,150,Atten_Percept_Psychophys_2012_Feb_22_74(2)_454-465.txt
3.26.2.834,...n and Performance 2000 26 834 846 10.1037/0096-1523.26.2.834 10811179,143,155,Atten_Percept_Psychophys_2013_Feb_14_75(2)_349-357.txt
3.25.3.596,...n and Performance 1999 25 596 616 10.1037/0096-1523.25.3.596,177,158,Atten_Percept_Psychophys_2011_May_25_73(6)_1780-1789.txt
4.18.4.287,...lopmental Biology devrep-18-28710.12717/devrep.2014.18.4.287ArticleGenetic Distances and Variations ...,3,163,Balsaenggwa_Saengsig_2014_Dec_18(4)_287-292.txt
2.4.1.6,2.4.1.6 Ewing sarcoma summar,188,1,BBA_Clin_2014_Jun_28_1_59-77.txt
4.12.4.590,...hol Aging 1997 12 590 599 9416628 10.1037/0882-7974.12.4.590,187,171,Behav_Brain_Funct_2009_Mar_2_5_14.txt
3.8.2.253,... Percept Perform 1982 8 2 253 272 10.1037/0096-1523.8.2.253 6461721,335,145,Behav_Brain_Funct_2014_Oct_24_10_38.txt
3.1.2.130,...um Percept Perform 1975 1 130 136 10.1037/0096-1523.1.2.130,389,134,Behav_Brain_Funct_2014_Sep_30_10_34.txt
6.97.2.107,...a) J Comp Psychol 1983 97 107 119 10.1037/0735-7036.97.2.107 6872507,65,165,Behav_Ecol_Sociobiol_2009_Dec_5_64(2)_161-167.txt
4.90.6.987,...ers Soc Psychol 2006 90 6 987 998 10.1037/0022-3514.90.6.987 16784347,317,309,Behav_Genet_2016_Sep_11_46_170-182.txt
5.21.2.207,...europsychology  2007 21 2 207 211 10.1037/0894-4105.21.2.207 2-s2.0-34247388882 17402820,448,207,Behav_Neurol_2015_May_17_2015_960725.txt
4.2.1.2,4.2.1.2 Experiment 3,149,1,Behav_Processes_2012_Jul_90(3)_311-322.txt
4.59.6.121,...cial Psychology 1990 59 1216 1229 10.1037/0022-3514.59.6.1216 2283588,305,168,Behav_Res_Methods_2011_Mar_18_43(2)_548-567.txt
2.3.4.1,2.3.4.1 Competency of treatment deliver,84,1,Behav_Res_Ther_2015_Dec_75_40-47.txt
5.17.2.221,...s Neuropsychology 2003 17 221 229 10.1037/0894-4105.17.2.221 12803427,273,177,Behav_Sci_(Basel)_2012_Jun_18_2(2)_115-134.txt
4.61.3.427,...rs. Soc. Psychol. 1991 61 427 434 10.1037/0022-3514.61.3.427 1941513,451,182,Behav_Sci_(Basel)_2013_Jul_12_3(3)_372-387.txt
5.16.4.481,...s Neuropsychology 2002 16 481 490 10.1037/0894-4105.16.4.481 12382987,189,261,Behav_Sci_(Basel)_2013_Apr_2_3(2)_192-205.txt
4.89.6.101,.... Soc. Psychol. 2005 89 1010 1028 10.1037/0022-3514.89.6.1010 16393031,218,168,Behav_Sci_(Basel)_2016_Mar_17_6(1)_8.txt
4.12.1.51,...rt Opin Invest Drugs 2003 12 51 64 10.1517/13543784.12.1.51,65,86,PMC4311645.txt
EC 2.4.2.3,...catalyzed by the recombinant E. coli uridine (UP; EC 2.4.2.3) and thymidine (TP; EC 2.4.2.4) phospho...,14,713,PMC5238616.txt
2.1.5.1,2.1.5 Manual installing the SBGN-ML add-on2.1.5.1 Fro,54,43,Biochem_Pharmacol_2013_Jul_1_86(1)_56-66.txt
1.14.13.98,Q9Y6A2	http://www.uniprot.org/uniprot/Q9Y6A2	1.14.13.98	27	CYP46A1	Cholesterol 24-hydroxylase	A...,205,46,Biochem_Pharmacol_2013_Jul_1_86(1)_56-66.txt
2.7.8.1,...olamine via ethanolamine-phosphotransferase (E.C. 2.7.8.1) (G) or to 1-O-alkyl-2-acyl-sn-glycero-3-p...,32,642,Biochimie_2013_Jan_95(1)_59-65.txt
3.1.4.3,"...sferase (E.C. 2.6.-.-), (K) phospholipase C (E.C. 3.1.4.3), (L) 1-alkylglycerophosphocholine O-acylt...",88,1202,Biochimie_2013_Jan_95(1)_59-65.txt
EC 4.1.1.3,"..., EC 1.1.1.37), oxaloacetate decarboxylase (OADC, EC 4.1.1.3) and L-LDH was also discussed11 or even...",28,608,Bioengineered_2013_May_1_4(3)_147-152.txt
1.2.1.12,...86	6.186	glyceraldehyde-3-phosphate dehydrogenase	1.2.1.12	D-glyceraldehyde 3-phosphate + NAD + phos...,60,61,Bioengineered_2013_Nov_1_4(6)_420-430.txt
3.4.21.59,7177	tryptase alpha/beta 1 [EC:3.4.21.59],165,34,Bioinformatics_2008_Jul_1_24(13)_i232-i240.txt
4.1.3.7,"by citrate synthase (CS, E.C. 4.1.3.7) to form citrate an",29,31,Bioinformation_2014_Jan_29_10(1)_1-7.txt
EC 3.5.1.5,Urease (urea amidohydrolase; EC 3.5.1.5) a metalloenzym,22,30,Bioinformation_2014_May_20_10(5)_299-307.txt
1.3.1.21,ec:1.3.1.21 7-dehydrocholesterol reductase,500,5,Bioinform_Biol_Insights_2012_Apr_23_6_69-96.txt
5.3.3.5,ec:5.3.3.5 cholestenol Delta-isomerase,503,5,Bioinform_Biol_Insights_2012_Apr_23_6_69-96.txt
3.1.1.13,ec:3.1.1.13 sterol esterase,527,5,Bioinform_Biol_Insights_2012_Apr_23_6_69-96.txt
5.3.1.9,"...s were fired: 5.3.1.9(r), 2.7.1.11, 3.1.3.11, and 5.3.1.9",118,193,Bioinform_Biol_Insights_2016_May_12_10_49-57.txt
4.1.1.1,...tation used for the fixed point analysis in Sect. 4.1.1.1 and can be implemented using local variabl...,710,400,Biol_Cybern_2008_Jun_20_98(6)_459-478.txt
2.15.4.1,...amming tools for model fitting. R package version 2.15.4.1,139,75,Biol_Lett_2016_Mar_12(3)_20160042.txt
2.13.11.545,...Cancer Prev 2012 13 11 5455 5461 10.7314/APJCP.2012.13.11.5455,235,238,Biol_Res_2014_Oct_23_47(1)_54.txt
2.19.2.108,... profession Pflege 2006 19 108 15 10.1024/1012-5302.19.2.108 16681223,270,207,Biomedicine_(Taipei)_2016_Nov_17_6(4)_23.txt
EC 3.2.1.8,"... enzyme in this process is endo-β-(1,4)-xylanase (EC 3.2.1.8), which cleaves the xylan backbone to x...",20,515,Biomed_Res_Int_2013_May_13_2013_728735.txt
3.1.1.8,... 3.1.1.7) and butyrylcholinesterase (BuChE) (E.C. 3.1.1.8) [12]. The zebrafish (Danio rerio) has lon...,46,485,Biomed_Res_Int_2013_Jun_20_2013_623789.txt
EC 3.4.11.2,...on and functional activities of aminopeptidase N (EC 3.4.11.2; APN; CD13) on murine macrophage J774 ...,127,130,Biomed_Res_Int_2013_Aug_26_2013_562984.txt
EC 6.3.2.2,...0 μL of added crude leaf extract. Assay of γ-ECS (EC 6.3.2.2) and LCD (EC 4.4.1.1) was done by follo...,27,1477,Biomed_Res_Int_2014_May_28_2014_479180.txt
2.82.4.453,...nal of Medicine  2012 82 4 453 458 10.3904/kjm.2012.82.4.453,243,191,Biomed_Res_Int_2015_Jan_21_2015_983656.txt
2.2.1.4,1.F2.2.1.4	1707.594	1695.8900	 	0	24–38	(R) IYIDSYGNV...,187,4,Biomed_Res_Int_2015_Feb_23_2015_527015.txt
3.20.2.330,...94 20 2 330 342 2-s2.0-0028414972 10.1037/0096-1523.20.2.330 8189196,141,190,Biomed_Res_Int_2015_Mar_9_2015_720856.txt
4.6.2.105,...nology Research  2014 6 2 105 113 10.4168/aair.2014.6.2.105 2-s2.0-84894447223,154,139,Biomed_Res_Int_2015_May_4_2015_421716.txt
2.5.1.33,...iovascular Therapy  2007 5 1 33 43 10.1586/14779072.5.1.33 2-s2.0-33846504815 17187455,182,203,Biomed_Res_Int_2015_Jun_4_2015_719316.txt
EC 3.2.1.91,"...-1,4-β-glucanase (also called cellobiohydrolase) (EC 3.2.1.91), and β-glucosidase (EC 3.2.1.21) [2–5...",10,975,Biomed_Res_Int_2015_Jul_26_2015_304523.txt
1.8.1.72,... Surgical Oncology  2001 8 1 72 79 10.1245/aso.2001.8.1.72 2-s2.0-0035155064 11206229,256,243,Biomed_Res_Int_2015_Oct_11_2015_397264.txt
4.15.7.331,... Prevention  2014 15 7 3311 3317 10.7314/apjcp.2014.15.7.3311 2-s2.0-84900855006 24815488,164,299,Biomed_Res_Int_2015_Nov_3_2015_623121.txt
2.51.3.182,...rgical Society  2012 51 3 182 186 10.3340/jkns.2012.51.3.182 2-s2.0-84862224364 22639720,250,202,Biomed_Res_Int_2015_Nov_24_2015_417801.txt
5.21.1.49,...ecular Hepatology  2015 21 1 49 59 10.3350/cmh.2015.21.1.49 25834802,832,249,Biomed_Res_Int_2015_Dec_16_2015_840542.txt
1.11.1.11,APX (EC1.11.1.11) activity was determined by monitoring t...,43,8,Biomed_Res_Int_2016_Mar_7_2016_9851095.txt
2.42.3.147,...ce in Dentistry  2012 42 3 147 154 10.5624/isd.2012.42.3.147 2-s2.0-84869056369 23071964,144,251,Biomed_Res_Int_2016_Mar_29_2016_4864195.txt
5.66.1.23,...of Periodontology  1995 66 1 23 29 10.1902/jop.1995.66.1.23 2-s2.0-0029201547 7891246,249,193,Biomed_Res_Int_2016_Apr_18_2016_8389020.txt
5.35.5.523,...ratory Medicine  2015 35 5 523 530 10.3343/alm.2015.35.5.523 2-s2.0-84942255217 26206690,259,299,Biomed_Res_Int_2016_May_30_2016_6950482.txt
2.13.4.113,... Prevention  2012 13 4 1137 1144 10.7314/APJCP.2012.13.4.1137 2-s2.0-84873023773 22799295,219,195,Biomed_Res_Int_2016_Oct_24_2016_2765464.txt
2.52.4.359,...rgical Society  2012 52 4 359 364 10.3340/jkns.2012.52.4.359 2-s2.0-84868643289 23133725,79,333,PMC5259603.txt
6.23.3.121,...is J. Bone Metab. 2016 23 121 127 10.11005/jbm.2016.23.3.121 27622175,271,173,PMC5197954.txt
3.2.2.1,3.2.2.1. Polyaromatic,137,1,Biomolecules_2013_Oct_17_3(4)_812-847.txt
5.1.2.5,5.1.2.5.1. Protein Disulfide Isomerase (PDI,393,1,Biomolecules_2015_Sep_30_5(4)_2247-2337.txt
EC 2.1.1.6,"Catechol O-methyltransferase (COMT, EC 2.1.1.6) is a ubiquitous bisubstrate magnesium-...",10,37,PMC5343089.txt
2.20.3.280,...cology 24130924ooomb4-20-28010.4062/biomolther.2012.20.3.280ArticlesSuppression of HIF-1α by Valproi...,3,173,Biomol_Ther_(Seoul)_2012_May_20(3)_280-285.txt
1.16.8.145,...sts J Bone Miner Res 16 1453 1464 10.1359/jbmr.2001.16.8.1453 1149986,158,260,Biomol_Ther_(Seoul)_2015_Sep_1_23(5)_391-399.txt
3.29.3.178,...and ulcers Lab Anim Res 29 178 181 10.5625/lar.2013.29.3.178 24106514,216,210,Biomol_Ther_(Seoul)_2015_Sep_1_23(5)_449-457.txt
3.2.2.4,3.2.2.4 Synthesis of 3-azido-N-phenylpropanamide (...,94,1,Bioorg_Med_Chem_2012_Feb_15_20(4)_1607-1615.txt
4.1.6.5,4.1.6.5 3-(4-Bromo-phenyl)-1-(4-methoxy-benzyl)-4-...,182,1,Bioorg_Med_Chem_2010_Sep_15_18(18)_6934-6952.txt
4.1.6.8,4.1.6.8 3-(4-Bromo-phenyl)-4-chloro-1H-pyrazole (3...,191,1,Bioorg_Med_Chem_2010_Sep_15_18(18)_6934-6952.txt
4.1.8.17,4.1.8.17 [4-(2-Dimethylamino-ethyl)-piperazin-1-yl...,285,1,Bioorg_Med_Chem_2010_Sep_15_18(18)_6934-6952.txt
4.54.6.106,...and Soc Psychol 1988 54 1063 1070 10.1037/0022-3514.54.6.1063,225,184,Biopsychosoc_Med_2010_Aug_12_4_8.txt
4.51.6.117,...ers Soc Psychol 1986 51 1173 1182 10.1037/0022-3514.51.6.1173 3806354,135,204,Biopsychosoc_Med_2010_Sep_3_4_10.txt
EC 3.2.1.91,"...ntaining at least the two main cellobiohydrolases EC 3.2.1.91 (Cel6A and Cel7A), five different endo...",162,287,Biotechnol_Biofuels_2011_May_13_4_11.txt
EC 1.1.1.44,"...C 1.2.1.12; GND, 6-phosphogluconate dehydrogenase EC 1.1.1.44; GPD, NAD-dependent glycerol 3-phospha...",151,2626,Biotechnol_Biofuels_2012_May_15_5_34.txt
EC 5.3.1.9,"... mutase EC 5.4.2.1; PGI, Phosphoglucose isomerase EC 5.3.1.9; PGK, 3-phosphoglycerate kinase EC 2.7....",151,3182,Biotechnol_Biofuels_2012_May_15_5_34.txt
1.1.1.49,"Glucose-6-phosphate dehydrogenase (G6PD, EC: 1.1.1.49)	−1.41",118,46,Biotechnol_Biofuels_2012_Sep_24_5_74.txt
4.1.2.13,"Fructose-bisphosphate aldolase (fbaB, EC: 4.1.2.13)	0.17",128,43,Biotechnol_Biofuels_2012_Sep_24_5_74.txt
1.5.1.29,"...FK (EC: 2.7.1.26), RBFSb (EC: 2.5.1.9) and FMNRx (1.5.1.29). Half of the flux of RBFSb was responsib...",218,169,Biotechnol_Biofuels_2014_Aug_27_7_118.txt
3.1.1.3,...[105]. Lipases (triacylglycerol acylhydrolase; EC.3.1.1.3) hydrolyse lipids or triacylglycerols to d...,162,4074,PMC5210281.txt
4.37.4.422,...iochem Mol Biol 2004 37 422 428 10.5483/BMBRep.2004.37.4.422 15469729,390,246,Biotechnol_Biofuels_2016_Oct_18_9_216.txt
5.50.2.118,...ociety on Thrombosis and Hemostasis 10.5045/br.2015.50.2.118Letter to the EditorNew approaches for c...,3,242,Blood_Res_2015_Jun_25_50(2)_118-121.txt
6.51.1.3,...ociety on Thrombosis and Hemostasis 10.5045/br.2016.51.1.3PerspectivePlatelet-rich plasma: a healing...,3,242,Blood_Res_2016_Mar_25_51(1)_3-5.txt
6.51.1.8,...ociety on Thrombosis and Hemostasis 10.5045/br.2016.51.1.8Review ArticleRecent advances in haploiden...,3,242,Blood_Res_2016_Mar_25_51(1)_8-16.txt
1.44.6.399,...ls. BMB Rep.  (2011) 44 399 404 10.5483/BMBRep.2011.44.6.399 21699753,97,236,BMB_Rep_2014_Sep_47(9)_524-529.txt
3.46.4.160,...ls. BMB Rep.  (2013) 46 201 206 10.5483/BMBRep.2013.46.4.160 23615261,89,314,BMB_Rep_2014_May_47(5)_262-267.txt
5.48.7.121,Biology 26129673BMB-48-37110.5483/BMBRep.2015.48.7.121PerspectiveModulation of autophagy by mi...,4,45,BMB_Rep_2015_Jul_31_48(7)_371-372.txt
2.45.2.85,...athway. BMB Rep (2012) 45 85 90 10.5483/BMBRep.2012.45.2.85 22360885,91,192,BMB_Rep_2015_Jun_30_48(6)_324-329.txt
5.48.9.176,...hagy. BMB Rep (2015) 48 487 488 10.5483/BMBRep.2015.48.9.176 26303972,174,158,BMB_Rep_2016_Feb_29_49(2)_73-80.txt
2.62.4.350,...ean J Anesthesiol 2012 62 350 357 10.4097/kjae.2012.62.4.350 22558502,198,168,BMC_Anesthesiol_2013_Oct_4_13_29.txt
2.6.5.555,...er Targets 2002 6 555 561 12387679 10.1517/14728222.6.5.55,149,179,BMC_Biochem_2005_Dec_16_6_29.txt
EC 2.1.2.3,"...cleotidase (EC 3.1.3.5), 2) AICAR transformylase (EC 2.1.2.3), 3) adenylsuccinate synthetase (EC 6.3...",27,198,BMC_Biochem_2007_Nov_29_8_25.txt
EC 3.3.2.6,"...ogenetic relationship with LTA4 hydrolase (LTA4H; EC 3.3.2.6; [18]), which hydrolyzes LTA4 into LTB4...",19,573,BMC_Biochem_2007_Oct_31_8_21.txt
EC 1.5.1.12,"... catalyzed by EC 1.1.1.1 (alcohol dehydrogenase), EC 1.5.1.12 (1-pyrroline-5-carboxylate dekydrogena...",123,119,BMC_Bioinformatics_2004_Feb_18_5_15.txt
4.2.1.58,"...ase/ β-hydroxy-acyl ACP dehydratase (FabZ)	P94584	4.2.1.58	Lpx C in Q8KBX0	Fatty acid biosynthesis, ...",186,152,BMC_Bioinformatics_2004_Aug_12_5_109.txt
4.6.1.3,4.6.1.3	aroB	4.6.1.3	4.2.3.4	4.2.3.4	N.A.	inconsistency of EC (...,201,14,BMC_Bioinformatics_2006_Mar_23_7_168.txt
5.3.1.10,...5.99.6	left3.5.99.6	3.5.99.6	inconsistency of EC (5.3.1.10 is changed to3.5.99.6),204,76,BMC_Bioinformatics_2006_Mar_23_7_168.txt
2.5.1.18,URE2 protein.	2.5.1.18	523.71,221,40,BMC_Bioinformatics_2006_Jun_15_7_304.txt
1.1.1.101,1.1.1.101	difficult	2.1.1.143	artifact	3.2.1.56	di...,148,1,BMC_Bioinformatics_2007_Jul_10_8_244.txt
2.3.1.49,1.1.1.258	artifact	2.3.1.49	difficult	3.4.11.16	good,157,20,BMC_Bioinformatics_2007_Jul_10_8_244.txt
2.3.1.49,1.1.1.258	artifact	2.3.1.49	difficult	3.4.11.16	good,157,20,BMC_Bioinformatics_2007_Jul_10_8_244.txt
4.2.1.5,1.8.1.5	artifact	2.6.1.32	difficult	4.2.1.5	difficult,193,37,BMC_Bioinformatics_2007_Jul_10_8_244.txt
1.13.11.14,1.13.11.14	difficult	2.7.1.54	difficult	4.2.1.81	d...,197,1,BMC_Bioinformatics_2007_Jul_10_8_244.txt
1.14.13.23,1.14.13.23	good	2.7.7.44	difficult	4.3.1.20	diffic...,205,1,BMC_Bioinformatics_2007_Jul_10_8_244.txt
4.1.1.39,"... Ribulose 1,5-bisphosphate carboxylase/oxygenase (4.1.1.39). The latter enzyme, also called Rubisco,...",101,733,BMC_Bioinformatics_2003_Nov_7_4_56.txt
EC 4.1.1.39,"...to examine the loci at individual EC. All loci of EC 4.1.1.39 are significant. On the other hand, on...",120,483,BMC_Bioinformatics_2003_Nov_7_4_56.txt
5.1.2.4,b.1.1.5.24	20	c.45.1.2.4	11	c.3.1.5.14	3.770	c.69.1.1.4	1.8074	c.2....,430,18,BMC_Bioinformatics_2005_Nov_29_6_282.txt
3.1.1.10,c.93.1.1.10	22	c.29.1.1.2	14	g.18.1.1.12	3.700	a.144....,435,4,BMC_Bioinformatics_2005_Nov_29_6_282.txt
EC 1.6.5.3,RP268	NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 2 (EC 1.6.5.3).	Heme exporter protein B related clust...,124,47,BMC_Bioinformatics_2005_Jun_16_6_151.txt
3.40.50.970,"1POX	D447, N474, Q476	3.40.50.970+ 3.40.50.1220	Oxidoreductasei	1.2.3.3",88,24,BMC_Bioinformatics_2007_Mar_28_8_106.txt
5.1.3.487,...Toxicology 2005 1 487 503 16863457 10.1517/17425255.1.3.487,194,194,BMC_Bioinformatics_2008_Jun_2_9_258.txt
EC 2.7.1.11,Figure 7 Case II: isozymes. EC 2.7.1.11 and six gamma-proteobacteria species w...,123,29,BMC_Bioinformatics_2008_Mar_6_9_145.txt
3.5.4.19,"3.5.4.19	100%	100%	97%	0,98	99%	100%	91%	0.95",79,1,BMC_Bioinformatics_2009_Jul_24_10_231.txt
5.3.1.24,5.3.1.24	100%	96%	100%	0.98,155,1,BMC_Bioinformatics_2009_Jul_24_10_231.txt
3.5.2.6,"3.5.2.6	1YLJ (A)	70S, 73K, 130S, 132N	254",48,1,BMC_Bioinformatics_2010_May_11_11_242.txt
2.6.1.1,2.6.1.1	66.7% (70)	99.1% (153)	82.9 ± 5.4% (87)	99...,122,1,BMC_Bioinformatics_2010_May_11_11_242.txt
EC 1.2.1.59,...closer to the EC 1.2.1.12 cloud than to the other EC 1.2.1.59 proteins in the CI space and thus are ...,103,654,BMC_Bioinformatics_2005_Dec_14_6_302.txt
2.28.1.3,25	2.28.1.3	56	3875	6	415	52	2.5.1.3	14	2525	10	1803,210,4,BMC_Bioinformatics_2010_Jan_18_11(Suppl_1)_S16.txt
EC 3.1.2.22,"P50897	Palmitoyl-protein thioesterase 1 (PPT-1) (EC 3.1.2.22) (Palmitoyl-protein hydrolase 1), Homo...",97,50,BMC_Bioinformatics_2014_Sep_17_15(1)_305.txt
1.1.-.-,"...composed to EC = 1, EC = 1.1, EC = 1.1.- and EC = 1.1.-.-) are extracted and compared with each othe...",82,821,BMC_Bioinformatics_2015_Mar_21_16_96.txt
1.3.5.14,...ok of Statistical Methods. Retrieved January 2012:1.3.5.14–16. 7.2.1. http://www.itl.nist.gov/div898...,373,100,BMC_Bioinformatics_2015_Jul_22_16_225.txt
4.2.1.9,BU600	EG10496	4.2.1.9	dihydroxyacid dehydratase (DHAD),58,16,BMC_Biol_2014_Dec_20_12_110.txt
3.28.6.109,...n Limnol Oceanogr 1983 28 1094 1103 10.4319/lo.1983.28.6.1094,307,127,BMC_Biol_2014_Aug_14_12_65.txt
EC 3.2.1.31,...3); β-mannosidase (EC 3.2.1.25); β-glucuronidase (EC 3.2.1.31); β-fucosidase (EC 3.2.1.38); 6-phosph...,35,387,BMC_Biotechnol_2013_Mar_15_13_22.txt
EC 4.2.2.2,"...ong the pectin depolymerases, pectate lyase (Pel, EC 4.2.2.2) has attracted a great deal of interest...",19,58,BMC_Biotechnol_2014_Mar_10_14_18.txt
1.1.1.288,...1.14.13.90; ZEP) and xanthoxin dehydrogenase (EC: 1.1.1.288; ABA2) also increased 2.80- and 1.95-fol...,59,794,BMC_Biotechnol_2015_Sep_15_15_81.txt
2.4.1.21,"...y, the activity of soluble starch synthetase (EC: 2.4.1.21; SSS), which promotes amylopectin biosynt...",66,760,BMC_Biotechnol_2015_Sep_15_15_81.txt
3.2.3.253,...markers in Medicine 2008 2 253 289 10.2217/17520363.2.3.253 20477414,281,185,BMC_Cancer_2010_Aug_6_10_410.txt
6.9.12.186,...armacogenomics 2008 9 12 1861 1868 10.2217/14622416.9.12.1861 19072644,189,121,BMC_Cancer_2014_Nov_17_14_830.txt
4.17.2.113,...cer J Breast Cancer 2014 17 113 20 10.4048/jbc.2014.17.2.113 25013431,401,260,BMC_Cancer_2015_Oct_8_15_664.txt
2.13.5.179,... J Cancer Prev 2012 13 1793 1797 10.7314/APJCP.2012.13.5.1793 22901124,359,212,BMC_Cancer_2016_Mar_16_16_225.txt
4.46.2.109,... Cancer Res Treat 2014 46 2 109 23 10.4143/crt.2014.46.2.109 24851102,220,186,BMC_Cancer_2016_Jul_21_16_515.txt
3.22.5.443,...s Health Psychol 2003 22 5 443 52 10.1037/0278-6133.22.5.443 14570527,373,215,BMC_Cancer_2016_Aug_16_16_637.txt
3.23.3.227,...ms Health Psychol 2004 23 227 238 10.1037/0278-6133.23.3.227 15099162,354,230,BMC_Cardiovasc_Disord_2014_Nov_29_14_171.txt
3.5.2.3,"...Reviews of Interventions, version 5.1.0. Section 13.5.2.3. Tools for Assessing Methodological Qualit...",342,111,BMC_Cardiovasc_Disord_2014_Sep_26_14_129.txt
1.32.3.189,... Korean J Fam Med 2011 32 189 196 10.4082/kjfm.2011.32.3.189 22745854,290,283,BMC_Cardiovasc_Disord_2016_Nov_14_16_220.txt
1.72.5.590,...ue J Periodontol 2001 72 5 590 597 10.1902/jop.2001.72.5.590 11394393,137,145,BMC_Complement_Altern_Med_2013_Apr_30_13_92.txt
4.26.3.295,...ang Constit Med 2014 26 3 295 303 10.7730/JSCM.2014.26.3.295,198,190,BMC_Complement_Altern_Med_2015_Jul_14_15_231.txt
3.17.5.427,... Physiol Pharma 2013 17 5 427 433 10.4196/kjpp.2013.17.5.427,96,196,BMC_Complement_Altern_Med_2015_Jul_14_15_226.txt
3.1.9.2,...ions were performed using G*Power™ software (ver. 3.1.9.2) for Mac,146,741,BMC_Complement_Altern_Med_2016_Feb_2_16_46.txt
5.16.8.338,...Pac J Cancer Prev 2015 16 3383 7 10.7314/APJCP.2015.16.8.3383 25921149,258,268,BMC_Complement_Altern_Med_2016_May_10_16_126.txt
4.20.3.129,... Biomed Sci Lett 2014 20 3 129 38 10.15616/BSL.2014.20.3.129,170,246,BMC_Complement_Altern_Med_2016_Jul_28_16_252.txt
1.1.2.53,...a Pac Allergy 2011 1 2 53 63 10.5415/apallergy.2011.1.2.53 22053298,139,156,PMC5297152.txt
EC 3.1.3.1,"...4.2.1.3), AK (EC 2.7.4.3), ADH (EC 1.1.1.1), ALP (EC 3.1.3.1), ATT (EC 2.6.1.1), EST (EC 3.1.1.1), H...",187,682,BMC_Ecol_2005_Jun_29_5_5.txt
2.47.6.172,...s Limnol Oceanogr 2002 10 1723 1733 10.4319/lo.2002.47.6.1723,263,149,BMC_Ecol_2010_Jul_12_10_17.txt
5.6.2.12,...anag Biol Invasions 2015 6 215 225 10.3391/mbi.2015.6.2.12,206,326,BMC_Ecol_2016_Jul_22_16(Suppl_1)_16.txt
2.1.44.137,...nuria J Hist Neurosci 2003 12 44 54 10.1076/jhin.12.1.44.13788 12785112,80,108,BMC_Endocr_Disord_2014_Apr_28_14_38.txt
EC 6.3.5.3,"...namidine synthases (FGAM synthases; Pfam PF02700, EC 6.3.5.3). There are at least 50 enzymes with si...",43,836,BMC_Evol_Biol_2004_Feb_19_4_6.txt
EC 3.2.1.153,"...ase (EC 2.4.1.99, EC 2.4.1.100) and fructosidase (EC 3.2.1.153, EC 3.2.1.154) activities [6]. GH32 e...",19,487,BMC_Evol_Biol_2009_Jun_30_9_148.txt
2.9.3.2,"...sts. These analyses were performed using FSTAT v. 2.9.3.2. [48]. In addition, estimates of allele ri...",166,285,BMC_Evol_Biol_2009_Nov_6_9_262.txt
EC 2.3.1.87,...rhythm enzyme arylalkylamine N-acetyltransferase (EC 2.3.1.87) J Biol Chem 2001 276 47239 47247 10.1...,308,177,BMC_Evol_Biol_2010_May_25_10_154.txt
1.3.4.7,"...nce phenotypes (i.e. 1.3.4.7.8.11, 1.3.4.7.11 and 1.3.4.7) to dominate in P. infestans populations c...",89,921,BMC_Evol_Biol_2010_Sep_16_10_283.txt
4.1.1.2,Network 4.1.1.2 Fluxus Technology Ltd 2004 http://www.flux...,269,9,BMC_Evol_Biol_2011_Sep_22_11_264.txt
EC 3.2.1.4,"...mbers that display endo-β-1,4-glucanase activity (EC 3.2.1.4). These endo-glucanases are distributed...",260,223,BMC_Evol_Biol_2012_Sep_20_12_186.txt
1.3.2.1,"...nean anisotopic Trechini from the Alps (our clade 1.3.2.1), stressing the need to include more Dinar...",79,622,BMC_Evol_Biol_2013_Nov_13_13_248.txt
1.2.1.11,...; X: lysine. Enzymes – 2.7.2.4: aspartate kinase; 1.2.1.11: aspartate-semialdehyde dehydrogenase; 4....,36,498,BMC_Evol_Biol_2013_Sep_9_13_190.txt
2.5.1.47,.... Enzymes – 2.3.1.30: serine O-acetyltransferase; 2.5.1.47: cysteine synthase; 4.4.1.1: cystathionin...,45,477,BMC_Evol_Biol_2013_Sep_9_13_190.txt
2.2.1.6,"...lactate, is mediated by acetolactate synthase (EC:2.2.1.6), whose gene is present exclusively in the...",69,357,BMC_Evol_Biol_2013_Sep_9_13_190.txt
4.2.3.5,...19: 3-phosphoshikimate 1-carboxyvinyltransferase; 4.2.3.5: chorismate synthase; 4.1.3.27: anthranila...,80,1012,BMC_Evol_Biol_2013_Sep_9_13_190.txt
2.6.1.57,...ctional prephenate dehydratase/chorismate mutase; 2.6.1.57: aromatic amino acid aminotransferase; 1....,80,1360,BMC_Evol_Biol_2013_Sep_9_13_190.txt
4.2.1.51,"...rase (EC:2.6.1.57) and prephenate dehydratase (EC:4.2.1.51), whose genes are absent in symbiont-harb...",82,1084,BMC_Evol_Biol_2013_Sep_9_13_190.txt
2.1.1.14,"...ept for Herpetomonas, which lacks the latter). EC:2.1.1.14 appears to be of bacterial origin, groupi...",135,255,BMC_Evol_Biol_2013_Sep_9_13_190.txt
3.5.1.3,"...(AMOVA; [90]). The AMOVA, implemented in Arlequin 3.5.1.3 [91], evaluated a priori hierarchical grou...",205,664,BMC_Evol_Biol_2016_Jan_4_16_2.txt
EC 1.14.11.19,"...FR, EC 1.1.1.219), leucocyanidin oxygenase (LDOX, EC 1.14.11.19, synonym: anthocyanidin synthase, AN...",20,682,BMC_Evol_Biol_2016_Sep_17_16_191.txt
EC 3.1.3.16,...:BSU00640 spoIIE; stage II sporulation protein E (EC 3.1.3.16,300,54,PMC5270213.txt
EC 2.7.4.6,bsu:BSU22730 ndk; nucleoside diphosphate kinase (EC 2.7.4.6,580,50,PMC5270213.txt
1.40.1.106,...s Contemp Nurse 2011 40 1 106 117 10.5172/conu.2011.40.1.106 22545909,224,211,BMC_Fam_Pract_2013_Jan_3_14_2.txt
3.21.3.219,...ts Health Psychol 2002 21 319 228 10.1037/0278-6133.21.3.219,140,238,BMC_Gastroenterol_2007_Jun_8_7_20.txt
3.10.4.259,...ing Health Psychol 1991 10 259 67 10.1037/0278-6133.10.4.259 1915212,209,163,BMC_Gastroenterol_2016_Aug_2_16_87.txt
3.7.5.546,...a-analysis Gut Liver 2013 7 546 51 10.5009/gnl.2013.7.5.546 24073312,255,217,PMC5251227.txt
4.86.1.130,... Psychol 2004 86 130 147 14717632 10.1037/0022-3514.86.1.130,619,220,BMC_Genet_2007_Jul_2_8_43.txt
4.94.5.520,...Phytopathology 2004 94 5 520 526 10.1094/PHYTO.2004.94.5.520 18943772,181,215,BMC_Genet_2012_Mar_12_13_14.txt
6.2.1.1,Archaea	afu	AF1938	11790732	6.2.1.1	6.2.1.-	3,250,29,BMC_Genomics_2006_Dec_13_7_315.txt
6.7.4.641,...cogenomics 2006 7 641 648 16768648 10.2217/14622416.7.4.641,285,186,BMC_Genomics_2008_Jan_18_9_21.txt
EC 3.2.1.1,"...ullulanase, EC 3.2.1.135) and SusG (an α-amylase, EC 3.2.1.1) are members of family GH13 [29-32]. Su...",23,547,BMC_Genomics_2005_Aug_30_6_112.txt
EC 2.5.1.32,...ase (EC 2.2.1.21). No ESTs for phytoene synthase (EC 2.5.1.32) were identified,178,1209,BMC_Genomics_2008_Jul_27_9_351.txt
1.11.1.7,...) were predominant in pods. Peroxidase enzyme (EC:1.11.1.7) found abundant in pods have multiple rol...,59,655,BMC_Genomics_2009_Jun_12_10_265.txt
1.14.1.63,...nt Microbe Interact 2001 14 63 71 10.1094/MPMI.2001.14.1.63 11194873,310,219,BMC_Genomics_2009_Nov_16_10_525.txt
5.5.1.4,"...zed by myo-inositol-1-phosphate synthase (MIPS, EC5.5.1.4), which is the first and rate-limiting ste...",107,852,BMC_Genomics_2009_Jun_2_10_256.txt
EC 4.2.1.17,...H95) Enoyl-CoA hydratase mitochondrial precursor (EC 4.2.1.17),58,108,BMC_Genomics_2010_Jul_5_11_418.txt
1.4.1.3,1.4.1.3	glutamate dehydrogenase	GDH2	AT5G07440		1....,158,1,BMC_Genomics_2010_Mar_22_11_190.txt
3.5.1.4,...ways using a specific EC number. a: The EC number 3.5.1.4 was searched against all 20 genomes availa...,162,74,BMC_Genomics_2010_Feb_1_11_81.txt
6.2.1.12,"...cinnamate 4-monooxygenase] (10), Light-yellow; EC:6.2.1.12 [4-coumarate---CoA ligase] (15)",503,715,BMC_Genomics_2010_Nov_23_11_650.txt
1.8.1.9,R576	OTHIOxt + NADPH = RTHIO + NAD	1.8.1.9	SCO6834,111,36,BMC_Genomics_2010_Dec_1_11_682.txt
EC 2.7.1.71,5	Shikimate-3-phosphate	Shikimate kinase II EC 2.7.1.71 (aroL)	monofunctional shikimate kinase...,35,45,BMC_Genomics_2010_Nov_11_11_628.txt
EC 1.3.5.1,...star-E17-F12	2.2	3.3	1.8	succinate dehydrogenase (EC 1.3.5.1)	EAZ38613.1,170,54,BMC_Genomics_2011_Jan_18_12_41.txt
3.1.16.14,3.1.16.14	7.7	AAL24147.1	cardiolipin synthase/phos...,80,1,BMC_Genomics_2011_May_24_12_264.txt
2.5.1.1,"...EC:5.3.3.2; GPS: geranyl diphosphate synthase, EC:2.5.1.1; FPS: farnesyl diphosphate synthase/farnes...",17,1008,BMC_Genomics_2011_Jul_5_12_343.txt
EC 3.4.11.5,...y the enzymatic action of proline iminopeptidase (EC 3.4.11.5) encoded by the pepI gene. The enzymat...,113,686,BMC_Genomics_2011_Nov_3_12_545.txt
1.3.3.9,1.3.3.9	secologanin synthase	17	165	0,71,1,BMC_Genomics_2011_Oct_30_12_533.txt
6.1.1.9,...strains of the same species. The results from ECs 6.1.1.9 and 6.1.1.3 seemingly agree with the speci...,266,1169,BMC_Genomics_2012_Feb_10_13_65.txt
1.1.1.2,psbB	1.1.1.2	psbB	0.6	+/- 0.2	25	68.6	+/- 20.3,79,6,BMC_Genomics_2012_May_31_13_215.txt
3.2.1.21,JU497338	3.2.1.21	Beta-glucosidase	0.94±0.08	0.47±0.04	0.18...,158,10,BMC_Genomics_2012_Aug_16_13_397.txt
2.7.1.25,[53]. An adenylylsulfate kinase (EC:2.7.1.25) was only found in M. phosphovorus. The c...,303,37,BMC_Genomics_2012_Oct_19_13_562.txt
3.2.1.25,3.2.1.25	β-mannosidase	GH2	 	 	 	 	An01g06630	1725...,45,1,BMC_Genomics_2012_Jul_16_13_313.txt
3.2.1.22,3.2.1.22	α-galactosidase	GH27	 	 	 	 	An01g01320	1...,48,1,BMC_Genomics_2012_Jul_16_13_313.txt
3.2.1.21,3.2.1.21	β-glucosidase	GH3	 	 	 	 	An15g04800	1818...,51,1,BMC_Genomics_2012_Jul_16_13_313.txt
3.93.5.564,...n Phytopathology 2003 93 564 572 10.1094/PHYTO.2003.93.5.564 18942978,199,192,BMC_Genomics_2013_Mar_12_14_168.txt
2.12.8.995,...in Ther Targets 2008 12 8 995 1007 10.1517/14728222.12.8.995 18620521,298,141,BMC_Genomics_2014_May_8_15(1)_345.txt
2.7.1.100,2.7.1.100	OL002217	B9RY82	64	24	1.36E-05	S-methyl-...,362,2,BMC_Genomics_2013_Dec_9_14(1)_866.txt
2.7.8.24,"...s encoding phosphatidylcholine synthase (Pcs, EC: 2.7.8.24), which catalyzes the formation of phosph...",104,1168,BMC_Genomics_2014_May_13_15(1)_363.txt
EC 2.3.1.51,...-acylglycerol-3-phosphate acyltransferase (LPAAT; EC 2.3.1.51). A number of LPAAT genes are highly e...,254,89,BMC_Genomics_2014_Apr_8_15_271.txt
EC 2.4.1.21,"....7.7.27: glucose-1-phosphate adenylyltransferase, EC 2.4.1.21: starch synthase, EC 2.4.1.18: 1,4-alp...",75,1210,BMC_Genomics_2014_Jun_30_15(1)_540.txt
EC 3.2.1.37,"...[25], GH 43 s are homologous to beta-xylosidases (EC 3.2.1.37) [26], while the GH 92 s are alpha-1,2...",474,1204,BMC_Genomics_2014_Feb_27_15_164.txt
EC 3.1.3.37,EC 3.1.3.37	Sedoheptulose-bisphosphatase (SBPase)	...,78,1,BMC_Genomics_2013_Feb_16_14_107.txt
EC 4.1.1.31,EC 4.1.1.31	Phosphoenolpyruvate carboxylase (PEPC)...,86,1,BMC_Genomics_2013_Feb_16_14_107.txt
1.3.3.36,"TGME49_047500	acyl-coenzyme A oxidase, putative	1.3.3.36	fatty acid β-oxidation	92	37	49	6.76E-12",58,49,BMC_Genomics_2013_Mar_15_14_183.txt
4.4.1.1,"TGME49_112930	cystathionine beta-lyase, putative	4.4.1.1	amino acid metabolism	23	2	3	2.90E-10",82,50,BMC_Genomics_2013_Mar_15_14_183.txt
4.2.1.-,"hpaH	2-oxo-hept-3-ene-1,7-dioate hydratase [EC:4.2.1.-]	5406	3376	0812	-",120,48,BMC_Genomics_2013_Apr_22_14_271.txt
6.7.6.813,...ty Pharmacogenomics 2006 7 813 818 10.2217/14622416.7.6.813 16981842,439,190,BMC_Genomics_2013_May_28_14_355.txt
2.5.1.1,Pq25790	FPS/DMAPP	2.5.1.1.1/10	K00787	Farnesyl diphosphate synthase/...,122,19,BMC_Genomics_2013_Aug_19_14_564.txt
3.6.3.35,AGOS_AEL301W	3.6.3.35	Manganese-transporting ATPase	No,164,14,BMC_Genomics_2014_Sep_24_15(1)_810.txt
2.7.4.22,AGOS_AFR369W	2.7.4.22	UMP kinase	No,173,14,BMC_Genomics_2014_Sep_24_15(1)_810.txt
3.5.99.6,"...he presence of glucosamine-6-phosphate deaminase (3.5.99.6), which enables the utilization of chitin...",277,403,BMC_Genomics_2014_Sep_24_15(1)_810.txt
4.1.2.5,"...ce it is less specific than L-threonine aldolase (4.1.2.5), the presence of this enzyme in A. gossyp...",306,555,BMC_Genomics_2014_Sep_24_15(1)_810.txt
3.2.1.50,"...linked oligosaccharides	α-N-acetylglucosaminidase	3.2.1.50	2	43, 139",117,53,BMC_Genomics_2014_Sep_11_15(1)_785.txt
2.3.1.144,...tion – anthocyanin 5-aromatic (anthocyanin5a) (EC:2.3.1.144) and UDP-glycosyltransferase 85a2-like (...,105,92,BMC_Genomics_2014_Nov_5_15(1)_957.txt
EC 1.1.1.-,"...he categories “HA: Small molecule binding” (e.g., EC 1.1.1.-/EC 1.3.1.-, binding to NAD or NADP; EC ...",130,1009,BMC_Genomics_2014_Sep_29_15(1)_822.txt
2.4.1.83,"...and dolichol-phosphate-mannose synthase (DPMS; EC:2.4.1.83) are prominent among the genes lost, due ...",267,351,BMC_Genomics_2014_Aug_20_15(1)_696.txt
3.5.1.3,...n all possible population pairs using Arlequin (v.3.5.1.3) [131] and microsa,480,730,BMC_Genomics_2014_Nov_18_15(1)_990.txt
1.14.11.22,"... synthase 1 (FS1; EC: 1.14.11.22) and 2 (FS2; EC: 1.14.11.22). Secondly, flavanones may also be furt...",406,215,BMC_Genomics_2014_Nov_18_15(1)_984.txt
EC 4.3.2.1,"... HGT1 is annotated as an argininosuccinate lyase (EC 4.3.2.1), the enzyme that catalyzes the formati...",94,689,BMC_Genomics_2015_Jan_2_16(1)_2.txt
EC 1.1.1.35,...63_08062	CGSP_09354	Hydroxlacyl-CoA dehydrogenase	EC 1.1.1.35,115,56,BMC_Genomics_2015_Jan_2_16(1)_2.txt
4.3.3.2,Strictosidine synthase	4.3.3.2	140.37	35.36	121.67,238,24,BMC_Genomics_2015_Apr_3_16(1)_265.txt
EC 1.1.1.37,"...treated samples. Enzymes are given as EC numbers. EC 1.1.1.37, malate dehydrogenase; EC:1.1.1.41, is...",220,1357,BMC_Genomics_2015_Apr_21_16(1)_329.txt
1.1.1.211,"... E. cautella. In particular, EP_unigene_3_ACD [EC:1.1.1.211] and EP_unigene_2_ACD are the most abund...",487,738,BMC_Genomics_2015_Jul_18_16(1)_532.txt
2.2.1.2,13161_M	EC:2.2.1.2	Transaldolase,280,12,BMC_Genomics_2015_Jul_22_16(1)_544.txt
6.1.3.1,...pMan sub-bins 11.6 (lipid transfer proteins) and 16.1.3.1 (hydroxyphenylpyruvate dioxygenases) was u...,141,864,BMC_Genomics_2015_Aug_16_16(1)_612.txt
EC 4.3.2.1,99	0	Fungus	EC 4.3.2.1,269,14,BMC_Genomics_2015_Aug_22_16(1)_628.txt
3.1.1.17,"...entified or not different (EC:3.1.1.17, 1.1.1.49, 3.1.1.17, .1.1.1,44, 5.1.3.1; Additional file 4: T...",275,364,BMC_Genomics_2015_Oct_23_16_839.txt
1.85.3.236,...nges Plant Disease 2001 85 236 45 10.1094/PDIS.2001.85.3.236,254,138,BMC_Genomics_2015_Dec_14_16_1058.txt
5.4.2.2,"...hoglycerate-dependent phosphoglycerate mutase; EC:5.4.2.2, phosphoglucomutase; EC:6.2.1.1, acetyl-Co...",182,2546,BMC_Genomics_2016_Mar_15_17_234.txt
EC 2.4.1.241,...or the production of glycolipids (EC 2.4.1.46 and EC 2.4.1.241) were added to models for M. hyopneum...,225,973,BMC_Genomics_2016_May_13_17_353.txt
EC 2.7.1.36,...oxal-phosphate by the action of pyridoxal kinase (EC 2.7.1.36 missing in all species). From the pant...,234,321,BMC_Genomics_2016_May_13_17_353.txt
3.3.2.1,...e/Isochorismatase/Isochorismate synthase	2.7.7.58/3.3.2.1/5.4.4.2	fig|306537.3.peg.2089	Isochorismat...,231,94,BMC_Genomics_2016_Jun_24_17_473.txt
1.1.1.37,"...e synthase; 1.3.5.1, succinate dehydrogenase; and 1.1.1.37, malate dehydrogenase",95,1489,BMC_Genomics_2016_Aug_9_17_585.txt
EC 1.11.1.1,"...tase (GR; EC 1.6.4.2), Ascorbate peroxidase (APX; EC 1.11.1.1) and Catalase (EC 1.11.7.6) was prepar...",44,129,BMC_Genomics_2016_Oct_4_17_774.txt
2.7.1.148,...- 2-C-methyl- D-erythritol kinase (CDP-MEK) [E.C. 2.7.1.148] (10 transcripts upregulated in leaf in ...,96,285,PMC5220608.txt
4.18.1.140,...ol Aging 2003 18 140 148 12641318 10.1037/0882-7974.18.1.140,239,228,BMC_Geriatr_2007_Dec_5_7_28.txt
3.20.6.438,... Psychol 2001 20 438 444 11714186 10.1037/0278-6133.20.6.438,238,180,BMC_Geriatr_2008_Jul_25_8_17.txt
6.21.26.302,...urveillance 2016 21 30266 10.2807/1560-7917.ES.2016.21.26.30266,246,252,PMC5303243.txt
1.90.4.54,...4.1.17]	1.27	[0.83.1.92]	1.43*	[1.35.1.51]	2.94*	[1.90.4.54],173,67,BMC_Health_Serv_Res_2013_Jul_12_13_271.txt
4.49.1.95,... Social Psychology 1985 49 95 112 10.1037/0022-3514.49.1.95,487,142,BMC_Health_Serv_Res_2015_Sep_7_15_363.txt
2.24.6.549,... AIDS Educ Prev 2012 24 6 549 563 10.1521/aeap.2012.24.6.549 23206203,252,167,BMC_Health_Serv_Res_2015_Dec_8_15_542.txt
3.8.1.4,... Care International 2010 8 1 4 13 10.1891/1540-4153.8.1.4,161,231,BMC_Health_Serv_Res_2015_Dec_23_15_570.txt
1.18.2.52,...pproach Nurse Res 2011 18 2 52 62 10.7748/nr2011.01.18.2.52.c8284 21319484,545,116,BMC_Health_Serv_Res_2016_Apr_19_16_137.txt
6.15.7.208,...xiety Br J Nurs 2006 15 7 359 61 10.12968/bjon.2006.15.7.20896 16723934,280,112,BMC_Health_Serv_Res_2016_Jul_12_16_250.txt
4.2.2.269,...v Vaccines 2003 2 269 283 12899577 10.1586/14760584.2.2.269,177,137,BMC_Immunol_2008_Jul_22_9_38.txt
2.45.1.32,...levance BMB Rep 2012 45 1 32 37 10.5483/BMBRep.2012.45.1.32 22281010,144,248,BMC_Immunol_2012_Jun_13_13_30.txt
6.6.2.157,...armacother 2005 6 157 164 15757414 10.1517/14656566.6.2.157,263,157,BMC_Infect_Dis_2005_Jul_7_5_56.txt
2.3.2.1,"...clade 2.3.2 virus, and that it evolved into clade 2.3.2.1 to escape the vaccine pressure since 2006....",262,581,BMC_Infect_Dis_2015_Feb_13_15_54.txt
5.22.2.81,... Infectioon Vaccine 2015 22 81 90 10.14776/piv.2015.22.2.81,381,194,BMC_Infect_Dis_2016_Jun_14_16_287.txt
3.28.8.118,...py Korean Med Sci 2013 28 1187 93 10.3346/jkms.2013.28.8.1187,197,211,BMC_Infect_Dis_2016_Aug_8_16_377.txt
3.1.3.235,...routine TBE diagnostics procedure according to SP 3.1.3.2352-08. Procedures on animals were performe...,329,336,BMC_Infect_Dis_2016_Oct_7_16_544.txt
1.26.1.131,... J Korean Med Sci 2011 26 131 134 10.3346/jkms.2011.26.1.131 2121804,524,173,BMC_Infect_Dis_2016_Nov_8_16_652.txt
2.5.5.2,"... receptor blocker (ARB) (all drugs in BNF chapter 2.5.5.2), any beta blocker (all drugs in BNF chapt...",35,997,BMC_Med_2013_Dec_23_11_263.txt
4.1.1.41,...Gastroenterol Hepatol 2007 1 41 45 10.1586/17474124.1.1.41 19072432,963,166,BMC_Med_2014_Sep_18_12_145.txt
1.3.3.351,...industry Regen Med 2008 3 3 351 63 10.2217/17460751.3.3.351,109,142,BMC_Med_2016_Aug_10_14_115.txt
3.68.1.83,...cational Psychology 1976 68 83 91 10.1037/0022-0663.68.1.83,108,158,BMC_Med_Educ_2009_Aug_25_9_55.txt
4.99.2.342,...hav. Neuroscience. 1985 99 342 80 10.1037/0735-7044.99.2.342,361,193,BMC_Med_Educ_2014_Dec_31_14_1051.txt
4.58.3.472,...J Pers Soc Psychol 1990 58 472 86 10.1037/0022-3514.58.3.472 2324938,232,143,BMC_Med_Educ_2015_Mar_19_15_54.txt
1.6.1.1,"..., something new Per Med 2009 6 1 5 10.2217/17410541.6.1.1",236,97,BMC_Med_Ethics_2010_Apr_9_11_5.txt
5.19.3.267,... Med Anthropol Q 2005 19 3 267 289 10.1525/maq.2005.19.3.267 16222962,226,244,BMC_Med_Ethics_2014_May_13_15_38.txt
4.19.3.39,...esearch Nurse Res 2012 19 3 39 43 10.7748/nr2012.04.19.3.39.c9058 22662377,164,146,BMC_Med_Ethics_2015_Sep_29_16_66.txt
EC 4.1.3.4,"... 3-Hydroxy-3-Methylglutaryl CoA lyase (HL, HMGCL, EC 4.1.3.4). HL is encoded by HMGCL gene and many ...",6,204,BMC_Med_Genet_2006_Dec_16_7_86.txt
EC 3.4.21.5,...019568/IPI00006618	70037	Prothrombin [Precursor] (EC 3.4.21.5),578,63,BMC_Med_Genomics_2008_Sep_15_1_41.txt
6.38.2.99,... Cancer Res Treat 2006 38 2 99 107 10.4143/crt.2006.38.2.99 19771267,382,245,BMC_Med_Genomics_2011_May_19_4_44.txt
1.5.1.1,... G2600D using Agilent Feature Extract software v.11.5.1.1. Data were required to pass stringent qual...,45,336,BMC_Med_Genomics_2016_Apr_23_9_21.txt
2.20.3.149,...erschiede Pflege 2007 20 3 149 56 10.1024/1012-5302.20.3.149 17879551,360,262,BMC_Med_Inform_Decis_Mak_2015_Sep_17_15_75.txt
2.58.2.103,...n Psychol Rundsch 2007 58 103 117 10.1026/0033-3042.58.2.103,265,184,PMC5270206.txt
3.2.1.40,GH78	Pectin	α-L-rhamnosidase	3.2.1.40	6,104,30,BMC_Microbiol_2016_Jul_12_16_147.txt
EC 2.3.3.1,"...nzymatic step of the TCA cycle (citrate synthase, EC 2.3.3.1, gltA) is also absent and apparently th...",81,604,BMC_Microbiol_2012_Jan_18_12(Suppl_1)_S5.txt
4.6.2.147,...pert Rev Vaccines 2007 6 2 147 152 10.1586/14760584.6.2.147 17408365,113,129,BMC_Microbiol_2012_Nov_30_12_286.txt
1.14.3.349,...-Microbe Interac 2001 14 3 349 57 10.1094/MPMI.2001.14.3.349,308,194,BMC_Microbiol_2015_Oct_22_15_223.txt
6.3.4.14,biotin carboxylase	BC	EC:6.3.4.14	comp12323_c26_seq1	0.82	2.55,159,26,BMC_Microbiol_2016_Sep_26_16_223.txt
EC 3.6.3.4,"...r homeostasis	Copper-translocating P-type ATPase (EC 3.6.3.4)	peg.608, peg.990, peg.1254",76,56,BMC_Microbiol_2016_Dec_15_16_292.txt
3.18.5.859,... J Bone Miner Res 2003 18 859 867 10.1359/jbmr.2003.18.5.859 12733725,189,222,BMC_Musculoskelet_Disord_2010_Jun_1_11_109.txt
1.16.3.572,... J Bone Min Res 2001 16 3 572 580 10.1359/jbmr.2001.16.3.572,187,227,BMC_Musculoskelet_Disord_2013_Mar_5_14_81.txt
2.17.2.321,... J Bone Min Res 2002 17 2 321 330 10.1359/jbmr.2002.17.2.321,207,330,BMC_Musculoskelet_Disord_2013_Mar_5_14_81.txt
1.16.6.100,...one Miner Res 2001 16 6 1004 1014 10.1359/jbmr.2001.16.6.1004 11393777,95,286,BMC_Musculoskelet_Disord_2014_May_29_15_184.txt
2.1.1.1,...c.550delAFukutin related proteinERDF2010/0223/2DP/2.1.1.1.0/10/APIA/VIAA/025Lace Baiba issue-copyrig...,20,121,BMC_Musculoskelet_Disord_2016_May_4_17_200.txt
2.53.4.801,... knee Yonsei Med J 2012 53 801 805 10.3349/ymj.2012.53.4.801 22665349,237,200,BMC_Musculoskelet_Disord_2016_Nov_2_17_451.txt
4.16.1.59,...estig Drugs 2007 16 59 72 17155854 10.1517/13543784.16.1.59,43,199,BMC_Neurol_2009_Jun_12_9(Suppl_1)_I1.txt
2.97.6.132,...ings J Neurosurg 2002 97 1322 1332 10.3171/jns.2002.97.6.1322 12507130,166,369,BMC_Neurol_2011_Jan_21_11_8.txt
1.10.2.2,"...(mitochondrial respiratory chain complex III, E.C.1.10.2.2) (MRC cIII). Mammalian cIII consists of 1...",20,484,BMC_Neurol_2014_Jan_7_14_5.txt
5.19.3.267,...ns Neuropsychology 2005 19 267 77 10.1037/0894-4105.19.3.267 15910113,581,252,BMC_Neurol_2015_Apr_23_15_61.txt
3.19.2.443,... Perform 1993 19 315 330 8473842 10.1037//0096-1523.19.2.443,143,150,BMC_Neurosci_2005_Aug_24_6_51.txt
1.1.1.27,...onocarboxylates are lactate dehydrogenase (LDH; EC1.1.1.27) that catalyses the interconversion of la...,8,122,BMC_Neurosci_2007_May_23_8_35.txt
4.97.6.857,...Neurosci 1983 97 857 872 6651961 10.1037//0735-7044.97.6.857,357,136,BMC_Neurosci_2005_May_13_6_36.txt
6.18.10.172,...ogn Neurosci 2006 18 10 1723 1733 10.1162/jocn.2006.18.10.1723 17014376,214,128,BMC_Neurosci_2010_Sep_8_11_113.txt
4.6.5.957,...ural Computation 1994 6 5 957 982 10.1162/neco.1994.6.5.957,11,119,BMC_Neurosci_2013_Jul_8_14(Suppl_1)_P43.txt
1.48.2.669,...weight Psychol Rep 1981 48 669 670 10.2466/pr0.1981.48.2.669 7291403,322,114,PMC5219768.txt
2.53.7.103,... Ophthalmol Soc 2012 53 1035 1040 10.3341/jkos.2012.53.7.1035,97,181,BMC_Ophthalmol_2015_Oct_29_15_148.txt
2.73.9.988,...ease J Periodontol 2002 73 988 994 10.1902/jop.2002.73.9.988 12296599,244,175,BMC_Oral_Health_2012_Jun_22_12_17.txt
3.74.3.391,...tion J Periodontol 2003 74 391 401 10.1902/jop.2003.74.3.391 12710761,302,167,BMC_Oral_Health_2015_Apr_1_15_43.txt
3.19.2.67,...t J Palliat Nurs 2013 19 2 67 74 10.12968/ijpn.2013.19.2.67 23435535,235,272,BMC_Palliat_Care_2015_Apr_23_14_14.txt
6.12.3.206,...t J Palliat Nurs 2006 12 123 131 10.12968/ijpn.2006.12.3.20697 16628179,368,190,BMC_Palliat_Care_2016_Mar_31_15_37.txt
2.21.5.299,... back home Pflege 2008 21 299 307 10.1024/1012-5302.21.5.299 18850534,234,224,BMC_Pediatr_2012_Jun_8_12_65.txt
1.14.3.416,...Interact 2001 14 416 421 11277440 10.1094/MPMI.2001.14.3.416,423,249,BMC_Plant_Biol_2007_Oct_23_7_56.txt
2.15.6.529,...Interact 2002 15 529 359 12059101 10.1094/MPMI.2002.15.6.529,188,215,BMC_Plant_Biol_2008_Mar_26_8_30.txt
EC 1.1.1.1,16	Alcohol dehydrogenase (EC 1.1.1.1)	FG345166	k2.2	30	3.0,165,27,BMC_Plant_Biol_2008_Dec_1_8_122.txt
5.3.1.5,Fructose and mannose metabolism	3.1.3.11	3.1.3.46	5.3.1.5	5.3.1.8,263,51,BMC_Plant_Biol_2009_Jan_28_9_14.txt
4.17.2.202,...Interact 2004 17 202 215 14964534 10.1094/MPMI.2004.17.2.202,245,271,BMC_Plant_Biol_2009_Sep_29_9_124.txt
EC 5.1.3.18,"...nzymes include GDP-D-mannose-3,5-epimerase (GME), EC 5.1.3.18; GDP-L-galactose phosphorylase (VTC2),...",17,873,BMC_Plant_Biol_2009_Dec_9_9_145.txt
5.1.3.18,"...clude GME encoding GDP-mannose-3,5-epimerase (E.C.5.1.3.18), Vtc2 encoding GDP-L-galactose-phosphory...",55,323,BMC_Plant_Biol_2009_Dec_9_9_145.txt
2.7.2.3,"...otiana tabacum	phosphoglycerate kinase, cytosolic	2.7.2.3	PGK	36.7/5.4	42.4/5.7	44",45,66,BMC_Plant_Biol_2010_Dec_1_10_268.txt
2.5.1.6,...lus trichocarpa	S-adenosylmethionine synthetase 1	2.5.1.6	MAT1-b	40.1/5.3	43.2/5.7	31,114,67,BMC_Plant_Biol_2010_Dec_1_10_268.txt
EC 2.4.1.82,...galactomannan synthesis. Raffinose synthases (RS; EC 2.4.1.82) catalyze the synthesis of raffinose f...,307,437,BMC_Plant_Biol_2011_Feb_8_11_30.txt
1.1.2.1,".../1DP/1.1.2.1.2/09/IPIA/VIAA/004 and 2009/0162/1DP/1.1.2.1.1./09/IPIA/VIAA/004, respectively). Author...",126,313,BMC_Plant_Biol_2011_Apr_15_11_66.txt
4.1.2.13,"...ruvate kinase; 3.1.3.11, fructose-bisphosphatase; 4.1.2.13, fructose bisphosphate aldolase; 4.2.1.11...",122,718,BMC_Plant_Biol_2010_Jul_17_10_150.txt
2.4.1.15," 	EC:2.4.1.15 - alpha,alpha-trehalose-phosphate synthas...",75,6,BMC_Plant_Biol_2012_May_1_12_60.txt
2.4.1.15," 	EC:2.4.1.15 - alpha,alpha-trehalose-phosphate synthas...",75,6,BMC_Plant_Biol_2012_May_1_12_60.txt
EC 2.6.1.1,"...s instructions, while aspartate aminotransferase (EC 2.6.1.1) (AST) activity was assayed according t...",226,200,BMC_Plant_Biol_2012_Oct_11_12_189.txt
1.10.3.9,"... dehydrogenase), 1.4.4.2 (glycine dehydrogenase), 1.10.3.9 (photosystem II D2 protein), 1.10.9.1 (cy...",62,496,BMC_Plant_Biol_2013_Mar_21_13_49.txt
3.1.3.3,"....2.4 (aspartate kinase-homoserine dehydrogenase), 3.1.3.3 (phosphoserine phosphatase), 4.1.2.5 (thre...",66,1212,BMC_Plant_Biol_2013_Mar_21_13_49.txt
2.5.1.54,...11). Phospho-2-dehydro-3-deoxyheptonate aldolase (2.5.1.54) is the first critical step for the shiki...,90,264,BMC_Plant_Biol_2013_Mar_21_13_49.txt
3.73.1.79,...ology Physiol Rev 1993 73 1 79 118 10.2466/pr0.1993.73.1.79 8419966,153,107,BMC_Plant_Biol_2013_Aug_8_13_114.txt
4.2.3.15,"... (Limonene synthase), 4.2.3.14 (Pinene synthase), 4.2.3.15 (Myrcene synthase), 2.3.3.1 (Citrate (Si)...",101,743,BMC_Plant_Biol_2014_Jul_26_14_188.txt
1.4.1.3,"...(Aconitase), 1.1.1.41 (Isocitrate dehydrogenase), 1.4.1.3 (Glutamate dehydrogenase), 4.3.2.1 (Argini...",101,863,BMC_Plant_Biol_2014_Jul_26_14_188.txt
4.4.1.8,Cystathionine b-lyase	4.4.1.8	1	3.7,168,23,BMC_Plant_Biol_2014_Aug_15_14_215.txt
4.4.1.5,"...abolism	ec:1.1.1.37, ec:2.3.1.12, ec:4.1.1.49, ec:4.4.1.5",523,64,BMC_Plant_Biol_2015_Mar_6_15_76.txt
1.1.1.49,"Glutathione metabolism	ec:1.1.1.42, ec:1.1.1.49, ec:1.11.1.11, ec:1.11.1.12, ec:1.11.1.15...",528,41,BMC_Plant_Biol_2015_Mar_6_15_76.txt
2.6.1.96,...ate---pyruvate transaminase	comp112962_c5_seq1	EC:2.6.1.96	map00650	2.78	3.51,242,70,BMC_Plant_Biol_2015_Sep_30_15_233.txt
1.14.13.21,flavonoid 3'-monooxygenase	comp112481_c0_seq1	EC:1.14.13.21	map00941	2.04,249,51,BMC_Plant_Biol_2015_Sep_30_15_233.txt
EC 2.4.1.15,... up-regulation of trehalose-6-phosphate synthase (EC 2.4.1.15) genes is also involved in SnRK1 signa...,469,1606,BMC_Plant_Biol_2016_Feb_1_16_38.txt
EC 1.6.4.2,...se 1 μM of ascorbate/minute/g tissue.d) GR assay (EC 1.6.4.2,178,476,BMC_Plant_Biol_2016_Jun_10_16_131.txt
EC 1.12.99.6,"...l-ACP, catalysed by stearoyl-ACP desaturase (SAD, EC 1.12.99.6) [6, 7]. Oleoyl-ACP is a precursor fo...",22,365,BMC_Plant_Biol_2016_Jun_14_16_137.txt
4.46.2.180,...es Contemp Nurse 2014 46 2 184 90 10.5172/conu.2014.46.2.180,208,192,BMC_Pregnancy_Childbirth_2016_Nov_9_16_347.txt
3.10.1.47,...it und Entwicklung 2001 10 47 55 10.1026//0942-5403.10.1.47,222,256,BMC_Psychiatry_2008_Jan_17_8_5.txt
5.19.3.315,...onality Disorders 2005 19 315 338 10.1521/pedi.2005.19.3.315 16175740,180,171,BMC_Psychiatry_2010_Jan_28_10_10.txt
2.42.3.369,...Korean Acad Nurs 2012 42 3 369 76 10.4040/jkan.2012.42.3.369 22854549,167,227,BMC_Psychiatry_2015_Feb_5_15_14.txt
4.42.5.963,...nal Soc Psychol 1982 42 5 963 969 10.1037/0022-3514.42.5.963,913,220,BMC_Psychiatry_2014_Aug_20_14_235.txt
4.48.1.28,...erapie Diagnostica 2002 48 28 36 10.1026//0012-1924.48.1.28,327,218,BMC_Psychiatry_2014_Aug_6_14_210.txt
4.74.2.407,... Pers Soc Psychol 1998 74 407 419 10.1037/0022-3514.74.2.407,559,134,BMC_Psychiatry_2014_Sep_16_14_257.txt
3.16.4.240,...und Entwicklung 2007 16 4 240 249 10.1026/0942-5403.16.4.240,539,159,BMC_Psychiatry_2015_Jun_10_15_126.txt
4.77.5.106,... Pers Soc Psychol 1999 77 1061 72 10.1037/0022-3514.77.5.1061 10573880,235,152,BMC_Psychiatry_2016_Jun_7_16_189.txt
1.26.3.270,... Cogn Psyhother 2012 26 3 270 280 10.1891/0889-8391.26.3.270,422,242,BMC_Psychiatry_2016_Nov_7_16_377.txt
4.67.2.319,...nality Soc Psychol 1994 67 319 33 10.1037/0022-3514.67.2.319,308,208,BMC_Psychiatry_2016_Dec_8_16_439.txt
4.15.2.259,...udy Psychol Aging 2005 15 259 271 10.1037/0882-7974.15.2.259,233,222,PMC5288942.txt
4.4.3.276,...hology and Aging 1989 4 3 276 283 10.1037/0882-7974.4.3.276 2803620,314,109,BMC_Psychol_2013_Jun_25_1(1)_12.txt
4.76.2.284,...cial Psychology 1999 76 2 284 304 10.1037/0022-3514.76.2.284 10074710,485,216,BMC_Psychol_2014_Jul_7_2(1)_18.txt
1.1.5.623,...inology & Metabolism 2006 1 623 32 10.1586/17446651.1.5.623,278,160,BMC_Psychol_2015_Jul_5_3(1)_22.txt
3.1.9.2,"...easures ANOVA within-between interaction, G*Power 3.1.9.2). For our secondary aim (main effects on c...",110,410,BMC_Psychol_2016_Jun_6_4_33.txt
6.3.2.52,...arch & Social Policy 2006 3 52 67 10.1525/srsp.2006.3.2.52,252,193,BMC_Public_Health_2007_Jul_5_7_141.txt
5.17.6.568,...Educ Prev 2005 17 568 89 16398578 10.1521/aeap.2005.17.6.568,297,141,BMC_Public_Health_2009_Jul_21_9_255.txt
4.65.6.115,...ers Soc Psychol 1993 65 1154 1166 10.1037/0022-3514.65.6.1154,238,169,BMC_Public_Health_2010_May_10_10_239.txt
3.26.4.392,...ns Health Psychol 2007 26 392 400 10.1037/0278-6133.26.4.392 17605558,430,249,BMC_Public_Health_2010_Aug_3_10_452.txt
3.11.3.170,...ng Health Psychol 1992 11 170 180 10.1037/0278-6133.11.3.170 1618171,340,149,BMC_Public_Health_2010_Oct_27_10_649.txt
3.25.3.282,...al Health Psychol 2006 25 282 291 10.1037/0278-6133.25.3.282 16719599,294,208,BMC_Public_Health_2010_Nov_16_10_701.txt
3.21.1.3,... Health Psychology 2002 21 1 3 15 10.1037/0278-6133.21.1.3 11846342,269,268,BMC_Public_Health_2011_Feb_21_11_122.txt
3.15.2.114,...on Health Psychol 1996 15 114 123 10.1037/0278-6133.15.2.114 8681919,230,267,BMC_Public_Health_2011_Feb_17_11_113.txt
4.54.6.106,...ers Soc Psychol 1988 54 1063 1070 10.1037/0022-3514.54.6.1063 3397865,221,178,BMC_Public_Health_2011_Apr_11_11_223.txt
4.54.6.106,...ers Soc Psychol 1988 54 1063 1070 10.1037/0022-3514.54.6.1063 3397865,221,178,BMC_Public_Health_2011_Apr_11_11_223.txt
6.9.1.15,...ert Opin Pharmacother 2008 9 15 22 10.1517/14656566.9.1.15 18076335,166,132,BMC_Public_Health_2012_Apr_4_12_271.txt
2.13.8.419,... J Canc Prev 2012 13 8 4191 4197 10.7314/APJCP.2012.13.8.4191,311,205,BMC_Public_Health_2014_Sep_26_14_1004.txt
3.25.5.595,...is Health Psychol 2006 25 595 603 10.1037/0278-6133.25.5.595 17014277,293,283,BMC_Public_Health_2015_Aug_14_15_777.txt
3.22.2.178,...e Health Psychol 2003 22 2 178 88 10.1037/0278-6133.22.2.178 12683738,808,211,BMC_Public_Health_2016_Feb_17_16_163.txt
3.17.6.551,...ses? Health Psychol 1998 17 551 8 10.1037/0278-6133.17.6.551 9848806,184,244,BMC_Public_Health_2016_Jul_12_16_553.txt
3.26.4.381,...cal Association 2007 26 4 381 391 10.1037/0278-6133.26.4.381,191,249,BMC_Public_Health_2016_Aug_19_16_837.txt
2.49.1.11,...pulations Soc Probl 2002 49 1 11 34 10.1525/sp.2002.49.1.11,411,178,BMC_Public_Health_2016_Sep_5_16(1)_927.txt
4.54.6.106,...s Soc Psychol 1988 54 6 1063 1070 10.1037/0022-3514.54.6.1063 3397865,181,187,PMC5241917.txt
6.1.4.401,...bstruct Pulmon Dis 2006 1 401 407 10.2147/copd.2006.1.4.401 18044096,169,241,BMC_Pulm_Med_2012_Aug_24_12_45.txt
2.7.1.116,2.7.1.116 [Isocitrate dehydrogenase (NADP+)] kinas...,44,3,BMC_Struct_Biol_2005_Mar_16_5_6.txt
2.7.1.48,2.7.1.48 Uridine kinase (*),78,3,BMC_Struct_Biol_2005_Mar_16_5_6.txt
2.7.4.8,2.7.4.8 Guanylate kinase,92,3,BMC_Struct_Biol_2005_Mar_16_5_6.txt
EC 5.1.2.2,"... [43]. Mandelate racemases, the second subfamily (EC 5.1.2.2), convert (R)-mandelate to and from (S)...",109,571,BMC_Struct_Biol_2013_Nov_8_13(Suppl_1)_S10.txt
EC 5.3.1.6,"... (EC 5.1.3.22), rpi – Ribose phosphate isomerase (EC 5.3.1.6), talA – Transaldolose (EC 2.2.1.2), tk...",327,901,BMC_Syst_Biol_2008_May_7_2_41.txt
3.1.1.19,"Ascorbate biosynthesis	uronolactonase	3.1.1.19	cattle [37], pig [37], rabbit [37], monke...",104,39,BMC_Syst_Biol_2009_Mar_12_3_33.txt
5.3.1.17,9	ec5.3.1.17 → ec1.2.4.2	2-oxo-valerate	1.900	1.605	0....,96,5,BMC_Syst_Biol_2010_Mar_28_4_35.txt
1.1.1.267,STM0220	dxr	1.1.1.267	1-deoxy-D-xylulose 5-phosphate reductois...,127,13,BMC_Syst_Biol_2010_May_3_4_56.txt
1.6.5.3,_1.6.5.3	0	0	+∞	0	0	+∞	2.134	0	+∞	0	0	+∞	NADH + UQ ...,164,2,BMC_Syst_Biol_2010_Nov_17_4_156.txt
4.2.1.1,...1.39 in iSyn669) and carbonic anhydrase (reaction 4.2.1.1b) respectively. As iSyn669 biomass equatio...,179,1081,BMC_Syst_Biol_2010_Nov_17_4_156.txt
EC 1.14.15.7,"... by a ferredoxin-dependent choline monooxygenase (EC 1.14.15.7, CsaI2455), betaine aldehyde dehydrog...",170,397,BMC_Syst_Biol_2011_Jan_21_5_12.txt
2.7.7.27,...2980); 5.4.2.2 - Phosphoglucomutase (Ot15g02630); 2.7.7.27 - ADP-glucose pyrophosphorylase (Ot07g032...,25,208,BMC_Syst_Biol_2011_Feb_26_5_36.txt
5.69.2.25,The data set is available at http://155.69.2.25:8080/DBAC data,29,39,BMC_Syst_Biol_2011_Jun_20_5(Suppl_1)_S5.txt
2.7.2.7, 	2.7.2.7	butyrate kinase	 + 	 	 + 	 +,128,3,BMC_Syst_Biol_2012_May_14_6_40.txt
2.10.4.613,...Opin Ther Targets 2006 7 4 613 625 10.1517/14728222.10.4.613 16848696,208,202,BMC_Syst_Biol_2013_Dec_9_7(Suppl_5)_S8.txt
2.7.4.22,... overview (see Figure 1). Note that the EC number 2.7.4.22 is unlikely to be correct in this case as...,56,318,BMC_Syst_Biol_2013_Jun_26_7_50.txt
6.2.1.4,... Excerpt of the C2Card centered at the EC number ‘6.2.1.4’ (succinate-CoA ligase (GDP-forming)). The...,115,59,BMC_Syst_Biol_2013_Jun_26_7_50.txt
3.2.1.67,"....C. 3.2.1.15) and one exo-polygalacturonase (E.C. 3.2.1.67), which are members of the GH family 28, ...",125,326,BMC_Syst_Biol_2015_Nov_14_9_77.txt
2.4.1.121,4.4.1.14	2.4.1.121	2.6.1.5	2.1.1.-	2.6.1.5	1.13.11.-	4.4.1....,76,10,BMC_Syst_Biol_2016_Sep_2_10(1)_87.txt
1.14.11.23,2.4.1.237	6.2.1.-	1.14.11.13	1.14.13.-	1.14.11.23	2.5.1.18	1.2.4.1	3.1.4.4	2.4.1.263	1.14...,79,40,BMC_Syst_Biol_2016_Sep_2_10(1)_87.txt
1.1.1.288,3.1.4.4	1.14.13.93	1.14.13.93	6.2.1.-	1.1.1.288	2.4.1.263	3.2.1.1	1.1.1.-	4.1.1.19	1.11....,98,39,BMC_Syst_Biol_2016_Sep_2_10(1)_87.txt
3.54.7.454,...hotripsy Korean J Urol 2013 54 454 10.4111/kju.2013.54.7.454 23878688,181,236,BMC_Urol_2015_Jul_23_15_72.txt
2.1.1.70,...lin Exp Vaccine Res 2012 1 1 70 6 10.7774/cevr.2012.1.1.70 23596579,166,230,BMC_Vet_Res_2016_Jul_4_12_138.txt
3.18.7.125,... J Bone Miner Res 2003 18 1254 60 10.1359/jbmr.2003.18.7.1254 12854835,162,167,BMC_Womens_Health_2012_Apr_24_12_11.txt
3.23.6.595,...is Heal Psychol 2004 23 6 595 598 10.1037/0278-6133.23.6.595,242,196,BMC_Womens_Health_2016_May_4_16_22.txt
3.46.4.403,2013 ;46 :403 –6 . doi:10.5946/ce.2013.46.4.40323964340,236,38,PMC5337649.txt
1.31.11.632,doi:10.2519/jospt.2001.31.11.63211720296,328,22,BMJ_Open_2015_Mar_27_5(3)_e007701.txt
3.10.28.6,2014 ;28 :50 –8 . doi:10.7748/ns2013.10.28.6.50.e733324107063,216,36,BMJ_Open_2016_Feb_11_6(2)_e009196.txt
5.20.25.211,doi:10.2807/1560-7917.ES2015.20.25.2116,164,28,BMJ_Open_2016_Feb_22_6(2)_e009936.txt
4.74.3.763,1998 ;74 :763 –73 . doi:10.1037/0022-3514.74.3.7639523418,368,41,BMJ_Open_2016_May_27_6(5)_e009834.txt
5.7.9.459,2015 ;7 :459 –65 . doi:10.12968/jpar.2015.7.9.45,324,41,BMJ_Open_2016_Aug_5_6(8)_e011218.txt
5.14.15.185,2005 ;14 :802 –8 . doi:10.12968/bjon.2005.14.15.185971611640,352,41,BMJ_Open_2016_Aug_17_6(8)_e012597.txt
4.18.3.375,2003 ;18 :375 –84 . doi:10.1037/0882-7974.18.3.37514518801,463,41,BMJ_Open_2016_Nov_25_6(11)_e014082.txt
2.26.5.775,... J Personal Disord 2012 26 775 92 10.1521/pedi.2012.26.5.775,95,188,Borderline_Personal_Disord_Emot_Dysregul_2015_Sep_17_2_12.txt
4.8.4.257,...rder J Pers Disord 1994 8 257 267 10.1521/pedi.1994.8.4.257,181,173,Borderline_Personal_Disord_Emot_Dysregul_2014_Sep_25_1_14.txt
4.54.6.106,...ers Soc Psychol 1988 54 1063 1070 10.1037/0022-3514.54.6.1063 3397865,267,186,PMC5319948.txt
5.2.2.2,5.2.2.2. General Plausibility of the Duff Brown-Sc...,577,1,Brain_Sci_2013_Mar_27_3(2)_415-459.txt
1.18.4.491,...rome Music Percept. 2001 18 491 503 10.1525/mp.2001.18.4.491,165,124,Brain_Sci_2014_May_15_4(2)_376-395.txt
2.8.4.494,...easurement Emotion 2008 8 494 521 10.1037/1528-3542.8.4.494 18729581,187,172,Brain_Sci_2015_Mar_23_5(1)_69-91.txt
3.77.1.55,...Percept. Mot. Skills 1993 77 55 66 10.2466/pms.1993.77.1.55 8367265,178,114,PMC5332959.txt
4.2.1.36,...orean Society for Neuro-Oncology 10.14791/btrt.2014.2.1.36Case ReportGlioblastoma in a Patient with ...,3,189,PMC4049554.txt
EC 3.2.1.23,"liquid nitrogen. The digestive enzymes lactase (EC 3.2.1.23), sucrase (E",136,49,Braz_J_Med_Biol_Res_2013_Mar_15_46(3)_287-292.txt
EC 3.2.1.8,"...ike xylooligosaccharides (13, 16, 17). Xylanases (EC 3.2.1.8; endo-β-1, 4-xylanase) are primary hydr...",8,997,Braz_J_Microbiol_2011_Dec_1_Oct-Dec_42(4)_1349-1353.txt
EC 1.13.11.3,"...11). Activity of protocatechuate 3,4-dioxygenase [EC 1.13.11.3] was measured by protocatechuate depl...",37,868,Braz_J_Microbiol_2009_Jun_1_Apr-Jun_40(2)_285-291.txt
EC 3.2.1.21,"...llobiose, respectively. The enzyme β-glucosidase (EC 3.2.1.21) cleaves the disaccharide cellobiose i...",8,895,Braz_J_Microbiol_2013_Oct_30_44(2)_569-576.txt
EC 3.2.1.8,"...c action of several enzymes, including xylanases (EC 3.2.1.8) and β-xylosidases (EC 3.2.1.37). β-Xyl...",11,393,Braz_J_Microbiol_2016_Apr_27_47(3)_680-690.txt
1.35.4.579,...011 35 4 579 582 http://dx.doi.org/10.5535/arm.2011.35.4.579  22506177,499,130,Braz_J_Phys_Ther_2014_Sep-Oct_18(5)_419-427.txt
EC 2.4.1.99,"...s, sucrose:sucrose 1-fructosyltransferase (1-SST, EC 2.4.1.99) and sucrose:fructan 6-fructosyltransf...",20,127,Breed_Sci_2015_Dec_1_65(5)_363-371.txt
2.9.3.2,...st gene diversities and fixation indices. Version 2.9.3.2 . Available from http://www.unil.ch/izea/s...,251,107,Breed_Sci_2015_Mar_1_65(2)_127-137.txt
EC 2.1.1.63,"...tein 06-alkylguanine-DNA alkyltransferase (ATase, EC 2.1.1.63). Pretreating cells with th",18,65,Br_J_Cancer_1993_Jun_67(6)_1299-1302.txt
EC 3.2.1.24,"ot-D-mannosidase (EC 3.2.1.24), ,B-D-man",142,19,Br_J_Cancer_1974_Jun_29(6)_438-446.txt
2.4.1.17,...)Pglucuronate glucuronyltransferase.-(1) Step 14; 2.4.1.17. (2) Dutto,332,53,Br_J_Cancer_1964_Mar_18(1)_179-196.txt
EC 3.4.24.11,...e) by the addition of the selective endopeptidase EC 3.4.24.11 inhibitor phosphoramidon (0.1 ng ml-1...,78,65,Br_J_Cancer_1999_Jan_79(2)_214-220.txt
3.4.24.11,3.4.24.11-labile growth factors being expressed by...,404,1,Br_J_Cancer_1999_Jan_79(2)_214-220.txt
EC 3.4.24.11,the role of a soluble EC 3.4.24.11 in FCS is yet to be studied,433,23,Br_J_Cancer_1999_Jan_79(2)_214-220.txt
2.5.2.113,...nitive Therapy 2012 5 113 117 doi:10.1521/ijct.2012.5.2.113,201,199,Br_J_Clin_Psychol_2013_Nov_20_52(4)_438-449.txt
4.95.2.385,"... Psychology , 95 , 385 –403 . doi:10.1037/0022‐3514.95.2.38",461,230,Br_J_Health_Psychol_2016_Nov_6_21(4)_796-811.txt
1.1.1.102,"3-ketodihydrosphingosine reductase	KDSR, Q06136	1.1.1.102: 3-Ketosphinganine + NADPH -> sphinganin...",254,49,Br_J_Pharmacol_2013_Dec_17_170(8)_1797-1867.txt
1.14.14.1,"CYP2A13	CYP2A13, Q16696	1.14.14.1	–",455,25,Br_J_Pharmacol_2013_Dec_17_170(8)_1797-1867.txt
1.14.13.97,"CYP3A4	CYP3A4, P08684	1.14.13.67, 1.14.13.97, 1.14.13.32	Metabolises a vast range of...",474,35,Br_J_Pharmacol_2013_Dec_17_170(8)_1797-1867.txt
1.14.99.3,EC number	1.14.99.3	1.14.99.3,774,11,Br_J_Pharmacol_2013_Dec_17_170(8)_1797-1867.txt
3.1.3.36,"...01432) generate 1,5,-IP2 and 5-phosphatases (E.C. 3.1.3.36 or 3.1.3.56) generate 1,4,-IP2",802,320,Br_J_Pharmacol_2013_Dec_17_170(8)_1797-1867.txt
2.7.1.36,EC number	2.7.1.36: ATP + (R)-mevalonate -> ADP + (R)-5-phos...,840,11,Br_J_Pharmacol_2013_Dec_17_170(8)_1797-1867.txt
2.5.1.10,"...hosphate = geranyl diphosphate + diphosphate ion, 2.5.1.10: geranyl diphosphate + isopentenyl diphos...",853,113,Br_J_Pharmacol_2013_Dec_17_170(8)_1797-1867.txt
3.4.11.18,"....-	3.4.11.-	3.4.11.7	3.4.11.1	3.4.11.3, 3.4.11.18	3.4.11.18",918,67,Br_J_Pharmacol_2013_Dec_17_170(8)_1797-1867.txt
2.7.11.1,2.7.11.,1559,1,Br_J_Pharmacol_2015_Dec_9_172(24)_6024-6109.txt
4.1.1.28,4.1.1.28: levodopa ‐>dopamine + CO,2834,1,Br_J_Pharmacol_2015_Dec_9_172(24)_6024-6109.txt
4.6.1.1,4.6.1.,3756,1,Br_J_Pharmacol_2015_Dec_9_172(24)_6024-6109.txt
3.1.4.17,3.1.4.1,3971,1,Br_J_Pharmacol_2015_Dec_9_172(24)_6024-6109.txt
EC 1.13.11.40,"An 8‐LOX (EC 1.13.11.40, arachidonate:oxygen 8‐oxidoreductas...",4889,11,Br_J_Pharmacol_2015_Dec_9_172(24)_6024-6109.txt
1.14.99.3,1.14.99.,5748,1,Br_J_Pharmacol_2015_Dec_9_172(24)_6024-6109.txt
2.5.1.10,...sphate ‐>geranylgeranyl diphosphate + diphosphate 2.5.1.10: geranyl diphosphate + isopentenyl diphos...,6100,113,Br_J_Pharmacol_2015_Dec_9_172(24)_6024-6109.txt
2.7.11.30,2.7.11.3,1752,1,Br_J_Pharmacol_2015_Dec_9_172(24)_5979-6023.txt
EC 3.4.21.-,"..., highly similar to Hyaluronan-binding protein 2 (EC 3.4.21.-) OS=Homo sapiens PE=2 SV=1 - [B7Z8U5_H...",266,71,Cancer_Biol_Med_2015_Sep_12(3)_246-254.txt
4.15.14.561,...Prev: APJCP 2014 15 14 5611 5615 10.7314/APJCP.2014.15.14.5611 25081674,478,181,Cancer_Causes_Control_2015_Sep_3_26(11)_1671-1684.txt
3.2.4.2,...mor cell death and better tumor control (sections 3.2.4.2 Inhibition of COX-2 and 3.2.4.3 Inhibition...,202,690,Cancer_Metastasis_Rev_2015_Oct_29_34(4)_643-690.txt
3.46.1.38,... Clinical Endoscrophy 2013 46 38 44 10.5946/ce.2013.46.1.38,801,134,Cancer_Metastasis_Rev_2015_Oct_29_34_643-690.txt
1.43.3.176,...2005-9256Korean Cancer Association 10.4143/crt.2011.43.3.176Original ArticleThe Usefulness of Procal...,3,156,Cancer_Res_Treat_2011_Sep_30_43(3)_176-180.txt
1.43.3.160,...2005-9256Korean Cancer Association 10.4143/crt.2011.43.3.160Original ArticleClinical Analysis for Br...,3,156,Cancer_Res_Treat_2011_Sep_30_43(3)_160-169.txt
3.45.2.126,...2005-9256Korean Cancer Association 10.4143/crt.2013.45.2.126Original ArticleSrc Family Kinase Inhibi...,3,172,Cancer_Res_Treat_2013_Jun_30_45(2)_126-133.txt
3.1.3.3,3.1.3.3. Hormone receptor statu,85,1,Cancers_(Basel)_2011_May_13_3(2)_2358-2381.txt
3.25.4.155,...lated Research  2013 25 4 155 164 10.5792/ksrr.2013.25.4.155 24368992,210,174,Can_J_Infect_Dis_Med_Microbiol_2016_May_30_2016_5753489.txt
2.4.1.64,"α,α-1,1	Trehalose (d-Glc-d-Glc)	GH65	I	2	2.4.1.64	16",203,42,Carbohydr_Res_2015_Feb_11_403_23-37.txt
2.4.1.279,"α-1,3	Nigerose (d-Glc-d-Glc)	GH65	I	2	2.4.1.279	44",210,39,Carbohydr_Res_2015_Feb_11_403_23-37.txt
4.11.3.379,...t Opin Emerg Drugs 2006 11 379 401 10.1517/14728214.11.3.379 16939380,128,226,Cardiovasc_Diabetol_2011_Jan_20_10_7.txt
3.28.2.252,... Korean Med Sci 2013 28 2 252 260 10.3346/jkms.2013.28.2.252 23400641,226,338,Cardiovasc_Diabetol_2013_Jul_24_12_110.txt
4.38.6.456,...es Diabetes Metab J 2014 38 456 63 10.4093/dmj.2014.38.6.456 25541609,301,237,Cardiovasc_Diabetol_2015_Jun_24_14_84.txt
1.41.6.788,...an Acad Nursing 2011 41 6 788 794 10.4040/jkan.2011.41.6.788,335,184,Cardiovasc_Diabetol_2016_Jan_27_15_16.txt
5.39.5.373,... Diabetes Metab J. 2015 39 373 383 10.4093/dmj.2015.39.5.373 26566494,919,201,Cardiovasc_Diabetol_2016_Aug_5_15_110.txt
2.4.4.523,.... Cardiovasc. Ther. 2006 4 523 533 10.1586/14779072.4.4.523 16918271,358,102,Cardiovasc_Eng_Technol_2011_Mar_18_2(1)_35-47.txt
2.63.3.260,...Anesthesiology  2012 63 3 260 262 10.4097/kjae.2012.63.3.260 2-s2.0-84866931209 23060984,120,200,Case_Rep_Crit_Care_2015_Jun_11_2015_967560.txt
3.51.1.119,...of Parasitology  2013 51 1 119 123 10.3347/kjp.2013.51.1.119 2-s2.0-84874609059 23467858,79,188,Case_Rep_Dent_2016_Jan_3_2016_2197450.txt
3.25.2.223,...s of Dermatology  2013 25 2 223 225 10.5021/ad.2013.25.2.223 2-s2.0-84878560226 23717016,69,175,Case_Rep_Dermatol_Med_2015_Nov_24_2015_840193.txt
6.1.4.411,...of Nanomedicine  2006 1 4 411 416 10.2147/nano.2006.1.4.411 2-s2.0-34548654454 17722275,60,146,Case_Rep_Endocrinol_2015_Dec_6_2015_147265.txt
3.43.12.785,...lation Journal  2013 43 12 785 792 10.4070/kcj.2013.43.12.785 2-s2.0-84892592258 24385988,132,141,Case_Rep_Genet_2015_May_5_2015_259627.txt
6.47.3.423,...Medical Journal  2006 47 3 423 427 10.3349/ymj.2006.47.3.423 2-s2.0-33745609201 16807994,46,132,Case_Rep_Obstet_Gynecol_2015_Jun_18_2015_791408.txt
4.14.2.135,... Gastric Cancer  2014 14 2 135 137 10.5230/jgc.2014.14.2.135 2-s2.0-84903952395 25061542,76,182,Case_Rep_Oncol_Med_2016_Jun_26_2016_8264140.txt
3.3.3.236,...endons Journal  2013 3 3 236 239 10.11138/mltj/2013.3.3.236 2-s2.0-84892893026,170,248,Case_Rep_Pathol_2016_May_10_2016_9104839.txt
2.17.1.77,...on J Bone Miner Res 2002 17 77 90 10.1359/jbmr.2002.17.1.77 11771672,159,219,Cell_Adh_Migr_2012_Mar_1_6(2)_148-156.txt
4.8.12.198,...in Investig Drugs 1999 8 1981 2008 10.1517/13543784.8.12.1981 11139836,293,168,Cell_Commun_Signal_2011_May_15_9_13.txt
2.12.5.621,... Opin Ther Targets 2008 12 621 635 10.1517/14728222.12.5.621 18410244,539,128,Cell_Commun_Signal_2012_Dec_20_10_43.txt
EC 1.1.1.14,"...tains sorbitol DH (SDH) and xylitol DH(XDH). SDH (EC 1.1.1.14), also known as glucitol DH, polyol DH...",107,69,Cell_Mol_Life_Sci_2008_Dec_14_65(24)_3879-3894.txt
2.17.6.104,...one Miner Res 2002 17 6 1044 1050 10.1359/jbmr.2002.17.6.1044 12054159,364,214,Cell_Mol_Life_Sci_2014_Jul_12_71(22)_4325-4346.txt
3.6.3.8,...) RBDmap data for SERCA2 (amino acids 612–758; EC:3.6.3.8) and mapping onto Phyre2-modeled structure...,197,53,Cell_Rep_2016_Jul_21_16(5)_1456-1469.txt
1.14.7.914,...icrobe. Interact. 2001 14 914 917 10.1094/MPMI.2001.14.7.914 11437266,124,233,Cells_2012_Sep_11_1(3)_646-666.txt
1.38.4.216,...Exp. Reprod. Med. 2011 38 216 221 10.5653/cerm.2011.38.4.216 22384445,186,290,Cells_2012_Oct_18_1(4)_851-873.txt
4.4.1.2,4.4.1.2. Heating Methods.4.4.1.2.1. Boiling. Boiling (heating in boiling wa...,792,26,Chem_Rev_2010_Apr_14_110(4)_2313-2365.txt
3.4.5.5,3.4.5.5 Spectroscopi,4160,1,Chem_Rev_2014_Apr_23_114(8)_4366-4469.txt
3.4.6.1,3.4.6.1.1 [NiFe] Hydrogenase Cluste,4267,1,Chem_Rev_2014_Apr_23_114(8)_4366-4469.txt
2.3.3.2,2.3.3.2 Translationa,671,1,Chem_Rev_2014_Jul_9_114(13)_6661-6714.txt
3.3.2.3,briefly discussed in subsections 3.3.2.3 and 3.3.2.4,1786,34,Chem_Rev_2016_Sep_14_116(17)_9748-9815.txt
3.4.2.5,(subsection 3.4.2.4) and others (subsection 3.4.2.5),2642,45,Chem_Rev_2016_Sep_14_116(17)_9748-9815.txt
3.1.3.1,3.1.3.1 Basi,495,1,Chem_Rev_2016_Jun_8_116(11)_6370-6390.txt
6.7.6.179,...Intensive Care Med 2006 7 179 180 10.1383/anes.2006.7.6.179,134,119,Chin_Med_2011_May_27_6_21.txt
4.27.1.43,...ue Korean J Pain 2014 27 43 8 doi: 10.3344/kjp.2014.27.1.43 24478900,124,179,Chin_Med_J_(Engl)_2016_Oct_5_129(19)_2313-2318.txt
2.36.6.433,... Diabetes Metab J 2012 36 433 42 doi: 4093/dmj.2012.36.6.433 23275937,169,199,PMC5221113.txt
1.35.3.412,...n Phys Rehabil Med 2011 35 3 412 7 10.5535/arm.2011.35.3.412,325,203,Chiropr_Man_Therap_2016_Dec_5_24_47.txt
1.44.1.51,...ciety of Gastrointestinal Endoscopy 10.5946/ce.2011.44.1.51Case ReportA Case of Gossypiboma Masquera...,3,124,Clin_Endosc_2011_Sep_30_44(1)_51-54.txt
1.44.2.116,...ciety of Gastrointestinal Endoscopy 10.5946/ce.2011.44.2.116Original ArticleClinical Outcomes of End...,3,124,Clin_Endosc_2011_Dec_31_44(2)_116-122.txt
2.45.2.132,...ciety of Gastrointestinal Endoscopy 10.5946/ce.2012.45.2.132Focused Review Series: What Should We Kn...,3,124,Clin_Endosc_2012_Jun_30_45(2)_132-137.txt
2.45.2.117,...ciety of Gastrointestinal Endoscopy 10.5946/ce.2012.45.2.117Focused Review Series: What Should We Kn...,3,124,Clin_Endosc_2012_Jun_30_45(2)_117-123.txt
3.46.2.172,...ciety of Gastrointestinal Endoscopy 10.5946/ce.2013.46.2.172Original ArticleEndoscopic Ultrasound El...,3,124,Clin_Endosc_2013_Mar_31_46(2)_172-177.txt
3.46.6.671,...ciety of Gastrointestinal Endoscopy 10.5946/ce.2013.46.6.671Case ReportA Case of Parasite Invasion o...,3,124,Clin_Endosc_2013_Nov_19_46(6)_671-674.txt
4.47.6.490,...ciety of Gastrointestinal Endoscopy 10.5946/ce.2014.47.6.490Focused Review Series: Endoscopic Screen...,3,124,Clin_Endosc_2014_Nov_30_47(6)_490-496.txt
4.16.5.659,...pin Investig Drugs 2007 16 659 678 10.1517/13543784.16.5.659 17461739,187,143,Clin_Epigenetics_2010_Jul_27_1(1-2)_45-54.txt
1.4.2.67,...olaryngology-Head and Neck Surgery 10.3342/ceo.2011.4.2.67Original ArticleExpression of EGFR and Mic...,3,167,Clin_Exp_Otorhinolaryngol_2011_Jun_31_4(2)_67-71.txt
1.4.2.67,...olaryngology-Head and Neck Surgery 10.3342/ceo.2011.4.2.67Original ArticleExpression of EGFR and Mic...,3,167,Clin_Exp_Otorhinolaryngol_2011_Jun_31_4(2)_67-71.txt
1.4.2.95,...olaryngology-Head and Neck Surgery 10.3342/ceo.2011.4.2.95Original ArticleReliable Early Prediction ...,3,167,Clin_Exp_Otorhinolaryngol_2011_Jun_31_4(2)_95-100.txt
1.4.4.204,...olaryngology-Head and Neck Surgery 10.3342/ceo.2011.4.4.204Case ReportSynovial Sarcoma of the Thyroi...,3,167,Clin_Exp_Otorhinolaryngol_2011_Dec_7_4(4)_204-206.txt
4.7.1.30,"...olaryngology-Head and Neck Surgery 10.3342/ceo.2014.7.1.30Original ArticleA Randomized, Multi-Center...",3,192,Clin_Exp_Otorhinolaryngol_2014_Mar_5_7(1)_30-35.txt
5.8.3.194,...olaryngology-Head and Neck Surgery 10.3342/ceo.2015.8.3.194Original ArticleRelationship Between Otor...,3,192,Clin_Exp_Otorhinolaryngol_2015_Sep_13_8(3)_194-197.txt
5.8.3.194,...olaryngology-Head and Neck Surgery 10.3342/ceo.2015.8.3.194Original ArticleRelationship Between Otor...,3,192,Clin_Exp_Otorhinolaryngol_2015_Sep_13_8(3)_194-197.txt
1.38.3.174,...Society for Reproductive Medicine 10.5653/cerm.2011.38.3.174Case ReportPulmonary and retroperitoneal...,3,150,Clin_Exp_Reprod_Med_2011_Sep_30_38(3)_174-177.txt
3.40.2.83,...Society for Reproductive Medicine 10.5653/cerm.2013.40.2.83Original ArticleCessation of gonadotropin...,3,169,Clin_Exp_Reprod_Med_2013_Jun_30_40(2)_83-89.txt
4.41.4.158,...Society for Reproductive Medicine 10.5653/cerm.2014.41.4.158Original ArticleEarly gonadotropin-relea...,3,169,Clin_Exp_Reprod_Med_2014_Dec_31_41(4)_158-164.txt
3.2.2.144,...87-366XThe Korean Vaccine Society 10.7774/cevr.2013.2.2.144GuidelineRecommended immunization schedul...,3,148,Clin_Exp_Vaccine_Res_2013_Jul_3_2(2)_144-147.txt
6.21.2.109,...ean J Intern Med 2006 21 2 109 15 10.3904/kjim.2006.21.2.109 16913440,214,143,Clin_Hypertens_2016_Feb_16_22_13.txt
4.14.8.101,...pin Investig Drugs 2005 14 1019 31 10.1517/13543784.14.8.1019,81,229,Clinics_(Sao_Paulo)_2011_May_66(5)_837-841.txt
1.26.3.438,...y J Korean Med Sci 2011 26 438 43 10.3346/jkms.2011.26.3.438 21394315,163,262,Clinics_(Sao_Paulo)_2011_Oct_66(10)_1735-1742.txt
4.39.1.1,... 2014 39 (1) 1 6 http://dx.doi.org/10.5395/rde.2014.39.1.1 24516822,102,168,PMC5304401.txt
2.18.3.279,...ciation for the Study of the Liver 10.3350/cmh.2012.18.3.279Original ArticleEnhanced A-FABP expressi...,3,152,Clin_Mol_Hepatol_2012_Sep_25_18(3)_279-286.txt
2.18.4.375,...ciation for the Study of the Liver 10.3350/cmh.2012.18.4.375Original ArticlePrognostic indicators in...,3,152,Clin_Mol_Hepatol_2012_Dec_21_18(4)_375-382.txt
4.20.2.154,...ciation for the Study of the Liver 10.3350/cmh.2014.20.2.154Original ArticleAlcoholic fatty liver di...,3,152,Clin_Mol_Hepatol_2014_Jun_30_20(2)_154-161.txt
2.73.2.191,"...cts J Periodontol. 2002 73 191 197 10.1902/jop.2002.73.2.191 Fowler EB, Cuenin MF, Hokett SD, et al....",78,179,Clin_Orthop_Relat_Res_2008_Feb_10_466(2)_481-486.txt
2.4.2.129,...he Korean Orthopaedic Association 10.4055/cios.2012.4.2.129Original ArticleIntra-articular Patterns ...,3,135,Clin_Orthop_Surg_2012_Jun_17_4(2)_129-133.txt
2.4.3.193,...he Korean Orthopaedic Association 10.4055/cios.2012.4.3.193Original ArticleThree Dimensional CT-base...,3,135,Clin_Orthop_Surg_2012_Sep_14_4(3)_193-199.txt
6.8.1.65,...he Korean Orthopaedic Association 10.4055/cios.2016.8.1.65Original ArticleLumbar Lordosis of Spinal ...,3,135,Clin_Orthop_Surg_2016_Mar_13_8(1)_65-70.txt
5.1.3.1,5.1.3.1 Performanc,123,1,Clin_Psychol_Rev_2007_Apr_27(3)_287-306.txt
5.2.3.2,5.2.3.2.3 Genetic,197,1,Clin_Psychol_Rev_2007_Apr_27(3)_287-306.txt
1.9.3.102,...College of Neuropsychopharmacology 10.9758/cpn.2011.9.3.102ReviewPrepulse Inhibition of Startle Resp...,3,181,Clin_Psychopharmacol_Neurosci_2011_Dec_31_9(3)_102-110.txt
3.11.3.165,...College of Neuropsychopharmacology 10.9758/cpn.2013.11.3.165Case ReportBlonanserin-induced Mood Alte...,3,181,Clin_Psychopharmacol_Neurosci_2013_Dec_24_11(3)_165-167.txt
4.12.2.163,...College of Neuropsychopharmacology 10.9758/cpn.2014.12.2.163Case ReportLate-onset Quetiapine-related...,3,181,Clin_Psychopharmacol_Neurosci_2014_Aug_12_12(2)_163-165.txt
5.13.2.188,"...of Neuropsychopharmacology 2624384710.9758/cpn.2015.13.2.188cpn-13-188Original ArticleA Randomized, ...",3,186,Clin_Psychopharmacol_Neurosci_2015_Aug_31_13(2)_188-193.txt
6.14.1.26,...hopharmacol Neurosci 2016 14 26 32 10.9758/cpn.2016.14.1.26 26792037,116,232,Clin_Psychopharmacol_Neurosci_2016_Nov_30_14(4)_378-382.txt
6.5.6.124,...pin Pharmacother. 2004 5 1243 1256 10.1517/14656566.5.6.1243,667,180,Clin_Sarcoma_Res_2016_May_4_6_7.txt
3.32.1.101,"...ry, and Cognition 2006 32 101 117 10.1037/0278-7393.32.1.101 16478344",178,233,Cogn_Affect_Behav_Neurosci_2011_Sep_6_11(3)_344-353.txt
2.8.3.395,"...ashington, D.C.) 2008 8 3 395 409 10.1037/1528-3542.8.3.395",315,191,PMC5306169.txt
3.86.3.389,...onal Psychology 1994 86 3 389 401 10.1037/0022-0663.86.3.389,249,193,PMC5256450.txt
6.18.7.152,... Computation  2006 18 7 1527 1554 10.1162/neco.2006.18.7.1527 MR2224485 2-s2.0-33745805403 16764513,495,146,Comput_Intell_Neurosci_2015_Aug_27_2015_909123.txt
1.48.3.555,...atical Society  2011 48 3 555 574 10.4134/BKMS.2011.48.3.555 MR2827765 2-s2.0-79958267634,1174,180,PMC5198507.txt
EC 3.2.1.176,...he non-reducing end acting cellobiohydrolases and EC 3.2.1.176 for the reducing end acting ones) and...,16,506,Comput_Struct_Biotechnol_J_2012_Nov_9_2_e201209015.txt
EC 2.7.6.3,"...lK, hydroxymethyldihydropterin pyrophosphokinase (EC 2.7.6.3)	COG0801",128,58,Comput_Struct_Biotechnol_J_2014_Jun_11_10(16)_41-50.txt
3.2.2.1,"...ingly protonated teaH2− exhibits the bonding mode 3.2.2.1.1, described using Harris notation [15], u...",38,56,Coord_Chem_Rev_2014_Feb_1_260(100)_1-20.txt
2.2.1.1,"...e lanthanide with a protonated arm, overall being 2.2.1.1. The third nBudeaH− links across the end o...",99,479,Coord_Chem_Rev_2014_Feb_1_260(100)_1-20.txt
3.1.1.4,Secretory phospholipase A2 (sPLA2; EC: 3.1.1.4) belongs to an ubiquitous enzyme superfami...,16,40,Crit_Care_2013_Jul_24_17(4)_R163.txt
4.15.5.479,...in Investig Drugs. 2006 15 479 486 10.1517/13543784.15.5.479 16634686,268,177,Crit_Care_2015_Apr_27_19(1)_192.txt
1.2.2.1,1.2.2.1	frozen	0,228,1,Crit_Rev_Environ_Sci_Technol_2012_Feb_8_42(4)_378-411.txt
1.6.2.7,1.6.2.7	fermented	1,276,1,Crit_Rev_Environ_Sci_Technol_2012_Feb_8_42(4)_378-411.txt
1.7.2.3,1.7.2.3	canned	0,285,1,Crit_Rev_Environ_Sci_Technol_2012_Feb_8_42(4)_378-411.txt
4.16.1.73,... Opin Investig Drugs 2007 16 73 82 10.1517/13543784.16.1.73 17155855,128,179,Croat_Med_J_2015_Aug_56(4)_326-333.txt
2.1.2.3,2.1.2.3. Myocardial Perfusion Assessment with Tech...,50,1,PMC4807716.txt
2.3.5.1,"...the motoneurones in the facial nucleus [208]; see 2.3.5.1, Part I, which innervates the orbicularis ...",57,615,Curr_Neuropharmacol_2008_Sep_6(3)_254-285.txt
EC 1.2.7.1,"...ue) and Pyruvate:ferrodoxin oxidoreductase (PFOR, EC 1.2.7.1) (shown in red) structures highlights t...",81,295,Curr_Opin_Genet_Dev_2015_Dec_35_40-49.txt
1.8.1.-, 	Captopril	Cysteine-captopril disulfide	 	1.8.1.-|1.11.1.-,336,44,Curr_Pharm_Des_2015_Feb_21(6)_806-822.txt
1.4.3.-, 	Diltiazem	N-desmethyl diltiazem	CYP3A4	1.4.3.-|1.5.99.-,403,42,Curr_Pharm_Des_2015_Feb_21(6)_806-822.txt
1.3.1.-, 	Felodipine	Dehydro felodipine	CYP3A4	5.3.3.-|1.3.1.-+1.5.3.-|1.5.1.- +3.1.1.-+.1.14.13.-,405,48,Curr_Pharm_Des_2015_Feb_21(6)_806-822.txt
5.3.3.-,...ubsequent oxidation to the carboxylic acid	CYP3A4	5.3.3.- + 1.5.1.-|1.5.3.- + 1.14.13.-,418,116,Curr_Pharm_Des_2015_Feb_21(6)_806-822.txt
2.3.1.-, 	 	Spironolactone-dethioacetate	 	1.2.1.-|2.3.1.-|3.1.2.-+3.3.1.-+4.2.1.-+1.3.1.-,440,44,Curr_Pharm_Des_2015_Feb_21(6)_806-822.txt
4.2.1.-,...e-dethioacetate	 	1.2.1.-|2.3.1.-|3.1.2.-+3.3.1.-+4.2.1.-+1.3.1.-,440,68,Curr_Pharm_Des_2015_Feb_21(6)_806-822.txt
1.14.13.-,... 	4-Hydroxy-sulfate-triamterene	Sulfotransferases	1.14.13.- + 2.8.2.-,445,53,Curr_Pharm_Des_2015_Feb_21(6)_806-822.txt
EC 3.5.1.5,Urease (urea amidohydrolase; EC 3.5.1.5) was the first enzyme to be crystallize...,13,30,Curr_Protein_Pept_Sci_2012_Dec_13(8)_789-806.txt
2.2.2.3,2.2.2.3 Handednes,71,1,Data_Brief_2015_Nov_6_5_846-851.txt
EC 1.14.16.5,...i H  Armarego WL   Glyceryl-ether monooxy-genase [EC 1.14.16.5]. A microsomal enzyme of ether lipid ...,199,60,Dermatoendocrinol_2011_Apr_1_Apr-Jun_3(2)_91-99.txt
2.24.3.243,...asian Ann Dermatol. 2012 24 243 252 10.5021/ad.2012.24.3.243 22879706,105,115,Dermatol_Ther_(Heidelb)_2016_Feb_20_6(1)_59-68.txt
4.19.1.40,"...chology and Aging , 19 , 40 –56 . 10.1037/0882-7974.19.1.40 15065930",174,219,Dev_Psychol_2015_May_16_51(5)_573-582.txt
3.17.4.421,...ental Biology 25949158devrep-17-42110.12717/DR.2013.17.4.421ArticleIn Vitro Steroidogenesis on Oocyt...,3,137,Dev_Reprod_2013_Dec_17(4)_421-426.txt
3.17.4.345,...ental Biology 25949150devrep-17-34510.12717/DR.2013.17.4.345ArticleEvaluation of Fertilizing Ability...,3,137,Dev_Reprod_2013_Dec_17(4)_345-351.txt
4.18.3.139,...lopmental Biology 25949182DR-18-13910.12717/DR.2014.18.3.139ArticleStudies of In Vitro Embryo Cultur...,3,129,Dev_Reprod_2014_Sep_18(3)_139-143.txt
6.20.2.163,...n Society of Developmental Biology 10.12717/DR.2016.20.2.163ArticleRad51 Regulates Reprogramming Eff...,3,126,Dev_Reprod_2016_Jun_20(2)_163-169.txt
3.17.2.141,... arrest Dev Reprod 2013 17 141 147 10.12717/DR.2013.17.2.141 25949130,258,100,PMC5270610.txt
2.7.1.91,"...EC:3.1.4.12); SPHK1/2, sphingosine kinase 1/2 (EC:2.7.1.91); UGT8, UDP glycosyltransferase 8 (EC:2.4...",82,2005,Diabetes_2012_Aug_17_61(8)_2166-2175.txt
1.35.6.567,...33-6087Korean Diabetes Association 10.4093/dmj.2011.35.6.567ReviewCosts of Diabetes Mellitus in Kore...,3,110,Diabetes_Metab_J_2011_Dec_26_35(6)_567-570.txt
3.37.5.393,...33-6087Korean Diabetes Association 10.4093/dmj.2013.37.5.393ResponseResponse: Diabetic Retinopathy a...,3,126,Diabetes_Metab_J_2013_Oct_17_37(5)_393-394.txt
6.40.2.147,...orean Diabetes Association 2712688510.4093/dmj.2016.40.2.147Original ArticleObesity and Metabolic Sy...,3,134,Diabetes_Metab_J_2016_Apr_27_40(2)_147-153.txt
6.30.5.363,...r Diabetes Assoc 2006 30 5 363 71 10.4093/jkda.2006.30.5.363,324,205,Diabetol_Metab_Syndr_2015_Feb_15_7_8.txt
2.27.11.135,...rean Med Sci 2012 27 11 1359 1363 10.3346/jkms.2012.27.11.1359 23166418,308,237,Diabetol_Metab_Syndr_2014_Jul_30_6_82.txt
1.5.6.560,...eans Nutr Res Pract 2011 5 560 568 10.4162/nrp.2011.5.6.560 22259682,374,219,Diabetol_Metab_Syndr_2014_Oct_17_6_112.txt
4.16.2.231,...pin Investig Drugs 2007 16 231 237 10.1517/13543784.16.2.231 17243943,166,164,Diabetol_Metab_Syndr_2016_Mar_22_8_26.txt
6.1.8.1,e.g. 1.3.6.1.4.1.19376.1.8.1.4.151	e.g. Histological grade (WHO)	Grade,73,22,Diagn_Pathol_2014_Dec_19_9(Suppl_1)_S4.txt
6.1.8.1,e.g. 1.3.6.1.4.1.19376.1.8.1.4.169	e.g. Lesion site	Site,81,22,Diagn_Pathol_2014_Dec_19_9(Suppl_1)_S4.txt
5.4.8.109,"...rug Metab Toxicol 2008 4 1091 1097 10.1517/17425255.4.8.1091 Ginzburg R, Ambizas EM. Clinical pharma...",122,183,Dig_Dis_Sci_2009_Oct_6_54(10)_2063-2069.txt
6.31.2.206,"31 , 206 -212 . 10.3803/enm.2016.31.2.206",207,32,PMC5200896.txt
2.5.3.1,2.5.3.1 Correlation Between Subjective Rating,80,1,EBioMedicine_2016_Jul_14_10_249-257.txt
2.9.3.2,...e) heterozigosity were calculated using the FSTAT 2.9.3.2 software (Goudet 2002). The allelic richne...,51,216,Ecol_Evol_2012_Dec_8_2(12)_3145-3159.txt
1.52.1.12,...era pest and pathogen research. doi: 10.3896/IBRA.1.52.1.12,125,276,Ecol_Evol_2014_Oct_26_4(20)_3960-3967.txt
2.57.5.126,"...ceanography , 57 , 1266 –1278 . doi:10.4319/lo.2012.57.5.126",585,148,PMC5216622.txt
2.1.7.1,2.1.7.1 Maintenanc,65,1,Ecol_Modell_2014_May_24_280_5-17.txt
2.5.10.755,...so observed biphasic kinetics of unwinding with gp2.5.10.7554/eLife.06562.023Author response image 1...,351,253,eLife_4_e06562.txt
1.5.71.3, I/σI (overall/inner/outer)	21.5.71.3/2.2,102,30,eLife_4_e07236.txt
4.6.4.305,... Cognitive Neuroscience 6 305 320 10.1162/jocn.1994.6.4.305 23961727,475,185,eLife_4_e07902.txt
2.3.4.4,The models for the H5Nx clade 2.3.4.4 virus also had high GOF metrics estimated ...,428,31,PMC5161450.txt
2.3.4.4,.... The suitability maps for H5Nx HPAI and H5 clade 2.3.4.4 for Sets 2 and 3 are presented in Figure 4...,508,223,PMC5161450.txt
3.11.2.56,... Society of Electrolyte Metabolism 10.5049/EBP.2013.11.2.56Case ReportSevere Hyponatremia Associated...,3,166,Electrolyte_Blood_Press_2013_Dec_31_11(2)_56-59.txt
2.7.1.102,... 1 102 11 url:http://dx.doi.org/10.1902/annals.2002.7.1.102  16013223,163,253,Electron_Physician_2015_Mar_1_7(1)_1010-1016.txt
3.20.3.235,...iew Int J Nurs Stud 2005 42 2 211 10.5953/jmjh.2013.20.3.235 15680619,84,130,Electron_Physician_2016_Jun_25_8(6)_2524-2530.txt
5.16.3.863,...ac J Cancer Prev 2015 16 3 863 8 10.7314/APJCP.2015.16.3.863 25735374,97,221,Electron_Physician_2016_Oct_25_8(10)_3150-3155.txt
4.4.5.757,10.1586/14760584.4.5.757 16221076,182,16,Emerg_Infect_Dis_2010_Nov_16(11)_1695-1701.txt
2.3.2.1,...d 2008; all other subtype H5N1 viruses from clade 2.3.2.1 clustered in a separate group (Technical A...,89,620,Emerg_Infect_Dis_2012_Oct_18(10)_1596-1602.txt
2.3.2.1,The potential of clade 2.3.2.1 HPAIV (H5N1) to cause an outbreak is heigh...,106,24,Emerg_Infect_Dis_2012_Oct_18(10)_1596-1602.txt
2.3.4.5,"...d be assigned new fourth-order clades of 2.3.4.4, 2.3.4.5, and 2.3.4.6 to reflect the wide divergenc...",54,352,Emerg_Infect_Dis_2013_Dec_19(12)_2021-2024.txt
6.21.32.303,... Surveill . 2016 ;21 :21 .10.2807/1560-7917.ES.2016.21.32.30316 27542178,127,55,PMC5176231.txt
2.12.6.6,Neurosurg Focus . 2002 ;12 :e5 . 10.3171/foc.2002.12.6.6 15926784,294,49,Emerg_Infect_Dis_2015_Jun_21(6)_969-976.txt
5.20.4.210,...veill . 2015 ;20 :21022  . 10.2807/1560-7917.ES2015.20.4.21022 2565505,120,59,Emerg_Infect_Dis_2016_Jan_22(1)_121-123.txt
2.3.4.4,The continued reassortment of H5 clade 2.3.4.4 HPAI viruses with co-circulating HPAI an,156,40,Emerg_Infect_Dis_2016_Jul_22(7)_1283-1285.txt
2.3.2.1,...a human case in this study suggests that subclade 2.3.2.1 has emerged as the dominant variant in som...,33,2561,Emerg_Microbes_Infect_2012_Sep_19_1(9)_e25.txt
2.3.2.1,"...and 2.3.2.1. Residue R189G found in several clade 2.3.2.1 isolates from Bangladesh was unique, where...",68,154,Emerg_Microbes_Infect_2014_Feb_12_3(2)_e11.txt
2.3.2.1,"... method, the cluster shared a node with the clade 2.3.2.1 viruses from the A/HK/6841/10-like lineage...",104,241,Emerg_Microbes_Infect_2014_Feb_12_3(2)_e11.txt
2.3.2.1,...lates from the A/Hubei/1/10-like lineage of clade 2.3.2.1; • indicates Bangladesh isolates from the ...,163,323,Emerg_Microbes_Infect_2014_Feb_12_3(2)_e11.txt
2.3.2.1,A/Ck/BD/12197/11	2.3.2.1	08/14/11	Chicken	W	1,173,18,Emerg_Microbes_Infect_2014_Feb_12_3(2)_e11.txt
2.3.2.1,A/Env/BD/15126/12	2.3.2.1	01/18/12	Quail	F	4,181,19,Emerg_Microbes_Infect_2014_Feb_12_3(2)_e11.txt
2.4.1.461,"Emotion , 4 , 46 –64 . doi:10.1037/1528-3542.4.1.4615053726",115,44,Emotion_2012_Dec_9_12(6)_1200-1205.txt
5.2.98.102,...erly men Aging Male 5 2002 98 102 doi:10.1080/tam.5.2.98.102 12198740,186,126,Endocr_Connect_2015_Oct_5_4(4)_R68-R80.txt
5.30.2.117,...X2093-5978Korean Endocrine Society 10.3803/EnM.2015.30.2.117Review ArticleMitochondrial Energy Metab...,3,138,Endocrinol_Metab_(Seoul)_2015_Jun_30_30(2)_117-123.txt
6.31.1.134,...78Korean Endocrine Society 2667633410.3803/EnM.2016.31.1.134Original ArticleClinical StudyGlucose-De...,3,146,Endocrinol_Metab_(Seoul)_2016_Mar_16_31(1)_134-141.txt
6.31.4.559,...X2093-5978Korean Endocrine Society 10.3803/EnM.2016.31.4.559Original ArticleClinical StudyWaist Circ...,3,138,PMC5195833.txt
4.88.5.565,...esearch Plant Dis 2004 88 565 571 10.1094/PDIS.2004.88.5.565,203,241,Environ_Health_2014_Oct_1_13_75.txt
5.11.3.221,...p Environ Health 2005 11 3 221 232 10.1179/oeh.2005.11.3.221 16130962,220,199,Environ_Health_2014_Nov_20_13_98.txt
6.32.3.195,...erences Toxicol Res 2016 32 195 205 10.5487/TR.2016.32.3.195 27437086,401,256,PMC5316181.txt
3.13.3.3,...iscussions. The study was supported by grant CPBR 3.13.3.3.3,235,52,Environ_Health_Perspect_1992_Jul_97_255-257.txt
EC 1.10.3.1,(EC 1.10.3.1) (12). These oxidise tyrosine to dihyd...,127,2,Environ_Health_Perspect_1989_Mar_80_49-59.txt
4.53.2.337,...h J Pers Soc Psychol 53 2 337 348 10.1037/0022-3514.53.2.337 3625471,195,162,Environ_Health_Perspect_2007_Aug_19_115(8)_1154-1159.txt
3.26.3.173,...ea J Fish Pathol 2013 26 3 173 183 10.7847/jfp.2013.26.3.173,196,220,Environ_Sci_Pollut_Res_Int_2015_May_6_22(17)_13546-13555.txt
EC 1.4.1.4,"...ation of L-glutamate, and NADP(H)-dependent GDHs (EC 1.4.1.4) involved in biosynthetic reductive ami...",10,756,Enzyme_Res_2011_Aug_16_2011_595793.txt
EC 3.2.1.21,"...-β-D-glucanase (EC 3.2.1.91), and β-glucosidases (EC 3.2.1.21). The exoglucanase (CBH) acts on the e...",19,182,Enzyme_Res_2011_Sep_7_2011_280696.txt
3.1.1.20,...halam M   Screening of tannin acyl hydrolase (E.C.3.1.1.20) producing tannery effluent fungal isolat...,470,88,Enzyme_Res_2011_Sep_19_2011_823619.txt
EC 2.3.2.13,...rotein-glutamine glutamyltransferase E precursor (EC 2.3.2.13),192,82,EPMA_J_2014_Nov_28_5(1)_20.txt
1.1.57.64,...s Acta Odontol Scand 2003 61 1 57 64 10.1080/ode.61.1.57.64 12635783,220,233,EPMA_J_2016_Jun_2_7_12.txt
2.2.1.2,2.2.1.2 The screening par,76,1,Ergonomics_2015_Sep_2_58(9)_15195-1528.txt
4.19.2.278,...sychology and Aging  19 2 278 289 10.1037/0882-7974.19.2.278 15222821,284,183,PMC5213401.txt
5.14.3.370,...sia Neuropsychology 2000 14 3 370 10.1037/0894-4105.14.3.370 10928740,117,195,Eur_Arch_Otorhinolaryngol_2014_Oct_23_271(11)_2891-2896.txt
4.6.5.569,...Opin Investig Drugs 1997 6 569 582 10.1517/13543784.6.5.569 15989621,158,153,Eur_Biophys_J_2016_Jun_24_45(7)_621-633.txt
3.36.3.691,...Percept Mot Skills 1973 36 691 694 10.2466/pms.1973.36.3.691 4704305,270,130,Eur_J_Epidemiol_2015_Oct_31_30_1317-1328.txt
4.2.3.23,4.2.3.23 1-Pentyl-2-[(1E)-dodecenyl]-4-(1H)-quinol...,173,1,Eur_J_Med_Chem_2011_Jun_46(6)_2091-2101.txt
5.1.1.29,"5.1.1.29 3-((6,7-Dimethoxyquinazolin-4-yl)oxy)phen...",187,1,Eur_J_Med_Chem_2016_Apr_13_112_20-32.txt
3.2.1.1,3.2.1.1 Effect of NPs siz,73,1,Eur_J_Pharm_Biopharm_2014_Feb_86(2)_145-155.txt
3.2.1.2,3.2.1.2 Effect of NPs polymer composition and hydr...,76,1,Eur_J_Pharm_Biopharm_2014_Feb_86(2)_145-155.txt
4.76.1.72,"...Social Psychology , 76 , 72 –89 . 10.1037/0022-3514.76.1.72 9972554",192,78,Eur_J_Psychol_2016_Feb_29_12(1)_137-152.txt
4.71.3.498,...Social Psychology 1996 71 498 511 10.1037/0022-3514.71.3.498 8831159,212,222,Eur_J_Psychotraumatol_2014_Sep_12_5_10_3402_ejpt_v5_24797.txt
4.19.16.207,...l . 2014 ;19 (16 ):20780 . 10.2807/1560-7917.ES2014.19.16.20780 24786262,320,343,Euro_Surveill_2016_Sep_22_21(38)_30346.txt
2.3.4.4,"..., while the current 2016 viruses cluster in clade 2.3.4.4 group B (Gochang-like)",64,692,PMC5291128.txt
4.19.50.209,...l . 2014 ;19 (50 ):20996 . 10.2807/1560-7917.ES2014.19.50.20996 25597538,172,63,PMC5291128.txt
6.30.3.229,...yball player VASA 2001 30 229 232 10.1024/0301-1526.30.3.229 11582956,254,161,PMC5306316.txt
1.12.1.1,...tions Korean J Radiol 2011 12 1 14 10.3348/kjr.2011.12.1.1 21228935,293,191,PMC5334375.txt
4.17.6.8,...erica Neurosurg Focus 2004 17 6 E8 10.3171/foc.2004.17.6.8 15636578,134,119,Eur_Spine_J_2013_May_16_22(Suppl_3)_329-336.txt
1.11.2.95,...mes Immune Network  2011 11 2 95 99 10.4110/in.2011.11.2.95 21637386,202,159,Evid_Based_Complement_Alternat_Med_2015_Mar_23_2015_608126.txt
2.24.4.438,...s of Dermatology  2012 24 4 438 443 10.5021/ad.2012.24.4.438 2-s2.0-84870799881 23197910,138,199,Evid_Based_Complement_Alternat_Med_2015_Jul_15_2015_676897.txt
1.72.2.146,... Periodontology  2001 72 2 146 151 10.1902/jop.2001.72.2.146 2-s2.0-0035259222 11288786,211,209,Evid_Based_Complement_Alternat_Med_2015_Sep_14_2015_175497.txt
3.26.1.46,...n Journal of Pain  2013 26 1 46 50 10.3344/kjp.2013.26.1.46 2-s2.0-84873549444 23342207,1294,175,Evid_Based_Complement_Alternat_Med_2015_Oct_12_2015_657809.txt
2.17.1.81,... Medical Science  2002 17 1 81 85 10.3346/jkms.2002.17.1.81 2-s2.0-0036480130 11850594,108,184,Evid_Based_Complement_Alternat_Med_2015_Nov_26_2015_520454.txt
2.9.3.2,"...tions, 100 batches, and 5000 iterations. FSTAT v. 2.9.3.2 (Goudet 2002) was used to calculate FIS fo...",34,481,Evol_Appl_2014_Dec_23_7(10)_1192-1208.txt
1.3.1.38,"Enoyl-CoA reductase (TER)	1.3.1.38	KOG1639	K10258	GO:0019166	Q8LCU7•, F4J6R6...",155,27,Evol_Bioinform_Online_2012_Sep_20_8_545-564.txt
EC 4.2.1.22,"...(CS, EC 2.5.1.47), cystathionine β synthase (CβS, EC 4.2.1.22), and cystathionine gamma lyase (CGL, ...",20,565,Evol_Bioinform_Online_2016_Nov_7_12_263-275.txt
EC 3.1.1.3,"...pancreatic lipase (triacylglycerol acyl hydrolase EC 3.1.1.3), an important enzyme of pancreatic jui...",43,327,EXCLI_J_2014_Aug_22_13_897-921.txt
3.5.1.1,"...ore, asparaginase (L-asparagine amidohydrolase, EC3.5.1.1), the enzyme that catalyzes the hydrolysis...",12,354,EXCLI_J_2016_Apr_18_15_268-279.txt
4.55.6.156,doi: 10.3349/ymj.2014.55.6.1562 25323892,495,21,Exp_Anim_2015_Jun_9_64(4)_343-352.txt
3.18.4.891,...m Percept Perform 1992 18 891 905 10.1037/0096-1523.18.4.891 1431753,99,156,Exp_Brain_Res_2010_May_19_203(1)_227-232.txt
3.18.3.849,...Percept Perform 1992 18 3 849 860 10.1037/0096-1523.18.3.849 1500880,120,182,Exp_Brain_Res_2010_Sep_5_205(3)_415-422.txt
EC 5.3.99.2,"... (6). PGD2 is formed by prostaglandin D synthase (EC 5.3.99.2) (PGDS), an isoform of which, lipocali...",12,236,Exp_Dermatol_2010_Aug_19(8)_751-753.txt
3.99.6.104,...mide J Neurosurg 99 1047 1052 2003 10.3171/jns.2003.99.6.1047 14705733,104,182,Exp_Ther_Med_2016_Jun_24_11(6)_2153-2162.txt
1.3.2.67,...y Asthma Immunol Res 3 67 73 2011 10.4168/aair.2011.3.2.67 21461244,41,174,Exp_Ther_Med_2016_Oct_7_12(4)_2383-2386.txt
EC 1.2.7.1,"...e kinase (7; EC 2.7.1.40), POR pyruvate synthase (EC 1.2.7.1), PRS ribose phosphate pyrophosphokinas...",105,2667,Extremophiles_2010_Jan_4_14(1)_119-142.txt
3.1.1.17,SSO2705	1B	Gluconolactonase (GL)	3.1.1.17	−0.16 (±0.20)	0.34 (±0.06),209,34,Extremophiles_2010_Jan_4_14(1)_119-142.txt
6.31.5.101,...t Limnol Oceanogr 1986 31 1010 1021 10.4319/lo.1986.31.5.1010,239,177,Extremophiles_2015_Jun_24_19(5)_885-897.txt
5.17.3.439,...sychology 2003 17 439 50 12959510 10.1037/0894-4105.17.3.439,115,200,F1000_Biol_Rep_2009_Oct_14_1_78.txt
5.1.47.51,10.1080/tam.5.1.47.51,696,13,F1000Res_2016_Mar_31_5_F1000_Faculty_Rev-420.txt
EC 1.14.14.1,"Cytochrome P450 monooxygenase CYP109E1, EC 1.14.14.1, UniProt ID: D5DKI8, Adrenodoxin redu...",48,41,FEBS_J_2016_Nov_17_283(22)_4128-4148.txt
EC 5.4.2.1,"...ssays performed for phosphoglycerate mutase (GPM, EC 5.4.2.1) in the direction of 3-phosphoglycerate...",130,56,FEBS_Lett_2013_Sep_2_587(17)_2832-2841.txt
2.4.2.3,2.4.2.3 Antioxidant enzymes determination,73,1,FEBS_Open_Bio_2012_May_30_2_119-128.txt
EC 5.1.1.4,... also includes the archetypical proline racemase (EC 5.1.1.4) and T4LHyp epimerase (EC 5.1.1.8) (Fig...,41,346,FEBS_Open_Bio_2014_Jul_10_4_617-626.txt
EC 2.4.2.11,Nicotinic acid phosphoribosyltransferase (EC 2.4.2.11) (NaPRTase) is the rate-limiting enzym...,16,43,FEBS_Open_Bio_2015_May_7_5_419-428.txt
3.4.6.551,...l Learn Mem Cogn 1978 4 6 551 578 10.1037/0278-7393.4.6.551,538,156,Fire_Sci_Rev_2015_Jan_8_4(1)_1.txt
EC 2.3.2.13,...anufacturing transglutaminase from animal origin (EC 2.3.2.13) have prompted scientists to search fo...,4,309,Folia_Microbiol_(Praha)_2014_Nov_8_59(3)_241-250.txt
5.21.6.680,"... . Neuropsychology  21 , 657 –673 10.1037/0894-4105.21.6.680 17983277",107,141,Front_Aging_Neurosci_2011_Dec_8_3_18.txt
4.75.1.115,10.2466/pr0.1994.75.1.115 7984717,213,16,Front_Aging_Neurosci_2013_Oct_2_5_56.txt
4.4.2.217,10.1037/0882-7974.4.2.217 2789749,110,17,Front_Aging_Neurosci_2014_Apr_9_6_64.txt
4.19.3.482,"19 , 482 –494 . 10.1037/0882-7974.19.3.482 15382998",380,33,Front_Aging_Neurosci_2014_Nov_12_6_307.txt
EC 3.4.24.15,"...t Aβ degrading activity of thimet oligopeptidase (EC 3.4.24.15) (Philibert et al., 2014)",13,1210,Front_Aging_Neurosci_2014_Nov_20_6_310.txt
3.20.4.267,10.1037/0278-6133.20.4.267 11515738,310,17,Front_Aging_Neurosci_2014_Nov_26_6_332.txt
4.13.3.405,"13 , 405 –423 .10.1037/0882-7974.13.3.405 9793117",233,32,Front_Aging_Neurosci_2014_Dec_17_6_338.txt
2.4.3.257,"4 , 257 –267 .10.1162/jocn.1992.4.3.257 23964882",368,31,Front_Aging_Neurosci_2014_Dec_17_6_338.txt
5.10.1.74,10.1037/0894-4105.10.1.74,200,17,Front_Aging_Neurosci_2015_Feb_25_7_17.txt
4.17.1.85,"17 , 85 –100 . 10.1037//0882-7974.17.1.85 11931290",143,33,Front_Aging_Neurosci_2015_Sep_29_7_186.txt
4.12.1.12,"12 , 12 –21 . 10.1037/0882-7974.12.1.12 9100264",97,31,Front_Aging_Neurosci_2016_Mar_1_8_39.txt
3.21.34.224,"21 , 224 –230 . 10.1027/0269-8803.21.34.224",179,33,PMC5281596.txt
5.21.6.657,"21 , 657 –673 . 10.1037/0894-4105.21.6.657 17983277",151,33,PMC5296296.txt
3.7.2.87,"...hol. Anim. Behav. Process. 7 , 87 10.1037/0097-7403.7.2.87 7241054",135,149,Front_Behav_Neurosci_2010_Jan_27_4_1.txt
EC 1.14.16.1,"...that encodes for the enzyme Phe hydroxylase (PAH, EC 1.14.16.1). This mutation results in a loss of ...",12,804,PMC5167755.txt
4.13.1.88,"13 , 88 –119 10.1037/0882-7974.13.1.88 9533193",195,30,Front_Behav_Neurosci_2013_Aug_26_7_111.txt
3.26.3.649,"26 , 649 –657 10.1037/0278-7393.26.3.649 10855423",205,31,Front_Behav_Neurosci_2013_Oct_8_7_139.txt
4.22.4.781,"22 , 781 –795 10.1037/0882-7974.22.4.781 18179297",239,31,Front_Behav_Neurosci_2013_Dec_6_7_189.txt
5.10.3.396,10.1037//0894-4105.10.3.396,228,18,Front_Behav_Neurosci_2014_Feb_13_8_30.txt
1.12.2.111,10.1515/REVNEURO.2001.12.2.111 11392453,127,21,Front_Behav_Neurosci_2014_Jun_23_8_218.txt
3.34.4.859,10.1037/0278-7393.34.4.859 18605874,281,17,Front_Behav_Neurosci_2014_Jul_25_8_250.txt
3.4.2.95,"4 , 95 –103 . 10.1037//0097-7403.4.2.95 670892",162,32,Front_Behav_Neurosci_2014_Oct_17_8_361.txt
4.67.2.319,10.1037/0022-3514.67.2.319,152,17,Front_Behav_Neurosci_2015_Jan_5_8_439.txt
5.11.1.138,"11 , 138 –146 . 10.1037/0894-4105.11.1.138 9055277",257,33,Front_Behav_Neurosci_2015_Nov_18_9_301.txt
3.27.1.195,"27 , 195 –205 . 10.1037/0096-1523.27.1.195 11248933",212,33,Front_Behav_Neurosci_2016_Feb_5_10_8.txt
2.61.5.336,"61 , 336 –347 . 10.13109/prkk.2012.61.5.336 22957394",291,34,Front_Behav_Neurosci_2016_Feb_5_10_8.txt
3.1.1.96,3.1.1.96		Insignificant E-value,93,2,Front_Bioeng_Biotechnol_2014_Dec_10_2_68.txt
1.16.6.100,"16 , 1004 –1014 .10.1359/jbmr.2001.16.6.1004 11393777",302,34,Front_Bioeng_Biotechnol_2015_Jun_2_3_79.txt
1.3.8.1,Enoyl-CoA reductase	fadE	1.3.8.1,66,26,Front_Cell_Dev_Biol_2015_Mar_24_3_17.txt
6.3.4.557,"3 , 557 –560 . 10.1517/14622416.3.4.557 12164778",249,31,Front_Cell_Dev_Biol_2016_Oct_25_4_116.txt
EC 1.16.1.1,... within this group encode mercury (II) reductase (EC 1.16.1.1). This enzyme mediates the generation ...,155,386,Front_Cell_Infect_Microbiol_2014_Aug_14_4_108.txt
4.9.8.172,"9 , 1723 –1729 . 10.1517/13543784.9.8.1723 11060771",194,33,PMC5186781.txt
5.3.6.737,10.1586/14737175.3.6.737 19810877,218,16,Front_Cell_Neurosci_2014_Sep_24_8_298.txt
3.21.34.188,188 –203 . 10.1027/0269-8803.21.34.188,286,28,Front_Cell_Neurosci_2016_Mar_7_10_53.txt
2.11.2.123,"11 , 123 –132 . 10.1517/14728222.11.2.123 17227229",110,32,PMC5288339.txt
EC 1.-.-.-,"... and nuclear lysine specific demethylase 1 (LSD1, EC 1.-.-.-) were tested as client flavoproteins. R...",93,543,Front_Chem_2015_Apr_22_3_30.txt
1.1.1.1,... ). Dicopper and disilver complexes of octaphyrin(1.1.1.1.1.1.1.1): reversible hydrolytic cleavage o...,271,97,PMC5338300.txt
4.6.1.100,"...ing . Neural Comput. 6 , 100 –126 10.1162/neco.1994.6.1.100",249,131,Front_Comput_Neurosci_2009_Sep_29_3_15.txt
3.7.3.242,10.1037/0097-7403.7.3.242 7252428,241,17,Front_Comput_Neurosci_2014_Jan_9_7_194.txt
3.1.2.5,(3.1.2.5) Ut(at)=Qt(at)−αsign(Qt(at))ht(at),84,3,Front_Comput_Neurosci_2014_Apr_16_8_47.txt
6.18.3.320,"18 , 320 –334 . 10.1162/jocn.2006.18.3.320 16512999",172,33,Front_Comput_Neurosci_2016_Oct_26_10_114.txt
3.16.1.79,...crinol Metab  (2003 ) 16 :79 –90 .10.1515/JPEM.2003.16.1.79 12585344,182,229,Front_Endocrinol_(Lausanne)_2014_Dec_1_5_205.txt
2.17.2.349,...ner Res  (2002 ) 17 (2 ):349 –57 .10.1359/jbmr.2002.17.2.349 11811566,226,188,Front_Endocrinol_(Lausanne)_2016_Jul_14_7_94.txt
2.4.2.62,10.4168/aair.2012.4.2.62 22379600,143,17,Front_Genet_2013_Apr_30_4_73.txt
6.3.1.117,10.1517/14622416.3.1.117 11966408,367,16,Front_Genet_2013_Dec_23_4_297.txt
6.8.11.151,10.2217/14622416.8.11.1511 18034616,227,16,Front_Genet_2014_Apr_16_5_78.txt
4.2.3.12,"1B66	4.2.3.12	[88, 42, 133, 89]	75	0.7033398",259,6,Front_Genet_2014_Sep_2_5_302.txt
1.1.2.1,1.1.2.1	Fos factors,186,1,Front_Genet_2016_Apr_5_7_42.txt
3.13.3.501,".... Learn. Mem. Cogn. 13 , 501 –508 10.1037/0278-7393.13.3.501",310,138,Front_Hum_Neurosci_2010_Oct_8_4_166.txt
3.19.6.125,"...ercept. Perform.  19 , 1251 –1265 10.1037/0096-1523.19.6.1251 8294890",173,228,Front_Hum_Neurosci_2011_Sep_30_5_97.txt
3.34.4.958,"34 , 958 –973 10.1037/0096-1523.34.4.958 18665738",153,31,Front_Hum_Neurosci_2012_Feb_3_6_3.txt
2.7.4.882,"...ppression . Emotion  7 , 882 –886 10.1037/1528-3542.7.4.882 18039058",370,174,Front_Hum_Neurosci_2011_Dec_20_5_167.txt
3.34.1.158,10.1037/0096-1523.34.1.158 18248146,330,17,Front_Hum_Neurosci_2012_Mar_28_6_65.txt
3.11.3.501,10.1037/0278-7393.11.3.501 3160813,252,17,Front_Hum_Neurosci_2012_Apr_12_6_80.txt
6.18.7.115,10.1162/jocn.2006.18.7.1156 16839289,258,17,Front_Hum_Neurosci_2012_Apr_12_6_80.txt
3.32.3.618,10.1037/0096-1523.32.3.618 16822128,373,17,Front_Hum_Neurosci_2012_Apr_24_6_82.txt
5.12.1.3,10.1037/0894-4105.12.1.3 9460730,542,17,Front_Hum_Neurosci_2012_Apr_20_6_66.txt
3.32.3.633,10.1037/0096-1523.32.3.633 16822129,284,17,Front_Hum_Neurosci_2013_Feb_1_7_11.txt
2.1.2.166,10.1037/1528-3542.1.2.166 1289919,212,17,Front_Hum_Neurosci_2013_May_13_7_188.txt
2.7.2.336,10.1037/1528-3542.7.2.336 17516812,347,17,Front_Hum_Neurosci_2013_Jun_11_7_261.txt
3.21.34.224,10.1027/0269-8803.21.34.224,132,17,Front_Hum_Neurosci_2013_Jun_12_7_267.txt
4.73.4.733,10.1037/0022-3514.73.4.733 9325591,222,17,Front_Hum_Neurosci_2013_Jun_13_7_240.txt
2.30.3.275,10.1525/mp.2012.30.3.275,106,15,Front_Hum_Neurosci_2013_Jun_13_7_280.txt
3.16.2.391,"16 , 391 –397 10.1037/0096-1523.16.2.391 2142207",635,31,Front_Hum_Neurosci_2013_Jul_30_7_428.txt
4.67.6.972,"67 , 972 –983 10.1037/0022-3514.67.6.972",306,31,Front_Hum_Neurosci_2013_Aug_2_7_450.txt
6.18.9.158,"18 , 1586 –1594 10.1162/Jocn.2006.18.9.1586 16989558",329,33,Front_Hum_Neurosci_2013_Aug_30_7_535.txt
4.77.1.135,10.1037/0022-3514.77.1.135,155,17,Front_Hum_Neurosci_2013_Sep_3_7_528.txt
3.35.1.94,10.1037/0096-1523.35.1.94 19170473,187,17,Front_Hum_Neurosci_2013_Sep_4_7_519.txt
4.45.3.513,10.1037/0022-3514.45.3.513,451,17,Front_Hum_Neurosci_2013_Sep_19_7_508.txt
6.18.10.163,10.1162/jocn.2006.18.10.1631 17014368,154,17,Front_Hum_Neurosci_2013_Dec_2_7_821.txt
5.9.2.229,10.1037/0894-4105.9.2.229,227,17,Front_Hum_Neurosci_2013_Nov_22_7_779.txt
1.39.4.503,10.2224/sbp.2011.39.4.503,160,16,Front_Hum_Neurosci_2013_Dec_18_7_875.txt
6.39.3.253,"39 , 253 –256 10.1162/leon.2006.39.3.253",313,31,Front_Hum_Neurosci_2014_Jan_13_7_938.txt
4.80.6.101,10.1037/0022-3514.80.6.1011,268,17,Front_Hum_Neurosci_2014_Feb_25_8_84.txt
4.54.6.106,10.1037/0022-3514.54.6.1063 3397865,178,17,Front_Hum_Neurosci_2014_Feb_28_8_97.txt
3.10.1.72,10.1037/0278-7393.10.1.72,180,17,Front_Hum_Neurosci_2014_Mar_7_8_126.txt
4.70.3.614,"...Pers. Soc. Psychol. 70 , 614 –636 10.1037/0022-3514.70.3.614 8851745",297,136,Front_Hum_Neurosci_2010_Feb_26_4_19.txt
6.18.5.715,10.1162/jocn.2006.18.5.715 16768372,269,17,Front_Hum_Neurosci_2014_Mar_26_8_152.txt
5.21.6.657,10.1037/0894-4105.21.6.657 17983277,270,17,Front_Hum_Neurosci_2014_Apr_11_8_219.txt
4.70.3.614,10.1037/0022-3514.70.3.614 8851745,241,17,Front_Hum_Neurosci_2014_May_5_8_275.txt
3.25.6.678,10.1037/0278-6133.25.6.678 17100496,399,17,Front_Hum_Neurosci_2014_May_5_8_258.txt
3.28.2.335,10.1037/0278-7393.28.2.335 11911388,644,17,Front_Hum_Neurosci_2014_May_6_8_236.txt
3.10.5.601,10.1037/0096-1523.10.5.601 6238122,458,17,Front_Hum_Neurosci_2014_May_22_8_331.txt
3.34.4.811,10.1037/0096-1523.34.4.811 18665727,165,17,Front_Hum_Neurosci_2014_Aug_1_8_582.txt
3.27.4.907,10.1037//0278-7393.27.4.907 11486923,365,18,Front_Hum_Neurosci_2014_Aug_11_8_598.txt
3.34.2.460,10.1037/0096-1523.34.2.460 18377182,330,17,Front_Hum_Neurosci_2014_Sep_1_8_628.txt
4.92.1.56,10.1037/0022-3514.92.1.56 17201542,208,17,Front_Hum_Neurosci_2014_Sep_24_8_748.txt
4.94.4.547,10.1037/0022-3514.94.4.547 18361671,303,17,Front_Hum_Neurosci_2014_Sep_29_8_747.txt
6.18.4.871,"18 , 871 –903 . 10.1162/neco.2006.18.4.871 16494694",113,33,Front_Hum_Neurosci_2014_Dec_5_8_977.txt
1.22.3.228,10.1891/0889-8391.22.3.228,652,17,Front_Hum_Neurosci_2014_Dec_16_8_958.txt
3.17.1.103,"17 , 103 –114 . 10.1037/0278-7393.17.1.103 1826727",225,33,Front_Hum_Neurosci_2015_Feb_11_9_49.txt
4.64.5.723,"...s. Soc. Psychol . 64 , 723 –739 . 10.1037/0022-3514.64.5.723 8505704",53,195,Front_Hum_Neurosci_2015_Mar_5_9_122.txt
6.39.2.155,10.1162/leon.2006.39.2.155,445,17,Front_Hum_Neurosci_2015_Apr_28_9_218.txt
4.61.3.413,10.1037/0022-3514.61.3.413 1941512,289,17,Front_Hum_Neurosci_2015_May_5_9_187.txt
3.10.3.266,"10 , 266 –272 . 10.4306/pi.2013.10.3.266 24302950",256,31,Front_Hum_Neurosci_2015_Jun_16_9_356.txt
2.4.1.46,"4 , 46 –64 . 10.1037/1528-3542.4.1.46 15053726",212,30,Front_Hum_Neurosci_2015_Aug_28_9_482.txt
2.1.1.4,2.1.1.4. Adulthoo,52,1,Front_Hum_Neurosci_2016_May_11_10_211.txt
6.23.4.234,"26 , 234 –244 . 10.2519/jospt.1996.23.4.234 8775368",103,34,Front_Hum_Neurosci_2016_Jun_28_10_323.txt
4.61.1.115,"61 , 115 –121 . 10.1037/0022-3514.61.1.115 1890582",252,33,Front_Hum_Neurosci_2016_Nov_2_10_553.txt
2.8.2.250,10.1037/1528-3542.8.2.250,419,17,PMC5289964.txt
4.23.1.104,"23 , 104 –118 . 10.1037/0882-7974.23.1.104 18361660",275,33,PMC5337694.txt
4.7.3.373,...t Rev Vaccines  (2008 ) 7 :373 –81 10.1586/14760584.7.3.373 18393607,461,137,Front_Immunol_2013_Dec_9_4_433.txt
5.2.6.809,... Rev Neurother  (2002 ) 2 :809 –14 10.1586/14737175.2.6.809 19810914,225,86,Front_Immunol_2014_Apr_7_5_143.txt
3.4.14.5,"Dipeptidyl-peptidase 4 (EC3.4.14.5) is a type II transmembrane protein, whic...",22,27,Front_Immunol_2015_Jul_27_6_386.txt
3.6.2.8,"... IgG1κ Isotype Control-FITC (eBioscience, clone: P3.6.2.8.1), Mouse IgG1κ Isotype Control-PE (eBiosc...",38,670,PMC5179518.txt
1.3.3.168,...unol Res  (2011 ) 3 (3 ):168 –77 .10.4168/aair.2011.3.3.168 21738882,156,112,PMC5303715.txt
3.24.1.15,"...nim. Behav. Process.  24 , 15 –33 10.1037/0097-7403.24.1.15 9438963",74,215,Front_Integr_Neurosci_2011_Sep_9_5_47.txt
4.85.2.231,"85 , 231 –248 10.1037/0022-3514.85.2.231 12916567",58,31,Front_Integr_Neurosci_2012_Jun_18_6_33.txt
3.30.3.411,10.1037/0096-1523.30.3.411 15161376,921,17,Front_Integr_Neurosci_2012_Mar_6_6_7.txt
3.32.4.973,10.1037/0096-1523.32.4.973 16846292,336,17,Front_Integr_Neurosci_2014_Sep_11_8_70.txt
4.2.3.323,...nterol Hepatol  (2008 ) 2 :323 –35 10.1586/17474124.2.3.323 19072383,220,121,Front_Med_(Lausanne)_2014_Mar_24_1_5.txt
EC 4.1.1.82,"...led enzyme, phosphonopyruvate decarboxylase (Ppd; EC 4.1.1.82), which subsequently converts phosphon...",22,660,Front_Microbiol_2012_Jan_26_3_19.txt
1.36.8.185,"36 , 1851 –1864 10.4319/lo.1991.36.8.1851",280,31,Front_Microbiol_2012_Jun_7_3_204.txt
1.13.11.-,"1.13.11.-	2,3-dihydroxy-p-cumate dioxygenase (CmtC...",58,1,Front_Microbiol_2014_Jul_15_5_346.txt
4.94.6.561,10.1094/PHYTO.2004.94.6.561 18943480,206,18,Front_Microbiol_2014_Jul_18_5_360.txt
1.56.5.157,10.4319/lo.2011.56.5.1577,210,15,Front_Microbiol_2015_Apr_28_6_364.txt
1.6.5.4,...K.   (1984 ). Mono dehydro ascorbate reductase EC-1.6.5.4 in spinach chloroplasts and its participat...,216,78,Front_Microbiol_2015_May_21_6_387.txt
4.19.20.208,...uro Surveill . 19 :20809 . 10.2807/1560-7917.es2014.19.20.20809 24871756,144,209,Front_Microbiol_2015_Jun_16_6_595.txt
3.58.5.160,1605 –1620 . 10.4319/lo.2013.58.5.1605,310,28,Front_Microbiol_2015_Jul_10_6_696.txt
4.2.1.24,...7	0.85	Delta-aminolevulinic acid chloroplastic	EC:4.2.1.24; EC:3.1.3.11	1659	XP_001701779	0	Chlamydo...,103,71,Front_Microbiol_2015_Jul_14_6_526.txt
3.1.3.32,...ctional polynucleotide phosphatase kinase-like	EC:3.1.3.32; EC:2.7.1.78	1958	XP_004336369	9.31E-100	...,112,83,Front_Microbiol_2015_Jul_14_6_526.txt
6.8.12.188,1885 –1902 . 10.1517/14656566.8.12.1885 17696791,369,29,Front_Microbiol_2015_Nov_19_6_1208.txt
EC 1.6.5.11,"...cluding genes for an NADH-quinone oxidoreductase (EC 1.6.5.11), a succinate dehydrogenase/fumarate r...",87,253,Front_Microbiol_2015_Dec_10_6_1396.txt
3.2.6.605,605 –618 . 10.2217/17460913.2.6.605 1804190,362,27,Front_Microbiol_2016_Jan_28_7_27.txt
EC 2.3.3.1,"...ailable drafts, only a putative citrate synthase (EC 2.3.3.1) and both subunits of a putative succin...",229,1535,Front_Microbiol_2016_Feb_25_7_211.txt
3.2.1.4,"...1666	Chitin, xylan, or cellulose-binding function	3.2.1.4",68,130,Front_Microbiol_2016_Apr_29_7_624.txt
6.5.4.433,433 –438 . 10.1517/14622416.5.4.433 15165179,217,27,Front_Microbiol_2016_Jun_21_7_964.txt
EC 3.2.1.139,"...to cleave glucuronic acid [i.e., α-glucuronidase (EC 3.2.1.139)], ferulic acid [i.e., ferulic acid e...",127,696,Front_Microbiol_2016_Jun_28_7_979.txt
EC 4.2.2.3,"....2.11), the second type specific toward M blocks (EC 4.2.2.3), and the third type is bifunctional fo...",18,684,Front_Microbiol_2016_Jul_19_7_1120.txt
EC 3.4.17.-,"...ptidases (EC 3.4.11.-), metallocarboxypeptidases (EC 3.4.17.-), omega peptidases (EC 3.4.19.-), seri...",63,755,Front_Microbiol_2016_Aug_25_7_1333.txt
EC 5.1.99.5,"...mate racemases (EC 5.1.1.3), hydantoin racemases (EC 5.1.99.5) and maleate isomerases (EC 5.2.1.1). ...",14,2681,Front_Microbiol_2016_Aug_25_7_1332.txt
4.94.10.112,1129 –1135 . 10.1094/PHYTO.2004.94.10.1129 18943802,244,31,Front_Microbiol_2016_Sep_21_7_1482.txt
1.14.17.4,"...e ACC oxidase (ACO or ethylene-forming enzyme; EC:1.14.17.4), and regulates a number of physiologica...",16,444,Front_Microbiol_2016_Sep_30_7_1577.txt
2.7.8.20,2	4	2.7.8.20	Glycerophosphotransferase	Glycerolipid me...,590,5,Front_Microbiol_2016_Nov_18_7_1854.txt
EC 1.4.1.3,"...abolism: gdhA, glutamate dehydrogenase (NAD(P)+) [EC 1.4.1.3]; glnA, glutamine synthetase [EC 6.3.1....",137,64,Front_Microbiol_2016_Nov_30_7_1902.txt
3.3.3.361,"3 , 361 –370 . 10.2217/17460913.3.3.361 18505401",229,31,PMC5174137.txt
4.19.13.207,19 :20751 . 10.2807/1560-7917.ES2014.19.13.20751 24721538,253,36,PMC5290000.txt
6.41.6.120,1208 –1219 . 10.4319/lo.1996.41.6.1208,259,28,PMC5323390.txt
EC 2.3.3.5,"...yl-CoA with oxaloacetate to form 2-methylcitrate (EC 2.3.3.5), which is converted to methylisocitrat...",94,139,Front_Mol_Biosci_2015_Mar_4_2_6.txt
5.6.2.125,10.1515/REVNEURO.1995.6.2.125 8564024,266,21,Front_Neural_Circuits_2013_Aug_14_7_132.txt
3.27.4.316,10.1037/0097-7403.27.4.316 11676083,248,17,Front_Neural_Circuits_2014_Apr_24_8_39.txt
2.25.1.7,10.3344/kjp.2012.25.1.7 22259710,254,16,Front_Neural_Circuits_2014_Jun_11_8_62.txt
5.16.4.359,10.1515/REVNEURO.2005.16.4.359 16519011,169,21,Front_Neuroanat_2013_Nov_12_7_38.txt
2.3.1.1,2.3.1.1. Dimensionality of the inpu,81,1,Front_Neuroinform_2016_Aug_3_10_31.txt
4.16.5.8,"...e Report . Neurosurg. Focus 16 , 7 10.3171/foc.2004.16.5.8",61,231,Front_Neurol_2010_Jul_12_1_11.txt
5.7.3.273,...ropsychology  (1993 ) 7 :273 –95 .10.1037/0894-4105.7.3.273,101,174,Front_Neurol_2015_Aug_20_6_176.txt
4.79.6.995,...ychol  (2000 ) 79 (6 ):995 –1006 .10.1037/0022-3514.79.6.995 11138768,226,64,PMC5331032.txt
2.2.3.3,2.2.3.3.2 HRI Categor,431,1,Front_Neurorobot_2016_Oct_3_10_10.txt
2.2.4.2,2.2.4.2.3 Pragmatic Fram,465,1,Front_Neurorobot_2016_Oct_3_10_10.txt
4.32.2.311,"32 , 311 –328 10.1037/0022-3514.32.2.311",377,31,Front_Neurosci_2012_Apr_18_6_46.txt
2.1.3.3,2.1.3.3. Stimulus Specific Information. As artific...,49,1,Front_Neurosci_2014_Jan_17_7_278.txt
4.2.2.2,4.2.2.2. Hidden markov model with volatility. The ...,211,1,Front_Neurosci_2014_Feb_21_8_30.txt
2.7.2.377,10.1037/1528-3542.7.2.377 17516815,196,17,Front_Neurosci_2014_May_1_8_94.txt
3.26.6.179,10.1037/0096-1523.26.6.1797 11129375,203,17,Front_Neurosci_2014_May_1_8_94.txt
3.26.2.648,10.1037/0096-1523.26.2.648 10811168,476,17,Front_Neurosci_2014_Aug_19_8_243.txt
3.25.4.997,"...arn. Mem. Cogn . 25 , 997 –1010 . 10.1037/0278-7393.25.4.997 10439505",142,184,Front_Neurosci_2014_Nov_5_8_354.txt
2.73.5.511,".... J. Periodontol . 73 , 511 –516 . 10.1902/jop.2002.73.5.511 12027253",268,249,Front_Neurosci_2015_Mar_4_9_69.txt
4.97.4.595,"...Behav. Neurosci . 97 , 595 –601 . 10.1037/0735-7044.97.4.595 6615635",230,219,Front_Neurosci_2015_Jun_16_9_219.txt
3.19.3.204,"19 , 204 –215 . 10.1027/0269-8803.19.3.204",292,33,Front_Neurosci_2016_Feb_15_10_23.txt
2.1.3.2,2.1.3.2. Single fi,101,1,Front_Neurosci_2016_Apr_25_10_176.txt
2.45.11.232,"45 , 612 –622 . 10.5483/BMBRep.2012.45.11.232 23186999",39,35,Front_Neurosci_2016_May_10_10_213.txt
4.57.4.249,"57 , 249 –259 . 10.5468/ogs.2014.57.4.249 25105097",189,32,Front_Neurosci_2016_Sep_30_10_435.txt
2.1.4.4,2.1.4.4. Step 4: the selection of the linking func...,73,1,PMC5307491.txt
4.76.1.129,...Soc Psychol  (1999 ) 76 (1 ):129 .10.1037/0022-3514.76.1.129 9972558,229,187,Front_Nutr_2015_Apr_1_2_8.txt
2.11.11.144,"11 , 1443 –1457 10.1517/14728222.11.11.1443 18028009",665,32,Front_Oncol_2011_May_3_1_5.txt
3.16.2.138,...reast Cancer  (2013 ) 16 :138 –45 .10.4048/jbc.2013.16.2.138 23843844,138,178,Front_Oncol_2014_Nov_26_4_340.txt
2.30.3.99,...diat Oncol J  (2012 ) 30 :99 –107 .10.3857/roj.2012.30.3.99 23170288,326,202,Front_Oncol_2015_Dec_22_5_286.txt
6.9.3.267,...ure. Pharmacogenomics  9  267 –276 10.2217/14622416.9.3.267 18303963,107,255,Front_Pharmacol_2010_Oct_4_1_118.txt
3.12.1.24,"12 , 24 –32 10.1037/0278-6133.12.1.24 8462495",94,29,Front_Pharmacol_2012_Jul_25_3_147.txt
5.4.2.165,10.1517/17425255.4.2.165 18248310,145,16,Front_Pharmacol_2014_Sep_23_5_216.txt
3.45.1.32,"45 , 32 –43 . 10.3947/ic.2013.45.1.32 24265948",180,29,Front_Pharmacol_2016_Jun_17_7_170.txt
5.21.1.76,"21 , 76 –88 . 10.18553/jmcp.2015.21.1.76 25562775",157,32,Front_Pharmacol_2016_Jul_26_7_222.txt
3.14.3.207,"14 , 207 –216 10.1515/REVNEURO.2003.14.3.207",191,35,Front_Physiol_2012_Sep_25_3_372.txt
2.62.3.209,10.4097/kjae.2012.62.3.209 22474545,229,17,Front_Physiol_2014_May_19_5_187.txt
2.9.3.447,"9 , 447 –456 . 10.1517/14728222.9.3.447 15948666",211,31,Front_Physiol_2014_Oct_30_5_422.txt
5.6.4.591,"...rt Rev. Neurother . 6 , 591 –598 . 10.1586/14737175.6.4.591 16623657",152,55,Front_Physiol_2015_Apr_7_6_108.txt
1.14.10.113,"14 , 1131 –1139 10.1094/MPMI.2001.14.10.1131 11605952",185,33,Front_Plant_Sci_2011_Oct_31_2_71.txt
2.4.15.7,chr3.CM0135.11_at	1.81	0.029	2.4.15.7	2.76	0.01	At2g05990	Enoyl-ACP reductase (...,125,30,Front_Plant_Sci_2012_Jun_11_3_120.txt
4.94.2.171,171 –176 10.1094/PHYTO.2004.94.2.171 18943540,255,27,Front_Plant_Sci_2013_Jun_24_4_206.txt
2.1.1.46,"...-); HI4′OMT, isoflavone 4-O-methyltransferase (EC:2.1.1.46); IF7MaT, isoflavone 7-O-methyltransferas...",105,2306,Front_Plant_Sci_2013_Sep_5_4_317.txt
2.15.6.522,10.1094/MPMI.2002.15.6.522 12059100,411,17,Front_Plant_Sci_2013_Sep_26_4_376.txt
3.2.1.23,...ase; EC2.7.7.27: ADP-glucose pyrophosphorylase; EC3.2.1.23: β-galactosidase; EC23.2.1.26: β-fructofu...,123,681,Front_Plant_Sci_2014_May_15_5_197.txt
2.1.1.1,Plastid ribosomal protein L12-3 (PRPL12-3)	2	29.2.1.1.1.2.12	15232276	AT3G27850	cTP 0.955 RC 1	Thi...,63,49,Front_Plant_Sci_2014_Oct_29_5_557.txt
EC 5.5.1.6,"...kins, 1998). One such is chalcone isomerase (CHI, EC 5.5.1.6), which is involved in the very early p...",16,137,Front_Plant_Sci_2015_Apr_21_6_268.txt
4.17.6.633,633 –643 . 10.1094/MPMI.2004.17.6.633 15195946,214,28,Front_Plant_Sci_2015_Aug_3_6_599.txt
2.92.8.893,"92 , 893 –899 . 10.1094/PHYTO.2002.92.8.893 18942969",356,34,Front_Plant_Sci_2015_Aug_6_6_573.txt
EC 1.11.1.7,"...ends of changes comparing D10 and D20—peroxidase (EC 1.11.1.7)—D10 decrease, D20 increase, S-adenosy...",79,3190,Front_Plant_Sci_2015_Aug_14_6_627.txt
1.8.5.1,...reductase (DHAR). Dehydroascorbate reductase (EC: 1.8.5.1) activity was determined by the procedure ...,66,68,Front_Plant_Sci_2015_Oct_14_6_868.txt
EC 4.3.1.5,"...media activates phenylalanine ammonia lyase (PAL, EC 4.3.1.5), the key enzyme of phenylpropanoid com...",81,769,Front_Plant_Sci_2015_Oct_30_6_927.txt
EC 1.7.99.4,Activity of nitrate reductase (NR; EC 1.7.99.4) in leaf was measured by preparing enz...,45,36,Front_Plant_Sci_2016_Feb_3_7_44.txt
2.7.1.36,"MVK, mevalonate kinase	2.7.1.36	4",97,24,Front_Plant_Sci_2016_Mar_29_7_339.txt
1.11.1.7,LjSGA_043353.1	2.85	5.00E−05	Peroxidase [EC:1.11.1.7]	K00430,119,47,Front_Plant_Sci_2016_Mar_30_7_374.txt
1.77.1.3,"77 , 3 –11 . 10.1024/0300-9831.77.1.3 17685090",509,30,Front_Plant_Sci_2016_Apr_28_7_531.txt
1.85.11.116,"...a . Plant Dis . 85 , 1160 –1164 . 10.1094/PDIS.2001.85.11.1160",212,218,Front_Plant_Sci_2016_May_24_7_686.txt
EC 1.14.13.11,"...tion of cinnamic acid by cinnamate 4-hydroxylase (EC 1.14.13.11, 2 transcripts) produces p-coumaric ...",83,438,Front_Plant_Sci_2016_Oct_27_7_1610.txt
1.14.13.72,"....1.1.41); (6) Sterol-4a-methyl oxidase (SMO, EC 1 1.14.13.72); (7) Cycloeucalenol cycloisomerase (CE...",22,1173,PMC5167740.txt
1.15.1.1,"...cavenging enzymes, superoxide dismutase (SOD, EC; 1.15.1.1), ascorbate peroxidase (APX, EC; 1.11.1.1...",14,1335,PMC5177644.txt
1.1.1.44,...ig_1414*	6-phosphogluconate decarboxylating 3 (EC:1.1.1.44)	1	4.47±0.2	3.82±0.56	0.71±0.27,336,64,PMC5322231.txt
5.12.3.426,"... . Neuropsychology  12 , 426 –445 10.1037/0894-4105.12.3.426 9673998",236,173,Front_Psychiatry_2011_Jul_25_2_46.txt
2.7.4.715,"7 , 715 –723 10.1037/1528-3542.7.4.715 18039038",323,30,Front_Psychiatry_2010_Dec_21_1_149.txt
3.97.2.451,"97 , 451 –460 10.2466/pms.2003.97.2.451 14620232",177,30,Front_Psychiatry_2013_Feb_26_3_97.txt
5.12.3.426,"12 , 426 –445 10.1037/0894-4105.12.3.426 9673998",298,31,Front_Psychiatry_2013_Jun_24_4_35.txt
4.79.5.776,... Soc Psychol  (2000 ) 79 :776 –92 10.1037/0022-3514.79.5.776 11079241,393,158,Front_Psychiatry_2013_Dec_27_4_179.txt
4.11.3.281,...iatry Investig  (2014 ) 11 :281 –9 .10.4306/pi.2014.11.3.281 25110501,226,140,Front_Psychiatry_2015_Feb_18_6_13.txt
5.16.1.5,...sychology  (2002 ) 16 (1 ):5 –14 .10.1037/0894-4105.16.1.5 11853357,142,257,Front_Psychiatry_2015_Dec_3_6_170.txt
3.17.3.696,...erform  (1991 ) 17 (3 ):696 –714 .10.1037/0096-1523.17.3.696 1834785,241,245,Front_Psychiatry_2016_Jun_16_7_106.txt
1.11.3.347,... Policy Law  (2005 ) 11 :347 –83 .10.1037/1076-8971.11.3.347,308,130,Front_Psychiatry_2016_Aug_24_7_144.txt
5.20.5.578,"... . Neuropsychology  20 , 578 –588 10.1037/0894-4105.20.5.578 16938020",200,230,Front_Psychol_2011_Jul_14_2_163.txt
3.4.5.527,"...l. Hum. Learn. Mem.  4 , 527 –538 10.1037/0278-7393.4.5.527",155,193,Front_Psychol_2011_Sep_9_2_197.txt
3.30.2.370,"... Learn. Mem. Cogn.  30 , 370 –381 10.1037/0278-7393.30.2.370 14979811",252,187,Front_Psychol_2011_Sep_9_2_211.txt
5.19.1.18,"...ts . Neuropsychology  19 , 18 –27 10.1037/0894-4105.19.1.18 15656759",209,190,Front_Psychol_2011_Sep_15_2_228.txt
4.51.3.505,"... J. Pers. Soc. Psychol.  51 , 505 10.1037/0022-3514.51.3.505 3761146",565,233,Front_Psychol_2011_Sep_27_2_224.txt
3.15.6.115,"...earn. Mem. Cogn.  15 , 1157 –1165 10.1037/0278-7393.15.6.1157 2530309",88,167,Front_Psychol_2011_Sep_28_2_245.txt
3.10.4.541,"...xp. Psychol. Gen.  109 , 444 –474 10.1037/0096-1523.10.4.541 6235318",150,155,Front_Psychol_2011_Sep_21_2_218.txt
3.19.6.129,"...earn. Mem. Cogn.  19 , 1297 –1320 10.1037/0278-7393.19.6.1297 8270888",294,200,Front_Psychol_2011_Oct_12_2_257.txt
2.5.1.55,"... or arousal?  Emotion  5 , 55 –66 10.1037/1528-3542.5.1.55 15755219",119,150,Front_Psychol_2011_Oct_31_2_281.txt
4.19.3.541,"...ory . Neurosci. Lett.  449 , 1 –5 10.1037/0882-7974.19.3.541 15383004",130,178,Front_Psychol_2011_Nov_1_2_268.txt
6.18.5.859,"...J. Cogn. Neurosci.  18 , 859 –870 10.1162/jocn.2006.18.5.859 16768383",241,187,Front_Psychol_2011_Nov_1_2_275.txt
6.18.5.859,"...J. Cogn. Neurosci.  18 , 859 –870 10.1162/jocn.2006.18.5.859 16768383",241,187,Front_Psychol_2011_Nov_1_2_275.txt
3.29.2.441,"... Percept. Perform.  29 , 441 –454 10.1037/0096-1523.29.2.441 12760627",349,268,Front_Psychol_2011_Nov_4_2_319.txt
3.22.2.336,"...ling. (Camb. Engl.)  1 , 193 –211 10.1037/0278-7393.22.2.336",330,209,Front_Psychol_2011_Dec_13_2_374.txt
3.18.3.849,"18 , 849 –860 10.1037/0096-1523.18.3.849 1500880",319,31,Front_Psychol_2012_Mar_29_3_92.txt
3.21.1.68,"21 , 68 –81 10.1037/0096-1523.21.1.68",715,29,Front_Psychol_2012_Apr_2_3_85.txt
4.64.4.613,"64 , 613 –623 10.1037/0022-3514.64.4.613 8473978",83,31,Front_Psychol_2012_May_14_3_144.txt
3.36.1.18,"36 , 18 –25 10.1026/1616-3443.36.1.18",317,29,Front_Psychol_2012_Jul_25_3_253.txt
3.29.2.289,"29 , 289 –297 10.1037/0278-7393.29.2.289 12696816",257,31,Front_Psychol_2012_Jul_27_3_265.txt
4.73.6.122,"73 , 1224 –1237 10.1037/0022-3514.73.6.1224",194,33,Front_Psychol_2012_Sep_14_3_343.txt
3.31.5.862,"31 , 862 –877 10.1037/0278-7393.31.5.862 16248738",498,31,Front_Psychol_2012_Jul_4_3_204.txt
3.11.5.598,"11 , 598 –616 10.1037/0096-1523.11.5.598",356,31,Front_Psychol_2012_Jul_16_3_213.txt
2.3.3.254,"3 , 254 –269 10.1037/1528-3542.3.3.254 14498795",454,30,Front_Psychol_2012_Oct_25_3_435.txt
4.56.4.543,"56 , 543 –554 10.1037/0022-3514.56.4.543",224,31,Front_Psychol_2012_Nov_2_3_475.txt
1.7.1.3,"7 , 3 –35 10.1037/1076-8971.7.1.3",146,27,Front_Psychol_2012_Nov_2_3_467.txt
3.27.1.229,"27 , 229 –240 10.1037/0096-1523.27.1.229 11248937",166,31,Front_Psychol_2012_Dec_21_3_535.txt
3.22.1.216,"22 , 216 –230 10.1037/0278-7393.22.1.216",381,31,Front_Psychol_2013_Feb_13_4_50.txt
3.33.1.32,"33 , 32 –41 10.1037/0097-7403.33.1.32 17227193",171,29,Front_Psychol_2013_May_2_4_253.txt
3.21.3.451,10.1037/0096-1523.21.3.451 7790827,219,17,Front_Psychol_2013_May_29_4_289.txt
4.10.3.307,"10 , 307 –313 10.1037/0882-7974.10.3.307 8527052",233,31,Front_Psychol_2013_May_31_4_309.txt
3.26.1.103,10.1037/0278-7393.26.1.103 10682292,80,17,Front_Psychol_2013_Jun_3_4_317.txt
2.4.2.243,"4 , 243 –248 10.1162/neco.1992.4.2.243",431,30,Front_Psychol_2013_Jun_7_4_313.txt
4.79.5.776,10.1037/0022-3514.79.5.776 11079241,107,17,Front_Psychol_2013_Jun_19_4_355.txt
3.24.1.227,10.1037/0278-7393.24.1.227 10689036,250,17,Front_Psychol_2013_Jun_25_4_366.txt
6.23.2.399,10.2466/pms.1966.23.2.399,312,16,Front_Psychol_2013_Jul_11_4_415.txt
4.75.1.242,10.1037/0022-3514.75.1.242 9686462,647,17,Front_Psychol_2013_Jul_11_4_415.txt
6.24.2.135,10.1525/mp.2006.24.2.135,284,15,Front_Psychol_2013_Aug_6_4_512.txt
5.7.4.519,...: Sheridan Psychological Services 10.1037/0894-4105.7.4.519,183,62,Front_Psychol_2013_Aug_23_4_555.txt
3.10.3.340,10.1037/0096-1523.10.3.340 6242411,219,17,Front_Psychol_2013_Aug_30_4_556.txt
3.57.1.155,10.2466/pms.1983.57.1.155 6622153,205,16,Front_Psychol_2013_Sep_13_4_629.txt
1.10.1.37,10.1515/zfsw.1991.10.1.37,212,17,Front_Psychol_2013_Sep_20_4_645.txt
4.51.2.67,10.1026/0012-1924.51.2.67,230,17,Front_Psychol_2013_Sep_30_4_669.txt
2.1.2.166,10.1037//1528-3542.1.2.166 1289919,275,18,Front_Psychol_2013_Sep_30_4_672.txt
5.3.1.1,5.3.1.1. Attention span and experimenter decision ...,170,1,Front_Psychol_2013_Oct_4_4_676.txt
5.13.4.557,10.1037/0894-4105.13.4.557 10527064,111,17,Front_Psychol_2013_Oct_8_4_652.txt
3.33.5.117,1170 –1176 10.1037/0096-1523.33.5.1170 17924815,195,28,Front_Psychol_2013_Oct_21_4_716.txt
3.20.5.976,10.1037/0096-1523.20.5.976 7964532,352,17,Front_Psychol_2013_Nov_5_4_825.txt
3.20.6.150,"...earn. Mem. Cogn.  18 , 1504 –1510 10.1037/0278-7393.20.6.1504 7983474",247,191,Front_Psychol_2010_Jun_17_1_16.txt
3.34.4.958,10.1037/0096-1523.34.4.958 18665738,305,17,Front_Psychol_2013_Dec_18_4_947.txt
3.26.5.119,1198 –1214 10.1037/0278-7393.26.5.1198 11009253,264,28,Front_Psychol_2013_Dec_19_4_943.txt
3.32.5.955,10.1037/0278-7393.32.5.955 16938039,265,17,Front_Psychol_2013_Dec_26_4_982.txt
4.21.4.561,10.1525/mp.2004.21.4.561,320,15,Front_Psychol_2013_Dec_30_4_998.txt
1.52.3.727,727 –732 10.2466/pms.1981.52.3.727 24171230,214,25,Front_Psychol_2014_Jan_2_4_987.txt
3.33.5.125,10.1037/0096-1523.33.5.1256 17924821,261,17,Front_Psychol_2014_Jan_24_5_17.txt
4.22.1.147,10.1037/0882-7974.22.1.147 17385991,232,17,Front_Psychol_2014_Feb_4_5_30.txt
3.12.3.397,10.1037/0278-7393.12.3.397,358,17,Front_Psychol_2014_Feb_5_5_11.txt
3.20.3.555,10.1037/0096-1523.20.3.555,516,17,Front_Psychol_2014_Feb_6_5_84.txt
3.74.4.506,10.1037/0022-0663.74.4.506,257,17,Front_Psychol_2014_Feb_7_5_75.txt
4.59.2.321,10.1037/0022-3514.59.2.321,283,17,Front_Psychol_2014_Feb_7_5_83.txt
3.26.3.547,10.1037//0278-7393.26.3.547 10855417,251,18,Front_Psychol_2014_Apr_22_5_328.txt
6.8.6.551,551 –565 10.1162/jocn.1996.8.6.551 20740065,141,26,Front_Psychol_2014_Apr_24_5_367.txt
4.7.3.331,10.1037/0882-7974.7.3.331 1388852,327,17,Front_Psychol_2014_Apr_28_5_338.txt
3.12.1.92,10.1037/0278-7393.12.1.92,317,17,Front_Psychol_2014_Apr_28_5_360.txt
4.15.4.684,10.1037/0882-7974.15.4.684 11144327,195,17,Front_Psychol_2014_May_6_5_380.txt
3.9.2.299,10.1037/0096-1523.9.2.299,684,17,Front_Psychol_2014_May_12_5_412.txt
3.30.5.795,10.1037/0096-1523.30.5.795 15462621,522,17,Front_Psychol_2014_May_13_5_409.txt
3.33.1.182,10.1037/0278-7393.33.1.182 17201561,122,17,Front_Psychol_2014_May_21_5_410.txt
3.33.1.182,10.1037/0278-7393.33.1.182 17201561,122,17,Front_Psychol_2014_May_21_5_410.txt
3.16.1.17,10.1037//0278-7393.16.1.17,185,18,Front_Psychol_2014_May_21_5_465.txt
4.87.6.974,10.1037/0022-3514.87.6.974 15598118,65,17,Front_Psychol_2014_May_26_5_498.txt
4.42.5.891,10.1037/0022-3514.42.5.891,340,17,Front_Psychol_2014_Jun_6_5_508.txt
3.93.2.346,10.1037/0022-0663.93.2.346,259,17,Front_Psychol_2014_Jun_10_5_556.txt
4.76.6.893,10.1037/0022-3514.76.6.893 10402679,243,17,Front_Psychol_2014_Jun_10_5_537.txt
3.78.4.243,10.1037/0022-0663.78.4.243,300,17,Front_Psychol_2014_Jun_11_5_575.txt
4.57.6.106,10.1037/0022-3514.57.6.1069,325,17,Front_Psychol_2014_Jun_23_5_497.txt
3.31.6.137,10.1037/0278-7393.31.6.1372 16393052,142,17,Front_Psychol_2014_Jun_24_5_644.txt
3.34.4.104,10.1037/0096-1523.34.4.1044,479,17,Front_Psychol_2014_Aug_8_5_855.txt
3.30.3.203,10.1037/0097-7403.30.3.203 15279511,129,17,Front_Psychol_2014_Aug_12_5_893.txt
4.40.2.290,10.1037/0022-3514.40.2.290,49,17,Front_Psychol_2014_Aug_14_5_897.txt
4.37.10.171,10.1037/0022-3514.37.10.1713 512835,250,17,Front_Psychol_2014_Sep_5_5_979.txt
6.28.2.211,10.1525/mts.2006.28.2.211,204,16,Front_Psychol_2014_Sep_16_5_1036.txt
2.5.3.267,10.1037/1528-3542.5.3.267 16187863,228,17,Front_Psychol_2014_Oct_2_5_1091.txt
3.18.1.50,10.1037/0096-1523.18.1.50,157,17,Front_Psychol_2014_Oct_2_5_1122.txt
6.18.10.166,"18 , 1663 –1665 . 10.1162/jocn.2006.18.10.1663 17014371",211,35,Front_Psychol_2014_Oct_21_5_1175.txt
4.92.6.110,"... Soc. Psychol . 92 , 1102 –1117 . 10.1037/0022-3514.92.6.1102 17547491",341,208,Front_Psychol_2014_Nov_17_5_1311.txt
3.21.34.147,10.1027/0269-8803.21.34.147,244,17,Front_Psychol_2014_Nov_18_5_1295.txt
3.33.6.132,"...cept. Perform . 33 , 1322 –1334 . 10.1037/0096-1523.33.6.1322 18085946",729,173,Front_Psychol_2015_Jan_14_5_1457.txt
3.33.3.461,"...earn. Mem. Cogn . 33 , 461 –474 . 10.1037/0278-7393.33.3.461 17470000",290,174,Front_Psychol_2015_Jan_28_6_23.txt
3.31.1.210,"31 , 210 –220 . 10.1037/0096-1523.31.1.210 15709874",121,33,Front_Psychol_2015_Jan_30_6_69.txt
4.67.6.949,10.1037/0022-3514.67.6.949,413,17,Front_Psychol_2015_Feb_16_6_100.txt
3.60.4.298,10.1037/1065-9293.60.4.298,231,17,Front_Psychol_2015_Feb_27_6_150.txt
3.17.3.807,10.1037/0096-1523.17.3.807 1834792,306,17,Front_Psychol_2015_Mar_20_6_270.txt
2.5.1.3,10.1037/1528-3542.5.1.3 15755215,136,17,Front_Psychol_2015_Mar_20_6_262.txt
4.87.3.327,...J. Pers. Soc. Psychol . 87 :327 . 10.1037/0022-3514.87.3.327 15382983,138,166,Front_Psychol_2015_Mar_25_6_315.txt
3.22.5.116,".... Mem. Cognit . 22 , 1166 –1183 . 10.1037/0278-7393.22.5.1166 8926483",213,189,Front_Psychol_2015_Mar_27_6_351.txt
3.32.1.101,"...J. Exp. Psychol . 32 , 101 –117 . 10.1037/0278-7393.32.1.101 16478344",369,200,Front_Psychol_2015_Mar_27_6_336.txt
3.29.3.692,"29 , 692 –712 . 10.1037/0096-1523.29.3.692 12848334",131,33,Front_Psychol_2015_Apr_7_6_403.txt
3.27.6.140,10.1037/0278-7393.27.6.1401 11713875,754,17,Front_Psychol_2015_Apr_10_6_384.txt
3.60.4.298,10.1037/1065-9293.60.4.298,225,17,Front_Psychol_2015_Apr_15_6_412.txt
4.57.6.102,"....Soc. Psychol . 57 , 1024 –1040 . 10.1037/0022-3514.57.6.1024 2614656",808,293,Front_Psychol_2015_May_6_6_481.txt
4.88.3.447,"88 , 447 –466 . 10.1037/0022-3514.88.3.447 15740439",285,33,Front_Psychol_2015_May_27_6_692.txt
4.54.6.106,1063 –1070 . 10.1037/0022-3514.54.6.1063 3397865,255,30,Front_Psychol_2015_Jun_4_6_732.txt
3.4.1.47,"... . J. Exp. Psychol . 4 , 47 –60 . 10.1037/0096-1523.4.1.47 627850",146,190,Front_Psychol_2015_Jun_8_6_756.txt
4.77.5.100,1004 –1010 . 10.1037/0022-3514.77.5.1004 10573877,269,30,Front_Psychol_2015_Jun_11_6_810.txt
3.28.5.114,1149 –1162 . 10.1037//0096-1523.28.5.1149 12421061,250,31,Front_Psychol_2015_Jun_15_6_827.txt
3.18.3.849,849 –860 . 10.1037//0096-1523.18.3.849 1500880,262,29,Front_Psychol_2015_Jun_15_6_827.txt
3.22.4.892,"22 , 892 –903 . 10.1037/0096-1523.22.4.892",362,33,Front_Psychol_2015_Jul_9_6_969.txt
4.82.4.582,"82 , 582 –593 . 10.1037/0022-3514.82.4.582 11999925",264,33,Front_Psychol_2015_Aug_4_6_1052.txt
4.59.3.538,"59 , 538 –549 . 10.1037//0022-3514.59.3.538 2231284",218,34,Front_Psychol_2015_Aug_7_6_1129.txt
2.71.1.87,87 –97 . 10.1037/0002-9432.71.1.87 1127172,374,26,Front_Psychol_2015_Aug_11_6_1210.txt
4.75.4.887,"75 , 887 –900 . 10.1037/0022-3514.75.4.887 9825526",271,33,Front_Psychol_2015_Aug_11_6_1137.txt
4.88.4.686,"88 , 686 –702 . 10.1037/0022-3514.88.4.686 15796668",178,33,Front_Psychol_2015_Aug_12_6_1180.txt
3.16.1.92,"16 , 92 –105 . 10.1037/0096-1523.16.1.92 2137526",216,32,Front_Psychol_2015_Aug_3_6_986.txt
4.56.1.5,5 –18 . 10.1037/0022-3514.56.1.5,340,25,Front_Psychol_2015_Aug_31_6_1311.txt
4.19.1.4,"19 , 4 –12 . 10.1037/0882-7974.19.1.4 15065927",436,30,Front_Psychol_2015_Sep_1_6_1323.txt
4.88.6.102,1029 –1038 . 10.1037/0022-3514.88.6.1029 15982120,300,30,Front_Psychol_2015_Sep_3_6_1337.txt
4.81.1.33,"81 , 33 –43 . 10.1037/0022-3514.81.1.33 11474723",340,31,Front_Psychol_2015_Sep_8_6_1321.txt
3.33.2.305,305 –320 . 10.1037/0278-7393.33.2.305,351,28,Front_Psychol_2015_Sep_8_6_1320.txt
3.90.3.435,"90 , 435 –447 . 10.1037/0022-0663.90.3.435",187,33,Front_Psychol_2015_Sep_8_6_1292.txt
3.32.2.230,"32 , 230 –248 . 10.1037/0278-7393.32.2.230 16569143",605,33,Front_Psychol_2015_Sep_16_6_1289.txt
3.34.1.178,178 –184 . 10.1037/0097-7403.34.1.178 18248124,99,28,Front_Psychol_2015_Sep_2_6_1334.txt
2.18.34.201,"18 , 201 –212 . 10.1024/1010-0652.18.34.201",195,33,Front_Psychol_2015_Sep_17_6_1404.txt
4.15.2.323,"15 , 323 –334 . 10.1037/0882-7974.15.2.323 10879586",168,33,Front_Psychol_2015_Aug_11_6_1065.txt
4.63.4.596,"63 , 596 –612 . 10.1037/0022-3514.63.4.596",297,33,Front_Psychol_2015_Oct_14_6_1459.txt
3.29.3.416,"29 , 416 –431 . 10.1037/0278-7393.29.3.416 12776752",177,33,Front_Psychol_2015_Oct_15_6_1571.txt
4.57.4.731,731 –739 . 10.1037/0022-3514.57.4.731,343,28,Front_Psychol_2015_Oct_29_6_1650.txt
3.5.3.345,345 –362 . 10.1162/jocn.1993.5.3.345 23972222,422,28,Front_Psychol_2015_Oct_30_6_1638.txt
3.6.1.77,"...sycho. Hum. Learn . 6 , 91 –105 . 10.1037/0278-7393.6.1.77 7373245",290,193,Front_Psychol_2015_Nov_5_6_1702.txt
3.2.5.509,509 –522 . 10.1037/0278-7393.2.5.509 1003124,398,28,Front_Psychol_2015_Nov_16_6_1741.txt
3.1.1.1,3.1.1.1. Experiment 2,85,1,Front_Psychol_2016_Jan_5_6_1977.txt
3.33.2.407,"...earn. Mem. Cogn . 33 , 407 –430 . 10.1037/0278-7393.33.2.407 17352621",578,189,Front_Psychol_2016_Jan_5_6_1966.txt
4.67.4.674,674 –687 . 10.1037/0022-3514.67.4.674 7965613,772,28,Front_Psychol_2016_Jan_7_6_1882.txt
4.74.2.345,"74 , 345 –359 . 10.1037/0022-3514.74.2.345",348,33,Front_Psychol_2016_Jan_8_6_2000.txt
4.56.5.698,698 –708 . 10.1037/0022-3514.56.5.698 2724065,710,28,Front_Psychol_2016_Jan_20_7_8.txt
4.35.12.847,847 –862 . 10.1037/0022-3514.35.12.847,303,28,Front_Psychol_2016_Jan_27_7_23.txt
4.16.1.145,145 –160 . 10.1037/0882-7974.16.1.145 11302363,325,28,Front_Psychol_2016_Jan_27_7_23.txt
6.18.8.138,"18 , 1380 –1393 . 10.1162/jocn.2006.18.8.1380 16859422",265,35,Front_Psychol_2016_Mar_4_7_300.txt
1.1.3.85,86 –92 . 10.1027/1614-2241.1.3.85,288,26,Front_Psychol_2016_Mar_17_7_384.txt
4.77.6.129,1296 –1312 . 10.1037/0022-3514.77.6.1296 10626371,518,30,Front_Psychol_2016_Mar_23_7_383.txt
4.43.5.997,"43 , 997 –1013 . 10.1037/0022-3514.43.5.997",248,34,Front_Psychol_2016_Apr_20_7_532.txt
3.29.4.823,"29 , 238 –831 . 10.1037/0096-1523.29.4.823 12669760",199,33,Front_Psychol_2016_Apr_22_7_535.txt
5.14.2.188,"14 , 188 –198 . 10.1037/1072-5245.14.2.188",546,33,Front_Psychol_2016_Apr_26_7_590.txt
4.80.3.501,501 –519 . 10.1037//0022-3514.80.3.501 11300582,252,29,Front_Psychol_2016_May_2_7_603.txt
4.7.3.331,331 –338 . 10.1037/0882-7974.7.3.331 1388852,144,28,Front_Psychol_2016_Jun_15_7_846.txt
4.79.4.644,644 –655 . 10.1037/0022-3514.79.4.644 11045744,156,28,Front_Psychol_2016_Jun_15_7_846.txt
4.18.4.714,714 –726 . 10.1037/0882-7974.18.4.714 14692859,193,28,Front_Psychol_2016_Jun_17_7_907.txt
4.7.1.72,72 –82 . 10.1037/0882-7974.7.1.72 1558708,568,26,Front_Psychol_2016_Jun_17_7_907.txt
4.61.1.85,10.1037/0022-3514.61.1.85,208,17,Front_Psychol_2016_Jun_17_7_893.txt
2.8.1.132,132 –137 . 10.1037/1528-3542.8.1.132 18266524,262,28,Front_Psychol_2016_Jul_7_7_1011.txt
3.34.2.353,353 –368 . 10.1037/0278-7393.34.2.353 18315411,358,28,Front_Psychol_2016_Aug_4_7_1161.txt
2.4.2.189,"4 , 189 –200 . 10.1037/1528-3542.4.2.189 15222855",507,32,Front_Psychol_2016_Aug_18_7_1200.txt
3.23.3.632,632 –650 . 10.1037/0096-1523.23.3.632,357,28,Front_Psychol_2016_Aug_29_7_1286.txt
4.77.4.785,77 :785 . 10.1037/0022-3514.77.4.785 24113521,413,27,Front_Psychol_2016_Aug_29_7_1166.txt
3.33.6.126,1261 –1268 . 10.1037/0096-1523.33.6.1261 18085941,148,30,Front_Psychol_2016_Aug_30_7_1315.txt
4.76.5.839,10.1037/0022-3514.76.5.839,226,17,Front_Psychol_2016_Aug_31_7_1330.txt
4.59.1.73,"59 , 73 –81 . 10.1037/0022-3514.59.1.73 2213491",111,31,Front_Psychol_2016_Sep_12_7_1370.txt
3.25.6.153,1534 –1555 . 10.1037/0278-7393.25.6.1534,250,30,Front_Psychol_2016_Sep_13_7_1395.txt
6.8.6.497,497 –506 . 10.1162/jocn.1996.8.6.497 23961981,325,28,Front_Psychol_2016_Sep_21_7_1443.txt
4.48.3.614,614 –623 . 10.1037/0022-3514.48.3.614,386,28,Front_Psychol_2016_Sep_22_7_1453.txt
4.94.2.292,"94 , 292 –306 . 10.1037/0022-3514.94.2.292 18211178",171,33,Front_Psychol_2016_Sep_22_7_1382.txt
4.62.5.753,"62 , 753 –759 . 10.1037/0022-3514.62.5.753",452,33,Front_Psychol_2016_Oct_21_7_1624.txt
5.54.4.515,515 –522 . 10.4306/jknpa.2015.54.4.515,288,29,Front_Psychol_2016_Nov_1_7_1668.txt
3.12.2.288,288 –294 . 10.1037/0278-7393.12.2.288,413,28,Front_Psychol_2016_Nov_1_7_1693.txt
4.93.6.927,927 –939 . 10.1037/0022-3514.93.6.927 1807284,528,28,Front_Psychol_2016_Nov_15_7_1775.txt
2.2.3.2,2.2.3.2. Learning algorith,207,1,PMC5167744.txt
4.92.4.631,631 –648 . 10.1037/0022-3514.92.4.631 17469949,219,28,PMC5220094.txt
4.63.3.452,63 :452 . 10.1037/0022-3514.63.3.452 1403624,163,27,PMC5225733.txt
5.65.4.213,213 –220 . 10.1024/1421-0185.65.4.213,395,28,PMC5239787.txt
3.74.1.3,3 –17 . 10.1037/0022-0663.74.1.3,373,25,PMC5239817.txt
3.22.6.142,10.1037/0278-7393.22.6.1423,87,17,PMC5259696.txt
5.40.2.55,55 –65 . 10.1027/1864-9335.40.2.55,327,26,PMC5282796.txt
4.71.6.126,1268 –1278 . 10.1037/0022-3514.71.6.1268 8979391,260,30,PMC5296334.txt
4.67.6.106,"67 , 1063 –1078 . 10.1037/0022-3514.67.6.1063 7815302",441,35,PMC5337503.txt
3.18.3.281,...Psychol . (1999 ) 18 (3 ):281 –7 .10.1037/0278-6133.18.3.281 10357509,181,163,Front_Public_Health_2014_Oct_20_2_183.txt
3.16.4.374,... Psychol  (1997 ) 16 (4 ):374 –9 .10.1037/0278-6133.16.4.374 9237090,189,213,Front_Public_Health_2015_Oct_6_3_223.txt
3.1.1.75,...ture Microbiol  (2006 ) 1 :75 –87 .10.2217/17460913.1.1.75 17661687,250,158,Front_Public_Health_2016_Jun_27_4_131.txt
5.7.3.469,"...on?  Neural Comput.  7 , 469 –485 10.1162/neco.1995.7.3.469 8935960",221,146,Front_Synaptic_Neurosci_2010_Aug_23_2_32.txt
EC 5.1.1.18,"...by glial and neuronal enzyme serine racemase (SR, EC 5.1.1.18) (De Miranda et al., 2002) (Figure 1) ...",28,89,Front_Synaptic_Neurosci_2014_Apr_21_6_9.txt
2.3.1.2,2.3.1.2. Rate change metho,129,1,Front_Syst_Neurosci_2016_Jun_22_10_51.txt
4.15.1.110,10.1037//0882-7974.15.1.110 10755294,303,18,Front_Syst_Neurosci_2014_Feb_25_8_21.txt
6.18.4.665,665 –679 . 10.1162/jocn.2006.18.4.665 16768368,171,28,Front_Syst_Neurosci_2015_Sep_14_9_128.txt
3.20.5.100,"20 , 1000 –1014 . 10.1037/0096-1523.20.5.1000 7964526",180,35,Front_Syst_Neurosci_2015_Nov_5_9_153.txt
4.15.5.333,"15 , 333 –352 . 10.1515/revneuro.2004.15.5.333 15575490",326,37,Front_Syst_Neurosci_2016_Jan_5_9_182.txt
EC 2.7.7.9,"...ansporter; UGPase, UDP-glucose pyrophosphorylase (EC 2.7.7.9); ADP-Glc, ADP-glucose; Fruc6P, fructos...",15,1225,G3_(Bethesda)_2014_Jul_31_4(10)_1797-1811.txt
4.45.5.936,...Medical Journal  2004 45 5 936 940 10.3349/ymj.2004.45.5.936 2-s2.0-9144269979 15515208,100,161,Gastroenterol_Res_Pract_2015_Apr_28_2015_306938.txt
4.15.24.108,...evention  2015 15 24 10887 10891 10.7314/apjcp.2014.15.24.10887 2-s2.0-84923063202 25605196,233,160,Gastroenterol_Res_Pract_2016_Dec_31_2016_5037254.txt
4.8.3.271,...ia Gut and Liver  2014 8 3 271 276 10.5009/gnl.2014.8.3.271 2-s2.0-84901193886 24827623,258,171,Gastroenterol_Res_Pract_2016_Dec_31_2016_5037254.txt
3.5.-.-,...-01-000387	SIMILAR-TO metallo-beta-lactamase [EC] 3.5.-.-,396,82,Genes_(Basel)_2012_May_16_3(2)_291-319.txt
2.13.6.286,.... Cancer Prev. 2012 13 2867 2871 10.7314/APJCP.2012.13.6.2867 22938475,349,234,Genes_(Basel)_2016_Feb_16_7(2)_9.txt
6.31.1.100,...ol. Metab. (Seoul) 2016 31 100 104 10.3803/EnM.2016.31.1.100 26676331,122,232,Genes_(Basel)_2016_Jul_29_7(8)_43.txt
EC 2.7.7.44,... UDP-glucuronate-1-phosphate uridylyltransferase (EC 2.7.7.44). Studies on enzymes participating in ...,12,645,Genet_Mol_Biol_2010_Dec_1_Oct-Dec_33(4)_686-695.txt
2.9.3.2,"...sher's exact test. FSTAT software package version 2.9.3.2 (Goudet, 2002) was used to test linkage di...",15,459,Genet_Mol_Biol_2010_Mar_1_Jan-Mar_33(1)_131-134.txt
2.9.3.2,"...entiation (FST) were computed using Fstat version 2.9.3.2 (Goudet, 1995). Linkage disequilibrium (LD...",25,710,Genet_Mol_Biol_2012_Feb_3_Jan-Mar_35(1)_74-80.txt
1.1.1.204,...tase (SOD) 1.15.1.1; Xanthine Dehydrogenase (XDH) 1.1.1.204,610,76,Genet_Sel_Evol_2001_Nov_15_33(6)_671-685.txt
EC 1.11.1.6,(EC 1.11.1.6.) (Boeringhe,145,2,Genet_Sel_Evol_1984_16(2)_211-220.txt
3.5.1.3,...nalysis of Molecular Variance) module of ARLEQUIN 3.5.1.3,53,234,Genet_Sel_Evol_2013_Jun_14_45(1)_18.txt
5.10.1.100,"...ve Perl software for windows (Active Perl version 5.10.1.1007 for Windows), CDF_masking.zip was down...",50,968,Genom_Data_2015_Mar_20_4_60-64.txt
EC 4.2.99.21,"...thase (EC 5.4.4.2), isochorismate pyruvate lyase (EC 4.2.99.21), bifunctional isochorismate lyase/ar...",14,1525,Genome_Announc_2013_Apr_4_1(2)_e00138-13.txt
EC 2.1.2.10,"...ltransferase (glycine cleavage system T protein) (EC 2.1.2.10), cystathionine beta-synthase (EC 4.2....",18,951,Genome_Announc_2013_Apr_18_1(2)_e00150-13.txt
2.15.1.43,15 :43 –53 . 10.1094/MPMI.2002.15.1.43 1184330,120,30,Genome_Announc_2014_Apr_10_2(2)_e00306-14.txt
2.3.4.4,... Unported license.Eurasian (EA)-origin H5N8 clade 2.3.4.4 avian influenza viruses were first detecte...,5,257,Genome_Announc_2015_Apr_2_3(2)_e00195-15.txt
EC 6.3.4.6,...en source (1) and contains both urea carboxylase (EC 6.3.4.6) and a putative allophanate hydrolase (...,17,99,Genome_Announc_2016_Mar_10_4(2)_e00094-16.txt
5.4.4.2,...(EC: 6.3.5.4) (9) and isochorismate synthase (EC: 5.4.4.2) (10). Other enzymes such as trehalose-pho...,13,424,PMC5270703.txt
3.6.1.19,3.6.1.19	b2954,232,1,Genome_Biol_2003_Aug_28_4(9)_R54.txt
3.1.1.3,...7690	Lipase -related	Glycerol biosynthesis	Lipase	3.1.1.3,213,56,Genome_Biol_2004_Jul_15_5(8)_R53.txt
5.1.2.8,...mary: Cyclophilins (Enzyme Commission (EC) number 5.1.2.8) belong to a group of proteins that have p...,5,54,Genome_Biol_2005_Jun_27_6(7)_226.txt
1.13.11.46,4-Hydroxymandelate synthase	1.13.11.46	1/6	0,249,30,Genome_Biol_2006_Jan_31_7(1)_R8.txt
EC 1.2.1.24,...olved in the same glutamate metabolism pathway as EC 1.2.1.24. The closeness of yneI and yneH on the...,84,1047,Genome_Biol_2006_Feb_15_7(2)_R17.txt
EC 3.4.21.47,...166285	5	5	4	0	1	0	Complement factor B precursor (EC 3.4.21.47; C3/C5 convertase; properdin factor B...,234,63,Genome_Biol_2006_Apr_28_7(4)_R35.txt
EC 1.11.1.9,"...hione disulfide (GSSG) by glutathione peroxidase, EC 1.11.1.9 (NMB1621), thereby controlling the cel...",68,487,Genome_Biol_2007_Jul_6_8(7)_R136.txt
5.3.1.16,"...ng rise, for instance, to the isomerases HisA (EC:5.3.1.16) and TrpC (EC:5.3.1.24), which act in his...",17,437,Genome_Biol_2008_Jun_9_9(6)_R95.txt
2.6.1.39,...:2.3.3.14) to α-aminoadipate aminotransferase (EC:2.6.1.39). This core contains the four enzymes for...,61,2486,Genome_Biol_2008_Jun_9_9(6)_R95.txt
EC 1.1.1.145,"...rogenases, while assigned to the 'same' reaction (EC 1.1.1.145), have unique expression patterns, ac...",32,1954,Genome_Biol_2009_Aug_14_10(8)_R84.txt
2.4.2.1,"... enzymes (with EC numbers in parentheses) PNPase (2.4.2.1), glucokinase (2.7.1.2), deoxycytidine kin...",137,868,Genome_Biol_2011_Mar_21_12(3)_R24.txt
5.3.1.9,"...ase (5.1.3.3), and glucose-6-phosphate isomerase (5.3.1.9). Furthermore, changes in amino acid metab...",137,1083,Genome_Biol_2011_Mar_21_12(3)_R24.txt
EC 1.3.99.1,...7/1.57	Succinate:(acceptor) oxidoreductase	R00408/EC 1.3.99.1,264,84,Genome_Biol_2012_Nov_29_13(11)_R111.txt
EC 4.2.1.47,"...phase-variable gene, GDP-mannose 4,6-dehydratase (EC 4.2.1.47) (wcbK, CAMP1649), which may be a key ...",178,851,Genome_Biol_Evol_2014_Sep_4_6(9)_2424-2438.txt
EC 3.5.1.9,...erase/lipase domain functions as arylformamidase (EC 3.5.1.9) (Pabarcus and Casida 2002; Wogulis et ...,69,303,Genome_Biol_Evol_2014_Aug_27_6(9)_2335-2349.txt
1.4.1.14,"...identification using Proteome Discoverer (version 1.4.1.14, Thermo Scientific) connected to a Mascot...",42,472,Genome_Biol_Evol_2015_Sep_2_7(9)_2716-2726.txt
1.4.1.14,"...identification using Proteome Discoverer (version 1.4.1.14, Thermo Scientific) connected to a Mascot...",42,472,Genome_Biol_Evol_2015_Sep_2_7(9)_2716-2726.txt
2.1.1.107,...Rev Cardiovasc Ther 2003 1 107 119 10.1586/14779072.1.1.107 15030301,44,177,Genome_Med_2009_Oct_27_1(10)_96.txt
2.10.3.206,"...X2234-0742Korea Genome Organization 10.5808/GI.2012.10.3.206Original ArticleDNA Barcoding of Fish, I...",3,114,Genomics_Inform_2012_Sep_28_10(3)_206-211.txt
1.1.1.184,...889668	rcu:RCOM_0902850	Short-chain dehydrogenase	1.1.1.184	590	253	156	70,199,95,Genomics_Insights_2010_Oct_28_3_29-56.txt
2.5.1.18,FM893192		osa:4332456	Glutathione S-transferase	2.5.1.18	982	243	60	55,367,50,Genomics_Insights_2010_Oct_28_3_29-56.txt
EC 3.2.1.1,BLi00656	α-Amylase precursor (EC 3.2.1.1),138,31,Genomics_Insights_2013_Aug_18_6_25-36.txt
3.-.-.-,"... of the most important classes is hydrolases (E.C.3.-.-.-), which catalyze the hydrolytic cleavage o...",25,216,Genomics_Proteomics_Bioinformatics_2015_Oct_10_13(5)_290-295.txt
4.2.1.17,"Lysine degradation	4.2.1.17	Trifunctional protein deficiency, type 2	...",128,20,Genomics_Proteomics_Bioinformatics_2007_Feb_8_5(3-4)_166-176.txt
4.1.1.85,...0053	Ascorbate and aldarate metabolism	4.2.1.42 | 4.1.1.85 | 4.2.1.40 | 3.1.1.- | 4.1.2.20 | 3.7.1.-...,168,55,Gigascience_2015_Sep_14_4_42.txt
3.5.1.78,map00480	Glutathione metabolism	3.5.1.78 | 3.4.11.23 | 4.1.1.17 | 6.3.2.3 | 1.8.1....,169,33,Gigascience_2015_Sep_14_4_42.txt
6.6.1.61,...outcome . Prev Treat. 2003 ; doi: 10.1037/1522-3736.6.1.61,156,150,Glob_Adv_Health_Med_2014_Jul_1_3(4)_14-19.txt
6.5.5.479,... Pharmacogenomics 2004 5 5 479 486 10.1517/14622416.5.5.479 15212584,253,188,Global_Health_2011_Aug_24_7_30.txt
2.2.1.2,2.2.1.2 Self-Efficacy Scal,39,1,Glob_J_Health_Sci_2016_Jul_3_8(7)_26-34.txt
EC 3.2.1.52,Most known exo-β-hexosaminidases (EC 3.2.1.52) can process different terminal β-link...,134,35,Glycobiology_2015_Apr_8_25(4)_448-464.txt
5.5.2.1,5.5.2.1 Neurectomy of the vestibular nerv,323,1,GMS_Curr_Top_Otorhinolaryngol_Head_Neck_Surg_2005_Sep_28_4_Doc05.txt
5.2.2.2,... surgery will be dealt with in chapters 5.1.4 and 5.2.2.2. Postoperative BPPV is treated with the sa...,216,333,GMS_Curr_Top_Otorhinolaryngol_Head_Neck_Surg_2013_Dec_13_12_Doc05.txt
4.3.3.1,4.3.3.1 Spinal accessory nerve lesion,195,1,GMS_Curr_Top_Otorhinolaryngol_Head_Neck_Surg_2013_Dec_13_12_Doc08.txt
5.1.5.4,5.1.5.4 Open reposition without reconstruction of ...,611,1,GMS_Curr_Top_Otorhinolaryngol_Head_Neck_Surg_2015_Dec_22_14_Doc06.txt
3.2.7.2,3.2.7.2.3 assessed in the review article of the Co...,560,1,PMC5169082.txt
3.5.4.2,3.5.4.2 2013 [26,136,1,PMC5169081.txt
1.1.9.260,...0 Available from: http://dx.doi.org/10.1076/orbi.21.1.9.2600  12029577,300,275,GMS_Interdiscip_Plast_Reconstr_Surg_DGPW_2013_Feb_27_2_Doc06.txt
5.61.3.275,...vailable from: http://dx.doi.org/10.13109/zptm.2015.61.3.275  26388058,121,355,PMC5327656.txt
1.5.2.228,"...ciety of Pancreatobiliary Diseases 10.5009/gnl.2011.5.2.228Original ArticleLiver, Pancreas and Bilia...",3,427,Gut_Liver_2011_Jun_28_5(2)_228-233.txt
1.5.4.468,...ciety of Pancreatobiliary Diseases 10.5009/gnl.2011.5.4.468Original ArticleAlimentary TractFailure o...,3,427,Gut_Liver_2011_Dec_21_5(4)_468-471.txt
3.7.2.239,"...Society of Gastrointestinal Cancer 10.5009/gnl.2013.7.2.239Original ArticleLiver, Pancreas and Bilia...",3,471,Gut_Liver_2013_Mar_14_7(2)_239-245.txt
3.7.5.513,...Society of Gastrointestinal Cancer 10.5009/gnl.2013.7.5.513Original ArticleAlimentary TractSOX9 Is H...,3,471,Gut_Liver_2013_Sep_11_7(5)_513-518.txt
3.7.6.675,...Society of Gastrointestinal Cancer 10.5009/gnl.2013.7.6.675Original ArticleAlimentary TractIschemia-...,3,471,Gut_Liver_2013_Nov_14_7(6)_675-680.txt
3.7.6.712,... response Gut Liver 2013 7 712 718 10.5009/gnl.2013.7.6.712 24312713,196,186,Gut_Liver_2015_Nov_13_9(6)_776-783.txt
1.5.4.506,...ype-1 HCV Gut Liver 2011 5 506 512 10.5009/gnl.2011.5.4.506 22195251,218,185,Gut_Liver_2016_May_19_10(3)_446-455.txt
2.22.4.256,...Theory Nurs Pract 2008 22 256 272 10.1891/0889-7182.22.4.256 19093663,391,119,Harm_Reduct_J_2009_Nov_20_6_32.txt
1.7.2.108,2011 ;7 :108 –12 . doi:10.15420/ecr.2011.7.2.10,253,40,Heart_2016_Feb_15_102(4)_313-319.txt
5.76.8.140,...odontol 2005 76 1406 1419 16101377 10.1902/jop.2005.76.8.1406,184,146,Head_Face_Med_2006_May_25_2_16.txt
1.72.4.517,...riodontol 2001 72 517 525 11338305 10.1902/jop.2001.72.4.517,127,223,Head_Face_Med_2006_Jun_20_2_17.txt
1.72.2.167,...riodontol 2001 72 167 173 11288789 10.1902/jop.2001.72.2.167,108,202,Head_Face_Med_2006_May_19_2_13.txt
4.69.4.719,...Social Psychology 1995 69 719 727 10.1037/0022-3514.69.4.719 7473027,169,154,Health_Care_Anal_2016_Mar_25_24_133-147.txt
3.2.3.1,3.2.3.1. Health Car,109,1,Healthcare_(Basel)_2013_Jul_25_1(1)_20-52.txt
4.51.6.117,.... Soc. Psychol. 1986 51 1173 1182 10.1037/0022-3514.51.6.1173,257,223,Healthcare_(Basel)_2016_Aug_26_4(3)_62.txt
4.51.6.117,.... Soc. Psychol. 1986 51 1173 1182 10.1037/0022-3514.51.6.1173,354,224,Healthcare_(Basel)_2016_Aug_10_4(3)_56.txt
6.22.4.351,...ean Society of Medical Informatics 10.4258/hir.2016.22.4.351Book ReviewBook Review: Deep Learning Ki...,3,142,Healthc_Inform_Res_2016_Oct_31_22(4)_351-354.txt
6.22.4.253,...ean Society of Medical Informatics 10.4258/hir.2016.22.4.253EditorialEmerging New Era of Mobile Heal...,3,142,Healthc_Inform_Res_2016_Oct_31_22(4)_253-254.txt
3.28.1.83,...dex Health Psychology  28 1 83 90 10.1037/0278-6133.28.1.83 19210021,146,151,Health_Psychol_Behav_Med_2014_Jan_1_2(1)_888-99.txt
3.27.3.379,...chological Association  3 379 387 10.1037/0278-6133.27.3.379,123,229,Health_Psychol_Rev_2016_Jul_2_10(3)_2979-312.txt
3.17.2.190,...ychology 1998 17 190 198 9548710 10.1037//0278-6133.17.2.190,198,193,Health_Qual_Life_Outcomes_2004_Sep_17_2_50.txt
3.21.5.419,...Psychol 2002 21 419 426 12211508 10.1037//0278-6133.21.5.419,105,206,Health_Qual_Life_Outcomes_2004_Mar_31_2_18.txt
6.1.5.156,...almic Epidemiol 1999 6 5 17 10384680 10.1076/opep.6.1.5.1565,316,204,Health_Qual_Life_Outcomes_2005_Oct_26_3_65.txt
4.54.6.106,...s J Pers Soc Psych 1988 6 1063 70 10.1037/0022-3514.54.6.1063,338,174,Health_Qual_Life_Outcomes_2007_Nov_27_5_63.txt
4.69.4.719,...sychology 1995 69 719 727 7473027 10.1037/0022-3514.69.4.719,186,157,Health_Qual_Life_Outcomes_2009_Jul_16_7_66.txt
6.19.1.3,...ability Psychol Rep 1966 19 1 3 11 10.2466/pr0.1966.19.1.3 5942109,432,120,Health_Qual_Life_Outcomes_2011_Nov_23_9_103.txt
3.14.1.571,...ac J Cancer Prev 2013 14 571 578 10.7314/APJCP.2013.14.1.571 23534797,316,166,Health_Qual_Life_Outcomes_2014_Dec_20_12_183.txt
3.28.4.413,...Korean J Intern Med 2013 28 413 9 10.3904/kjim.2013.28.4.413 23864799,355,185,Health_Qual_Life_Outcomes_2015_May_12_13_55.txt
1.5.1.29,...el syndrome Gut Liver 2011 5 29 36 10.5009/gnl.2011.5.1.29 21461069,222,176,Health_Qual_Life_Outcomes_2015_Jul_30_13_113.txt
5.27.1.48,...vulgaris Ann Dermatol 2015 27 48 52 10.5021/ad.2015.27.1.48 25673931,176,157,Health_Qual_Life_Outcomes_2015_Sep_26_13_156.txt
3.3.4.1,3.3.4.1.2. Comment,454,1,Hepat_Mon_2011_Aug_1_11(8)_601-611.txt
6.39.5.479,...ochem Mol Biol 2006 39 5 479 91 10.5483/BMBRep.2006.39.5.479 17002867,160,153,Hepat_Mon_2012_Apr_30_12(4)_278-285.txt
3.2.4.3,3.2.4.3. Content Validit,49,1,Hepat_Mon_2012_Dec_31_12(12)_e7650.txt
2.63.1.18,...an J Anesthesiol. 2012 63 1 18 24 10.4097/kjae.2012.63.1.18 22870360,165,202,Hepat_Mon_2013_Aug_25_13(8)_e13162.txt
3.13.5.4,3.13.5.4 Breast-feeding is discouraged during mate...,1433,1,Hepatol_Int_2015_Nov_13_10(1)_1-98.txt
1.1.1.2,"...European Social Fund, agreement Nr. 2009/0230/1DP/1.1.1.2.0/09/APIA/VIAA/070. AV is supported by ESF...",307,295,Hered_Cancer_Clin_Pract_2010_Oct_29_8(1)_8.txt
5.27.2.110,...287-32602287-3279Korean Hip Society 10.5371/hp.2015.27.2.110Case ReportArthroscopic Treatment of Sub...,3,86,Hip_Pelvis_2015_Jun_30_27(2)_110-114.txt
6.28.2.104,...287-32602287-3279Korean Hip Society 10.5371/hp.2016.28.2.104Original ArticleRisk Factors Associated ...,3,86,Hip_Pelvis_2016_Jun_30_28(2)_104-111.txt
6.28.3.182,...287-32602287-3279Korean Hip Society 10.5371/hp.2016.28.3.182Case ReportPrimary Intraosseus Xanthoma ...,3,86,Hip_Pelvis_2016_Sep_30_28(3)_182-186.txt
4.15.17.722,...Cancer Prev 2014 15 17 7223 7228 10.7314/APJCP.2014.15.17.7223 25227818,208,241,Hum_Genomics_2016_Jul_25_10(Suppl_2)_19.txt
3.1.1.1,"...RM) network [59,60] were calculated using Network 3.1.1.1 [61] to visualise the mutational relations...",75,935,Hum_Genomics_2004_May_1_1(4)_255-273.txt
4.51.6.117,... and Social Psychology  1173 1182 10.1037/0022-3514.51.6.1173 3806354,381,238,Hum_Perform_2015_Aug_8_28(4)_2811-306.txt
3.30.2.343,30 (2 ): 343 –353 . DOI:10.1037/0278-7393.30.2.343.14979809,761,41,Hum_Psychopharmacol_2016_May_5_31(3)_227-242.txt
4.6.6.891,...Expert Rev Vaccines 2007 6 891 902 10.1586/14760584.6.6.891 18377352,189,133,Hum_Vaccin_Immunother_2014_Feb_1_10(2)_498-504.txt
4.6.5.723,...; PMID:17931153; http://dx.doi.org/10.1586/14760584.6.5.723 17931153,360,69,Hum_Vaccin_Immunother_2015_Jun_10_11(7)_168918-1702.txt
1.41.1.1,...f Oral and Maxillofacial Radiology 10.5624/isd.2011.41.1.1Review ArticleAssessment of panoramic radi...,3,132,Imaging_Sci_Dent_2011_Mar_26_41(1)_1-6.txt
1.5.1.3,"...on data were then reconstructed with NRecon (ver. 1.5.1.3, Skyscan, Antwerp, Belgium) to create 3D i...",54,543,Imaging_Sci_Dent_2013_Dec_12_43(4)_227-233.txt
3.43.4.273,...f Oral and Maxillofacial Radiology 10.5624/isd.2013.43.4.273Original ArticleAnatomy and morphology o...,3,148,Imaging_Sci_Dent_2013_Dec_12_43(4)_273-281.txt
4.44.2.155,...f Oral and Maxillofacial Radiology 10.5624/isd.2014.44.2.155Technical ReportUse of a gesture user in...,3,148,Imaging_Sci_Dent_2014_Jun_11_44(2)_155-160.txt
5.45.1.23,...f Oral and Maxillofacial Radiology 10.5624/isd.2015.45.1.23Original ArticleAccuracy of virtual model...,3,148,Imaging_Sci_Dent_2015_Mar_13_45(1)_23-29.txt
6.46.2.133,...f Oral and Maxillofacial Radiology 10.5624/isd.2016.46.2.133Original ArticleThe impact of reorientin...,3,148,Imaging_Sci_Dent_2016_Jun_23_46(2)_133-139.txt
1.11.5.253,...Korean Association of Immunologists 10.4110/in.2011.11.5.253Original ArticleVitamin D Receptor Gene ...,3,100,Immune_Netw_2011_Oct_31_11(5)_253-257.txt
4.14.5.249,...Korean Association of Immunologists 10.4110/in.2014.14.5.249Original ArticleTRIF Deficiency does not...,3,111,Immune_Netw_2014_Oct_22_14(5)_249-254.txt
6.16.4.256,...Korean Association of Immunologists 10.4110/in.2016.16.4.256Brief CommunicationStevens–Johnson Syndr...,3,111,Immune_Netw_2016_Aug_23_16(4)_256-260.txt
6.16.4.242,...Korean Association of Immunologists 10.4110/in.2016.16.4.242Original ArticleThe Anti-apoptotic Effec...,3,111,Immune_Netw_2016_Aug_23_16(4)_242-248.txt
4.51.2.389,...d Social Psychology 1986 51 2 389 10.1037/0022-3514.51.2.389 3746619,375,183,Implement_Sci_2010_Oct_20_5_79.txt
3.25.4.327,...tion & Prevention 2013 25 327 335 10.1521/aeap.2013.25.4.327 23837810,391,188,Implement_Sci_2014_Sep_27_9_136.txt
2.6.1.2,"...se (l-alanine 2-oxoglutarate aminotransferase, ec 2.6.1.2) Clin Chim Acta 1980 105 145 72",182,176,Indian_J_Nephrol_2008_Apr_18(2)_51-57.txt
EC 2.6.1.2,The principle is same as AST except that ALT (EC 2.6.1.2) catalysis the conversion of L-alanine ...,53,47,Indian_J_Pharmacol_2012_May-Jun_44(3)_333-339.txt
3.45.4.455,...and Korean Society for Chemotherapy 10.3947/ic.2013.45.4.455Special ArticleThe 2013 Clinical Guideli...,3,169,Infect_Chemother_2013_Dec_27_45(4)_455-461.txt
3.14.2.11,...ent Neurosurg Focus 2003 14 2 ecp1 10.3171/foc.2003.14.2.11 15727431,335,173,PMC5265194.txt
4.20.3.317,...e Clin Mol Hepatol 2014 20 317 326 10.3350/cmh.2014.20.3.317 25320738,178,177,Insights_Imaging_2015_Oct_6_6(6)_665-677.txt
1.2.1.70,...ysis Saf Health Work 2011 2 70 82 10.5491/SHAW.2011.2.1.70 22953190,79,229,Int_Arch_Occup_Environ_Health_2014_Nov_28_87(7)_801-803.txt
2.2.1.2,2.2.1.2 Shiftin,62,1,Intelligence_2014_Sep_46_73-83.txt
2.2.2.2,2.2.2.2 Measures at age,40,1,Intelligence_2015_Jan-Feb_48_30-36.txt
2.18.10.275,...urnal  2012 18 10 1475 1480 10.5829/idosi.wasj.2012.18.10.2753 2-s2.0-84866521530,154,253,Int_J_Anal_Chem_2014_Dec_29_2014_627038.txt
4.56.2.267,"...J Pers Soc Psychol 1989 56 267 83 10.1037/0022-3514.56.2.267 Carver CS, Scheier MF, Weintraub JK. As...",202,150,Int_J_Behav_Med_2009_Sep_8_16(3)_212-218.txt
3.21.2.194,...ychology 2002 21 194 201 11950110 10.1037/0278-6133.21.2.194,100,136,Int_J_Behav_Nutr_Phys_Act_2006_Sep_12_3_25.txt
3.22.2.178,...ealth Psychology 2003 22 2 178 88 10.1037/0278-6133.22.2.178 12683738,351,204,Int_J_Behav_Nutr_Phys_Act_2010_Feb_2_7_11.txt
3.12.5.390,...en Health Psychol 1993 12 390 398 10.1037/0278-6133.12.5.390 8223363,288,216,Int_J_Behav_Nutr_Phys_Act_2010_Sep_8_7_66.txt
3.27.2.179,...on Health Psychol 2008 27 179 184 10.1037/0278-6133.27.2.179 18377136,97,176,Int_J_Behav_Nutr_Phys_Act_2011_Jan_11_8_2.txt
5.8.3.4,"...nclination. Furthermore, the AP software (version 5.8.3.4) allows for classification of activities i...",52,417,Int_J_Behav_Nutr_Phys_Act_2014_Sep_28_11_119.txt
4.51.6.117,...s Soc Psychol 1986 51 6 1173 1182 10.1037/0022-3514.51.6.1173 3806354,133,209,Int_J_Bipolar_Disord_2016_Mar_16_4_7.txt
5.9.4.343,...way Nutr Res Pract 2015 9 343 9.13 10.4162/nrp.2015.9.4.343 26244071,188,209,PMC5316396.txt
6.2.1.5,"...s, and recognition in the wild and clutter (Sect. 6.2.1.5), where textures are a small portion of a ...",680,300,Int_J_Comput_Vis_2016_Jan_9_118_65-94.txt
3.24.1.96,...ch Health Psychol. 2005 24 96 100 10.1037/0278-6133.24.1.96 15631567,278,217,Int_J_Environ_Res_Public_Health_2014_Apr_9_11(4)_3937-3955.txt
5.19.3.217,...eory Nurs. Pract. 2005 19 217 230 10.1891/rtnp.2005.19.3.217 16144240,173,219,Int_J_Environ_Res_Public_Health_2014_Jul_27_11(7)_6727-6742.txt
3.2.1.2,3.2.1.2. Neighbourhood Social Environmen,237,1,Int_J_Environ_Res_Public_Health_2014_Sep_19_11(9)_9790-9810.txt
2.77.3.386,.... Orthopsychiatr. 2007 77 386 391 10.1037/0002-9432.77.3.386,152,168,Int_J_Environ_Res_Public_Health_2015_May_15_12(5)_5196-5214.txt
2.79.5.2,.... J. Occup. Ther. 2012 79 264 274 10.2182/cjot.2012.79.5.2 23539771,170,173,Int_J_Environ_Res_Public_Health_2015_Oct_13_12(10)_12723-12734.txt
4.16.2.86,... on stroke J. Stroke 2014 16 86 90 10.5853/jos.2014.16.2.86 24949314,229,180,Int_J_Environ_Res_Public_Health_2015_Dec_3_12(12)_15339-15351.txt
1.7.1.58,...ccup. Environ. Health 2001 7 58 67 10.1179/oeh.2001.7.1.58 11210014,139,244,Int_J_Environ_Res_Public_Health_2016_Jan_23_13(1)_71.txt
3.46.2.82,...Med. Public Health 2013 46 82 88 10.3961/jpmph.2013.46.2.82 23573372,272,198,Int_J_Environ_Res_Public_Health_2016_Feb_19_13(2)_231.txt
3.25.3.292,...ants Ann. Dermatol. 2013 25 292 297 10.5021/ad.2013.25.3.292 24003270,114,203,Int_J_Environ_Res_Public_Health_2016_Feb_19_13(2)_242.txt
4.55.2.374,...fe Yonsei. Med. J. 2014 55 374 378 10.3349/ymj.2014.55.2.374 24532506,259,176,Int_J_Environ_Res_Public_Health_2016_Mar_24_13(3)_255.txt
2.24.3.55,...nate Neonatal Netw. 2005 24 55 71 10.1891/0730-0832.24.3.55 15960011,194,114,Int_J_Environ_Res_Public_Health_2016_Mar_18_13(3)_337.txt
2.3.1.11,...se” Saf. Health Work 2012 3 11 16 10.5491/SHAW.2012.3.1.11 22953225,228,196,Int_J_Environ_Res_Public_Health_2016_Mar_16_13(3)_328.txt
6.36.3.288,...fe Threat. Behav. 2006 36 288 295 10.1521/suli.2006.36.3.288 16805656,460,238,Int_J_Environ_Res_Public_Health_2016_May_11_13(5)_489.txt
4.47.1.1,.... Med. Public Health 2014 47 1 6 10.3961/jpmph.2014.47.1.1 24570801,390,173,Int_J_Environ_Res_Public_Health_2016_Jul_22_13(7)_744.txt
3.18.4.410,...2 Health Psychol. 1999 18 410 415 10.1037/0278-6133.18.4.410 10431943,198,214,Int_J_Environ_Res_Public_Health_2016_Oct_13_13(10)_1006.txt
6.8.2.92,...sthma Immunol. Res. 2016 8 92 100 10.4168/aair.2016.8.2.92 26739401,179,178,Int_J_Environ_Res_Public_Health_2016_Nov_4_13(11)_1084.txt
1.38.2.75,.... Exp. Reprod. Med. 2011 38 75 81 10.5653/cerm.2011.38.2.75 22384422,114,218,PMC5295269.txt
5.1.15.238,...aine AIDS Educ Prev 2003 15 1 15 32 10.1521/aeap.15.1.15.23843 12627741,443,182,Int_J_Equity_Health_2014_Aug_28_13_70.txt
3.19.6.576,...n Health Psychol 2000 19 6 576 85 10.1037/0278-6133.19.6.576 11129361,274,221,Int_J_Equity_Health_2015_Mar_7_14_25.txt
2.39.4.255,...Soc Welf Policy 2012 39 4 255 279 10.15855/swp.2012.39.4.255,256,175,Int_J_Equity_Health_2016_Jul_26_15_119.txt
2.1.1.241,"...transferase (K13230), a gene encoding enzymes [EC:2.1.1.241] involved in the last step of benzoxazin...",62,1164,Int_J_Genomics_2015_Jul_12_2015_528395.txt
EC 2.3.3.10,"...3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) by HMGS (EC 2.3.3.10, 18 unigenes). MVA was formulated by H...",77,225,Int_J_Genomics_2015_Oct_12_2015_782635.txt
EC 1.11.1.7,...ounds might also affect shoot Al uptake. The POD (EC 1.11.1.7) in the phenylpropanoid pathway can sc...,85,748,PMC5198156.txt
2.5.1.1,...rnesyl diphosphate synthase	c118250_g1_i1	FPS	EC: 2.5.1.1/2.5.1.10	 	GPY up	 ,236,53,PMC5206855.txt
2.53.5.311,...ique J Periodontol 1982 53 5 311 4 10.1902/jop.1982.53.5.311 6953228,168,215,Int_J_Implant_Dent_2016_Nov_23_2_22.txt
4.1.56.277,...uicide Life Threat Behav 2004 34 56 10.1521/suli.34.1.56.27773 15106888,547,136,Int_J_Ment_Health_Syst_2016_Jan_19_10_3.txt
1.1.2.67,...od and Nutrition  2011 1 2 67 73 10.5251/abjna.2011.1.2.67.73,678,199,Int_J_Microbiol_2015_May_27_2015_547156.txt
EC 2.7.1.40,"...ant anaplerotic enzyme [24], pyruvate kinase (PK, EC 2.7.1.40) can, as well, utilize PEP converting ...",21,103,Int_J_Mol_Sci_2009_Jun_29_10(7)_2896-2910.txt
EC 3.1.1.8,...cyclosarin-inhibited butyrylcholinesterase (BChE; EC 3.1.1.8). BChE is in plasma and also in brain. ...,20,139,Int_J_Mol_Sci_2009_Jul_7_10(7)_3065-3075.txt
2.2.1.2,2.2.1.2. Validation of H1s1-H1s2 Dimer,70,1,Int_J_Mol_Sci_2010_Oct_11_11(10)_3867-3884.txt
3.1.4.3,"...a secreted form in bacteria that prefers PC (E.C. 3.1.4.3), and a GPI-PLC form found in various orga...",29,708,Int_J_Mol_Sci_2011_Jan_18_12(1)_588-612.txt
3.4.1.2,3.4.1.2. Methods of in Situ Nasal Single Pass Perf...,44,1,Int_J_Mol_Sci_2010_Nov_26_11(12)_4882-4890.txt
3.2.1.4,3.2.1.4. Screening of in Vivo Inactivatio,65,1,Int_J_Mol_Sci_2011_Jul_13_12(7)_4522-4535.txt
EC 1.15.1.1,"Superoxide dismutase (SOD, EC 1.15.1.1) activity was assayed in the supernata...",45,28,Int_J_Mol_Sci_2012_Feb_8_13(2)_1790-1803.txt
3.1.1.3,3.1.1.3. Gp120 CD4-Induced Epitop,151,1,Int_J_Mol_Sci_2012_Apr_13_13(4)_4727-4794.txt
2.2.2.2,"...MS/MS files were processed with DeconMSn (version 2.2.2.2, Pacific Northwest National Laboratory (PN...",52,55,Int_J_Mol_Sci_2012_Jul_2_13(7)_8171-8188.txt
5.1.1.1,5.1.1.1.6. The Cylindrical Mode,239,1,Int_J_Mol_Sci_2012_Oct_8_13(10)_12773-12856.txt
EC 1.2.1.12,...ed observation indicates that the NAD+-dependent (EC 1.2.1.12) enzyme is more sensitive to the oxida...,23,220,Int_J_Mol_Sci_2013_Apr_12_14(4)_8073-8092.txt
3.2.2.1,3.2.2.1. Apoptosis Analysi,78,1,Int_J_Mol_Sci_2013_Apr_29_14(5)_9424-9439.txt
6.8.3.1,16.8.3.1	flavonoids. dihydroflavonols. dihydroflavo...,262,2,Int_J_Mol_Sci_2013_Jun_4_14(6)_11871-11894.txt
EC 2.7.7.9,"....27, ADP-Glc PPase) or unregulated UDP-Glc PPase (EC 2.7.7.9). In this work, we characterized the UD...",5,715,Int_J_Mol_Sci_2013_May_6_14(5)_9703-9721.txt
4.2.1.10,"...ddition, HTIP-2007063 and HTIP-2057051 (PLaroDE, E4.2.1.10/1.1.1.25) exhibit similar transcription p...",35,473,Int_J_Mol_Sci_2013_Sep_9_14(9)_18502-18519.txt
1.1.1.25,"....5.1.54; (C) E4.2.3.4; and (D,E) aroDE, E4.2.1.10/1.1.1.25 in different tissues of P. lactiflora. F,...",92,177,Int_J_Mol_Sci_2013_Sep_9_14(9)_18502-18519.txt
3.1.1.1,3.1.1.1. Biochemical Alterations Induced by Differ...,69,1,Int_J_Mol_Sci_2013_Nov_19_14(11)_22753-22781.txt
4.1.1.39,"...bisphosphate carboxylase/oxygenase (RUBISCO, E.C. 4.1.1.39). This enzyme is one of the most abundant...",8,734,Int_J_Mol_Sci_2007_Oct_23_8(10)_1039-1051.txt
4.1.1.4,4.1.1.4. CK,56,1,Int_J_Mol_Sci_2014_Mar_18_15(3)_4671-4713.txt
1.11.1.11,... metabolism	ath00053	1	l-ascorbate peroxidase [EC:1.11.1.11],66,73,Int_J_Mol_Sci_2014_Oct_31_15(11)_19877-19897.txt
EC 2.4.2.1,...odium falciparum purine nucleoside phosphorylase (EC 2.4.2.1) was inversely affected by the addition...,86,833,Int_J_Mol_Sci_2014_Dec_12_15(12)_23090-23140.txt
EC 4.1.1.1,... pyruvate decarboxylase (a homotetrameric enzyme (EC 4.1.1.1)) and glutamate decarboxylase (a monome...,269,390,Int_J_Mol_Sci_2014_Dec_12_15(12)_23090-23140.txt
3.22.18.106,...e Br. J. Nurs. 2013 22 1066 1074 10.12968/bjon.2013.22.18.1066 24121851,168,135,Int_J_Mol_Sci_2015_Feb_6_16(2)_3626-3655.txt
1.2.7.3,1.2.7.3	2-Oxoglutarate Synthase	2-Oxoglutarate + C...,149,1,Int_J_Mol_Sci_2015_Apr_22_16(4)_8949-8967.txt
2.1.1.176,2.1.1.176	16S rRNA (cytosine(967)-C(5))-methyltran...,177,1,Int_J_Mol_Sci_2015_Apr_22_16(4)_8949-8967.txt
2.11.4.263,...on J. Wound Care 2002 11 125 130 10.12968/jowc.2002.11.4.26389 11998592,116,132,Int_J_Mol_Sci_2015_Jun_18_16(6)_13973-13988.txt
4.12.1.87,...in. Investig. Drugs 2003 12 87 100 10.1517/13543784.12.1.87 12517256,217,176,Int_J_Mol_Sci_2015_Sep_17_16(9)_22485-22508.txt
2.2.4.5,"...mmission Framework 7 programme (EU FP7; HEALTH.2012.2.4.5-2, project number 305815). Ali Mobasheri i...",47,376,Int_J_Mol_Sci_2015_Aug_31_16(9)_20560-20575.txt
2.3.1.74,"...one synthase (CHS, enzyme commission number: E.C. 2.3.1.74) is an important enzyme which catalyzes t...",10,56,Int_J_Mol_Sci_2016_Jan_27_17(2)_161.txt
2.8.2.125,...Opin. Ther. Targets 2004 8 125 139 10.1517/14728222.8.2.125 15102554,116,136,Int_J_Mol_Sci_2016_Mar_8_17(3)_351.txt
2.7.1.30,Glycerol kinase (EC:2.7.1.30) plays a critical role in glycerol metabo...,38,21,Int_J_Mol_Sci_2016_May_7_17(5)_689.txt
1.4.1.3,"...s were calculated using Perseus software (version 1.4.1.3, Max Planck Institute of Biochemistry, Mar...",67,500,Int_J_Mol_Sci_2016_May_2_17(5)_631.txt
2.15.12.122,...crobe Interact. 2002 15 1228 1235 10.1094/MPMI.2002.15.12.1228 12481995,617,207,Int_J_Mol_Sci_2016_May_27_17(6)_815.txt
4.17.1.34,...t Microbe Interact. 2004 17 34 42 10.1094/MPMI.2004.17.1.34 14714866,202,222,Int_J_Mol_Sci_2016_Jun_1_17(6)_852.txt
5.5.2.5,"...2/CH3OH, 40:1) to produce seven fractions, Frs. 7.5.5.2.5.2.1–7.5.5.2.5.2.7. Fr. 7.5.5.2.5.2.6 yield...",43,2741,Int_J_Mol_Sci_2016_Sep_8_17(9)_1512.txt
3.93.7.799,...e Phytopathology 2003 93 799 804 10.1094/PHYTO.2003.93.7.799 18943160,448,179,Int_J_Mol_Sci_2016_Oct_18_17(10)_1706.txt
1.14.1.39,...ata J. Breast Cancer 2011 14 39 45 10.4048/jbc.2011.14.1.39 21847393,149,296,PMC5297796.txt
EC 3.3.1.1,12	A0A087SF19	Adenosylhomocysteinase (EC 3.3.1.1),116,39,PMC5297694.txt
3.14.2.963,...ac J Cancer Prev 14 963 968 2013 10.7314/APJCP.2013.14.2.963 23621269,588,209,Int_J_Oncol_2016_May_4_49(1)_5-32.txt
6.39.5.469,...iochem Mol Biol 39 469 478 2006 10.5483/BMBRep.2006.39.5.469 17002866,144,168,Int_J_Oncol_2015_Jul_14_47(3)_849-856.txt
5.16.6.225,... J Cancer Prev 16 2251 2256 2015 10.7314/APJCP.2015.16.6.2251 25824746,152,235,Int_J_Oncol_2016_May_16_49(1)_153-163.txt
3.2.2.2,3.2.2.2 Phacochoerida,136,1,Int_J_Parasitol_Parasites_Wildl_2014_Dec_24_4(1)_50-70.txt
5.18.9.845,... Endocrinol Metab 2005 18 9 845 7 10.1515/JPEM.2005.18.9.845 16279360,220,135,Int_J_Pediatr_Endocrinol_2011_Jul_12_2011(1)_7.txt
3.5.4.6,AMP-deaminase (AMPD-EC3.5.4.6) is an enzyme involved in purine metabolis...,14,23,Int_J_Pept_Res_Ther_2016_May_13_22(4)_511-515.txt
5.1.3.3,GL50803_7982	Aldose 1-epimerase	5.1.3.3,115,33,Int_J_Proteomics_2012_Oct_18_2012_980829.txt
3.27.3.215,...ean J Ophthalmol 2013 27 3 215 218 10.3341/kjo.2013.27.3.215 23730117,168,184,Int_J_Retina_Vitreous_2016_Nov_14_2_26.txt
1.15.4.222,...2093-6931Korean Continence Society 10.5213/inj.2011.15.4.222Original ArticleClinical ResearchContine...,3,112,Int_Neurourol_J_2011_Dec_31_15(4)_222-227.txt
2.16.4.159,...2093-6931Korean Continence Society 10.5213/inj.2012.16.4.159Review Article'Omics' Approaches to Unde...,3,127,Int_Neurourol_J_2012_Dec_31_16(4)_159-168.txt
4.18.3.133,...2093-6931Korean Continence Society 10.5213/inj.2014.18.3.133Original ArticleClinical Outcome in Male...,3,127,Int_Neurourol_J_2014_Sep_24_18(3)_133-137.txt
2.50.30.1,"(32) A=[0.25−2.50.30.1],  Ad1=[00.0010.0010],Ad2=[00.0010.0010]...",213,15,Int_Sch_Res_Notices_2014_Oct_28_2014_761959.txt
6.57.3.157,...XThe Korean Urological Association 10.4111/icu.2016.57.3.157Review ArticlePotential role for metform...,3,141,Investig_Clin_Urol_2016_May_10_57(3)_157-164.txt
4.17.4.469,...n Investig Drugs 2008 17 4 469 479 10.1517/13543784.17.4.469 18363513,143,189,Invest_New_Drugs_2012_Jun_22_30(3)_967-980.txt
3.6.3.280,... Int J Cogn Ther. 2013 6 3 280 91 10.1521/ijct.2013.6.3.280,445,189,Iran_J_Psychiatry_Behav_Sci_2015_Dec_23_9(4)_e3444.txt
5.81.2.627,...rcept Mot Skills. 1995 81 2 627 34 10.2466/pms.1995.81.2.627 8570369,191,165,Iran_J_Psychiatry_Behav_Sci_2015_Dec_23_9(4)_e2422.txt
3.43.3.154,...o. Korean Circ J. 2013 43 3 154 60 10.4070/kcj.2013.43.3.154 23613691,256,243,Iran_Red_Crescent_Med_J_2013_Dec_5_15(12)_e16616.txt
4.67.6.107,...s Soc Psychol. 1994 67 6 1079 100 10.1037/0022-3514.67.6.1079,302,116,Iran_Red_Crescent_Med_J_2015_Jan_17_17(1)_e25359.txt
2.4.3.4,2.4.3.4. Incomplete Outcome Data (Checking for Pos...,102,1,PMC5292136.txt
3.7.1.2,"...then trimmed for quality using CodonCode Aligner v3.7.1.2 (Centerville, MA, USA) and aligned with CO...",23,233,PMC5335547.txt
6.34.10.127,...34 10 1277 1284 2-s2.0-33751434030 10.2224/sbp.2006.34.10.1277,186,211,ISRN_Addict_2013_Sep_17_2013_360607.txt
5.22.3.426,...5 22 3 426 444 2-s2.0-24144455280 10.1037/0736-9735.22.3.426,103,122,ISRN_Addict_2013_Nov_11_2013_250751.txt
3.2.3.1,3.2.3.1. IL-6 and MM. Adhesion of multiple myeloma...,322,1,ISRN_Hematol_2013_Jan_29_2013_348212.txt
4.51.3.629,...Social Psychology 1986 51 629 639 10.1037/0022-3514.51.3.629 3761149,156,150,J_Abnorm_Child_Psychol_2010_Jan_13_38(1)_33-41.txt
3.5.3.278,...e Korean Academy of Prosthodontics 10.4047/jap.2013.5.3.278Original ArticlePush-out bond strengths o...,3,146,J_Adv_Prosthodont_2013_Aug_31_5(3)_278-286.txt
5.7.2.151,...e Korean Academy of Prosthodontics 10.4047/jap.2015.7.2.151Original ArticleMicroscopical and chemica...,3,146,J_Adv_Prosthodont_2015_Apr_23_7(2)_151-159.txt
6.8.2.116,...e Korean Academy of Prosthodontics 10.4047/jap.2016.8.2.116Original ArticleStrains around distally i...,3,146,J_Adv_Prosthodont_2016_Apr_21_8(2)_116-124.txt
6.8.3.229,...e Korean Academy of Prosthodontics 10.4047/jap.2016.8.3.229Original ArticleAnalysis of maxillofacial...,3,146,J_Adv_Prosthodont_2016_Jun_17_8(3)_229-234.txt
2.2.3.2,2.2.3.2 Clinical Interview Schedule-Revised (CIS-R...,59,1,J_Affect_Disord_2015_Jan_15_171_60-67.txt
6.1.20.1,6.1.20.1 Geology of the Vredefort Dome and surroun...,540,1,J_Afr_Earth_Sci_2014_May_93_57-175.txt
EC 6.3.1.2,"... activity that inhibits glutamine synthetase [GS; EC 6.3.1.2], an enzyme that catalyzes the conversi...",120,140,J_Agric_Food_Chem_2011_Jun_8_59(11)_5819-5829.txt
4.39.8.190,...d Oceanography  1994 39 8 1903 1916 10.4319/lo.1994.39.8.1903 2-s2.0-0028160135,172,200,J_Anal_Methods_Chem_2016_Jun_28_2016_1480857.txt
3.33.4.290,...r Grassl Forage Sci 2013 33 290 7 10.5333/KGFS.2013.33.4.290,390,198,J_Anim_Sci_Technol_2015_Jan_27_57_3.txt
5.47.5.759,...J Anim Sci Technol 2005 47 759 68 10.5187/JAST.2005.47.5.759,395,201,J_Anim_Sci_Technol_2015_Mar_21_57_14.txt
6.36.5.679,...d Sci Anim Resour 2016 36 679 88 10.5851/kosfa.2016.36.5.679,392,185,PMC5346816.txt
3.37.3.100,...rcept Mot Skills 1973 37 1000 1002 10.2466/pms.1973.37.3.1000 4764491,144,109,J_Assoc_Res_Otolaryngol_2016_Feb_4_17(1)_69-79.txt
5.19.2.79,...710The Korean Audiological Society 10.7874/jao.2015.19.2.79Original ArticleMeasurement of Acceptable...,3,125,J_Audiol_Otol_2015_Sep_16_19(2)_79-84.txt
6.20.3.168,...710The Korean Audiological Society 10.7874/jao.2016.20.3.168Original ArticleClinical Aspects and Sur...,3,125,J_Audiol_Otol_2016_Dec_30_20(3)_168-173.txt
3.96.1.31,...ucational Psychology 2004 96 1 31 10.1037/0022-0663.96.1.31,130,214,J_Autism_Dev_Disord_2016_Mar_24_46_2064-2071.txt
EC 2.3.2.2,"acid y-glutamyl-transferase, EC 2.3.2.2]. Journal of Clinica",638,30,J_Automat_Chem_1990_12(1)_22-40.txt
EC 3.1.3.1,"2.5.1.2); ALP, alkaline phosphatase (EC 3.1.3.1); AMP, 2-amino-2",50,38,J_Automat_Chem_1990_12(4)_153-162.txt
2.2.2.1,2.2.2.1 Internal consistenc,62,1,J_Behav_Ther_Exp_Psychiatry_2011_Jun_42(2)_225-232.txt
3.2.8.1,"...at Lack Complex and Hybrid N-Glycans, Lec1 and Lec3.2.8.",120,65,J_Biol_Chem_2010_Feb_19_285(8)_5759-5775.txt
5.38.4.486,...iochem Mol Biol 2005 38 486 490 10.5483/BMBRep.2005.38.4.486 16053717,368,246,J_Biol_Res_(Thessalon)_2014_May_21_21(1)_8.txt
3.4.21.26,"...EC3.4.24.11) [51], postproline cleaving enzyme (EC3.4.21.26) [52], and the recently described angiot...",53,993,J_Biomed_Biotechnol_2011_Dec_6_2011_286947.txt
3.18.6.101,...JBMREJ 0884-0431http://dx.doi.org/10.1359/jbmr.2003.18.6.101212817753,114,186,J_Biomed_Opt_2014_Nov_16_19(11)_111606.txt
5.22.1.17,...ety for Bone and Mineral Research 10.11005/jbm.2015.22.1.17Original ArticleIncidence and Mortality a...,3,137,J_Bone_Metab_2015_Feb_28_22(1)_17-21.txt
5.22.1.9,...ety for Bone and Mineral Research 10.11005/jbm.2015.22.1.9Original ArticleRelationship between Decre...,3,137,J_Bone_Metab_2015_Feb_28_22(1)_9-15.txt
1.14.1.14,...2-9900Korean Breast Cancer Society 10.4048/jbc.2011.14.1.14Original ArticleαB-Crystallin is a Novel ...,3,105,J_Breast_Cancer_2011_Mar_31_14(1)_14-19.txt
2.15.1.1,...2-9900Korean Breast Cancer Society 10.4048/jbc.2012.15.1.1Review ArticleSurgical Techniques for Pers...,3,120,J_Breast_Cancer_2012_Mar_28_15(1)_1-6.txt
3.16.1.112,...2-9900Korean Breast Cancer Society 10.4048/jbc.2013.16.1.112Case ReportGranulocytic Sarcoma in Breas...,3,120,J_Breast_Cancer_2013_Mar_31_16(1)_112-116.txt
3.16.1.60,...2-9900Korean Breast Cancer Society 10.4048/jbc.2013.16.1.60Original ArticleMale Breast Cancer: 37-Ye...,3,120,J_Breast_Cancer_2013_Mar_31_16(1)_60-65.txt
3.16.3.315,...2-9900Korean Breast Cancer Society 10.4048/jbc.2013.16.3.315Original ArticleThe Comparative Study of...,3,120,J_Breast_Cancer_2013_Sep_30_16(3)_315-321.txt
4.17.1.91,...2-9900Korean Breast Cancer Society 10.4048/jbc.2014.17.1.91Case ReportConcurrent Invasive Ductal Car...,3,120,J_Breast_Cancer_2014_Mar_28_17(1)_91-97.txt
5.18.1.87,...2-9900Korean Breast Cancer Society 10.4048/jbc.2015.18.1.87Original ArticleEffects of a 4-Week Multi...,3,120,J_Breast_Cancer_2015_Mar_27_18(1)_87-96.txt
4.50.5.992,...ocial Psychology 1986 50 992 1103 10.1037/0022-3514.50.5.992 3712234,215,231,J_Bus_Psychol_2015_Sep_26_30(3)_529-541.txt
3.14.2.101,...ts Health Psychol 1995 14 101 108 10.1037/0278-6133.14.2.101 7789344,205,178,J_Cancer_Educ_2011_Dec_31_26(4)_754-760.txt
4.19.4.301,...metry J Cancer Prev 2014 19 301 8 10.15430/JCP.2014.19.4.301 25574465,106,212,PMC5207611.txt
3.14.1.243,... J Cancer Prev 2013 14 1 243 248 10.7314/APJCP.2013.14.1.243 23534731,264,204,J_Cancer_Res_Clin_Oncol_2014_May_27_140(9)_1517-1525.txt
EC 3.6.1.3,"...tic assay of ATPase (adenosine 5’-triphosphatase, EC 3.6.1.3) followed the Sigma Prod. No. A-7510 pr...",46,61,J_Carcinog_2010_Nov_18_9_10.txt
3.21.2.100,...Korean Society of Echocardiography 10.4250/jcu.2013.21.2.100Images in Cardiovascular UltrasoundUnusu...,3,154,J_Cardiovasc_Ultrasound_2013_Jun_26_21(2)_100-101.txt
4.22.1.46,...Korean Society of Echocardiography 10.4250/jcu.2014.22.1.46Images in Cardiovascular UltrasoundSimila...,3,154,J_Cardiovasc_Ultrasound_2014_Mar_31_22(1)_46-47.txt
4.1.3.7,Citrate synthase (4.1.3.7 citrate oxaloacetate-lyas,221,19,J_Cell_Biol_1974_Oct_1_63(1)_125-135.txt
1.9.3.1,"1.9.3.1) was essentiallythe same, exceptthat Lubro...",77,1,J_Cell_Biol_1976_Jun_1_69(3)_581-588.txt
EC 3.2.1.31,/~-glucuronidase(EC 3.2.1.31) was assayed in duplicates as describe...,199,18,J_Cell_Biol_1983_Jul_1_97(1)_52-61.txt
2.4.1.38,"syltransferase (E.C. 2.4.1.22, 2.4.1.38, 2.4.1.90) became avail",50,32,J_Cell_Biol_1985_Jan_1_100(1)_118-125.txt
EC 4.2.2.4,tion of DS-PG with chondroitinABC lyase (EC 4.2.2.4; Seikagaku Kogyo,156,42,J_Cell_Biol_1987_Jun_1_104(6)_1683-1691.txt
EC 2.3.2.13,RANSGLUTAMINASE(EC 2.3.2.13) is an enzyme tha,34,17,J_Cell_Biol_1993_Mar_2_120(6)_1461-1470.txt
EC 1.11.1.6,"...(3-oxoacyl-CoA thiolase; EC  2.3.1.16), catalase (EC 1.11.1.6), and fumarate hydratase (fumarase; EC...",59,230,J_Cell_Biol_1998_Jan_12_140(1)_49-60.txt
4.3.4.4,"...twi-Gal4 and one of our UAS-antisense-rost (line 14.3.4.4) lines. In wild-type, the muscles are well...",664,418,J_Cell_Biol_1997_Jul_28_138(2)_337-348.txt
2.14.3.192,...n Society of Endovascular Surgery 10.7461/jcen.2012.14.3.192Original ArticleIntracranial Dural Arter...,3,242,J_Cerebrovasc_Endovasc_Neurosurg_2012_Sep_28_14(3)_192-202.txt
3.15.3.229,...n Society of Endovascular Surgery 10.7461/jcen.2013.15.3.229Case ReportThe Difference of Each Angiog...,3,242,J_Cerebrovasc_Endovasc_Neurosurg_2013_Sep_30_15(3)_229-234.txt
4.16.1.39,...Korean Endovascular Neurosurgeons 10.7461/jcen.2014.16.1.39Letter to the EditorIntravenous Versus In...,3,248,J_Cerebrovasc_Endovasc_Neurosurg_2014_Mar_31_16(1)_39-41.txt
6.7.7.107,... Pharmacogenomics 2006 7 1077 1086 10.2217/14622416.7.7.1077 17054417,241,171,J_Cheminform_2010_Oct_18_2_9.txt
4.84.4.822,...Social Psychology 2003 84 822 848 10.1037/0022-3514.84.4.822 12703651,174,180,J_Child_Fam_Stud_2012_Feb_2_21(1)_139-147.txt
EC 1.1.3.4,"...idase (GOD, β-D-glucose: oxygen 1-oxidoreductase, EC 1.1.3.4) is an important enzyme, which catalyze...",10,61,J_Clin_Biochem_Nutr_2007_Sep_29_41(2)_132-138.txt
3.16.3.315,... J Breast Cancer 2013 16 3 315 321 10.4048/jbc.2013.16.3.315 24155761,106,255,J_Clin_Med_Res_2015_Jun_8_7(6)_440-445.txt
1.31.3.191,31 :191 –196 . doi:10.3343/kjlm.2011.31.3.191 .21779194,202,36,PMC5328454.txt
2.8.3.238,...013Korean Neurological Association 10.3988/jcn.2012.8.3.238Case ReportMedial Temporal Activation in ...,3,139,J_Clin_Neurol_2012_Sep_27_8(3)_238-240.txt
2.8.4.305,...013Korean Neurological Association 10.3988/jcn.2012.8.4.305Case ReportA Case of Lambert-Eaton Myasth...,3,139,J_Clin_Neurol_2012_Dec_21_8(4)_305-307.txt
4.10.1.72,...013Korean Neurological Association 10.3988/jcn.2014.10.1.72Letter to the EditorCervical Myelitis Mim...,3,139,J_Clin_Neurol_2014_Jan_6_10(1)_72-73.txt
4.10.3.249,...013Korean Neurological Association 10.3988/jcn.2014.10.3.249Original ArticleDiffusion Tensor Tractog...,3,139,J_Clin_Neurol_2014_Jul_3_10(3)_249-256.txt
4.10.3.272,...013Korean Neurological Association 10.3988/jcn.2014.10.3.272Case ReportOpsoclonus-Myoclonus Syndrome...,3,139,J_Clin_Neurol_2014_Jul_3_10(3)_272-275.txt
5.11.1.106,...013Korean Neurological Association 10.3988/jcn.2015.11.1.106ErratumErratum: Hyperhomocysteinemia and...,3,139,J_Clin_Neurol_2015_Jan_2_11(1)_106.txt
5.11.3.220,...n Neurological Association 2617478410.3988/jcn.2015.11.3.220ReviewOrthostatic Hypotension: Mechanism...,3,147,J_Clin_Neurol_2015_Jul_1_11(3)_220-226.txt
6.12.4.517,...013Korean Neurological Association 10.3988/jcn.2016.12.4.517Letter to the EditorA Nonpregnant Woman ...,3,139,J_Clin_Neurol_2016_Oct_30_12(4)_517-518.txt
6.12.4.441,...013Korean Neurological Association 10.3988/jcn.2016.12.4.441Original ArticleProjected Numbers of Isc...,3,139,J_Clin_Neurol_2016_Oct_26_12(4)_441-445.txt
3.2.6.3,3.2.6.3 Representative members of the MDT should b...,240,1,J_Crohns_Colitis_2015_Aug_18_9(8)_685-691.txt
4.19.3.374,...edical Science  2004 19 3 374 383 10.3346/jkms.2004.19.3.374 2-s2.0-3042795227 15201503,457,241,J_Diabetes_Res_2015_Apr_7_2015_801348.txt
4.51.6.117,...l Psychology  1986 51 6 1173 1182 10.1037/0022-3514.51.6.1173 2-s2.0-0023020183 3806354,138,245,J_Diabetes_Res_2016_Nov_23_2016_3159103.txt
1.17.3.213,...Care Pharmacy  2011 17 3 213 223 10.18553/jmcp.2011.17.3.213 2-s2.0-79954488050 21434698,184,346,PMC5286474.txt
1.8.63.3,"Surgery	62.5 (61.8.63.3)	62.7 (54.9, 65.1)	60.5 (59.3-61.7)	59.0 ...",76,16,J_Educ_Eval_Health_Prof_2014_May_8_11_10.txt
1.70.3.102,10.1024/0300-9831.70.3.102 10883403,311,17,J_Epidemiol_2010_May_5_20(3)_197-203.txt
2.13.11.548,...ncer Prev . 2012 ;13 :5489 –95 . 10.7314/APJCP.2012.13.11.5489 23317205,242,265,J_Epidemiol_2016_Jan_5_26(1)_22-29.txt
3.17.4.483,... Med Anthropol Q 2003 17 4 483 500 10.1525/maq.2003.17.4.483 14716920,232,149,J_Ethnobiol_Ethnomed_2014_Feb_24_10_25.txt
EC 2.1.1.14,2	Methionine synthase protein (EC 2.1.1.14) [Sorghum bicolor]	5.93/83 788	Q8W0Q7	...,70,32,J_Exp_Bot_2008_Nov_13_59(15)_4183-4194.txt
EC 1.11.1.11,APX (EC 1.11.1.11) activity was measured based on the d...,53,6,J_Exp_Bot_2009_Mar_9_60(4)_1273-1288.txt
EC 4.3.2.1,"...nged to cluster 1, while argininosuccinate lyase (EC 4.3.2.1) had a more constant level of expressio...",183,203,J_Exp_Bot_2009_Jan_17_60(1)_153-167.txt
EC 1.1.5.4,"...1984) for monodehydroascorbate reductase (MDHAR) (EC 1.1.5.4), and Dalton et al. (1986) for dehydroa...",63,389,J_Exp_Bot_2012_Sep_21_63(15)_5659-5675.txt
EC 2.4.1.99,"Root 1-SST (EC 2.4.1.99), 1-FFT (EC 2.4.1.100), and 1-FEH (EC ...",64,13,J_Exp_Bot_2012_Jul_10_63(12)_4359-4373.txt
EC 4.1.2.15,"...rabino-heptulosonate-7-phosphate synthase (DAHPS; EC 4.1.2.15), soluble protein extracts (50 µg per ...",55,89,J_Exp_Bot_2013_Jan_22_64(1)_281-292.txt
EC 1.6.4.2,"...se (CAT; EC 1.11.1.6), glutathione reductase (GR; EC 1.6.4.2), and unspecific peroxidases (guaiacol ...",68,586,J_Exp_Bot_2013_Dec_22_64(18)_5651-5660.txt
EC 4.1.1.31,"Phosphoenolpyruvate carboxylase (PEPC, EC 4.1.1.31) is a tightly controlled cytosolic enz...",8,40,J_Exp_Bot_2011_Nov_12_62(15)_5485-5495.txt
EC 1.6.3.1,•–-generating (EC 1.6.3.1) activity in isolated plasma membrane v...,58,16,J_Exp_Bot_2014_Aug_4_65(15)_4371-4383.txt
EC 6.3.1.2,"...ential regulation of GS genes. For example, GS1a (EC 6.3.1.2), a cytosolic GS responsible for reassi...",218,1286,J_Exp_Bot_2015_Jun_1_66(11)_3113-3127.txt
EC 2.4.1.14,...ate is catalysed by sucrose 6-phosphate synthase (EC 2.4.1.14) which exhibited decreased activity in...,170,648,J_Exp_Bot_2015_Jun_20_66(11)_3141-3150.txt
4.15.16.646,...ac J Cancer Prev 2014 15 6463 75 10.7314/APJCP.2014.15.16.6463 25169472,137,197,J_Exp_Clin_Cancer_Res_2016_Mar_3_35_41.txt
3.17.6.531,...J Physiol Pharmacol 2013 64 531 4 10.4196/kjpp.2013.17.6.531 24304566,342,123,J_Exp_Clin_Cancer_Res_2016_Dec_5_35_182.txt
4.30.2.357,...ent Psychotherapy 1993 30 357 368 10.1037/0033-3204.30.2.357,460,135,J_Exp_Criminol_2011_Sep_21_7(3)_225-253.txt
4.42.64.53,5 i 0.511.82.3 4.42.64.53.6 ]3.4 ' 4.6 2.,130,16,J_Exp_Med_1952_Jan_1_95(1)_1-7.txt
3.30.4.643,"...and Performance , 30 , 643 –656 . 10.1037/0096-1523.30.4.643 15301615",220,273,J_Exp_Psychol_Hum_Percept_Perform_2016_Mar_19_42(3)_386-400.txt
3.28.1.12,"...and Cognition , 28 , 12 –28 . doi:10.1037/0278-7393.28.1.12",214,218,J_Exp_Psychol_Learn_Mem_Cogn_2014_Sep_5_40(5)_1257-1270.txt
3.28.1.153,"...ntal Psychology , 28 , 153 –161 . 10.1037/0278-7393.28.1.153 11827077",195,176,PMC5207169.txt
4.4.1.73,...Psychology and Aging 1989 4 73 78 10.1037/0882-7974.4.1.73 2803614,281,199,J_Fam_Econ_Issues_2010_Sep_27_31(3)_318-327.txt
1.1.5.715,...ghtrope Regen. Med. 2006 1 715 719 10.2217/17460751.1.5.715 17465740,221,177,J_Funct_Biomater_2015_Dec_11_6(4)_1064-1084.txt
1.11.2.131,... Korean Gastric Cancer Association 10.5230/jgc.2011.11.2.131Case ReportLaparoscopic Gastric Wedge Re...,3,116,J_Gastric_Cancer_2011_Jun_30_11(2)_131-134.txt
6.16.4.260,... Korean Gastric Cancer Association 10.5230/jgc.2016.16.4.260Original ArticleCould Adjuvant Chemother...,3,132,PMC5206317.txt
EC 1.11.1.7,"...ining choline oxidase (EC 1.1.3.17, 1 U/ml), HRP (EC 1.11.1.7, 2 U/ml), and 400 µM Amplex Red at roo...",52,409,J_Gen_Physiol_2016_Feb_147(2)_175-188.txt
4.2.1.3,"4.2.1.3 Comparison of the results obtained by ECG,...",72,1,J_Geriatr_Cardiol_2016_Feb_13(2)_118-125.txt
EC 1.1.1.14,"...0_seq1 (No. 18), encoding sorbitol dehydrogenase (EC 1.1.1.14), which catalyzes the conversion of so...",75,372,PMC5223079.txt
EC 2.7.1.11,...sphatase (EC 3.1.3.11) and 6-phosphofructokinase (EC 2.7.1.11) were detected at similar levels in al...,77,261,PMC5223079.txt
1.22.4.288,...ynecologic Oncology and Colposcopy 10.3802/jgo.2011.22.4.288Case ReportA mediastinal germ cell tumor...,3,137,J_Gynecol_Oncol_2011_Dec_5_22(4)_288-291.txt
2.23.3.168,...ynecologic Oncology and Colposcopy 10.3802/jgo.2012.23.3.168Original ArticleSalvage radiotherapy for...,3,152,J_Gynecol_Oncol_2012_Jul_2_23(3)_168-174.txt
3.24.3.229,...an Society of Gynecologic Oncology 10.3802/jgo.2013.24.3.229Original ArticleCervixPrognostic factors...,3,176,J_Gynecol_Oncol_2013_Jul_4_24(3)_229-235.txt
4.10.1.119,...pin Investig Drugs 2001 10 119 128 10.1517/13543784.10.1.119 11116285,129,113,J_Hematol_Oncol_2010_Oct_31_3_43.txt
4.8.2.239,...v Vaccines 2009 8 239 252 19196203 10.1586/14760584.8.2.239,140,184,J_Immune_Based_Ther_Vaccines_2009_Sep_15_7_4.txt
2.1.1.4,... N-acetylserotonin-O-methyltransferase (ASMT; EC: 2.1.1.4; previously known as hydroxyndole-O-methyl...,45,389,J_Immunol_Res_2015_Apr_19_2015_354957.txt
2.17.4.483,...edical Science  2002 17 4 483 489 10.3346/jkms.2002.17.4.483 2-s2.0-0036690605 12172043,179,153,J_Immunol_Res_2015_Apr_27_2015_156787.txt
1.27.4.283,...ogs Lab Anim Res 2011 27 4 283 291 10.5625/lar.2011.27.4.283 22232636,228,190,PMC5171656.txt
4.14.3.128,...nfection Immune Netw 2014 14 128 37 10.4110/in.2014.14.3.128 24999309,154,149,PMC5240396.txt
EC 3.2.1.22,...ity of the lysosomal hydrolase α-galactosidase A (EC 3.2.1.22) (Desnick and Ioannou 2001; Brady et a...,42,114,J_Inherit_Metab_Dis_2011_Jun_29_34(3)_605-619.txt
EC 3.1.1.7,"Acetylcholine esterase (AChE, EC 3.1.1.7), a key enzyme in neurotransmission, is...",17,31,J_Insect_Sci_2012_Mar_24_12_41.txt
6.42.6.379,...Oral and Maxillofacial Surgeons 10.5125/jkaoms.2016.42.6.379Case ReportLymphocytoma cutis: diagnosti...,3,239,PMC5206245.txt
4.40.2.61,...Oral and Maxillofacial Surgeons 10.5125/jkaoms.2014.40.2.61Original ArticleComparison of the reprodu...,3,239,J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Apr_28_40(2)_61-67.txt
4.40.5.250,...Oral and Maxillofacial Surgeons 10.5125/jkaoms.2014.40.5.250Case ReportA simple method of intraopera...,3,239,J_Korean_Assoc_Oral_Maxillofac_Surg_2014_Oct_24_40(5)_250-252.txt
5.41.4.217,...Oral and Maxillofacial Surgeons 10.5125/jkaoms.2015.41.4.217Case ReportSinonasal sarcoidosis of the ...,3,239,J_Korean_Assoc_Oral_Maxillofac_Surg_2015_Aug_21_41(4)_217-221.txt
5.41.5.270,...Oral and Maxillofacial Surgeons 10.5125/jkaoms.2015.41.5.270Case ReportDeep benign fibrous histiocyt...,3,239,J_Korean_Assoc_Oral_Maxillofac_Surg_2015_Oct_20_41(5)_270-272.txt
6.21.1.116,...orean Academy of Medical Sciences 10.3346/jkms.2006.21.1.116479055Original ArticleIncreased Expressi...,3,127,J_Korean_Med_Sci_2006_Feb_20_21(1)_1-4.txt
6.21.3.412,...orean Academy of Medical Sciences 10.3346/jkms.2006.21.3.41216778381Original ArticleCirculating Auto...,3,127,J_Korean_Med_Sci_2006_Jun_21_21(3)_412-417.txt
6.21.3.550,...orean Academy of Medical Sciences 10.3346/jkms.2006.21.3.55016778404Case ReportIsolated Biliary Gran...,3,127,J_Korean_Med_Sci_2006_Jun_21_21(3)_550-554.txt
6.31.8.121,...orean Academy of Medical Sciences 10.3346/jkms.2016.31.8.1215Original ArticleOncology & HematologyOT...,3,145,J_Korean_Med_Sci_2016_Aug_3_31(8)_1215-1223.txt
5.20.6.107,...orean Academy of Medical Sciences 10.3346/jkms.2005.20.6.107316361826Case ReportA Case of Hypersensi...,3,127,J_Korean_Med_Sci_2005_Dec_31_20(6)_1073-1075.txt
6.21.2.188,...orean Academy of Medical Sciences 10.3346/jkms.2006.21.2.18816614499Original ArticleSynergy of Arbek...,3,127,J_Korean_Med_Sci_2006_Apr_20_21(2)_188-192.txt
6.21.2.358,...orean Academy of Medical Sciences 10.3346/jkms.2006.21.2.35816614530Case ReportA Case of Santorinice...,3,127,J_Korean_Med_Sci_2006_Apr_20_21(2)_358-360.txt
6.21.6.109,...orean Academy of Medical Sciences 10.3346/jkms.2006.21.6.109217179693Original ArticleValidation in t...,3,127,J_Korean_Med_Sci_2006_Dec_31_21(6)_1092-1097.txt
5.20.2.182,...orean Academy of Medical Sciences 10.3346/jkms.2005.20.2.18215831984Original ArticleLow Birth Weight...,3,127,J_Korean_Med_Sci_2005_Apr_30_20(2)_182-187.txt
4.19.1.814,...orean Academy of Medical Sciences 10.3346/jkms.2004.19.1.814966334Original ArticleIncreasing Prevale...,3,127,J_Korean_Med_Sci_2004_Feb_28_19(1)_8-14.txt
1.26.2.264,...orean Academy of Medical Sciences 10.3346/jkms.2011.26.2.264Original ArticleRespiratory DiseasesInci...,3,127,J_Korean_Med_Sci_2011_Feb_24_26(2)_264-267.txt
1.26.3.379,...orean Academy of Medical Sciences 10.3346/jkms.2011.26.3.379Original ArticleRespiratory DiseasesPred...,3,127,J_Korean_Med_Sci_2011_Mar_25_26(3)_379-385.txt
1.26.3.417,...orean Academy of Medical Sciences 10.3346/jkms.2011.26.3.417Original ArticleDermatologyTranscription...,3,127,J_Korean_Med_Sci_2011_Mar_25_26(3)_417-424.txt
1.26.12.161,...orean Academy of Medical Sciences 10.3346/jkms.2011.26.12.1619Original ArticleObstetrics & Gynecolog...,3,127,J_Korean_Med_Sci_2011_Dec_29_26(12)_1619-1624.txt
2.27.1.64,...orean Academy of Medical Sciences 10.3346/jkms.2012.27.1.64Original ArticleNephrologyLower Residual ...,3,127,J_Korean_Med_Sci_2012_Jan_19_27(1)_64-71.txt
2.27.9.110,"...orean Academy of Medical Sciences 10.3346/jkms.2012.27.9.1105Case ReportInfectious Diseases, Microbi...",3,145,J_Korean_Med_Sci_2012_Sep_22_27(9)_1105-1108.txt
3.28.1.128,...orean Academy of Medical Sciences 10.3346/jkms.2013.28.1.128Original ArticlePsychiatry & PsychologyP...,3,145,J_Korean_Med_Sci_2013_Jan_8_28(1)_128-135.txt
3.28.3.348,...orean Academy of Medical Sciences 10.3346/jkms.2013.28.3.348Original ArticleMedicine General & Socia...,3,145,J_Korean_Med_Sci_2013_Mar_4_28(3)_348-356.txt
3.28.9.132,"...orean Academy of Medical Sciences 10.3346/jkms.2013.28.9.1329Original ArticleEndocrinology, Nutritio...",3,145,J_Korean_Med_Sci_2013_Sep_28_28(9)_1329-1333.txt
3.28.9.127,...orean Academy of Medical Sciences 10.3346/jkms.2013.28.9.1270Special ArticleMedicine General & Socia...,3,145,J_Korean_Med_Sci_2013_Sep_28_28(9)_1270-1275.txt
4.29.1.1,"...orean Academy of Medical Sciences 10.3346/jkms.2014.29.1.1EditorialEditing, Writing, & PublishingLau...",3,145,J_Korean_Med_Sci_2014_Jan_26_29(1)_1.txt
4.29.5.633,...orean Academy of Medical Sciences 10.3346/jkms.2014.29.5.633Original ArticleOccupation & Environment...,3,145,J_Korean_Med_Sci_2014_May_25_29(5)_633-639.txt
4.29.5.719,...orean Academy of Medical Sciences 10.3346/jkms.2014.29.5.719Original ArticlePsychiatry & PsychologyP...,3,145,J_Korean_Med_Sci_2014_May_25_29(5)_719-728.txt
4.29.6.751,...ademy of Medical Sciences 2493207310.3346/jkms.2014.29.6.751ReviewSurgeryOverview of Surgical Scar P...,3,153,J_Korean_Med_Sci_2014_Jun_30_29(6)_751-757.txt
4.29.7.995,...orean Academy of Medical Sciences 10.3346/jkms.2014.29.7.995Original ArticleMusculoskeletal Disorder...,3,145,J_Korean_Med_Sci_2014_Jul_11_29(7)_995-1000.txt
4.29.10.138,...orean Academy of Medical Sciences 10.3346/jkms.2014.29.10.1385Original ArticleCardiovascular Disorde...,3,145,J_Korean_Med_Sci_2014_Oct_8_29(10)_1385-1390.txt
6.31.3.410,...orean Academy of Medical Sciences 10.3346/jkms.2016.31.3.410Original ArticleGastroenterology & Hepat...,3,145,J_Korean_Med_Sci_2016_Mar_25_31(3)_410-416.txt
6.31.4.590,...orean Academy of Medical Sciences 10.3346/jkms.2016.31.4.590Original ArticlePsychiatry & PsychologyA...,3,145,J_Korean_Med_Sci_2016_Apr_2_31(4)_590-597.txt
6.31.9.150,...orean Academy of Medical Sciences 10.3346/jkms.2016.31.9.1505CorrespondenceOncology & HematologyThe ...,3,145,J_Korean_Med_Sci_2016_Sep_23_31(9)_1505-1506.txt
2.51.6.367,...6The Korean Neurosurgical Society 10.3340/jkns.2012.51.6.367Case ReportTerson Syndrome Caused by Int...,3,155,J_Korean_Neurosurg_Soc_2012_Jun_30_51(6)_367-369.txt
4.55.2.110,...6The Korean Neurosurgical Society 10.3340/jkns.2014.55.2.110Technical NoteMicrosurgical Excision of ...,3,155,J_Korean_Neurosurg_Soc_2014_Feb_28_55(2)_110-113.txt
4.56.6.517,...6The Korean Neurosurgical Society 10.3340/jkns.2014.56.6.517Case ReportCauda Equina Syndrome Associa...,3,155,J_Korean_Neurosurg_Soc_2014_Dec_31_56(6)_517-520.txt
4.56.6.496,...6The Korean Neurosurgical Society 10.3340/jkns.2014.56.6.496Case ReportUse of the Sundt Clip Graft i...,3,155,J_Korean_Neurosurg_Soc_2014_Dec_31_56(6)_496-499.txt
5.57.6.460,...6The Korean Neurosurgical Society 10.3340/jkns.2015.57.6.460Clinical ArticleUnilateral C1 Lateral Ma...,3,155,J_Korean_Neurosurg_Soc_2015_Jun_30_57(6)_460-464.txt
5.58.3.301,...6The Korean Neurosurgical Society 10.3340/jkns.2015.58.3.301Case ReportSpontaneous Resolution of a L...,3,155,J_Korean_Neurosurg_Soc_2015_Sep_30_58(3)_301-303.txt
5.58.5.454,...6The Korean Neurosurgical Society 10.3340/jkns.2015.58.5.454Clinical ArticleStereological and Morpho...,3,155,J_Korean_Neurosurg_Soc_2015_Nov_30_58(5)_454-461.txt
1.81.2.122,...3-0488The Korean Surgical Society 10.4174/jkss.2011.81.2.122Original ArticleClinicopathological feat...,3,122,J_Korean_Surg_Soc_2011_Aug_3_81(2)_122-127.txt
2.82.3.179,...3-0488The Korean Surgical Society 10.4174/jkss.2012.82.3.179Original ArticleReview of 100 cases of s...,3,122,J_Korean_Surg_Soc_2012_Mar_27_82(3)_179-184.txt
2.83.3.162,...3-0488The Korean Surgical Society 10.4174/jkss.2012.83.3.162Original ArticleRenal and abdominal visc...,3,139,J_Korean_Surg_Soc_2012_Sep_27_83(3)_162-170.txt
3.84.6.338,...3-0488The Korean Surgical Society 10.4174/jkss.2013.84.6.338Original ArticleOptimal timing of surger...,3,139,J_Korean_Surg_Soc_2013_Jun_28_84(6)_338-345.txt
6.4.3.198,...d J Neurosurg Spine 2006 4 198 205 10.3171/spi.2006.4.3.198 16572618,88,268,J_Mater_Sci_Mater_Med_2010_Mar_7_21(3)_871-878.txt
1.78.65.11,...://orcid.org/0000-0002-1304-952XFrasca Sophie +33 1.78.65.11.47sfrasca.irba@gmail.com 1Norol Françoi...,3,420,PMC5253158.txt
3.8.2.160,...rt J Korean Med Sci. 1993 8 160 1 10.3346/jkms.1993.8.2.160 8397932,77,136,J_Med_Case_Rep_2015_Mar_28_9_71.txt
2.1.7.280,...munol Inflamm 2004 12 7 16 15209459 10.1076/ocii.12.1.7.28072,77,102,J_Med_Case_Reports_2007_Oct_26_1_114.txt
5.2.1.15,"3-Azatetracyclo[5.2.1.15,8.01,5]undecane derivatives: from wild-ty...",985,17,J_Med_Chem_2014_Jul_10_57(13)_5738-5747.txt
EC 2.1.1.163,"(EC 2.1.1.163, 2-polyprenyl-1,4-naphthoquinon",366,2,J_Med_Chem_2014_Apr_10_57(7)_3126-3139.txt
1.2.2.2,"1.2.2.2 Triability – other	7 [32,102,109,153,154,1...",908,2,J_Med_Internet_Res_2013_Oct_8_15(10)_e210.txt
3.2.1.4,3.2.1.4 Support and promotion by colleagues (not f...,1574,2,J_Med_Internet_Res_2013_Oct_8_15(10)_e210.txt
4.1.3.7,4.1.3.7.2 New set of scholarly impact metrics,2388,2,J_Med_Internet_Res_2013_Oct_8_15(10)_e210.txt
3.26.1.1,...pain Health Psychol 2007 26 1 1 9 10.1037/0278-6133.26.1.1 17209691 17209691,316,166,J_Med_Internet_Res_2014_Mar_27_16(3)_e88.txt
4.42.1.116,...al Psychology 1982 1 42 1 116 131 10.1037/0022-3514.42.1.116,1229,132,J_Med_Internet_Res_2014_Jun_11_16(6)_e148.txt
3.27.3.379,...Health Psychol 2008 5 27 3 379 87 10.1037/0278-6133.27.3.379 18624603 18624603,247,139,J_Med_Internet_Res_2015_Jan_30_17(1)_e30.txt
1.29.6.738,...al Cognition 2011 12 29 6 738 762 10.1521/soco.2011.29.6.738,181,181,J_Med_Internet_Res_2015_Feb_5_17(2)_e37.txt
3.27.3.379,...ealth Psychol 2008 5 27 3 379 387 10.1037/0278-6133.27.3.379 18624603 18624603,248,139,J_Med_Internet_Res_2016_Jun_7_18(6)_e155.txt
4.29.6.818,... J Korean Med Sci 2014 29 818 824 10.3346/jkms.2014.29.6.818 24932084,106,172,PMC5222898.txt
3.19.3.130,...761The Korean Society of Menopause 10.6118/jmm.2013.19.3.130Original ArticleThe Relationship between...,3,131,J_Menopausal_Med_2013_Dec_27_19(3)_130-134.txt
5.21.2.79,...761The Korean Society of Menopause 10.6118/jmm.2015.21.2.79Review ArticleG-protein Coupled Estrogen ...,3,131,J_Menopausal_Med_2015_Aug_28_21(2)_79-81.txt
6.22.2.71,...761The Korean Society of Menopause 10.6118/jmm.2016.22.2.71Review ArticleCell Therapy Products in Me...,3,131,J_Menopausal_Med_2016_Aug_30_22(2)_71-75.txt
4.38.1.35,...abetes Metab J 2014 2 38 1 35 43   10.4093/dmj.2014.38.1.35 24627826 24627826,637,354,JMIR_Mhealth_Uhealth_2015_Aug_20_3(3)_e83.txt
4.16.2.86,...troke J Stroke 2014 5 16 2 86 90   10.5853/jos.2014.16.2.86 24949314 24949314,293,178,JMIR_Mhealth_Uhealth_2016_Jul_6_4(3)_e83.txt
4.8.6.695,...tr Res Pract 2014 12 8 6 695 704   10.4162/nrp.2014.8.6.695 25489410 25489410,298,333,JMIR_Res_Protoc_2015_Mar_26_4(1)_e36.txt
2.2.2.1,2.2.2.1.  Microwave storage and optical to microwa...,95,1,J_Mod_Opt_2016_Nov_12_63(20)_20051-2028.txt
2.1.1.1,.../2DP/2.1.1.1.0/10/APIA/VIAA/052 and 2010/0224/2DP/2.1.1.1.0/10/APIA/VIAA/164. This work was supporte...,117,215,J_Mol_Biol_2012_Oct_12_423(1)_63-78.txt
3.30.9.10,"...ce events are represented: Top, the fusion to the 3.30.9.10 CATH domain, and the concomitant split o...",182,379,J_Mol_Biol_2016_Jul_31_428(15)_3131-3146.txt
EC 1.6.5.3,"...one oxidoreductase 75 kDa subunit, mitochondrial (EC 1.6.5.3) (Sus scrofa)	NDUFS1	gi|311272935	877	3...",324,67,J_Mol_Endocrinol_2015_Dec_55(3)_277-293.txt
6.5.4.735,"...t Opin Pharmacother 2004 5 735 746 10.1517/14656566.5.4.735 Weiss MD, Weydt P, Carter GT (2004) Curr...",127,134,J_Neural_Transm_2008_Aug_21_115(8)_1119-1126.txt
5.14.3.353,"...y Neuropsychology 2000 14 353 360 10.1037/0894-4105.14.3.353 Gourovitch ML, Kirkby BS, Goldberg TE e...",213,151,J_Neural_Transm_2008_Sep_12_115(9)_1327-1337.txt
3.98.1.112,... J Educ Psychol 2006 98 1 112 121 10.1037/0022-0663.98.1.112 19444324,131,224,J_Neurodev_Disord_2010_Jun_20_2(2)_109-116.txt
3.83.2.264,... J Educ Psychol 1991 83 2 264 274 10.1037/0022-0663.83.2.264,202,199,J_Neurodev_Disord_2011_Dec_13_3(4)_335-347.txt
2.18.1.106,...Neurogastroenterology and Motility 10.5056/jnm.2012.18.1.106Journal ClubAcute Tryptophan Depletion a...,3,161,J_Neurogastroenterol_Motil_2012_Jan_16_18(1)_106-108.txt
3.19.1.104,...Neurogastroenterology and Motility 10.5056/jnm.2013.19.1.104Image and LearningMagnifying Endoscopy W...,3,187,J_Neurogastroenterol_Motil_2013_Jan_8_19(1)_104-106.txt
2.11.3.307,... Opin Ther Targets 2007 11 307 320 10.1517/14728222.11.3.307 17298290,103,224,J_Neuroinflammation_2011_Feb_4_8_10.txt
3.9.1.36,... levels J Clin Neurol 2013 9 36 42 10.3988/jcn.2013.9.1.36 23346159,117,237,J_Neuroinflammation_2014_Jan_27_11_16.txt
3.28.2.295,... Korean Med Sci 2013 28 2 295 299 10.3346/jkms.2013.28.2.295 23399872,137,231,J_Neuroinflammation_2014_Mar_28_11_62.txt
4.37.9.153,...cial Psychology 1979 37 1539 1553 10.1037/0022-3514.37.9.1539,169,170,PMC5283509.txt
4.7.2.171,...ychology and Aging 1992 7 171 184 10.1037/0882-7974.7.2.171 1610505,172,152,PMC5283509.txt
3.24.5.508,...r Health Psychol 2005 24 5 508 16 10.1037/0278-6133.24.5.508 16162045,114,207,J_Ocul_Biol_Dis_Infor_2009_Sep_19_2(3)_109-118.txt
2.17.12.227,...er Res 2002 17 2274 2280 12469922 10.1359/jbmr.2002.17.12.2274,183,252,J_Orthop_Surg_2008_Feb_27_3_11.txt
6.2.8.129,...Opin Pharmacother 2001 2 1299 1306 10.1517/14656566.2.8.1299 11584998,238,138,J_Ovarian_Res_2011_Nov_10_4_20.txt
5.26.2.156,...14 J Gynecol Oncol 2015 26 156 167 10.3802/jgo.2015.26.2.156 25872896,142,154,J_Ovarian_Res_2016_Nov_17_9_80.txt
1.41.1.23,...Academy of Periodontology 2139429410.5051/jpis.2011.41.1.23Research ArticleHealing pattern of the mu...,3,170,J_Periodontal_Implant_Sci_2011_Feb_28_41(1)_23-29.txt
1.41.5.242,...Academy of Periodontology 2208741510.5051/jpis.2011.41.5.242Research ArticleThe effect of fibronecti...,3,170,J_Periodontal_Implant_Sci_2011_Oct_31_41(5)_242-247.txt
3.43.5.207,...6Korean Academy of Periodontology 10.5051/jpis.2013.43.5.207EditorialWaiting for innovations in peri...,3,162,J_Periodontal_Implant_Sci_2013_Oct_29_43(5)_207-208.txt
4.44.6.280,...6Korean Academy of Periodontology 10.5051/jpis.2014.44.6.280Research ArticleEffects of adjunctive da...,3,162,J_Periodontal_Implant_Sci_2014_Dec_31_44(6)_280-287.txt
3.4.24.11,...roy B   (1990 ) Characterization of endopeptidase 3.4.24.11 (“enkephalinase”) activity in human plas...,204,90,J_Pharmacol_Exp_Ther_2016_May_357(2)_423-431.txt
4.77.4.161,...se Tuberc Respir Dis 2014 77 161 6 10.4046/trd.2014.77.4.161,156,162,J_Pharm_Health_Care_Sci_2015_Sep_3_1_24.txt
3.3.3.4,3.3.3.4 Angle Settin,131,1,J_Res_Natl_Inst_Stand_Technol_2003_Apr_1_Mar-Apr_108(2)_99-113.txt
6.2.2.1,6.2.2.1.3 Liquid-in-Glass Thermometer,259,1,J_Res_Natl_Inst_Stand_Technol_2001_Feb_1_Jan-Feb_106(1)_105-149.txt
6.2.2.4,6.2.2.4 Measurement Assurance Program (MAP,271,1,J_Res_Natl_Inst_Stand_Technol_2001_Feb_1_Jan-Feb_106(1)_105-149.txt
3.15.1.1,...63912287-6405Korean Stroke Society 10.5853/jos.2013.15.1.1EditorialWelcome to a New Stroke Journal K...,3,92,J_Stroke_2013_Jan_31_15(1)_1.txt
5.17.1.38,"...63912287-6405Korean Stroke Society 10.5853/jos.2015.17.1.38ReviewCase Characteristics, Hyperacute Tr...",3,92,J_Stroke_2015_Jan_30_17(1)_38-53.txt
4.16.3.114,...14;16(3):114-123 http://dx.doi.org/10.5853/jos.2014.16.3.11,5,71,J_Stroke_2015_Jan_30_17(1)_91.txt
5.17.3.320,...-6405Korean Stroke Society 2643799710.5853/jos.2015.17.3.320jos-17-3-320Original ArticleQuantitative...,3,100,J_Stroke_2015_Sep_30_17(3)_320-326.txt
5.4.2.223,...t J Healthcare Eng 2013 4 223 254 10.1260/2040-2295.4.2.223,190,126,J_Ther_Ultrasound_2015_Nov_11_3_20.txt
4.1.1.111,...v Vaccines 2002 1 111 118 12908518 10.1586/14760584.1.1.111,102,216,J_Transl_Med_2006_Oct_23_4_42.txt
2.10.1.87,...rtOpin Ther Targets 2006 10 87 118 10.1517/14728222.10.1.87,201,256,J_Transl_Med_2013_Aug_28_11_200.txt
2.44.3.157,...y Cancer Res Treat 2012 44 157 165 10.4143/crt.2012.44.3.157 23091441,203,303,J_Transl_Med_2016_May_3_14_113.txt
1.4.2.205,... wounding Regen Med 2009 4 205 223 10.2217/17460751.4.2.205 19317641,129,243,J_Transl_Med_2016_Nov_29_14_330.txt
EC 2.7.7.49,...n immunodeficiency virus type 1 (HIV-1) integrase EC 2.7.7.49 is a key enzyme responsible for integr...,21,59,Jundishapur_J_Microbiol_2016_Feb_15_9(5)_e29773.txt
1.26.5.612,... J Korean Med Sci 2011 26 5 612 8 10.3346/jkms.2011.26.5.612 21532850,127,261,J_Venom_Anim_Toxins_Incl_Trop_Dis_2015_May_30_21_18.txt
3.14.10.613,6135 –6140 . doi: 10.7314/APJCP.2013.14.10.6135 24289639,418,36,J_Vet_Med_Sci_2015_Jun_21_77(6)_677-684.txt
4.15.4.495,10.4142/jvs.2014.15.4.495 25234323,382,16,PMC5326940.txt
6.7.1.19,...iety of Veterinary Science 1643484410.4142/jvs.2006.7.1.19Original ArticleHistopathological changes ...,3,124,J_Vet_Sci_2006_Mar_31_7(1)_19-23.txt
1.12.2.177,...iety of Veterinary Science 2158687810.4142/jvs.2011.12.2.177Original ArticleEstablishment of a stand...,3,124,J_Vet_Sci_2011_Jun_19_12(2)_177-185.txt
2.13.3.315,...iety of Veterinary Science 2300058910.4142/jvs.2012.13.3.315Original ArticleImproved assessment of f...,3,135,J_Vet_Sci_2012_Sep_20_13(3)_315-322.txt
3.14.3.345,...rean Society of Veterinary Science 10.4142/jvs.2013.14.3.345Original ArticleBlack rice anthocyanidin...,3,127,J_Vet_Sci_2013_Sep_25_14(3)_345-353.txt
6.17.3.399,...iety of Veterinary Science 2672602510.4142/jvs.2016.17.3.399Original ArticleHematologic and serum bi...,3,135,J_Vet_Sci_2016_Sep_20_17(3)_399-405.txt
3.3.3.2,Repeat steps 3.3.3.2-3.3.3.4 for 35 cycles total for initial op...,88,14,J_Vis_Exp_2015_Feb_24_(96)_52488.txt
3.2.2.4,"... the same manner as described in Steps 3.2.2.3 to 3.2.2.4. After the final wash, resuspend the beads...",116,188,J_Vis_Exp_2016_Oct_15_(116)_54583.txt
1.4.4.3,1.4.4.3: Clinicians need to understand settings th...,244,1,Kidney_Int_Suppl_(2011)_2013_Jan_28_3(1)_5-14.txt
1.23.4.220,...62234-2451The Korean Knee Society 10.5792/ksrr.2011.23.4.220Original ArticleSeparate Vertical Wiring...,3,132,Knee_Surg_Relat_Res_2011_Dec_30_23(4)_220-226.txt
3.25.3.117,...62234-2451The Korean Knee Society 10.5792/ksrr.2013.25.3.117Original ArticleComparison between Autog...,3,132,Knee_Surg_Relat_Res_2013_Sep_29_25(3)_117-125.txt
1.41.1.1,...55The Korean Society of Cardiology 10.4070/kcj.2011.41.1.1ReviewTransradial Approach as a Default Ro...,3,109,Korean_Circ_J_2011_Jan_31_41(1)_1-8.txt
1.41.3.164,...55The Korean Society of Cardiology 10.4070/kcj.2011.41.3.164Case ReportImplantable Cardioverter-Defi...,3,109,Korean_Circ_J_2011_Mar_31_41(3)_164-166.txt
1.41.4.203,...55The Korean Society of Cardiology 10.4070/kcj.2011.41.4.203Original ArticleChange in Blood Pressure...,3,109,Korean_Circ_J_2011_Apr_30_41(4)_203-208.txt
1.41.4.184,...55The Korean Society of Cardiology 10.4070/kcj.2011.41.4.184Original ArticleDecreased Glomerular Fil...,3,109,Korean_Circ_J_2011_Apr_30_41(4)_184-190.txt
1.41.11.641,...55The Korean Society of Cardiology 10.4070/kcj.2011.41.11.641Original ArticleThe Effects of Statin a...,3,109,Korean_Circ_J_2011_Nov_29_41(11)_641-648.txt
2.42.7.458,...55The Korean Society of Cardiology 10.4070/kcj.2012.42.7.458Original ArticleA Comparison of Two Bran...,3,122,Korean_Circ_J_2012_Jul_26_42(7)_458-463.txt
3.43.4.284,...55The Korean Society of Cardiology 10.4070/kcj.2013.43.4.284Images in Cardiovascular MedicineVarious...,3,122,Korean_Circ_J_2013_Apr_30_43(4)_284-285.txt
3.43.8.561,...55The Korean Society of Cardiology 10.4070/kcj.2013.43.8.561Case ReportKounis Syndrome Presenting as...,3,122,Korean_Circ_J_2013_Aug_31_43(8)_561-564.txt
3.43.9.592,...55The Korean Society of Cardiology 10.4070/kcj.2013.43.9.592Original ArticleBortezomib Reduces Neoin...,3,122,Korean_Circ_J_2013_Sep_30_43(9)_592-599.txt
4.44.3.148,...55The Korean Society of Cardiology 10.4070/kcj.2014.44.3.148Original ArticleClinical Outcomes in Pat...,3,122,Korean_Circ_J_2014_May_20_44(3)_148-155.txt
6.46.5.613,...55The Korean Society of Cardiology 10.4070/kcj.2016.46.5.613EditorialRisk Factor Clustering in Korea...,3,122,Korean_Circ_J_2016_Sep_28_46(5)_613-614.txt
1.60.2.73,...rean Society of Anesthesiologists 10.4097/kjae.2011.60.2.73EditorialMechanism of emergence agitation...,3,131,Korean_J_Anesthesiol_2011_Feb_25_60(2)_73-74.txt
1.60.3.151,...rean Society of Anesthesiologists 10.4097/kjae.2011.60.3.151Review ArticleRisk and crisis management...,3,131,Korean_J_Anesthesiol_2011_Mar_30_60(3)_151-160.txt
1.60.3.149,...rean Society of Anesthesiologists 10.4097/kjae.2011.60.3.149EditorialIncreasing interest in PK and P...,3,131,Korean_J_Anesthesiol_2011_Mar_30_60(3)_149-150.txt
1.60.4.294,...rean Society of Anesthesiologists 10.4097/kjae.2011.60.4.294Case ReportPostanesthetic torsade de poi...,3,131,Korean_J_Anesthesiol_2011_Apr_26_60(4)_294-297.txt
1.61.6.475,...rean Society of Anesthesiologists 10.4097/kjae.2011.61.6.475Clinical Research ArticleFeasibility of ...,3,131,Korean_J_Anesthesiol_2011_Dec_20_61(6)_475-481.txt
2.62.2.142,...rean Society of Anesthesiologists 10.4097/kjae.2012.62.2.142Clinical Research ArticleEffect of ketam...,3,131,Korean_J_Anesthesiol_2012_Feb_20_62(2)_142-147.txt
2.62.5.429,...rean Society of Anesthesiologists 10.4097/kjae.2012.62.5.429Clinical Research ArticleEffect of intra...,3,151,Korean_J_Anesthesiol_2012_May_24_62(5)_429-434.txt
2.63.3.286,...rean Society of Anesthesiologists 10.4097/kjae.2012.63.3.286Letter to the EditorBrachial plexus inju...,3,151,Korean_J_Anesthesiol_2012_Sep_14_63(3)_286-287.txt
2.63.3.253,...rean Society of Anesthesiologists 10.4097/kjae.2012.63.3.253Experimental Research ArticleDexmedetomi...,3,151,Korean_J_Anesthesiol_2012_Sep_14_63(3)_253-259.txt
2.63.4.321,...rean Society of Anesthesiologists 10.4097/kjae.2012.63.4.321Clinical Research ArticleComparison of c...,3,151,Korean_J_Anesthesiol_2012_Oct_12_63(4)_321-326.txt
3.64.5.420,...rean Society of Anesthesiologists 10.4097/kjae.2013.64.5.420Clinical Research ArticleEffect of a sin...,3,151,Korean_J_Anesthesiol_2013_May_24_64(5)_420-425.txt
3.65.6.495,...rean Society of Anesthesiologists 10.4097/kjae.2013.65.6.495Review ArticleSugammadex: clinical devel...,3,151,Korean_J_Anesthesiol_2013_Dec_26_65(6)_495-500.txt
4.66.2.136,...rean Society of Anesthesiologists 10.4097/kjae.2014.66.2.136Experimental Research ArticleEffect of m...,3,151,Korean_J_Anesthesiol_2014_Feb_28_66(2)_136-142.txt
4.66.4.283,...rean Society of Anesthesiologists 10.4097/kjae.2014.66.4.283Clinical Research ArticleComparison of d...,3,151,Korean_J_Anesthesiol_2014_Apr_28_66(4)_283-289.txt
4.67.1.57,...rean Society of Anesthesiologists 10.4097/kjae.2014.67.1.57Case ReportUnusual venous route of pulmon...,3,151,Korean_J_Anesthesiol_2014_Jul_29_67(1)_57-60.txt
4.67.2.75,...iety of Anesthesiologists 2456781910.4097/kjae.2014.67.2.75EditorialImportance of alveolar recruitme...,3,159,Korean_J_Anesthesiol_2014_Aug_26_67(2)_75-76.txt
4.67.5.305,...rean Society of Anesthesiologists 10.4097/kjae.2014.67.5.305Clinical Research ArticleEffect of Trend...,3,151,Korean_J_Anesthesiol_2014_Nov_26_67(5)_305-309.txt
5.68.6.613,...rean Society of Anesthesiologists 10.4097/kjae.2015.68.6.613Case ReportBronchoconstriction following...,3,151,Korean_J_Anesthesiol_2015_Dec_25_68(6)_613-616.txt
5.68.6.622,...rean Society of Anesthesiologists 10.4097/kjae.2015.68.6.622Letter to the EditorRecurrence of herpes...,3,151,Korean_J_Anesthesiol_2015_Dec_25_68(6)_622-623.txt
6.69.6.599,...rean Society of Anesthesiologists 10.4097/kjae.2016.69.6.599Clinical Research ArticleCentral line-as...,3,151,Korean_J_Anesthesiol_2016_Dec_28_69(6)_599-603.txt
2.33.1.17,...Korean Academy of Family Medicine 10.4082/kjfm.2012.33.1.17Original ArticleThe Relationship between ...,3,142,Korean_J_Fam_Med_2012_Jan_31_33(1)_17-24.txt
6.37.3.164,...Korean Academy of Family Medicine 10.4082/kjfm.2016.37.3.164Original ArticleThe Association between ...,3,142,Korean_J_Fam_Med_2016_May_26_37(3)_164-170.txt
3.32.2.207,...Food Sci. Nutr. (2003) 32 207 210 10.3746/jkfn.2003.32.2.207,167,166,Korean_J_Food_Sci_Anim_Resour_2014_Jun_30_34(3)_378-386.txt
5.35.4.421,... of Animal Resources kosfa-35-42110.5851/kosfa.2015.35.4.421ArticleCombined Effects of Mugwort Herb ...,3,206,Korean_J_Food_Sci_Anim_Resour_2015_Aug_31_35(4)_421-430.txt
5.35.3.360,... of Animal Resources kosfa-35-36010.5851/kosfa.2015.35.3.360ArticleComparison of Antioxidant Activit...,3,206,Korean_J_Food_Sci_Anim_Resour_2015_Jun_30_35(3)_360-369.txt
4.34.3.297,... Ani. Resour. (2014a) 34 297 306 10.5851/kosfa.2014.34.3.297,208,269,Korean_J_Food_Sci_Anim_Resour_2015_Apr_30_35(2)_179-188.txt
5.35.6.831,... of Animal Resources kosfa-35-83110.5851/kosfa.2015.35.6.831ArticleBioactive Peptides in Milk and Da...,3,215,Korean_J_Food_Sci_Anim_Resour_2015_Dec_31_35(6)_831-840.txt
6.36.6.807,... of Animal Resources kosfa-36-80710.5851/kosfa.2016.36.6.807ArticleThe Effect of the Addition of Enc...,3,215,PMC5243966.txt
6.36.4.531,... of Animal Resources kosfa-36-53110.5851/kosfa.2016.36.4.531ArticleEvaluation of Natural Food Preser...,3,215,Korean_J_Food_Sci_Anim_Resour_2016_Aug_30_36(4)_531-537.txt
6.36.5.612,... of Animal Resources kosfa-36-61210.5851/kosfa.2016.36.5.612ArticleMonitoring of Used Frying Oils an...,3,215,Korean_J_Food_Sci_Anim_Resour_2016_Oct_31_36(5)_612-616.txt
4.34.6.836,...i. Anim. Resour. 2014 34 836 843 10.5851/kosfa.2014.34.6.836 26761682,157,245,PMC5355578.txt
2.47.2.136,...ciety on Thrombosis and Hemostasis 10.5045/kjh.2012.47.2.136Original ArticleChanges in hematologic i...,3,276,Korean_J_Hematol_2012_Jun_26_47(2)_136-141.txt
2.16.3.110,...ato-Biliary-Pancreatic Surgery 10.14701/kjhbps.2012.16.3.110Case ReportSuccessful percutaneous manag...,3,223,Korean_J_Hepatobiliary_Pancreat_Surg_2012_Aug_31_16(3)_110-114.txt
1.17.3.180,...r the Study of the Liver 2210238310.3350/kjhep.2011.17.3.180EditorialDurability of antiviral therapy...,3,147,Korean_J_Hepatol_2011_Sep_30_17(3)_180-182.txt
1.26.2.216,... Association of Internal Medicine 10.3904/kjim.2011.26.2.216Image of InterestA Case of Coarctation o...,3,141,Korean_J_Intern_Med_2011_Jun_1_26(2)_216-217.txt
2.27.4.407,... Association of Internal Medicine 10.3904/kjim.2012.27.4.407Original ArticleDNA Methylation of RUNX3...,3,162,Korean_J_Intern_Med_2012_Dec_27_27(4)_407-410.txt
3.28.5.605,... Association of Internal Medicine 10.3904/kjim.2013.28.5.605Case ReportReversible dilated cardiomyop...,3,162,Korean_J_Intern_Med_2013_Sep_14_28(5)_605-608.txt
6.21.3.206,...tion of Internal Medicine 1701767410.3904/kjim.2006.21.3.206Case ReportHepatic Subcapsular Steatosis...,3,170,Korean_J_Intern_Med_2006_Sep_30_21(3)_206-209.txt
6.21.1.10,...tion of Internal Medicine 1664655810.3904/kjim.2006.21.1.10Original ArticleSevere Airway Hyperrespon...,3,170,Korean_J_Intern_Med_2006_Mar_30_21(1)_10-14.txt
4.29.4.454,... Association of Internal Medicine 10.3904/kjim.2014.29.4.454Original ArticlePrediction of infarct se...,3,162,Korean_J_Intern_Med_2014_Jul_27_29(4)_454-465.txt
5.30.2.161,"... Association of Internal Medicine 10.3904/kjim.2015.30.2.161EditorialThe simpler, the better: culpri...",3,162,Korean_J_Intern_Med_2015_Mar_27_30(2)_161-162.txt
3.18.4.220,...tion of Internal Medicine 1471722910.3904/kjim.2003.18.4.220kjim-18-4-220-3Original ArticleClinical ...,3,162,Korean_J_Intern_Med_2003_Dec_18(4)_220-224.txt
2.17.2.122,...tion of Internal Medicine 1216408910.3904/kjim.2002.17.2.122kjim-17-2-122-7Original ArticleRelations...,3,162,Korean_J_Intern_Med_2002_Jun_17(2)_122-130.txt
1.6.2.85,...ation of Internal Medicine 180736910.3904/kjim.1991.6.2.85kjim-6-2-85-6Case ReportA Case of Intraper...,3,165,Korean_J_Intern_Med_1991_Jul_6(2)_85-89.txt
1.6.1.1,...ation of Internal Medicine 174225010.3904/kjim.1991.6.1.1kjim-6-1-1-1Original ArticleComputed Tomogr...,3,165,Korean_J_Intern_Med_1991_Jan_6(1)_1-7.txt
6.31.1.15,... Association of Internal Medicine 10.3904/kjim.2016.31.1.15kjim-31-1-15ReviewEmerging strategies for...,3,162,Korean_J_Intern_Med_2016_Jan_28_31(1)_15-29.txt
2.25.1.47,...592093-0569The Korean Pain Society 10.3344/kjp.2012.25.1.47Case ReportCatheter Obstruction of Intrat...,3,100,Korean_J_Pain_2012_Jan_2_25(1)_47-51.txt
3.26.1.21,...592093-0569The Korean Pain Society 10.3344/kjp.2013.26.1.21Original ArticleSurvey on the Treatment o...,3,113,Korean_J_Pain_2013_Jan_4_26(1)_21-26.txt
3.26.4.323,...592093-0569The Korean Pain Society 10.3344/kjp.2013.26.4.323EditorialA New Approach to Neuroplasty S...,3,113,Korean_J_Pain_2013_Oct_2_26(4)_323-326.txt
3.26.4.407,...592093-0569The Korean Pain Society 10.3344/kjp.2013.26.4.407Letter to EditorA Simple Working Classif...,3,113,Korean_J_Pain_2013_Oct_2_26(4)_407-408.txt
5.28.1.64,...592093-0569The Korean Pain Society 10.3344/kjp.2015.28.1.64Letters to EditorWhich Methods of Epidura...,3,113,Korean_J_Pain_2015_Jan_2_28(1)_64-65.txt
6.29.4.239,...592093-0569The Korean Pain Society 10.3344/kjp.2016.29.4.239Original ArticleChronic persistent post-...,3,113,Korean_J_Pain_2016_Oct_29_29(4)_239-248.txt
1.31.1.37,...y for Laboratory Medicine 2123986910.3343/kjlm.2011.31.1.37Original ArticleClinical MicrobiologyAppl...,3,138,Korean_J_Lab_Med_2011_Jan_10_31(1)_37-43.txt
1.31.2.72,...y for Laboratory Medicine 2147497910.3343/kjlm.2011.31.2.72ReviewNew Biomarkers of Acute Kidney Inju...,3,138,Korean_J_Lab_Med_2011_Apr_31_31(2)_72-80.txt
6.12.2.175,...Korean Neurotraumatology Society 10.13004/kjnt.2016.12.2.175Case ReportThe Neck and Posterior Fossa ...,3,141,Korean_J_Neurotrauma_2016_Oct_31_12(2)_175-179.txt
6.20.1.116,...he Korean Ophthalmological Society 10.3341/kjo.2006.20.1.116768183Original ArticleClinical Results o...,3,120,Korean_J_Ophthalmol_2006_Mar_31_20(1)_1-6.txt
1.25.6.434,...he Korean Ophthalmological Society 10.3341/kjo.2011.25.6.434Original Articlec-Fos Immunoreactivity i...,3,129,Korean_J_Ophthalmol_2011_Dec_22_25(6)_434-439.txt
2.26.6.473,...he Korean Ophthalmological Society 10.3341/kjo.2012.26.6.473Case ReportOptic Disc Atrophy in Patient...,3,148,Korean_J_Ophthalmol_2012_Dec_12_26(6)_473-477.txt
3.27.3.167,...he Korean Ophthalmological Society 10.3341/kjo.2013.27.3.167Original ArticleThe Effect of Topical Cy...,3,148,Korean_J_Ophthalmol_2013_Jun_8_27(3)_167-171.txt
3.27.3.178,...he Korean Ophthalmological Society 10.3341/kjo.2013.27.3.178Original ArticleStructural Recovery of t...,3,148,Korean_J_Ophthalmol_2013_Jun_7_27(3)_178-185.txt
3.27.4.229,...he Korean Ophthalmological Society 10.3341/kjo.2013.27.4.229Original ArticleComparison of Pain-relie...,3,148,Korean_J_Ophthalmol_2013_Aug_18_27(4)_229-234.txt
4.28.3.246,...he Korean Ophthalmological Society 10.3341/kjo.2014.28.3.246Original ArticleBone Marrow-derived Mese...,3,148,Korean_J_Ophthalmol_2014_Jun_19_28(3)_246-256.txt
4.28.5.379,...he Korean Ophthalmological Society 10.3341/kjo.2014.28.5.379Original ArticleThe Short-term Efficacy ...,3,148,Korean_J_Ophthalmol_2014_Oct_18_28(5)_379-385.txt
4.28.5.408,...he Korean Ophthalmological Society 10.3341/kjo.2014.28.5.408Original ArticleThe Effect of Pattern Sc...,3,148,Korean_J_Ophthalmol_2014_Oct_18_28(5)_408-416.txt
4.28.6.466,...he Korean Ophthalmological Society 10.3341/kjo.2014.28.6.466Original ArticleIntravitreal Anti-vascul...,3,148,Korean_J_Ophthalmol_2014_Dec_19_28(6)_466-472.txt
5.29.5.351,...he Korean Ophthalmological Society 10.3341/kjo.2015.29.5.351CorrespondenceThe Relationships between ...,3,148,Korean_J_Ophthalmol_2015_Oct_22_29(5)_351-352.txt
6.30.4.258,...he Korean Ophthalmological Society 10.3341/kjo.2016.30.4.258Original ArticleDiagnostic Value of the ...,3,139,Korean_J_Ophthalmol_2016_Aug_21_30(4)_258-264.txt
6.30.6.434,...he Korean Ophthalmological Society 10.3341/kjo.2016.30.6.434Original ArticleEffectiveness of Toric O...,3,139,Korean_J_Ophthalmol_2016_Dec_6_30(6)_434-442.txt
5.45.2.82,...rean Association of Orthodontists 10.4041/kjod.2015.45.2.82Original ArticleA reliable method for eva...,3,135,Korean_J_Orthod_2015_Mar_19_45(2)_82-88.txt
1.49.1.95,...he Korean Society for Parasitology 10.3347/kjp.2011.49.1.95Brief CommunicationRisk Factors Associate...,3,125,Korean_J_Parasitol_2011_Mar_18_49(1)_95-98.txt
1.49.4.457,...he Korean Society for Parasitology 10.3347/kjp.2011.49.4.457Brief CommunicationDiscovery of Maritrem...,3,125,Korean_J_Parasitol_2011_Dec_16_49(4)_457-460.txt
3.51.1.75,...Parasitology and Tropical Medicine 10.3347/kjp.2013.51.1.75Original ArticleAn Epidemiological Study ...,3,166,Korean_J_Parasitol_2013_Feb_18_51(1)_75-84.txt
3.51.1.75,...Parasitology and Tropical Medicine 10.3347/kjp.2013.51.1.75Original ArticleAn Epidemiological Study ...,3,166,Korean_J_Parasitol_2013_Feb_18_51(1)_75-84.txt
3.51.3.383,...Parasitology and Tropical Medicine 10.3347/kjp.2013.51.3.383Brief CommunicationInfection Status of H...,3,166,Korean_J_Parasitol_2013_Jun_30_51(3)_383-385.txt
3.51.6.763,...Parasitology and Tropical Medicine 10.3347/kjp.2013.51.6.763Brief CommunicationEvaluation of IgG4 Su...,3,166,Korean_J_Parasitol_2013_Dec_31_51(6)_763-766.txt
5.53.2.169,...logy and Tropical Medicine 2592517510.3347/kjp.2015.53.2.169kjp-53-2-169Original ArticleRelationship...,3,174,Korean_J_Parasitol_2015_Apr_22_53(2)_169-175.txt
5.53.3.279,...logy and Tropical Medicine 2617482110.3347/kjp.2015.53.3.279kjp-53-3-279Original ArticlePotential Zo...,3,174,Korean_J_Parasitol_2015_Jun_30_53(3)_279-287.txt
5.53.4.465,...logy and Tropical Medicine 2632384510.3347/kjp.2015.53.4.465kjp-53-4-465Case ReportAnisakiasis: Repo...,3,174,Korean_J_Parasitol_2015_Aug_25_53(4)_465-470.txt
5.53.5.545,...logy and Tropical Medicine 2653703310.3347/kjp.2015.53.5.545kjp-53-5-545Articles from Symposium on C...,3,174,Korean_J_Parasitol_2015_Oct_29_53(5)_545-551.txt
5.53.6.705,...logy and Tropical Medicine 2679743710.3347/kjp.2015.53.6.705kjp-53-6-705Original ArticleIntestinal P...,3,174,Korean_J_Parasitol_2015_Dec_31_53(6)_705-712.txt
2.46.2.137,...ociety for Cytopathology 10.4132/KoreanJPathol.2012.46.2.137Original ArticleSignificance of Electron...,3,180,Korean_J_Pathol_2012_Apr_25_46(2)_137-141.txt
2.46.4.318,...ociety for Cytopathology 10.4132/KoreanJPathol.2012.46.4.318Original ArticleClinicopathologic Implic...,3,180,Korean_J_Pathol_2012_Aug_23_46(4)_318-323.txt
2.46.5.478,...ociety for Cytopathology 10.4132/KoreanJPathol.2012.46.5.478Case ReportGhost Cell Odontogenic Carcin...,3,180,Korean_J_Pathol_2012_Oct_25_46(5)_478-482.txt
3.47.3.279,...ociety for Cytopathology 10.4132/KoreanJPathol.2013.47.3.279Case StudyHeterotopic Intestinal Cyst of...,3,180,Korean_J_Pathol_2013_Jun_25_47(3)_279-283.txt
4.48.4.315,...ociety for Cytopathology 10.4132/KoreanJPathol.2014.48.4.315Brief Case ReportSignet-Ring Cell Carcin...,3,180,Korean_J_Pathol_2014_Aug_26_48(4)_315-318.txt
3.56.6.254,...2-7258The Korean Pediatric Society 10.3345/kjp.2013.56.6.254Original ArticleCombined chemotherapy an...,3,126,Korean_J_Pediatr_2013_Jun_21_56(6)_254-259.txt
3.56.7.275,...2-7258The Korean Pediatric Society 10.3345/kjp.2013.56.7.275Review ArticleTemporal lobe epilepsy sur...,3,126,Korean_J_Pediatr_2013_Jul_19_56(7)_275-281.txt
3.56.12.505,...2-7258The Korean Pediatric Society 10.3345/kjp.2013.56.12.505Review ArticleMechanisms of immune tole...,3,126,Korean_J_Pediatr_2013_Dec_20_56(12)_505-513.txt
4.57.6.257,...2-7258The Korean Pediatric Society 10.3345/kjp.2014.57.6.257Review ArticlePsychosocial adjustment an...,3,126,Korean_J_Pediatr_2014_Jun_30_57(6)_257-263.txt
4.57.10.451,...2-7258The Korean Pediatric Society 10.3345/kjp.2014.57.10.451Original ArticleSerum procalcitonin as ...,3,126,Korean_J_Pediatr_2014_Oct_31_57(10)_451-456.txt
5.58.11.415,...e Korean Pediatric Society 2669287610.3345/kjp.2015.58.11.415Original ArticleLow levels of tissue in...,3,134,Korean_J_Pediatr_2015_Nov_22_58(11)_415-420.txt
2.16.4.281,...he Korean Society of Pharmacology 10.4196/kjpp.2012.16.4.281Original ArticleComparison of Neurite Ou...,3,306,Korean_J_Physiol_Pharmacol_2012_Aug_10_16(4)_281-285.txt
2.16.5.321,...he Korean Society of Pharmacology 10.4196/kjpp.2012.16.5.321Original ArticleAntiproliferative and Cy...,3,306,Korean_J_Physiol_Pharmacol_2012_Oct_18_16(5)_321-326.txt
6.20.1.91,...he Korean Society of Pharmacology 10.4196/kjpp.2016.20.1.91Original Article(E)-3-(3-methoxyphenyl)-1...,3,297,Korean_J_Physiol_Pharmacol_2016_Jan_31_20(1)_91-99.txt
3.4.4.252,...330The Korean Radiological Society 10.3348/kjr.2003.4.4.25214726643Case ReportPrimary Calcified T-Ce...,3,111,Korean_J_Radiol_2003_Dec_31_Oct-Dec_4(4)_252-254.txt
5.6.2.821,...330The Korean Radiological Society 10.3348/kjr.2005.6.2.8215968146Original ArticleMR Imaging of Orbi...,3,111,Korean_J_Radiol_2005_Jun_30_Apr-Jun_6(2)_82-88.txt
1.12.4.499,...330The Korean Society of Radiology 10.3348/kjr.2011.12.4.499Case ReportReversal in the Diameter of t...,3,111,Korean_J_Radiol_2011_Jul_22_Jul-Aug_12(4)_499-503.txt
1.12.5.602,...330The Korean Society of Radiology 10.3348/kjr.2011.12.5.602Original ArticleEvaluation of Antiangiog...,3,111,Korean_J_Radiol_2011_Aug_24_Sep-Oct_12(5)_602-610.txt
1.12.5.620,...330The Korean Society of Radiology 10.3348/kjr.2011.12.5.620Case ReportA Spinal Cord Astrocytoma and...,3,111,Korean_J_Radiol_2011_Aug_24_Sep-Oct_12(5)_620-625.txt
3.14.3.439,...330The Korean Society of Radiology 10.3348/kjr.2013.14.3.439InterventionOriginal ArticleThe Role of ...,3,126,Korean_J_Radiol_2013_May_2_May-Jun_14(3)_439-445.txt
3.14.5.781,...330The Korean Society of Radiology 10.3348/kjr.2013.14.5.781Gastrointestinal ImagingCase ReportUnusu...,3,126,Korean_J_Radiol_2013_Aug_30_Sep-Oct_14(5)_781-785.txt
3.14.6.935,...330The Korean Society of Radiology 10.3348/kjr.2013.14.6.935Musculoskeletal ImagingOriginal ArticleC...,3,126,Korean_J_Radiol_2013_Nov_5_Nov-Dec_14(6)_935-945.txt
4.15.4.488,...330The Korean Society of Radiology 10.3348/kjr.2014.15.4.488InterventionOriginal ArticlePercutaneous...,3,126,Korean_J_Radiol_2014_Jul_9_Jul-Aug_15(4)_488-493.txt
4.15.6.797,...330The Korean Society of Radiology 10.3348/kjr.2014.15.6.797Musculoskeletal ImagingCase ReportPercut...,3,126,Korean_J_Radiol_2014_Nov_7_Nov-Dec_15(6)_797-801.txt
5.16.1.1,...330The Korean Society of Radiology 10.3348/kjr.2015.16.1.1EditorialThanks to the Reviewers of the Ko...,3,126,Korean_J_Radiol_2015_Jan_9_Jan-Feb_16(1)_1-3.txt
6.17.6.903,...330The Korean Society of Radiology 10.3348/kjr.2016.17.6.903Musculoskeletal ImagingOriginal ArticleI...,3,126,Korean_J_Radiol_2016_Oct_31_Nov-Dec_17(6)_903-911.txt
2.9.2.79,...orean Spinal Neurosurgery Society 10.14245/kjs.2012.9.2.79Clinical ArticleClinical Efficacy of Bone ...,3,128,Korean_J_Spine_2012_Jun_30_9(2)_79-84.txt
5.12.3.235,...orean Spinal Neurosurgery Society 10.14245/kjs.2015.12.3.235Case ReportThree Cases of Calcifying Pse...,3,128,Korean_J_Spine_2015_Sep_30_12(3)_235-238.txt
2.45.5.295,...d Cardiovascular Surgery 2313030210.5090/kjtcs.2012.45.5.295Clinical ResearchDoes Additional Aortic ...,3,223,Korean_J_Thorac_Cardiovasc_Surg_2012_Oct_9_45(5)_295-300.txt
3.46.4.274,...racic and Cardiovascular Surgery 10.5090/kjtcs.2013.46.4.274Clinical ResearchAnaortic Off-pump Coron...,3,215,Korean_J_Thorac_Cardiovasc_Surg_2013_Aug_6_46(4)_274-278.txt
5.48.6.381,...racic and Cardiovascular Surgery 10.5090/kjtcs.2015.48.6.381kjtcvs-48-381Clinical ResearchSurgical O...,3,214,Korean_J_Thorac_Cardiovasc_Surg_2015_Dec_5_48(6)_381-386.txt
6.49.1.54,...racic and Cardiovascular Surgery 10.5090/kjtcs.2016.49.1.54kjtcv-49-054Case ReportSurgical Managemen...,3,214,Korean_J_Thorac_Cardiovasc_Surg_2016_Feb_5_49(1)_54-58.txt
2.53.4.234,...5The Korean Urological Association 10.4111/kju.2012.53.4.234Original ArticleUrological OncologyDisco...,3,122,Korean_J_Urol_2012_Apr_18_53(4)_234-239.txt
2.53.4.275,...5The Korean Urological Association 10.4111/kju.2012.53.4.275Original ArticlePediatric UrologyEfficac...,3,122,Korean_J_Urol_2012_Apr_18_53(4)_275-279.txt
2.53.10.737,...5The Korean Urological Association 10.4111/kju.2012.53.10.737Case ReportTubal Buccal Mucosa Graft wi...,3,122,Korean_J_Urol_2012_Oct_19_53(10)_737-740.txt
3.54.6.412,...5The Korean Urological Association 10.4111/kju.2013.54.6.412Case ReportPrimary Adenocarcinoma of the...,3,122,Korean_J_Urol_2013_Jun_12_54(6)_412-414.txt
3.54.8.522,...5The Korean Urological Association 10.4111/kju.2013.54.8.522Original ArticleLaparoscopy/RoboticsExpe...,3,122,Korean_J_Urol_2013_Aug_7_54(8)_522-526.txt
3.54.12.824,...5The Korean Urological Association 10.4111/kju.2013.54.12.824Original ArticleUrological OncologyPreo...,3,122,Korean_J_Urol_2013_Dec_10_54(12)_824-829.txt
1.3.9.7,"...ds ratio [OR], 3.5; 95% confidence interval [CI], 1.3.9.7; p=0.016). A distance between the tumor an...",11,686,Korean_J_Urol_2014_Apr_10_55(4)_254-259.txt
4.55.7.482,...5The Korean Urological Association 10.4111/kju.2014.55.7.482Original ArticleInfection/InflammationRe...,3,122,Korean_J_Urol_2014_Jul_11_55(7)_482-486.txt
4.55.9.581,...5The Korean Urological Association 10.4111/kju.2014.55.9.581Original ArticleEndourology/Urolithiasis...,3,122,Korean_J_Urol_2014_Sep_5_55(9)_581-586.txt
4.19.2.290,"...y and Aging , 19 , 290 –303 . doi:10.1037/0882-7974.19.2.29",174,145,Lang_Learn_2016_Sep_19_66(3)_690-713.txt
2.17.2.349,... Bone Miner. Res. 2002 17 349 357 10.1359/jbmr.2002.17.2.349 11811566,107,258,Life_(Basel)_2014_Apr_2_4(2)_117-130.txt
2.73.5.494,...vels J Periodontol 2002 73 494 500 10.1902/jop.2002.73.5.494 12027250,146,196,Lipids_Health_Dis_2012_Sep_19_11_121.txt
2.9.2.329,...; PMID:15934919; http://dx.doi.org/10.1517/14728222.9.2.329 15934919,189,69,MAbs_2014_Oct_30_6(5)_130019-1313.txt
6.8.1.75,...Pharmacother 2007 8 75 94 17163809 10.1517/14656566.8.1.7,203,166,Malar_J_2008_Dec_22_7_262.txt
4.6.5.835,...Expert Rev Vaccines 2007 6 835 847 10.1586/14760584.6.5.835 17931162,134,182,Malar_J_2010_Dec_15_9_362.txt
2.9.3.2,59. Goudet J. FSTAT 2.9.3.2: A program to estimate and test gene diver...,477,21,Malar_J_2016_Apr_12_15_205.txt
6.18.4.561,...olesc Med Health 2006 18 561 573 10.1515/IJAMH.2006.18.4.561 17340848,210,206,Malar_J_2016_Apr_14_15_212.txt
3.5.1.3,...e Pknbpxa types and was calculated using Arlequin 3.5.1.3,8,785,Malar_J_2016_Apr_26_15_241.txt
EC 5.2.1.8,...peptidyl-prolyl cis–trans isomerases are enzymes (EC 5.2.1.8) that control the stability of other pr...,38,2466,Mar_Biotechnol_(NY)_2013_Jun_15_15(3)_329-339.txt
3.2.10.6,"3.2.10.6. N-(3,4-Dihydroxyphenethyl)palmitamide (3...",181,1,Mar_Drugs_2013_Jan_28_11(2)_274-299.txt
EC 4.2.2.3,"...,12]. Further, an end product of alginate lyases (EC 4.2.2.3, EC 4.2.2.11), i.e., 4-deoxy-l-erythro-...",8,898,Mar_Drugs_2015_Jan_16_13(1)_493-508.txt
EC 3.2.1.157,ι-Carrageenan	ι-Carrageenase EC 3.2.1.157 GH 82	Zolbellia galacta	Endohydrolysi...,78,30,Mar_Drugs_2015_May_27_13(6)_3340-3359.txt
1.3.3.3,"...escribed above. From this separation, subfraction 1.3.3.3 (tR:18.2 min) resulted, and was further pu...",129,145,Mar_Drugs_2015_Aug_6_13(8)_4949-4966.txt
6.41.7.156,...Limnol. Oceanogr. 1996 41 1565 1572 10.4319/lo.1996.41.7.1565,150,198,Mar_Drugs_2013_Jun_27_11(7)_2239-2258.txt
EC 1.2.1.2,"...enase-linked formate dehydrogenase enzymes (FDHH [EC 1.2.1.2], encoded by enteric Gammaproteobacteri...",57,121,mBio_2012_Aug_21_3(4)_e00223-12.txt
EC 5.3.1.24,...′-5′-phosphoribosyl anthranilate (PRA) isomerase (EC 5.3.1.24) with its native promoter as well as t...,50,299,mBio_2014_Jul_8_5(4)_e01378-14.txt
EC 2.6.1.2,"...olized into pyruvate by alanine aminotransferase (EC 2.6.1.2), labeled pyruvate was undetectable. Th...",50,734,mBio_2014_Nov_4_5(6)_e01995-14.txt
EC 3.1.3.2,(EC 3.1.3.2) and tartrate-resistant acid phosphatas...,237,2,Mediators_Inflamm_1998_7(3)_201-210.txt
1.35.2.200,...inseng Research  2011 35 2 200 208 10.5142/jgr.2011.35.2.200 2-s2.0-79959863526 23717062,198,259,Mediators_Inflamm_2016_Jan_3_2016_1903849.txt
EC 3.2.1.22,...caused by a deficiency in α-galactosidase A (GLA; EC 3.2.1.22)[1] and manifests as either the classi...,17,86,PMC5313015.txt
4.16.6.540,...er 2004 16 540 8 http://dx.doi.org/10.1179/joc.2004.16.6.540  15700845,185,353,Mediterr_J_Hematol_Infect_Dis_2015_Jul_1_7(1)_e2015044.txt
2.2.4.1,"... situ	Ex situ (also possible in situ, see Section 2.2.4.1)	Ex situ and In situ	In situ	Ex situ",29,65,Membranes_(Basel)_2014_Apr_30_4(2)_227-242.txt
3.31.4.654,"...ry, and Cognition 2005 31 654 669 10.1037/0278-7393.31.4.654 16060771",340,248,Mem_Cognit_2011_Apr_20_39(3)_536-554.txt
1.12.4.419,...gy Public Policy and Law  419 441 10.1037/1076-8971.12.4.419,349,250,Memory_2015_Jul_4_23(5)_6331-656.txt
EC 2.3.1.30,"...ed by two enzymes: serine acetyltransferase (SAT, EC 2.3.1.30) and o-acetylserine(thiol)lyase (OASTL...",12,393,Metabolites_2014_Aug_4_4(3)_629-639.txt
2.7.1.11,"...ction “2.7.1.2a”), phosphofructokinase (reaction “2.7.1.11”) and pyruvate kinase (reaction “2.7.1.40...",203,126,Metabolites_2014_Aug_20_4(3)_680-698.txt
6.8.9.124,... Pharmacogenomics 2007 8 1243 1266 10.2217/14622416.8.9.1243 17924839,408,165,Metabolites_2015_Feb_27_5(1)_119-139.txt
EC 2.7.8.17,...-phosphotransferase (GlcNAc-1-phosphotransferase; EC 2.7.8.17) due to mutations in the GNPTAB gene (...,18,225,Meta_Gene_2014_Jun_1_2_403-406.txt
EC 5.3.1.8,...th the red font colour. Phosphomannose isomerase (EC 5.3.1.8) was characterized in this work (KB1_05...,84,184,Microb_Biotechnol_2015_Sep_16_9(1)_47-60.txt
EC 2.4.1.25,"...uefaction) can also be modified by amylomaltases (EC 2.4.1.25, and members of GH 77) that are 4-α-gl...",106,88,Microb_Cell_Fact_2007_Mar_15_6_9.txt
EC 1.1.1.12,"...ol is converted by L-arabitol dehydrogenase (LAD, EC 1.1.1.12) [19,27] to L-xylulose, which is reduc...",23,200,Microb_Cell_Fact_2009_Jul_24_8_40.txt
6.4.1.1,PC	6.4.1.1	pyruvate carboxylase,89,4,Microb_Cell_Fact_2010_Nov_22_9_90.txt
EC 4.3.1.3,"...ng of histidine ammonia-lyase (hutH, str/stu1313; EC 4.3.1.3) and a urocanate hydratase (hutU, str/s...",86,1240,Microb_Cell_Fact_2011_Aug_30_10(Suppl_1)_S22.txt
EC 4.2.1.28,"...obamide-enzyme-requiring propanediol dehydratase (EC 4.2.1.28), which may constitute a primary human...",62,432,Microb_Cell_Fact_2013_May_16_12_48.txt
EC 1.1.1.49,"...ities of glucose-6-phosphate dehydrogenase (G6PD, EC 1.1.1.49) and 6-phosphogluconate dehydrogenase ...",280,378,Microb_Cell_Fact_2015_Dec_23_14_205.txt
3.2.1.21,"...e (E.C. 3.2.1.10; LROS_1584), β-glucosidase (E.C. 3.2.1.21; LROS_2047), mannosyl-glycoprotein endo-β...",26,334,Microb_Cell_Fact_2016_May_3_15_72.txt
EC 5.1.3.2,... galE-gene coding for an UDP-glucose-4-epimerase (EC 5.1.3.2); 5: ugd-gene coding for an UDP-glucose...,96,1739,Microb_Cell_Fact_2016_Oct_4_15_170.txt
1.14.2.255,... Microbe Interact 2001 14 255 260 10.1094/MPMI.2001.14.2.255 11204790,142,284,Microb_Ecol_2011_Aug_24_62(2)_435-445.txt
2.4.1.-,"...12985	(Galactosyl)LPS 1,2-glucosyltransferase [EC:2.4.1.-]	Lipopolysaccharide biosynthesis proteins	...",55,52,Microbiome_2014_Sep_15_2_35.txt
EC 4.3.1.3,Histidine ammonia-lyase (EC 4.3.1.3)	−1.86	2.62E-03*	22,270,26,Microbiome_2015_Dec_19_3_69.txt
1.3.2.81,"...y, Asthma Immunol Res 2011 3 81 8 10.4168/aair.2011.3.2.81 21461246",232,132,PMC5288881.txt
4.58.3.519,...Social Psychology 1990 58 519 527 10.1037/0022-3514.58.3.519 2324941,103,178,Mindfulness_(N_Y)_2010_Mar_18_1(1)_21-27.txt
5.7.6.112,...al Computation 1995 7 6 1129 1159 10.1162/neco.1995.7.6.1129 7584893,197,160,PMC5241348.txt
4.78.1.136,... Pers Soc Psychol 2000 78 136 157 10.1037/0022-3514.78.1.136 10653511,383,200,Mol_Autism_2014_Dec_20_5_56.txt
EC 3.1.1.7,"Acetylcholinesterase (AChE, EC 3.1.1.7) is encoded by the acetylcholinesterase...",10,29,Mol_Biol_Rep_2014_Dec_10_41(1)_429-437.txt
1.1.1.27,"...d for the tetrameric lactate dehydrogenase (E. C. 1.1.1.27) [10, 11]. This is distinct from the tiss...",11,396,Mol_Biol_Res_Commun_2014_Mar_3(1)_21-32.txt
1.14.14.1,"...nstrated in Table 3, the following genes CYP2D14 (1.14.14.1), MECR (1.3.1.38), FASN (2.3.1.85), and ...",122,192,Mol_Biol_Res_Commun_2015_Jun_4(2)_93-103.txt
6.2.83.477,...Eur J Morphol 1998 36 83 96 9651742 10.1076/ejom.36.2.83.4776,160,297,Mol_Cancer_2006_Jun_8_5_23.txt
3.4.24.16,"...el EE Vincent JP Checler F  Role of endopeptidase 3.4.24.16 in the catabolism of neurotensin, in viv...",248,89,Mol_Cancer_2007_Jul_9_6_44.txt
EC 1.1.1.27,...0 mU/mL L-lactate dehydrogenase (from pig muscle; EC 1.1.1.27) and 300 μmol/L sodium pyruvate at 37°...,138,1149,Mol_Cancer_2009_Nov_19_8_108.txt
1.27.2.99,...alysis Lab Anim Res 2011 27 99 107 10.5625/lar.2011.27.2.99 21826169,287,200,Mol_Cancer_2012_Aug_24_11_62.txt
4.1.5.649,...gnosis Future Oncol 2005 1 649 660 10.2217/14796694.1.5.649 16556042,605,215,Mol_Cancer_2014_Nov_28_13_258.txt
3.14.9.553,... J Cancer Prev 2013 14 5533 5537 10.7314/APJCP.2013.14.9.5533 24175854,263,193,Mol_Cancer_2014_Aug_7_13_186.txt
1.4.1.2,...A spectra were analyzed with the MaxQuant Version 1.4.1.2 analysis software using default settings w...,40,484,Mol_Cell_Proteomics_2015_May_27_14(5)_1400-1410.txt
2.7.1.59,"...ylglucosamine kinase (GlcNAc kinase or NAGK; E.C. 2.7.1.59), an enzyme of the sugar-kinase/Hsp70/act...",13,404,Mol_Cells_2015_May_31_38(5)_402-408.txt
1.44.8.535,...l mice BMB Rep 2011 44 8 535 40 10.5483/BMBRep.2011.44.8.535 2187117,192,191,Mol_Cytogenet_2015_Jan_31_8_6.txt
3.4.23.16,...2.38	5-Lipoxygenase EC1.13.11.34	HIV-1 protease EC3.4.23.16,117,136,Mol_Genet_Genomics_2015_Sep_27_290_387-398.txt
1.11.4.210,"...e, SNU1 Immune Netw 11 210 215 2011 10.4110/in.2011.11.4.210 22039369",146,197,Mol_Med_Rep_2015_May_22_11(5)_3375-3381.txt
1.11.4.210,"...e, SNU1 Immune Netw 11 210 215 2011 10.4110/in.2011.11.4.210 22039369",146,197,Mol_Med_Rep_2015_May_22_11(5)_3375-3381.txt
EC 3.2.1.22,"... the lysosomal enzyme α-galactosidase A (α-Gal A; EC 3.2.1.22) (1,2). In Fabry disease, globotriaosy...",10,171,Mol_Med_Rep_2015_Oct_1_12(4)_5049-5057.txt
6.9.6.691,...na Pharmacogenomics 9 691 702 2008 10.2217/14622416.9.6.691 18518848,199,245,Mol_Med_Rep_2016_Mar_13_13(3)_2117-2123.txt
4.15.20.861,... J Cancer Prev 15 8617 8622 2014 10.7314/APJCP.2014.15.20.8617 25374178,99,202,Mol_Med_Rep_2016_Jun_12_13(6)_4613-4619.txt
2.13.5.226,... J Cancer Prev 13 2263 2267 2012 10.7314/APJCP.2012.13.5.2263 22901205,88,199,Mol_Med_Rep_2016_Oct_9_14(4)_2991-2996.txt
EC 3.5.1.33,"...te GlcNAc‐6‐phosphate, a deacetylase (Nag2/Dac1) (EC 3.5.1.33) that splits it into acetate and gluco...",25,967,Mol_Microbiol_2016_Feb_19_99(4)_640-657.txt
EC 3.5.3.11,"...erved in other ureohydrolases such as agmatinase (EC 3.5.3.11), formiminoglutamase (EC 3.5.3.8), pro...",6,724,Mol_Microbiol_2014_Jul_23_93(2)_369-389.txt
2.97.6.130,...hage J Neurosurg 2002 97 1302 1305 10.3171/jns.2002.97.6.1302 12507127,320,237,Mol_Neurobiol_2011_Feb_15_43(1)_27-40.txt
2.12.8.102,...n Ther Targets 2008 12 8 1021 1033 10.1517/14728222.12.8.1021 18620523,197,148,PMC4510916.txt
5.7.11.159,...ert Rev Neurother 2007 7 1597 1612 10.1586/14737175.7.11.1597 17997706,142,149,Mol_Pain_2012_Jul_24_8_54.txt
5.1.2.207,...ert Rev Neurother 2001 1 2 207 224 10.1586/14737175.1.2.207 19811033,209,131,Mol_Pain_2014_Jan_8_10_1.txt
5.8.5.781,...xpert Rev Neurother 2008 8 781 797 10.1586/14737175.8.5.781 18457535,350,113,Mol_Pain_2015_Oct_24_11_66.txt
EC 2.7.7.59,...ing uridylyltransferase/uridylyl-removing enzyme (EC 2.7.7.59) of Escherichia coli and its interacti...,241,146,Mol_Syst_Biol_2009_Aug_18_5_302.txt
EC 2.7.2.2,"...oyltransferase (EC 2.1.3.3) and carbamate kinase (EC 2.7.2.2). However, both reactions were set as r...",46,2048,Mol_Syst_Biol_2013_Nov_19_9_708.txt
4.62.6.893,...Social Psychology 1992 62 893 912 10.1037/0022-3514.62.6.893 1619549,124,177,Motiv_Emot_2011_Mar_17_35(1)_44-51.txt
3.97.4.630,...tional Psychology 2005 97 630 640 10.1037/0022-0663.97.4.630,284,199,Motiv_Emot_2011_Dec_20_35(4)_351-367.txt
4.32.2.311,...Social Psychology 1975 32 311 328 10.1037/0022-3514.32.2.311,167,114,Motiv_Emot_2016_Dec_9_40_203-211.txt
4.52.5.907,...Social Psychology 1987 52 907 916 10.1037/0022-3514.52.5.907 3585702,194,218,Motiv_Emot_2016_Sep_24_40(6)_830-841.txt
1.2.89.96,41 :89 –96 . doi:10.1080/mmy.41.2.89.96 .12964840,450,31,mSphere_2016_Sep_28_1(5)_e00213-16.txt
6.1.43.239,...Clin Exp Neuropsychol 2004 26 43 54 10.1076/jcen.26.1.43.23929 14972693,520,248,Multidiscip_Respir_Med_2016_Oct_11_11_35.txt
1.39.4.272,...323The Korean Society of Mycology 10.5941/MYCO.2011.39.4.272Research ArticleBreeding of New Strains ...,3,101,Mycobiology_2011_Dec_7_39(4)_272-277.txt
1.39.4.257,...323The Korean Society of Mycology 10.5941/MYCO.2011.39.4.257Review ArticleFungal and Plant Phenylala...,3,101,Mycobiology_2011_Dec_7_39(4)_257-265.txt
5.43.2.93,...323The Korean Society of Mycology 10.5941/MYCO.2015.43.2.93Mini-ReviewAlternaria in Food: Ecophysiol...,3,101,Mycobiology_2015_Jun_30_43(2)_93-106.txt
6.44.3.187,...323The Korean Society of Mycology 10.5941/MYCO.2016.44.3.187Research NoteFirst Report of Leaf Spot C...,3,101,Mycobiology_2016_Sep_30_44(3)_187-190.txt
1.2.3.282,...s Saf. Health Work 2011 2 282 289 10.5491/SHAW.2011.2.3.282 22953212,365,252,PMC5333034.txt
5.6.5.6,...DFT B3LYP Calculation of Molecular Structures of (5.6.5.6) Macrotetracyclic FeIII  and CoIII  Comple...,376,82,Nano_Rev_2014_Feb_7_5_10_3402_nano_v5_21485.txt
4.35.8.228,...ll Korean Chem Soc 2014 35 8 2281 10.5012/bkcs.2014.35.8.2281,115,180,Nanoscale_Res_Lett_2016_Feb_1_11_46.txt
3.5.1.28,"...hnology and Nanomaterials’ 2010-2014, project No. 3.5.1.28/9 and 3.5.1.12",104,192,Nanoscale_Res_Lett_2014_Dec_23_9_693.txt
4.2.1.45,"4.2.1.45	CDP-glucose-4,6-dehydratase	0.76	27.5	11....",158,2,Nat_Chem_Biol_2012_Oct_8(10)_848-854.txt
EC 3.3.2.1,"...oate (DDHB) and pyruvate by isochorismatase (ISC, EC 3.3.2.1). Escherichia coli EntB and Vibrio chol...",12,251,Nat_Commun_2014_Aug_26_5_4686.txt
4.1.2.1,Global collection of sublineage 4.1.2.1 isolates from Coll et al. (doi:10.1038/nco...,95,33,Nat_Commun_2015_May_11_6_7119.txt
1.5.1.6,...trument. Raw MS data were processed with MaxQuant 1.5.1.6 using the LFQ and iBAQ algorithms and the ...,88,777,Nat_Commun_2015_Sep_18_6_8192.txt
EC 2.7.1.31,"...th the production of ATP, via glycerate 3-kinase, EC 2.7.1.31. Although the final reaction of this p...",61,165,Nat_Commun_2015_Sep_29_6_8427.txt
1.7.7.2,"...d structure was then imported into PyMol (version 1.7.7.2; The PyMOL Molecular Graphics System, Schr...",89,284,Nat_Commun_2016_Dec_5_7_13695.txt
3.1.9.2,... tests calculation of Power analysis with G*Power 3.1.9.2,77,532,Nature_2015_Feb_12_518(7538)_236-239.txt
3.73.1.41,...ional Psychology  1981 73 1 41 50 10.1037/0022-0663.73.1.41 2-s2.0-0002473681,299,225,Neural_Plast_2016_Jan_14_2016_9696402.txt
3.2.1.2,3.2.1.2 Right HFC network difference,80,1,Neuroimage_Clin_2013_Sep_13_3_311-320.txt
3.3.1.1,3.3.1.1 Significant differences with FWE correctio...,65,1,Neuroimage_Clin_2014_Jul_24_7_87-97.txt
4.56.1.1,...rosurgical Society  2014 56 1 1 4 10.3340/jkns.2014.56.1.1 2-s2.0-84929936454 25289117,197,270,Neurol_Res_Int_2016_May_19_2016_9468193.txt
5.76.2.623,...bility Psychol Rep 1995 76 623 626 10.2466/pr0.1995.76.2.623,231,110,Neuropsychiatr_2016_Mar_4_30_42-49.txt
4.20.4.718,... Psychology and Aging  20 718 721 10.1037/0882-7974.20.4.718 16420146,450,155,Neuropsychol_Dev_Cogn_B_Aging_Neuropsychol_Cogn_2016_Jan_2_23(1)_785-102.txt
2.4.3.3,2.4.3.3 Analysis of white matter abnormalitie,85,1,Neuropsychologia_2015_Aug_75_233-241.txt
3.2.2.1,3.2.2.1 Recollection of perceived/imagined and tem...,57,1,Neuropsychologia_2008_46(5)_1442-1453.txt
6.18.7.113,"...roscience , 18 , 1133 –1146 . doi:10.1162/jocn.2006.18.7.1133 16839287",249,204,Neuropsychology_2013_Nov_27(6)_615-627.txt
2.41.2.283,"... www.koreamed.org/SearchBasic.php?RID=0055JKNA/2002.41.2.283&DT=1 Accessed February 17, 2016",419,181,Nicotine_Tob_Res_2017_Jan_7_19(1)_94-101.txt
EC 3.5.1.68,....13) (ForI) and of N-formylglutamate deformylase (EC 3.5.1.68) (NfoD). Variant 2 (yellow shading) is...,159,1381,Nucleic_Acids_Res_2005_Oct_7_33(17)_5691-5702.txt
EC 1.1.1.27,...evel of co-expression with lactate dehydrogenase (EC 1.1.1.27). Blue nodes show a high positive co-e...,54,816,Nucleic_Acids_Res_2006_Jul_1_34(Web_Server_issue)_W725-W728.txt
EC 2.1.1.56,...ed by RNA (guanine-N7) methyltransferase (MTase) (EC 2.1.1.56) to yield a cap0 structure. The three ...,12,741,Nucleic_Acids_Res_2011_Jun_9_39(11)_4756-4768.txt
1.15.1.1,"...EC1.15.1.1); (ii) EXP0100758 (B. licheniformis, EC1.15.1.1); (iii) EXP0102685 (Neisseria meningitidi...",103,399,Nucleic_Acids_Res_2008_Oct_1_36(17)_e110.txt
1.2.3.4,"... a 3D-Hit score of 150 to protein Si with EC-code 1.2.3.4, which has the four false-positive cutoff ...",39,587,Nucleic_Acids_Res_2008_Jul_1_36(Web_Server_issue)_W303-W307.txt
3.1.3.36,"... 3.1.13.4, 3.1.21.1, 3.1.3.n1, 3.1.3.8, 3.1.3.25, 3.1.3.36, 3.1.3.56, 3.1.4.3, 3.1.4.12, 4.2.1.51, 4...",253,596,Nucleic_Acids_Res_2010_Jan_18_38(3)_720-737.txt
1.1.5.4,...36) implemented in the GOSim package (37) version 1.1.5.4 written in R language (version 2.9.1) (38)...,60,879,Nucleic_Acids_Res_2010_Jan_17_38(Database_issue)_D540-D544.txt
1.3.3.1,"...d contains the enzymes 6.3.5.5, 2.1.3.2, 3.5.2.3, 1.3.3.1, 2.4.2.10 and 4.1.1.23. Five of the enzyme...",35,423,Nucleic_Acids_Res_2009_Jan_25_37(Database_issue)_D531-D538.txt
EC 1.14.19.3,"...a history of the enzyme since its creation, e.g. ‘EC 1.14.19.3 created 1986 as EC 1.14.99.25, transf...",62,398,Nucleic_Acids_Res_2009_Jan_6_37(Database_issue)_D593-D597.txt
3.1.1.3,"...TopSpin 2.1/3.1 software and analysed with Sparky 3.1.1.3 (22). All sample contained 100 μM 4,4-dime...",46,250,Nucleic_Acids_Res_2015_Jun_23_43(11)_5572-5585.txt
2.60.2.86,...an J. Gastroenterol. 2012 60 86 93 10.4166/kjg.2012.60.2.86 22926119,214,216,Nutrients_2013_Jan_10_5(1)_58-81.txt
3.2.3.2,3.2.3.2. Sensitivity Analysis for PN Omega-3 Studi...,106,1,Nutrients_2014_May_30_6(6)_2148-2164.txt
1.74.6.445,...Vitam. Nutr. Res. 2004 74 445 452 10.1024/0300-9831.74.6.445 15743020,303,143,Nutrients_2015_Feb_11_7(2)_1144-1173.txt
2.13.10.518,.... Cancer Prev. 2012 13 5183 5188 10.7314/APJCP.2012.13.10.5183 23244132,448,255,Nutrients_2015_Mar_10_7(3)_1769-1786.txt
2.21.18.107,...y Br. J. Nurs. 2012 21 1070 1075 10.12968/bjon.2012.21.18.1070 23123838,201,144,Nutrients_2015_Apr_8_7(4)_2524-2538.txt
1.74.3.187,...Vitam. Nutr. Res. 2004 74 187 192 10.1024/0300-9831.74.3.187 15296077,246,219,Nutrients_2015_Apr_10_7(4)_2663-2686.txt
3.10.2.133,...n Health Psychol. 1991 10 133 142 10.1037/0278-6133.10.2.133 2055211,516,160,Nutrients_2016_May_21_8(5)_315.txt
3.1.9.2,"...ze was calculated using G*Power software (version 3.1.9.2, Franz Faul, Universitat Kiel, Dusseldorf,...",52,60,Nutrients_2016_May_9_8(5)_269.txt
3.5.4.239,...thma Immunol. Res. 2013 5 239 241 10.4168/aair.2013.5.4.239 23814678,237,220,Nutrients_2016_Nov_3_8(11)_695.txt
2.17.3.521,...iner Res 2002 17 521 527 11874243 10.1359/jbmr.2002.17.3.521,189,253,Nutr_J_2007_Jan_16_6_2.txt
3.20.6.403,...Psychol 2001 20 403 410 11714181 10.1037//0278-6133.20.6.403,244,210,Nutr_J_2004_Nov_28_3_20.txt
1.79.56.271,... J Vitam Nutr Res 2009 79 271 280 10.1024/0300-9831.79.56.271 20533213,264,200,Nutr_J_2010_Nov_22_9_57.txt
1.78.2.87,...nt J Vitam Nutr Res 2008 78 87 95 10.1024/0300-9831.78.2.87 1879197,270,207,Nutr_J_2014_May_3_13_43.txt
2.13.9.471,... J Cancer Prev 2012 13 4713 4717 10.7314/APJCP.2012.13.9.4713 23167408,261,182,Nutr_J_2013_Dec_11_12_158.txt
4.10.9.166,...n Investig Drugs 2001 10 1665 1676 10.1517/13543784.10.9.1665 11772276,117,146,Nutr_Metab_(Lond)_2014_Jan_30_11_8.txt
EC 1.5.1.6,...ses 10-formyltetrahydrofolate dehydrogenase (FDH; EC 1.5.1.6.) activity in rat liver and suggested t...,9,254,Nutr_Res_Pract_2008_Dec_31_Winter_2(4)_195-199.txt
1.5.2.107,...ean Society of Community Nutrition 10.4162/nrp.2011.5.2.107Original ResearchQuercetin attenuates fas...,3,157,Nutr_Res_Pract_2011_Apr_23_5(2)_107-111.txt
2.6.3.187,...ean Society of Community Nutrition 10.4162/nrp.2012.6.3.187Original ResearchAntibacterial effect of ...,3,171,Nutr_Res_Pract_2012_Jun_30_6(3)_187-194.txt
3.7.2.139,...ean Society of Community Nutrition 10.4162/nrp.2013.7.2.139Original ResearchGender specific effect o...,3,171,Nutr_Res_Pract_2013_Apr_1_7(2)_139-145.txt
4.8.1.11,...ean Society of Community Nutrition 10.4162/nrp.2014.8.1.11Original ResearchEthanol extract of Synuru...,3,171,Nutr_Res_Pract_2014_Feb_29_8(1)_11-19.txt
4.8.2.198,...ean Society of Community Nutrition 10.4162/nrp.2014.8.2.198Original ResearchFood security experience...,3,171,Nutr_Res_Pract_2014_Apr_28_8(2)_198-204.txt
2.41.1.28,...ntemporary Nurse  2012 41 1 28 40 10.5172/conu.2012.41.1.28 2-s2.0-84865544093 22724904,209,141,Obstet_Gynecol_Int_2015_Aug_30_2015_439748.txt
4.15.16.669,...Prevention  2014 15 16 6691 6695 10.7314/APJCP.2014.15.16.6691 2-s2.0-84906834017 25169510 25169510,487,256,Obstet_Gynecol_Int_2016_Nov_2_2016_4840762.txt
3.56.1.15,...sound in Obstetrics and Gynecology 10.5468/OGS.2013.56.1.15Original ArticlePromising treatment resul...,3,422,Obstet_Gynecol_Sci_2013_Jan_9_56(1)_15-21.txt
4.57.1.86,...ogy; Korean Urogynecologic Society 10.5468/ogs.2014.57.1.86Case ReportGeneral GynecologyIncidental d...,3,453,Obstet_Gynecol_Sci_2014_Jan_16_57(1)_86-88.txt
4.57.4.338,...ogy; Korean Urogynecologic Society 10.5468/ogs.2014.57.4.338Case ReportGeneral GynecologyAcute abdom...,3,453,Obstet_Gynecol_Sci_2014_Jul_15_57(4)_338-341.txt
5.58.1.77,...ogy; Korean Urogynecologic Society 10.5468/ogs.2015.58.1.77Case ReportGeneral GynecologyCarvenous ly...,3,453,Obstet_Gynecol_Sci_2015_Jan_16_58(1)_77-79.txt
5.58.5.405,...ogy; Korean Urogynecologic Society 10.5468/ogs.2015.58.5.405Case ReportMaternal-Fetal MedicinePrenat...,3,453,Obstet_Gynecol_Sci_2015_Sep_22_58(5)_405-408.txt
6.59.2.103,...ogy; Korean Urogynecologic Society 10.5468/ogs.2016.59.2.103Original ArticleMaternal-Fetal MedicineS...,3,453,Obstet_Gynecol_Sci_2016_Mar_16_59(2)_103-109.txt
6.59.5.393,...ogy; Korean Urogynecologic Society 10.5468/ogs.2016.59.5.393Case ReportMaternal-Fetal MedicineAn ext...,3,453,Obstet_Gynecol_Sci_2016_Sep_13_59(5)_393-396.txt
6.59.6.506,...ogy; Korean Urogynecologic Society 10.5468/ogs.2016.59.6.506Original ArticleGeneral GynecologyStudy ...,3,453,Obstet_Gynecol_Sci_2016_Nov_15_59(6)_506-511.txt
5.18.4.908,...s Drug News Perspect 2005 18 243 9 10.1358/dnp.2005.18.4.908658 16034480,175,142,Oncoimmunology_2013_Jan_1_2(1)_e22840.txt
3.14.5.310,...ac J Cancer Prev 2013 14 3109 16 10.7314/APJCP.2013.14.5.3109 23803088,371,275,Oncoimmunology_2014_Aug_1_3_e29179.txt
3.1.1.2,3.1.1.2. NF-,283,1,Oncotarget_2015_Sep_5_6(27)_23058-23134.txt
3.2.2.4,3.2.2.4. Other microRNAs regulating Bim expressio,385,1,Oncotarget_2015_Sep_5_6(27)_23058-23134.txt
2.1.4.2,"...th an automated cell counter (Cellometer Vision, v2.1.4.2, Nexcelom Bioscience). We have previously ...",110,279,PMC5341331.txt
2.7.1.1,"Amino sugar and nucleotide sugar metabolism	2.7.1.1, 2.5.1.56, 2.5.1.57	0.05	hsa00520",126,45,Onco_Targets_Ther_2016_Apr_13_9_2169-2179.txt
4.2.5.633,"2 , 633 –648  (doi:10.1586/14760584.2.5.633)14711325",213,35,Open_Biol_2015_Apr_1_5(4)_140227.txt
2.36.4.262,2012 ;36 :262 –7 . doi:10.4093/dmj.2012.36.4.26222950055,565,39,Open_Heart_2015_Oct_19_2(1)_e000327.txt
EC 3.4.14.5,... specific peptidases (probably EC 3.4.14.2 and/or EC 3.4.14.5). We have also reasoned that another t...,15,694,Open_Med_Chem_J_2008_Oct_20_2_97-100.txt
6.21.1.131,...orean Med. Sci. 2006 21 1 131 135 10.3346/jkms.2006.21.1.131 16479079,129,190,Open_Ophthalmol_J_2015_Jul_31_9_121-125.txt
5.29.3.190,...orean J Ophthalmol 2015 29 190 194 10.3341/kjo.2015.29.3.190 26028948,167,216,Ophthalmol_Ther_2016_Dec_2_5(2)_183-190.txt
3.2.2.1,3.2.2.1. Electronic von Fre,100,1,Pain_2016_Jun_16_157(6)_1325-1332.txt
5.46.5.585,...Medical Journal  2005 46 5 585 596 10.3349/ymj.2005.46.5.585 2-s2.0-29144435210 16259055,327,161,Oxid_Med_Cell_Longev_2015_Oct_20_2015_314560.txt
2.28.1.1,...ory Animal Research  2012 28 1 1 9 10.5625/lar.2012.28.1.1 22474468,171,218,Oxid_Med_Cell_Longev_2016_Dec_29_2016_3620929.txt
3.28.1.630,...ricion Hospitalaria  2013 28 1 6 15 10.3305/nh.2013.28.1.6302 2-s2.0-84872790014 23808425,49,161,Oxid_Med_Cell_Longev_2016_Jan_6_2016_3218605.txt
EC 1.11.1.6,...y was measured at 412 nm [21]. The catalase (CAT; EC 1.11.1.6) converts H2O2 into water and its acti...,31,694,Oxid_Med_Cell_Longev_2016_May_16_2016_8679506.txt
5.16.8.357,... Prevention  2015 16 8 3573 3577 10.7314/APJCP.2015.16.8.3573 2-s2.0-84928996026 25921180,280,186,PMC5288547.txt
3.85.4.149,...rgical Society  2013 85 4 149 153 10.4174/jkss.2013.85.4.149 2-s2.0-84887832665 24106680,171,221,Pain_Res_Manag_2016_Sep_20_2016_7868152.txt
5.68.5.481,...Anesthesiology  2015 68 5 481 487 10.4097/kjae.2015.68.5.481 2-s2.0-84944315145 26495059,104,217,PMC5253487.txt
5.48.5.414,... Med Assoc 2005 48 5 414 422 doi: 10.5124/jkma.2005.48.5.414,166,147,Pak_J_Med_Sci_2015_Jan-Feb_31(1)_31-36.txt
3.15.30.230,...d Epidemiology Network PAMJ-15-3010.11604/pamj.2013.15.30.2301Case ReportAdénocarcinome vaginal prim...,3,137,Pan_Afr_Med_J_2013_May_21_15_30.txt
4.17.28.344,...d Epidemiology Network PAMJ-17-2810.11604/pamj.2014.17.28.3447ResearchProfil des cancers gynécologiq...,3,137,Pan_Afr_Med_J_2014_Jan_17_17_28.txt
4.17.37.322,...d Epidemiology Network PAMJ-17-3710.11604/pamj.2014.17.37.3226Case SeriesStroke in young adults: abo...,3,137,Pan_Afr_Med_J_2014_Jan_20_17_37.txt
5.20.6.507,...ld Epidemiology Network PAMJ-20-610.11604/pamj.2015.20.6.5073Case ReportCarcinome muco-épidermoide c...,3,136,Pan_Afr_Med_J_2015_Jan_5_20_6.txt
5.20.83.581,...d Epidemiology Network PAMJ-20-8310.11604/pamj.2015.20.83.5814Images in MedicineA rare image of spon...,3,137,Pan_Afr_Med_J_2015_Jan_29_20_83.txt
5.22.18.748,...d Epidemiology Network PAMJ-22-1810.11604/pamj.2015.22.18.7480ResearchEtude de facteurs de risque de...,3,137,Pan_Afr_Med_J_2015_Sep_9_22_18.txt
5.22.1.583,...rk 26600903PAMJ-SUPP-22-1-0310.11694/pamj.supp.2015.22.1.5837CommentaryBeyond Ebola: surveillance fo...,3,157,Pan_Afr_Med_J_2015_Oct_10_22(Suppl_1)_3.txt
5.22.65.793,...d Epidemiology Network PAMJ-22-6510.11604/pamj.2015.22.65.7937Images in MedicineLa rupture spontanée...,3,137,Pan_Afr_Med_J_2015_Sep_23_22_65.txt
5.22.92.783,...d Epidemiology Network PAMJ-22-9210.11604/pamj.2015.22.92.7830Images in MedicinePurpura vasculaire r...,3,137,Pan_Afr_Med_J_2015_Oct_1_22_92.txt
6.23.82.876,...d Epidemiology Network PAMJ-23-8210.11604/pamj.2016.23.82.8765Images in MedicineHydronéphrose géante...,3,137,Pan_Afr_Med_J_2016_Mar_11_23_82.txt
6.24.89.883,...d Epidemiology Network PAMJ-24-8910.11604/pamj.2016.24.89.8831ResearchChronic neck pain and anxiety-...,3,137,Pan_Afr_Med_J_2016_May_27_24_89.txt
6.25.93.989,...d Epidemiology Network PAMJ-25-9310.11604/pamj.2016.25.93.9896Case ReportCalcified wall portal venou...,3,137,PMC5325509.txt
1.4.2.3,... 1.39: 1 (1.38: 1 ± 0.06; n = 10). Palpal formula 1.4.2.3.5 (1.4.2.3.5; n = 10). Palpomere lengths: ...,33,943,Parasit_Vectors_2011_Aug_9_4_158.txt
1.4.2.3,... 1.39: 1 (1.38: 1 ± 0.06; n = 10). Palpal formula 1.4.2.3.5 (1.4.2.3.5; n = 10). Palpomere lengths: ...,33,943,Parasit_Vectors_2011_Aug_9_4_158.txt
1.3.2.173,...rt Opin Drug Discov 2008 3 173 186 10.1517/17460441.3.2.173 23480221,64,169,Parasit_Vectors_2013_Mar_21_6_78.txt
3.51.5.537,...Korean J Parasitol 2013 51 537 544 10.3347/kjp.2013.51.5.537 24327779,372,308,Parasit_Vectors_2014_Aug_29_7_407.txt
EC 4.2.1.2,"...mutase (PGM, EC 5.4.2.2), fumarate hydratase (FH, EC 4.2.1.2), mannose phosphate isomerase (MPI, EC ...",42,621,Parasit_Vectors_2015_Apr_1_8_198.txt
6.5.1.33,...rosurg Spine 2006 5 33 45 16850954 10.3171/spi.2006.5.1.33,128,265,Patient_Saf_Surg_2008_Jun_6_2_15.txt
6.32.2.111,...evice Vasa 2003 32 111 6 12945107 10.1024/0301-1526.32.2.111,82,242,Patient_Saf_Surg_2008_Dec_9_2_32.txt
2.15.4.197,"...erology, Hepatology and Nutrition 10.5223/pghn.2012.15.4.197Invited ReviewDiagnosis of Wilson Diseas...",3,232,Pediatr_Gastroenterol_Hepatol_Nutr_2012_Dec_31_15(4)_197-209.txt
4.17.4.248,"...erology, Hepatology and Nutrition 10.5223/pghn.2014.17.4.248Original ArticleThe Clinical Significanc...",3,232,Pediatr_Gastroenterol_Hepatol_Nutr_2014_Dec_31_17(4)_248-256.txt
6.19.2.96,"...erology, Hepatology and Nutrition 10.5223/pghn.2016.19.2.96Review ArticleUpdates on the Diagnosis of...",3,232,Pediatr_Gastroenterol_Hepatol_Nutr_2016_Jun_28_19(2)_96-103.txt
6.19.3.193,"...erology, Hepatology and Nutrition 10.5223/pghn.2016.19.3.193Original ArticleSpontaneous Perforation ...",3,232,Pediatr_Gastroenterol_Hepatol_Nutr_2016_Sep_29_19(3)_193-198.txt
6.9.5.585,...ts Pharmacogenomics 2008 9 585 596 10.2217/14622416.9.5.585 18466104,161,181,Pediatr_Nephrol_2012_Sep_23_27(9)_1489-1498.txt
6.41.8.161,... and Oceanography 1996 41 1619 1628 10.4319/lo.1996.41.8.1619,208,202,PeerJ_2014_Mar_13_2_e302.txt
4.57.6.106,...cial Psychology 1989 57 1069 1081 10.1037/0022-3514.57.6.1069,216,193,PeerJ_2015_Apr_2_3_e847.txt
4.70.1.17,...Social Psychology 1 1996 70 17 27 10.1037/0022-3514.70.1.17,132,182,PeerJ_2015_Jun_18_3_e1035.txt
1.2.2.57,...larity Methodology 2 2006 2 57 64 10.1027/1614-2241.2.2.57,196,183,PeerJ_2015_Jul_2_3_e1070.txt
5.90.2.1,"...) of the Mesoeucrocodylia indet. tooth (MFGI V 2015.90.2.1.), found between the villages of Olaszfal...",23,108,PeerJ_2015_Aug_13_3_e1160.txt
3.15.34.229,...rican Medical Journal 2013 15 34 10.11604/pamj.2013.15.34.2291 24009810,332,277,PeerJ_2015_Oct_13_3_e1325.txt
EC 1.14.18.1,...and removing reactive oxygen species. Tyrosinase (EC 1.14.18.1) is the rate-limiting enzyme involved...,8,519,PeerJ_2015_Oct_13_3_e1305.txt
3.48.4.139,... and Oceanography 2003 48 1394 1407 10.4319/lo.2003.48.4.1394,166,182,PeerJ_2015_Nov_24_3_e1434.txt
1.61.3.6,... landscape BioScience 61 3 203 216 10.1525/bio.2011.61.3.6,240,234,PeerJ_2016_Jun_30_4_e2108.txt
1.16.2.348,...e and Mineral Research 16 348 360 10.1359/jbmr.2001.16.2.348 11204435,204,232,PeerJ_2016_Aug_23_4_e2229.txt
1.29.3.937,...r Psychological Reports 29 937 938 10.2466/pr0.1971.29.3.937,115,198,PeerJ_2016_Oct_27_4_e2610.txt
4.92.1.82,... J Pers Soc Psychol 2007 92 82 96 10.1037/0022-3514.92.1.82 17201544,36,134,Perspect_Med_Educ_2016_Apr_13_5(2)_75-77.txt
4.37.6.822,"... Psychology , 37 , 822 -832 . doi:10.1037/0022-3514.37.6.822",515,208,PMC5302073.txt
3.2.2.1,3.2.2.1. Rivaroxaba,111,1,Pharmaceuticals_(Basel)_2012_Apr_5_5(4)_384-397.txt
5.5.2.211,"...]-14,30-dimethyl-8,14,24,30-tetraazaundecacyclo-[25.5.2.211,14.11,8.110,17.02,7.013,17.024,25.026,38...",102,100,Pharmaceuticals_(Basel)_2010_Aug_30_3(9)_2838-2860.txt
4.29.2.238,... Korean Med. Sci. 2014 29 238 242 10.3346/jkms.2014.29.2.238 24550651,277,306,Pharmaceuticals_(Basel)_2016_May_6_9(2)_24.txt
2.8.3.21,... Network processing was performed using Cytoscape 2.8.3.2,53,388,PMC5223086.txt
3.73.3.963,...ormance Psychol Rep 1993 73 963 70 10.2466/pr0.1993.73.3.963 8303000,205,153,Philos_Ethics_Humanit_Med_2011_Dec_16_6_16.txt
1.4.5.2,"...), where the nonlinear self-sustained oscillation(1.4.5.2) that develops closely resembles some form...",159,574,Philos_Trans_A_Math_Phys_Eng_Sci_2015_Sep_28_373(2051)_20140400.txt
2.2.3.3,...qualitative effect on the overall system response(2.2.3.3); and local/distributed could refer to the...,177,422,Philos_Trans_A_Math_Phys_Eng_Sci_2015_Sep_28_373(2051)_20140400.txt
2.2.2.1,...odel that accounts for the geometric nonlinearity(2.2.2.1.4) due to sag. These nonlinear terms not o...,210,611,Philos_Trans_A_Math_Phys_Eng_Sci_2015_Sep_28_373(2051)_20140400.txt
4.59.6.121,...10.1037/0022-3514.59.6.1216  (doi:10.1037/0022-3514.59.6.1216)2283588,199,194,Philos_Trans_R_Soc_Lond_B_Biol_Sci_2011_Feb_12_366(1563)_389-401.txt
1.1.8.1,   1.1.8.1 Superficial syste,127,4,Phlebology_2014_Oct_29(9)_587-593.txt
3.10.2.3,   3.10.2.3 Secondary prophylaxi,503,4,Phlebology_2014_Oct_29(9)_587-593.txt
4.59.3.102,...s Limnol Oceanogr 2014 59 1027 1034 10.4319/lo.2014.59.3.1027,260,143,PMC5167766.txt
1.2.1.2,...Asiat. 43. 1930 (urn:lsid:ipni.org:names:280422-1:1.2.1.2),122,88,PhytoKeys_2016_Mar_25_(62)_57-72.txt
4.57.5.749,...Pers Soc Psychol 1989 57 5 749 61 10.1037/0022-3514.57.5.749 2810024,199,173,PMC5292793.txt
EC 1.2.1.44,"....14.13.11; A11) and cinnamoyl CoA reductase (CCR, EC 1.2.1.44; A46). Cinnamyl alcohol dehydrogenase ...",216,1761,Planta_2013_May_7_237(5)_1337-1357.txt
EC 1.1.1.40,"...ADP oxidoreductase, oxaloacetate decarboxylating, EC 1.1.1.40; NADP-ME) are related to photosynthesi...",325,783,Planta_2016_Jun_22_244(4)_939-960.txt
EC 4.4.1.5,...esponsive; glyoxylase1 (lactoylglutathione lyase; EC 4.4.1.5) is involved in recycling the reduced g...,325,1005,Planta_2016_Jun_22_244(4)_939-960.txt
4.19.1.3,...thodology J Mater Res 2004 19 3 20 10.1557/jmr.2004.19.1.3,181,193,Planta_2015_Aug_26_242(6)_1453-1465.txt
3.2.1.151,"Xyloglucan‐specific Endo‐1,4‐β‐glucanase (3.2.1.151",232,43,Plant_Biotechnol_J_2016_Jun_2_14(6)_1329-1344.txt
3.2.1.4,"Endo‐1,4‐β‐glucanase (3.2.1.4",261,23,Plant_Biotechnol_J_2016_Jun_2_14(6)_1329-1344.txt
2.4.1.241,9	Os11g0158400	K09480 E2.4.1.241; digalactosyldiacylglycerol synthase [EC...,193,24,PMC5253468.txt
1.11.1.11,"...sium phosphate (pH 7.0) and 0.1 mM EDTA; APX (EC: 1.11.1.11), 50 mM potassium phosphate (pH 7.8) and...",98,288,Plant_Cell_Physiol_2009_Jan_2_50(1)_26-36.txt
6.3.2.17,"...functional folylpolyglutamate synthase (FPGS, EC# 6.3.2.17) that acts upstream of MTHFR in the ligni...",24,153,Plant_J_2015_Feb_9_81(3)_493-504.txt
2.15.4.341,... Microbe Interact 2002 15 341 349 10.1094/MPMI.2002.15.4.341 12026172,217,234,Plant_Methods_2012_Sep_12_8_38.txt
4.17.10.114,...ant-Microbe Interact 17 1146 1152 10.1094/MPMI.2004.17.10.1146 15497407,309,226,Plant_Pathol_J_2015_Mar_31_31(1)_12-24.txt
3.93.9.106,...rial Phytopathology 93 1068 1072 10.1094/PHYTO.2003.93.9.1068 18944089,486,205,Plant_Pathol_J_2015_Sep_30_31(3)_226-244.txt
2.92.11.124,...erry Phytopathology 92 1245 1252 10.1094/PHYTO.2002.92.11.1245 18944251,80,203,PMC5291401.txt
4.17.1.34,...t Microbe Interact. 2004 17 34 42 10.1094/MPMI.2004.17.1.34 14714866,139,222,Plants_(Basel)_2014_Aug_29_3(3)_427-441.txt
EC 1.4.7.1,...1.1.3)/glutamate synthase (ferredoxin [Fd]-GOGAT; EC 1.4.7.1; NADH-GOGAT; EC 1.4.1.14) cycle [32],77,152,Plants_(Basel)_2016_May_11_5(2)_24.txt
2.9.2.165,...2002 9 2 165 168 2-s2.0-0036207925 10.1245/aso.2002.9.2.165 11888874,150,229,Plast_Surg_Int_2014_Nov_11_2014_589068.txt
EC 6.3.5.5,"...bunits of carbamoyl phosphate synthetase (CPSase, EC 6.3.5.5). The product of CPSase, carbamoyl phos...",106,620,PLoS_Biol_2015_Mar_12_13(3)_e1002109.txt
EC 2.3.1.9,...g it into the thiolase family which includes both EC 2.3.1.9 and EC 2.3.1.16. Detailed phylogenomic ...,130,929,PMC1950344.txt
EC 4.2.1.99,...ative; EC:4.2.1.3	2-Methylisocitrate dehydratase; EC 4.2.1.99,418,82,PMC2563689.txt
2.10.90.10,52.1	0.07	2.10.90.10	g.17.1.2,98,12,PMC2759523.txt
6.3.2.13,6.3.2.13/6.3.2.9	0.83,437,1,PMC2796266.txt
EC 6.3.1.5,"...2.2.2 of the CSA were NAD+ synthase (MACiE M0200, EC 6.3.1.5, PDB 1kqp) [111]–[113] and uroporphyrin...",222,469,PMC2837397.txt
EC 6.3.1.2,...ion catalyzed by the enzyme glutamine synthetase (EC 6.3.1.2). This satisfies the glutamine biomass ...,71,378,PMC3053319.txt
2.3.1.8,"...se (E.C.1.12.7.2); 4, phosphotransacetylase (E.C. 2.3.1.8); 5, acetate kinase (E.C. 2.7.2.1); 6, ace...",95,262,PMC3349732.txt
2.3.1.8,"...e (E.C. 2.7.2.1), and phosphotransacetylase (E.C. 2.3.1.8), as present within C. acetobutylicum. Whe...",98,200,PMC3349732.txt
1.5.1.15,...lD	Methylenetetrahydrofolate dehydrogenase (NAD+)	1.5.1.15	1.00	Homology to Escherichia coli's FolD ...,203,83,PMC3764002.txt
2.4.1.8,Maltose phosphorylase	2.4.1.8	B-D-glucose-6-phosphate	Needed for maltose...,256,23,PMC3764002.txt
2.7.4.16,Thiamine-monophosphate kinase	2.7.4.16	Thiamine diphosphate	Needed to complete v...,271,31,PMC3764002.txt
3.6.3.7,Choline	Cytosol	added E.C. 3.6.3.7,334,28,PMC3764002.txt
3.40.50.970,"....0098) (which we have already mentioned) and CATH 3.40.50.970 (nd = 0.049), the second largest numbe...",243,158,PLoS_Comput_Biol_2014_May_29_10(5)_e1003642.txt
2.40.40.10,"...0 c) Expansin proteins (DPBB_1, Pollen_allerg_1): 2.40.40.10 and 2.60.40.760, respectively. For Bet ...",154,409,PLoS_Comput_Biol_2015_Oct_29_11(10)_e1004546.txt
2.7.4.3,TGME49_224900	Purine metabolism	2.7.4.3	no	NA,335,33,PLoS_Comput_Biol_2015_May_22_11(5)_e1004261.txt
3.20.20.80,Chitinase B	3.20.20.80	1E15	3.2.1.14,41,13,PLoS_Comput_Biol_2016_Mar_25_12(3)_e1004834.txt
2.7.7.1,2.7.7.18/2.7.7.1	NMNAT	NP_200392	142771115–2768696	FJ944016...,65,10,PLoS_Genet_2010_Sep_9_6(9)_e1001105.txt
4.2.2.5,"...Methodological Standards in Pharmacoepidemiology, 4.2.2.5. Unmeasured confounding  [Mar 10]. London,...",453,138,PLoS_Med_2015_Oct_6_12(10)_e1001885.txt
2.1.1.14,"...oyltriglutamate–homocysteine methyltransferase (EC2.1.1.14) were found in one, seven and four nemato...",117,622,PLoS_Negl_Trop_Dis_2008_Jul_2_2(7)_e258.txt
2.63.6.540,doi: 10.4097/kjae.2012.63.6.540,260,22,PLoS_Negl_Trop_Dis_2015_Dec_8_9(12)_e0004268.txt
4.19.13.207,doi: 10.2807/1560-7917.ES2014.19.13.20759,305,29,PLoS_Negl_Trop_Dis_2016_Apr_15_10(4)_e0004625.txt
EC 3.4.24.-,"gbs1257			−2.6		Endopeptidase, M10 family (EC 3.4.24.-)",82,44,PLoS_One_2009_Jul_1_4(7)_e6114.txt
EC 3.4.21.-,...y2010	scpA	−47.34	−2.64		C5A peptidase precursor (EC 3.4.21.-),100,65,PLoS_One_2010_Mar_23_5(3)_e9785.txt
4.1.1.1,"...ains, d1gt8a4 and d1mo9a1 (Case (D), SCOP folds c.4.1.1.1 and c.3.1.5 respectively). While MUSTANG a...",65,220,PLoS_One_2010_Apr_6_5(4)_e10048.txt
1.1.56.143,...tp://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.56.1431,109,183,PLoS_One_2010_Apr_21_5(4)_e10179.txt
4.1.1.9,"...acks the cycle-specific malonyl-CoA reductase (EC:4.1.1.9), an essential enzyme for the 3-hydroxypro...",335,134,PLoS_One_2010_May_5_5(5)_e10433.txt
EC 3.1.27.-,ANG	ENSG00000214274	Angiogenin precursor (EC 3.1.27.-) (Ribonuclease 5) (RNase 5).,108,43,PLoS_One_2010_Sep_27_5(9)_e12989.txt
1.3.5.3,"...1.3.4, H1g1.3.5.1, H1g1.3.5.2.1, H1g1.3.5.2.2, H1g1.3.5.3.1, H1g1.3.5.3.2, H1g2.2.4, H1g2.2.6, H3g1....",190,105,PLoS_One_2010_Dec_29_5(12)_e14454.txt
1.3.5.3,"...5.1, H1g1.3.5.2.1, H1g1.3.5.2.2, H1g1.3.5.3.1, H1g1.3.5.3.2, H1g2.2.4, H1g2.2.6, H3g1.5, H3g1.6.1, H...",190,119,PLoS_One_2010_Dec_29_5(12)_e14454.txt
EC 2.4.1.17,"... absence of UDP- glucuronosyl transferase (UDPGT: EC 2.4.1.17) 1A1, the enzyme that synthesizes excr...",14,603,PLoS_One_2011_Jan_31_6(1)_e16165.txt
4.5.1.6,...re estimated using the rho statistic in Network v 4.5.1.6. TMRCA estimates using Batwing are represe...,127,62,PLoS_One_2011_Mar_11_6(3)_e17548.txt
2.7.10.2,"JAK2 (EC-2.7.10.2) proteins JH1-JH2WT, JH1-JH2V617F and JH1...",162,10,PLoS_One_2011_Apr_18_6(4)_e18522.txt
1.1.1.37,...nge are only present in L. reuteri ATCC 55730. EC:1.1.1.37: malate dehydrogenase; EC:1.2.4.1; pyruva...,192,370,PLoS_One_2011_Apr_29_6(4)_e18783.txt
3.5.1.2,"...er of different alleles, implemented in Arlequin v3.5.1.2. Comparisons of the genetic differentiatio...",33,821,PLoS_One_2011_Jul_29_6(7)_e22965.txt
EC 4.2.1.22,"... EC 4.4.1.1) and cystathionine-β-synthetase (CBS, EC 4.2.1.22) [6]–[8]. CBS and CSE are widely distr...",17,343,PLoS_One_2011_Aug_23_6(8)_e23788.txt
4.87.6.832,jpsp	10.1037/0022–3514.87.6.832	832–844	8	0.021422	0.02079	4	4	1,87,22,PLoS_One_2011_Nov_2_6(11)_e26828.txt
EC 3.4.21.36,"...3.4.21.1), elastase (porcine pancreatic elastase; EC 3.4.21.36), and the chromogenic substrates Nα-b...",117,310,PLoS_One_2011_Nov_8_6(11)_e27548.txt
1.1.1.102,"....50), 3-ketodihydrosphingosine reductase (KDSR, EC1.1.1.102), alkaline ceramidase (ACER, EC3.5.1.23)...",115,3776,PLoS_One_2011_Dec_8_6(12)_e28319.txt
2.7.1.138,"...atase (PPAP, EC3.1.3.4), ceramide kinase (CERK, EC2.7.1.138), sphingomyelin phosphodiesterase (SMPD,...",115,4026,PLoS_One_2011_Dec_8_6(12)_e28319.txt
2.7.1.91,"...e (GLCM, EC3.2.1.45), sphingosine kinase (SPHK, EC2.7.1.91), sphingosine-1-phosphate lyase (SGPL, EC...",115,4261,PLoS_One_2011_Dec_8_6(12)_e28319.txt
2.7.8.1,"... choline/ethanolamine phosphotransferase (CEPT, EC2.7.8.1), phospholipase C (PLC, EC3.1.4.3), glycer...",115,4657,PLoS_One_2011_Dec_8_6(12)_e28319.txt
EC 1.15.1.1,The tSOD (EC 1.15.1.1) activity was assayed by measuring its...,91,11,PLoS_One_2012_Feb_8_7(2)_e31401.txt
EC 6.3.4.5,"...ree cytosolic, argininosuccinate synthetase (ASS; EC 6.3.4.5), argininosuccinate lyase (ASL; EC 4.3....",8,433,PLoS_One_2012_Feb_27_7(2)_e29527.txt
6.6.21.44,"NHMUK RR 76.6.21.44, single cervical vertebra",54,11,PLoS_One_2012_Mar_28_7(3)_e34094.txt
4.1.1.15,Glutamic acid decarboxylase 1	Gad1/4.1.1.15		1		25,76,36,PLoS_One_2012_Apr_13_7(4)_e35445.txt
1.17.3.2,Xanthine dehydrogenase/oxidase	Xdh/1.17.1.4/1.17.3.2		3	2 (1/1)	66,88,45,PLoS_One_2012_Apr_13_7(4)_e35445.txt
EC 3.2.1.14,"... chitin to GlcNAc, concerted action of chitinase (EC 3.2.1.14) and β-N-acetylglucosaminidase (EC 3.2...",8,247,PLoS_One_2012_May_9_7(5)_e36714.txt
EC 1.11.1.6,...oup of heme-containing mono-functional catalases (EC 1.11.1.6). It is a homo-tetrameric protein cont...,10,249,PLoS_One_2012_May_10_7(5)_e36725.txt
3.5.1.2,... π respectively) [22] were calculated in Arlequin 3.5.1.2 [23]. Pairwise Φst values were calculated ...,27,150,PLoS_One_2012_Jun_6_7(6)_e38042.txt
EC 5.2.2.8,... phosphomannomutase/phosphoglucomutase (PMM/PGM) (EC 5.2.2.8). PMM/PGM proteins comprise a widesprea...,10,141,PLoS_One_2012_Jun_7_7(6)_e38114.txt
1.8.1.4,"...2) and component E3, dihydrolipoyl dehydrogenase (1.8.1.4) [27]. A key enzymatic counterpart to the ...",50,703,PLoS_One_2012_Jun_13_7(6)_e29044.txt
6.3.5.5,...artate transcarbamylase 3.5.2.3 =  dihydroorotase 6.3.5.5 =  CAD; carbamoyl-phosphate synthetase 2 3...,101,312,PLoS_One_2012_Aug_8_7(8)_e40521.txt
EC 3.2.1.8,"...ymes [3], [5]; among them, endo-1,4-β-d-xylanase (EC 3.2.1.8) is a crucial component that cleaves th...",19,423,PLoS_One_2012_Aug_17_7(8)_e43480.txt
2.3.3.10,2.3.3.10	K01641	Unigene27186_All	309	465.9	95.8	2....,124,1,PLoS_One_2012_Aug_27_7(8)_e44031.txt
2.3.3.10,2.3.3.10	K01641	Unigene27186_All	309	465.9	95.8	2....,124,1,PLoS_One_2012_Aug_27_7(8)_e44031.txt
5.4.99.7,5.4.99.7	K01852	Unigene4718_All	1890	47.7	17.5	1.5...,136,1,PLoS_One_2012_Aug_27_7(8)_e44031.txt
2.4.1.-,"...f ancient folds. The three transferases (EC codes 2.4.1.-, 2.7.1.-, and 2.7.7.-) are associated with...",55,427,PLoS_One_2012_Sep_10_7(9)_e39912.txt
2.8.23.1,"...ndia, collected by A.A., T.S. and P.K.K. (BMNH 2012.8.23.1–3; IPCAS C-617; MHNG-PLAT 63241, 63250, 8...",309,258,PLoS_One_2012_Oct_3_7(10)_e46421.txt
EC 1.1.1.8,"...tifying Glycerol-3-phosphate dehydrogenase (GPDH, EC 1.1.1.8). GPDH activity is an enzyme that catal...",134,600,PLoS_One_2012_Oct_26_7(10)_e48069.txt
1.1.5.1,"...kull of Asiatic lion (Panthera leo persica; ♂, BM31.1.5.1) in lateral, dorsal and ventral views; and...",234,62,PLoS_One_2012_Oct_26_7(10)_e48352.txt
2.7.4.6,...etabolism	Nucleoside diphosphate kinase	K00940/EC:2.7.4.6	CNUS0000102089	8.86	map00240,113,84,PLoS_One_2012_Oct_26_7(10)_e47660.txt
2.4.1.-,...2.7.8.20) and N-acetyl-glucoseaminyl transferase (2.4.1.-) in lipoteichoacid synthesis and genes of ...,100,1364,PLoS_One_2012_Oct_25_7(10)_e48223.txt
1.10.3.3,Contig5036	1.10.3.3	Oxidoreductase activity	BNT/MTP	AT3G13390...,119,12,PLoS_One_2012_Nov_14_7(11)_e49244.txt
EC 3.2.1.4,"...have genes that encode endo (β-1, 4) –glucanases, EC 3.2.1.4, that catalyze the breaking of β-1, 4 g...",12,253,PLoS_One_2012_Nov_16_7(11)_e49363.txt
4.2.1.11,"...28	3869.75	1.75	G	COG0148	eno	K01689, enolase [EC:4.2.1.11]",326,67,PLoS_One_2012_Dec_7_7(12)_e50777.txt
3.5.3.19,3.5.3.19	Ureidoglycolate hydrolase	1,95,1,PLoS_One_2013_Feb_13_8(2)_e56686.txt
EC 4.2.1.3,...te synthase (EC 2.3.3.1) and aconitate hydratase (EC 4.2.1.3) are involved in the glyoxylate shunt w...,168,223,PLoS_One_2013_Feb_13_8(2)_e56686.txt
EC 3.2.1.1,"...D-glucan glucohydrolase) from Aspergillus oryzae (EC 3.2.1.1, MW = 52.4×103, Sigma, Cat. No. 10065) ...",97,137,PLoS_One_2013_Feb_25_8(2)_e57432.txt
3.5.3.1,...n our data. Arginine is degraded via arginase (EC.3.5.3.1) and ornithine aminotransferase (EC. 2.6.1...,127,442,PLoS_One_2013_Mar_12_8(3)_e58563.txt
EC 4.2.1.1,Carbonic anhydrase (EC 4.2.1.1) is a zinc-containing metalloenzyme tha...,20,21,PLoS_One_2013_Feb_25_8(2)_e56874.txt
2.3.3.10,Hydroxymethyl glutaryl CoA synthase	2.3.3.10	HMGS	7	4	5	1,125,37,PLoS_One_2013_May_8_8(5)_e62714.txt
EC 3.5.4.2,"...5.4.4), with slight ability to hydrolyze adenine (EC 3.5.4.2 - and see Discussion)",102,1774,PLoS_One_2013_Jun_18_8(6)_e66605.txt
2.9.3.2,... the microsatellite loci was assessed using FSTAT 2.9.3.2 [42]. FIS (inbreeding coefficient) for all...,46,894,PLoS_One_2013_Jul_2_8(7)_e66956.txt
3.5.1.2,...typic analyses were implemented through Arlequin v3.5.1.2 [21]. All statistical measures were consid...,34,820,PLoS_One_2013_Jul_5_8(7)_e67780.txt
2.6.1.1,"Aspartate aminotransferase, chloroplastic	K00811	2.6.1.1	2",112,50,PLoS_One_2013_Jul_29_8(7)_e70781.txt
3.13.3.474,...and Cognition 13 : 474 –479 doi: –10.1037/0278–7393.13.3.474,158,190,PLoS_One_2013_Jul_29_8(7)_e69937.txt
EC 3.1.4.3,"Phospholipase C (beta-hemolysin) (EC 3.1.4.3), truncated	SAKer_01914	×	×	×",131,35,PLoS_One_2013_Aug_20_8(8)_e72803.txt
EC 1.14.18.1,Tyrosinase (EC 1.14.18.1) is a copper-containing oxidase with ...,12,13,PLoS_One_2013_Aug_21_8(8)_e70090.txt
3.16.12.113,...Microbe Interact 16 : 1135 -1144 .10.1094/MPMI.2003.16.12.1135 PubMed: 1465134714651347,184,258,PLoS_One_2013_Aug_30_8(8)_e73091.txt
EC 5.4.2.2,"...carp hawthorn (S7), including phosphoglucomutase [EC 5.4.2.2], UGPase (UDP–glucose pyrophosphorylase...",126,504,PLoS_One_2013_Sep_5_8(9)_e72910.txt
EC 2.4.1.43,"...pressions of alpha-1,4-galacturonosyltransferase [EC 2.4.1.43], beta-fructofuranosidase [EC 3.2.1.26...",126,767,PLoS_One_2013_Sep_5_8(9)_e72910.txt
1.14.19.-,FAD7	Δ15(ω3)-Desaturase (chloroplast)	EC:1.14.19.-	5,106,42,PLoS_One_2013_Sep_11_8(9)_e74441.txt
3.8.3.392,...Hum Percept Perform 8 : 392 -406 .10.1037/0096-1523.8.3.392 PubMed: 62126306212630,388,157,PLoS_One_2013_Sep_18_8(9)_e72888.txt
3.81.4.497,...n . J Educ Psychol 81 : 497 –506 .10.1037/0022-0663.81.4.49,228,142,PLoS_One_2013_Sep_23_8(9)_e74972.txt
4.1.1.58,...ession analysis was performed using Array Studio v4.1.1.58 [23]. Differentially expressed genes are ...,44,857,PLoS_One_2013_Sep_27_8(9)_e75607.txt
EC 1.2.1.51,"...performed by a pyruvate:NADP oxidoreductase (PNO, EC 1.2.1.51) [10], [11] or pyruvate:formate lyase ...",14,684,PLoS_One_2013_Sep_27_8(9)_e69532.txt
EC 1.14.19.3,"...) for lipogenesis; Δ6 fatty acyl desaturase (D6D; EC 1.14.19.3), elongation of very long chain fatty...",64,3103,PLoS_One_2013_Oct_4_8(10)_e76570.txt
4.75.6.160,...Pers Soc Psychol 75 : 1604 -1613 .10.1037/0022-3514.75.6.1604 PubMed: 99146699914669,346,179,PLoS_One_2013_Oct_9_8(10)_e75701.txt
EC 2.3.1.85,"...e (ACC, EC 6.4.1.2) and fatty acid synthase (FAS, EC 2.3.1.85) [36]. In addition, we determined the ...",18,995,PLoS_One_2013_Oct_10_8(10)_e77569.txt
1.13.99.1,Unigene23754	1.39 	9.79 	Inositol oxygenase [EC:1.13.99.1] (K00469)	Inositol phosphate metabolism ...,190,49,PLoS_One_2013_Oct_10_8(10)_e77217.txt
EC 2.1.3.6,"...t step, catalyzed by putrescine transcarbamylase (EC 2.1.3.6, AguB), is the phosphorolysis of carbam...",16,772,PLoS_One_2013_Oct_14_8(10)_e76170.txt
EC 1.10.3.1,"Polyphenol oxidases (PPOs, EC 1.10.3.1) are type-3 copper enzymes (Figure 1A)...",12,28,PLoS_One_2013_Oct_21_8(10)_e77291.txt
3.5.1.2,...re population using the Arlequin program version v3.5.1.2 [39],37,739,PLoS_One_2013_Oct_25_8(10)_e71742.txt
EC 3.1.3.2,"Tartrate-resistant acid phosphatase (TRAP; EC 3.1.3.2), which is also called type 5 acid phos...",16,44,PLoS_One_2013_Nov_4_8(11)_e78612.txt
3.5.1.3,"...ar variance (AMOVA, [27]) implemented in Arlequin 3.5.1.3 [28] to partition genetic variation across...",67,86,PLoS_One_2013_Nov_5_8(11)_e79807.txt
2.13.5.232,...c J Cancer Prev 13 : 2329 -2334 .10.7314/APJCP.2012.13.5.2329 PubMed: 2290121622901216,117,196,PLoS_One_2013_Nov_12_8(11)_e80426.txt
EC 1.5.99.12,"...g of genes encoding cytokinin dehydrogenase (CKX; EC 1.5.99.12), a key enzyme in the regulation of c...",16,230,PLoS_One_2013_Nov_15_8(11)_e79029.txt
3.5.1.2,...ular variance (AMOVA) as implemented in ARLEQUIN v3.5.1.2 [28]. Loci which were putatively either ne...,110,107,PLoS_One_2013_Nov_18_8(11)_e79043.txt
4.1.1.33,Diphosphomevalonate Decarboxylase	Erg19	4.1.1.33	45181	190±52 (PPMVA)	2.8±0.5	15–60,59,41,PLoS_One_2013_Nov_20_8(11)_e79650.txt
2.27.7.761,.... J Korean Med Sci 27 : 761 -766 .10.3346/jkms.2012.27.7.761 PubMed: 2278737122787371,242,250,PLoS_One_2013_Dec_2_8(12)_e82005.txt
EC 1.14.16.2,"...contrast to the well-known tyrosine hydroxylases (EC 1.14.16.2) and tyrosinases (EC 1.14.18.1), LmbB...",9,730,PLoS_One_2013_Dec_4_8(12)_e79974.txt
EC 3.5.1.42,...zyme nicotinamide mononucleotide (NMN) deamidase (EC 3.5.1.42) catalyzes the conversion of NMN to ni...,12,57,PLoS_One_2013_Dec_5_8(12)_e82705.txt
2.20.4.41,"G2-3	4	0.77[0.38,1.59]		8	3.31[2.20.4.41]		12	3.57[2.59,4.55]		5	3.85[2.64,5.05]	...",121,32,PLoS_One_2013_Dec_6_8(12)_e80890.txt
2.13.2.411,...Pac J Cancer Prev 13 : 411 -420 .10.7314/APJCP.2012.13.2.411 PubMed: 2252479922524799,217,219,PLoS_One_2013_Dec_12_8(12)_e82519.txt
1.5.2.2,1.5.2.2_Pyrimidine_biosynthesis_,90,1,PLoS_One_2013_Dec_23_8(12)_e84027.txt
EC 1.14.13.70,"...cterization of obtusifoliol 14-alpha-demethylase (EC 1.14.13.70, 7 unigenes) of CYP51 family from So...",150,638,PLoS_One_2013_Dec_23_8(12)_e83336.txt
EC 2.4.1.91,"... unigenes), and flavonol-3-O-glucosyltransferase (EC 2.4.1.91, 46 unigenes). Presence of such glycos...",157,305,PLoS_One_2013_Dec_23_8(12)_e83336.txt
EC 2.2.1.1,"...us strains, appeared to code for a transketolase (EC 2.2.1.1) that interconnects the glycolysis and ...",139,570,PLoS_One_2013_Dec_30_8(12)_e83418.txt
EC 2.4.2.19,"... quinolinate phosphoribosyltransferase (hQPRTase; EC 2.4.2.19, CATH domain: 1qprF02), (B) α-galactos...",90,112,PLoS_One_2014_Jan_8_9(1)_e84623.txt
1.5.1.20,6	B	metF	1.5.1.20	Methylenetetrahydrofolate reductase	5-met...,88,10,PLoS_One_2014_Jan_15_9(1)_e85195.txt
5.3.1.13,83	Y	ksdD	5.3.1.13	Arabinose-5-phosphate isomerase	D-Arabino...,172,11,PLoS_One_2014_Jan_15_9(1)_e85195.txt
EC 2.4.99.16,"...ears: GH13 maltosyl-transferring starch synthase (EC 2.4.99.16) [3], GH65 nigerose phosphorylase (EC...",42,431,PLoS_One_2014_Jan_22_9(1)_e86548.txt
3.4.93.96,"...-35-033), the Netherlands Asthma Foundation (NAF, 3.4.93.96.3), GlaxoSmithKline of The Netherlands, ...",19,140,PLoS_One_2014_Feb_5_9(2)_e87443.txt
1.14.11.19,Leucoanthocyanidin dioxygenase	EC:1.14.11.19	LDOX	3	3	-	FV5G01390,179,35,PLoS_One_2014_Feb_5_9(2)_e88292.txt
1.2.3.4,"...5951, 06037, 06327	Germin-like oxalate oxidase	EC:1.2.3.4",180,73,PLoS_One_2014_Feb_10_9(2)_e86399.txt
EC 1.1.1.17,Fructose and mannose metabolism	DSB	EC 1.1.1.17: 5-dehydrogenase,139,37,PLoS_One_2014_Feb_18_9(2)_e88689.txt
EC 1.1.1.8,LAC	EC 1.1.1.8: dehydrogenase (NAD+),153,6,PLoS_One_2014_Feb_18_9(2)_e88689.txt
EC 3.2.1.83,"....207), agarase (EC 3.2.1.81), kappa-carrageenase (EC 3.2.1.83), endo-β-1,3-glucanase (EC 3.2.1.39), ...",336,394,PLoS_One_2014_Feb_18_9(2)_e88689.txt
3.1.-.-,"... In these cases (Table 3, common sources 2.3.1.-, 3.1.-.-, 3.2.1.18, 4.2.2.- and 6.-.-.-), if the cl...",214,678,PLoS_One_2014_Feb_19_9(2)_e89162.txt
2.3.1.-,2.3.1.-	0.07	0.91	0.88	0.89	0.87	J48	5	2,247,1,PLoS_One_2014_Feb_19_9(2)_e89162.txt
EC 1.13.11.12,"...lipoxidase from Glicine max (L.) Merr. (type V-S; EC 1.13.11.12), as well as degranulation stimuli, ...",26,162,PLoS_One_2014_Feb_28_9(2)_e90122.txt
EC 1.1.1.158,"..., for example UDP-N-acetylmuramate dehydrogenase (EC 1.1.1.158) is involved in peptoglycan metabolis...",157,155,PLoS_One_2014_Mar_11_9(3)_e89618.txt
EC 5.1.3.6,...	AT3G23820	0.45798	UDP-glucuronate 4-epimerase 6 (EC 5.1.3.6) (UDP-glucuronic acid epimerase 6) (AtU...,144,57,PLoS_One_2014_Mar_11_9(3)_e91814.txt
EC 3.2.1.22,"... also found genes encoding GH27 (α-galactosidase, EC 3.2.1.22), GH31 (α-glucosidase, EC 3.2.1.20), a...",34,595,PLoS_One_2014_Apr_9_9(4)_e94052.txt
EC 3.5.1.19,"...te genome encodes for a nicotinamidase (PFC0910w, EC 3.5.1.19), nicotinate phosphoribosyltransferase...",29,322,PLoS_One_2014_Apr_18_9(4)_e94061.txt
EC 2.7.7.18,"...te mononucleotide adenylyltransferase (PF13_0159, EC 2.7.7.18), and NAD+ synthase (PFI1310w, EC 6.3....",29,456,PLoS_One_2014_Apr_18_9(4)_e94061.txt
1.14.11.9,...eaf and root. [EC:2.3.1.74] chalcone synthase [EC:1.14.11.9] naringenin 3-dioxygenase [EC:1.14.13.21...,232,111,PLoS_One_2014_May_21_9(5)_e97487.txt
4.84.1.60,...Social Psychology 84 : 60 –79 doi:10.1037/0022-3514.84.1.60 12518971,161,158,PLoS_One_2014_Aug_1_9(8)_e104086.txt
EC 2.7.9.1,...nsis sporophytes and pyruvate phosphate dikinase (EC 2.7.9.1) in Pyropia (Porphyra) yezoensis were n...,147,326,PLoS_One_2014_Sep_25_9(9)_e108488.txt
4.81.5.800,...ers Soc Psychol 81 : 800 –814 doi:10.1037/0022-3514.81.5.800 11708558,134,216,PLoS_One_2014_Nov_3_9(11)_e110149.txt
EC 3.5.1.108,...trates. The product is then deacetylated by LpxC (EC 3.5.1.108) in an essentially irreversible react...,48,204,PLoS_One_2015_Apr_28_10(4)_e0121216.txt
2.9.3.2,...cus equilibrium were examined using FSTAT version 2.9.3.2 [30]. Significance level (0.05) for single...,103,111,PLoS_One_2015_Oct_16_10(10)_e0139832.txt
4.51.6.117,...ol . 1986 ;51 : 1173 –1182 . doi: 10.1037/0022-3514.51.6.1173,245,226,PLoS_One_2015_Oct_14_10(10)_e0140296.txt
EC 2.6.1.44,"...ase, EC 1.4.3.3, alanine-glyoxylate transaminase, EC 2.6.1.44) were downregulated resulting in high ...",107,1121,PLoS_One_2015_Oct_13_10(10)_e0140047.txt
3.7.1.8,...3.1; 1.14.13.172; 1.14.13.-; 2.1.1.274; 3.1.1.55; 3.7.1.8; 4.1.1.91; 4.1.1.-; 4.2.99.21,379,94,PLoS_One_2015_Oct_1_10(10)_e0139467.txt
4.1.2.13,Aldoa	aldolase a (muscle type)	4.1.2.13	TCAAGTCCAAGGGTGGTGTT	TGGGTAGTTGTCTCGCCATT...,54,32,PLoS_One_2015_Oct_1_10(10)_e0139502.txt
2.1.1.76,...279	E2.1.1.76; flavonol 3-O-methyltransferase	[EC:2.1.1.76]	00944 Flavone and flavonol biosynthesis,167,72,PLoS_One_2015_Oct_20_10(10)_e0140507.txt
5.2.3.4,"... per the stepdown rules of Bookstein. ([33], Sec. 5.2.3.4) Although the computation of these relativ...",47,1744,PLoS_One_2015_Aug_26_10(8)_e0133303.txt
4.2.1.-,-2	EC:4.2.1.-	-	CR3_0877 CR3_0878	/,111,8,PLoS_One_2015_Aug_24_10(8)_e0132881.txt
4.12.2.103,...on . 1994 ;12 (2 ):103 –28 . doi: 10.1521/soco.1994.12.2.103,206,246,PLoS_One_2015_Aug_19_10(8)_e0135944.txt
4.21.2.99,... Metab . 2014 ;21 :99 –116 . doi: 10.11005/jbm.2014.21.2.99,200,169,PLoS_One_2015_Aug_10_10(8)_e0135285.txt
2.53.10.699,...Urol . 2012 ; 53 : 699 –704 . doi: 10.4111/kju.2012.53.10.699,140,240,PLoS_One_2015_Aug_5_10(8)_e0134589.txt
2.24.4.377,... Prev . 2012 ;24 : 377 –87 . doi: 10.1521/aeap.2012.24.4.377,218,230,PLoS_One_2015_Aug_3_10(8)_e0134667.txt
EC 5.1.1.1,"Alanine racemase (Alr, EC 5.1.1.1) is a fold-type III pyridoxal 5’-phosph...",13,24,PLoS_One_2015_Jul_28_10(7)_e0133516.txt
4.38.3.763,...ot Ski . 1974 ;38 :763 –766 . doi: 10.2466/pms.1974.38.3.763,239,177,PLoS_One_2015_Jul_20_10(7)_e0132732.txt
2.2.1.3,"310 Rasnitsyn AP . 2.2.1.3.1. Superorder Palaeomanteidea Handlirsch, ...",536,20,PLoS_One_2015_Jul_15_10(7)_e0128554.txt
3.1.1.45,doi: 10.2217/17520363.1.1.45,347,21,PLoS_One_2015_Jul_15_10(7)_e0132000.txt
4.74.6.159,...ol . 1998 ;74 : 1592 –1605 . doi: 10.1037/0022-3514.74.6.1592,457,170,PLoS_One_2015_Jul_10_10(7)_e0131316.txt
4.38.1.51,2014 ;38 :51 –57 . doi: 10.4093/dmj.2014.38.1.51,197,40,PLoS_One_2015_Jul_10_10(7)_e0131427.txt
4.44.2.143,2014 ;44 (2 ):143 –148 . doi: 10.5624/isd.2014.44.2.143  Epub 2014 Jun 11. .24944964,187,46,PLoS_One_2015_Jul_6_10(7)_e0132104.txt
EC 4.2.2.17,"... interface. DFA IIIases (EC 3.2.1.-) and IFTases (EC 4.2.2.17, and EC 4.2.2.18) were categorized as ...",105,277,PLoS_One_2015_Nov_10_10(11)_e0142640.txt
1.1.1.27,"...dehydrogenases transcripts of L. lactis, ldhA (EC:1.1.1.27) and dld (EC:1.1.2.4), were generally det...",145,190,PLoS_One_2015_Apr_13_10(4)_e0124360.txt
4.94.1.33,94 : 33 –43 . doi: 10.1094/PHYTO.2004.94.1.33,275,37,PLoS_One_2015_Mar_26_10(3)_e0120987.txt
1.52.4.12,"...al Research , 52 : http://dx.doi.org/10.3896/IBRA.1.52.4.1",177,71,PLoS_One_2015_Mar_23_10(3)_e0121143.txt
EC 1.10.3.2,...) phosphate as a substrate. Phenol oxidase (PhOx; EC 1.10.3.2) and peroxidase (POD; EC 1.11.1.7) act...,40,448,PLoS_One_2014_Jul_16_9(7)_e102315.txt
1.3.3.220,doi:10.1162/jocn.1991.3.3.220 23964837,322,21,PLoS_One_2014_Jul_24_9(7)_e103387.txt
1.5.3.1,"...rcosine oxidase/L-pipecolate oxidase [EC:1.5.3.7, 1.5.3.1]) (Figure S2, Table S7 in File S1). Only 1...",232,1407,PLoS_One_2014_Oct_22_9(10)_e110548.txt
1.1.1.195,"...0499623, CAD; cinnamyl-alcohol dehydrogenase, EC: 1.1.1.195, NCBI-GeneID: 100777558, CHI; chalconeis...",88,732,PLoS_One_2014_Nov_4_9(11)_e111930.txt
EC 2.5.1.18,"...nce process [29]. Glutathione S-transferase (GST, EC 2.5.1.18) is another important enzyme that is r...",20,116,PLoS_One_2014_Nov_7_9(11)_e112271.txt
1.1.1.1,Glycolysis Gluconeogenesis	1	dehydrogenase	ec:1.1.1.1	1	C6TH27	map00010,235,47,PLoS_One_2014_Nov_25_9(11)_e113907.txt
EC 2.4.2.12,"...QaPRT (EC 2.4.2.19), NaPRT (EC 2.4.2.11), NamPRT (EC 2.4.2.12), NRK (EC 2.7.1.22), NMNAT (EC 2.7.7.1...",18,490,PLoS_One_2014_Nov_25_9(11)_e113939.txt
1.1.1.100,"...H-dependent beta-ketoacyl-ACP reductase (KAR, EC: 1.1.1.100) to generate the beta-hydroxyacyl-ACP. N...",115,1072,PLoS_One_2014_Aug_19_9(8)_e104150.txt
1.14.19.2,"...terified to ACP via acyl-ACP desaturase (AAD, EC: 1.14.19.2). The elongation of fatty acids was term...",150,157,PLoS_One_2014_Aug_19_9(8)_e104150.txt
2.6.1.3,"...s underwent CMR on a 1.5 Tesla scanner (Intera R 12.6.1.3, Philips Medical Systems, Best, The Nether...",30,72,PLoS_One_2014_Oct_6_9(10)_e109164.txt
4.7.1.119,7 : 119 –126 . doi: 10.1037/0882-7974.7.1.119,90,37,PLoS_One_2015_Jan_14_10(1)_e0114624.txt
5.19.3.262,19 : 262 –282 . doi: 10.1521/pedi.2005.19.3.262,356,38,PLoS_One_2015_Jan_27_10(1)_e0117353.txt
1.16.3.497,16 : 497 –500 . doi: 10.1359/jbmr.2001.16.3.497,270,38,PLoS_One_2015_Feb_2_10(2)_e0116833.txt
EC 3.3.2.10,"Soluble epoxide hydrolase (sEH, EC 3.3.2.10) is the major enzyme responsible for t...",13,33,PLoS_One_2015_Feb_6_10(2)_e0117438.txt
3.5.1.2,...the sudden expansion model using Arlequin version 3.5.1.2 [23],38,364,PLoS_One_2015_Feb_11_10(2)_e0117069.txt
4.16.3.414,16 : 414 –426 . doi:10.1037//0882-7974.16.3.414,248,38,PLoS_One_2015_Feb_18_10(2)_e0117196.txt
4.18.6.509,38/39 : 372 –394 . doi: 10.4196/kjpp.2014.18.6.509,423,41,PLoS_One_2015_Feb_18_10(2)_e0116830.txt
EC 1.97.1.12,...ing reduced ferredoxin produced by photosystem I (EC 1.97.1.12) to nitrite reduction via NiR. Follow...,130,1725,PLoS_One_2015_Feb_23_10(2)_e0116536.txt
EC 3.1.3.26,... control supplemented with 5000 FTU of 6-phytase (EC 3.1.3.26) per 1kg of complete fee,160,240,PLoS_One_2015_Mar_17_10(3)_e0119770.txt
2.47.4.260,...tol .2012 ;47 (4 ):260 –266 . doi: 10.5045/kjh.2012.47.4.260,190,237,PLoS_One_2015_Mar_20_10(3)_e0120734.txt
2.2.2.182,"...y and analysis (version 3.1 for entry and version 2.2.2.182 for analysis, EpiData Association, Odens...",56,89,PLoS_One_2015_Apr_24_10(4)_e0123286.txt
1.1.1.195,cinnamyl-alcohol dehydrogenase	1.1.1.195	comp20951_c0	31.67,204,32,PLoS_One_2015_May_4_10(5)_e0125722.txt
2.13.6.684,...iol . 2012 ;13 (6 ):684 –93 . doi: 10.3348/kjr.2012.13.6.684  ; PubMed Central PMCID: PMCPMC3484288....,195,342,PLoS_One_2015_May_6_10(5)_e0125943.txt
2.9.3.2,...ding coefficients (FIS) were estimated in FSTAT v.2.9.3.2 [65]. Sibship among females within nest ag...,77,546,PLoS_One_2015_May_7_10(5)_e0125719.txt
2.6.2.172,2012 ;6 (2 ):172 –187 . doi: 10.5009/gnl.2012.6.2.172,135,45,PLoS_One_2015_May_11_10(5)_e0126499.txt
4.2.1.-,"....100); HAD, 3R-hydroxymyristoyl ACP dehydrase (EC:4.2.1.-); EAR, enoyl-ACP reductase I (EC:1.3.1.9);...",108,331,PLoS_One_2015_May_12_10(5)_e0126250.txt
2.4.1.84,4 : 84 –97 . doi: 10.1162/neco.1992.4.1.84,354,35,PLoS_One_2015_May_13_10(5)_e0126629.txt
1.46.8.206,46 : 2061 –2066 . doi: 10.4319/lo.2001.46.8.2061,151,38,PLoS_One_2015_May_21_10(5)_e0125059.txt
1.1.1.86,Ketol-acid reductoisomerase	1.1.1.86	Unitig_16373	18.3	-,138,31,PLoS_One_2015_May_22_10(5)_e0126751.txt
EC 1.11.1.9,GPx (EC 1.11.1.9) activity was measured according to We...,55,6,PLoS_One_2015_May_26_10(5)_e0126606.txt
3.74.2.166,...chol . 1983 ;74 : 166 –169 . doi: 10.1037/0022-0663.74.2.166,356,158,PLoS_One_2015_Jun_1_10(6)_e0127650.txt
3.28.3.348,doi: 10.3346/jkms.2013.28.3.348,158,22,PLoS_One_2015_Jun_3_10(6)_e0129819.txt
5.18.2.212,...logy . 2004 ;18 : 212 –218 . doi: 10.1037/0894-4105.18.2.212,183,251,PLoS_One_2015_Jun_3_10(6)_e0129863.txt
5.18.2.212,...logy . 2004 ;18 : 212 –218 . doi: 10.1037/0894-4105.18.2.212,183,251,PLoS_One_2015_Jun_3_10(6)_e0129863.txt
2.62.3.260,2012 ; 62 : 260 –265 . doi: 10.4097/kjae.2012.62.3.260,243,45,PMC5167547.txt
EC 3.2.1.23,... MgCl2). 10 units of lyophilized β-galactosidase (EC 3.2.1.23) were added to the solution. The mixtu...,31,270,PLoS_One_2015_Jun_4_10(6)_e0128190.txt
3.99.4.715,...hology . 2007 ;99 :715 –33 . doi: 10.1037/0022-0663.99.4.715,251,206,PLoS_One_2015_Jun_8_10(6)_e0129630.txt
6.9.4.587,...rapy . 2008 ;9 (4 ):587 –99 . doi: 10.1517/14656566.9.4.587  .18312160,164,164,PLoS_One_2015_Jun_16_10(6)_e0129691.txt
3.28.3.322,...ine . 2013 ;28 (3 ):322 –9 . doi: 10.3904/kjim.2013.28.3.322  ; PubMed Central PMCID: PMC3654130.236...,227,195,PLoS_One_2015_Jun_19_10(6)_e0130412.txt
2.9.3.2,... (P99). The softwares Genodive 2.0 [54] and FSTAT 2.9.3.2 [55] were used to estimate the effective n...,99,508,PLoS_One_2015_Jun_24_10(6)_e0131298.txt
3.1.1.3,"...nzymes. The triacylglycerol acyl hydrolases (E.C. 3.1.1.3) hydrolyze carboxylic ester bonds, releasi...",13,378,PLoS_One_2015_Jun_25_10(6)_e0131624.txt
EC 4.2.1.2,"...omutase, PGM, EC 5.4.2.2; fumarate hydratase, FH, EC 4.2.1.2; mannose phosphate isomerase, MPI, EC 5...",162,568,PLoS_One_2015_Jun_26_10(6)_e0129418.txt
EC 3.5.4.27,"...gned EC) were added. These changes, together with EC 3.5.4.27 already present in the metamodel, cons...",105,1110,PLoS_One_2015_Dec_2_10(12)_e0143626.txt
4.19.2.97,...on . 2014 ;19 (2 ):97 –102 . doi: 10.15430/JCP.2014.19.2.97  ; PubMed Central PMCID: PMC4204162.2533...,300,170,PLoS_One_2015_Dec_7_10(12)_e0141392.txt
3.2.1.91,"...ydrolases (CBHIs, E.C. 3.2.1.176 and CBHIIs, E.C. 3.2.1.91) and β-glucosidases (BGLs, E.C. 3.2.1.21)...",13,592,PLoS_One_2015_Dec_14_10(12)_e0145166.txt
3.15.3.128,... ):128 –34 . Epub 2014/01/08. doi: 10.5853/jos.2013.15.3.128  ; PubMed Central PMCID: PMC3859004.243...,120,156,PLoS_One_2016_Jan_22_11(1)_e0145224.txt
2.7.13.3,Sensor protein 3	2.7.13.3	Transferase	phosphorus,366,18,PLoS_One_2016_Jan_22_11(1)_e0146796.txt
1.1.1.1,2	Cyprus	1.1.1.1.1.1.1.5 1412	1.1.1.1.1.1.1.6 6.1	1.1.1.1.1...,60,10,PLoS_One_2016_Jan_26_11(1)_e0146101.txt
1.1.1.32,9	Dead Sea	1.1.1.1.1.1.1.31 341	1.1.1.1.1.1.1.32 5.2	1.1.1.1.1.1.1.33 3.5	1.1.1.1.1.1.1.34...,67,41,PLoS_One_2016_Jan_26_11(1)_e0146101.txt
4.94.10.105,.... 2004 ;94 (10 ):1056 –60 . doi: 10.1094/PHYTO.2004.94.10.1056,317,287,PLoS_One_2016_Feb_3_11(2)_e0147221.txt
1.2.1.68,"...dase (EC:3.2.1.21) and aldehyde dehydrogenase (EC:1.2.1.68, ALDH) genes, showed significant changes ...",73,411,PLoS_One_2016_Feb_5_11(2)_e0148535.txt
2.5.1.113,...tion . 2005 ;5 (1 ):113 –8 . doi: 10.1037/1528-3542.5.1.113  ISI:000227768200010. 15755224,103,168,PLoS_One_2016_Feb_9_11(2)_e0148621.txt
3.45.4.351,...rapy . 2013 ;45 (4 ):351 –66 . doi: 10.3947/ic.2013.45.4.351  ; PubMed Central PMCID: PMC3902818.244...,385,179,PLoS_One_2016_Mar_18_11(3)_e0150320.txt
EC 3.1.1.34,"...ion pathway, the pathway hole for the reaction of EC 3.1.1.34 was modified to EC 3.1.1.79 and filled...",147,572,PLoS_One_2016_Mar_18_11(3)_e0150974.txt
EC 3.4.11.7,...glutamyl (aspartyl) specific aminopeptidase PepA (EC 3.4.11.7) [11]. The PepA is a metal-dependent e...,13,2327,PLoS_One_2016_Mar_22_11(3)_e0152139.txt
EC 1.4.3.3,...glycine was obtained by using recombinant RgDAAO (EC 1.4.3.3) and recombinant BsGO (EC 1.4.3.19) whi...,57,91,PLoS_One_2016_Mar_22_11(3)_e0151233.txt
1.5.2.8,"...s (including 1.2.0.18, 1.2.2.5, 1.3.0.5, 1.4.1.2, 1.5.2.8 and 1.5.3.8) of MaxQuant results for both ...",46,533,PLoS_One_2016_Mar_22_11(3)_e0152067.txt
1.3.5.1,"...present enzymes identified in proteomic analysis. 1.3.5.1 –Succinate dehydrogenase, 4.2.1.3 –Aconita...",70,453,PLoS_One_2016_Mar_29_11(3)_e0152382.txt
1.14.4.314,...ncer . 2011 ; 14 : 314 –321 . doi: 10.4048/jbc.2011.14.4.314,324,153,PLoS_One_2016_Mar_31_11(3)_e0152312.txt
EC 5.1.99.4,Alpha-methylacyl-CoA racemase (EC 5.1.99.4),119,36,PLoS_One_2016_Apr_1_11(4)_e0150413.txt
4.20.2.242,... Motil . 2014 ;20 : 242 –52 . doi: 10.5056/jnm.2014.20.2.242,308,165,PLoS_One_2016_Apr_26_11(4)_e0154258.txt
3.87.1.85,...ase . 2003 ;87 (1 ):85 –90 . doi: 10.1094/PDIS.2003.87.1.8,167,187,PLoS_One_2016_May_3_11(5)_e0154712.txt
2.1.3.2,"...ion: Assessing the Fit of Responses, FW7 ENV.2009.2.1.3.2) provided financial support. Data Availabi...",9,496,PLoS_One_2016_May_12_11(5)_e0155193.txt
3.5.1.2,...leotide diversity [52] per population in Arlequin 3.5.1.2 [53],56,355,PLoS_One_2016_May_19_11(5)_e0150991.txt
6.18.7.152,doi: 10.1162/neco.2006.18.7.1527,275,22,PLoS_One_2016_Jun_7_11(6)_e0155781.txt
1.1.59.285,...tp://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.59.285,163,53,PLoS_One_2016_Jun_28_11(6)_e0157636.txt
2.6.3.2,"...cated workstation (Extended MR WorkSpace, release 2.6.3.2; Philips Medical Systems, Best, Netherland...",83,114,PLoS_One_2016_Jul_13_11(7)_e0159047.txt
1.3.1.71,...ence . 1991 ;3 (1 ):71 –86 . doi: 10.1162/jocn.1991.3.1.71,278,133,PLoS_One_2016_Jul_14_11(7)_e0159084.txt
2.9.3.2,"...locus independent of sample size using FSTAT ver. 2.9.3.2 [74, 75]. FSTAT was also used to test for ...",83,122,PLoS_One_2016_Jul_21_11(7)_e0159545.txt
4.29.5.729,...p . 2014 ; 29 (5 ): 1149 –53 . doi: 10.3305/nh.2014.29.5.7299,182,138,PLoS_One_2016_Aug_5_11(8)_e0160480.txt
3.93.4.485,.... 2003 ; 93 (4 ):485 –492 . doi: 10.1094/PHYTO.2003.93.4.485,275,191,PLoS_One_2016_Aug_5_11(8)_e0160328.txt
1.14.99.45,"LUT1, CYP97C1; carotene epsilon-monooxygenase [EC:1.14.99.45]	/	/	/	/	/	/",51,51,PLoS_One_2015_Oct_20_10(10)_e0140609.txt
3.23.2.152,...(2 ):152 –61 . http://dx.doi.org/10.4332/KJHPA.2013.23.2.152,274,171,PLoS_One_2016_Aug_25_11(8)_e0161937.txt
EC 3.4.24.11,Overexpression of kidney neutral endopeptidase (EC 3.4.24.11) and renal function in experimental c...,358,49,PLoS_One_2016_Sep_16_11(9)_e0162644.txt
2.5.2.283,...rapy . 2007 ;5 (2 ):283 –94 . doi: 10.1586/14779072.5.2.283,179,177,PLoS_One_2016_Sep_22_11(9)_e0162487.txt
2.3.3.1,...47730	Chicken breast	New Mexico (USA)	2013	152	15	2.3.3.1,112,56,PLoS_One_2016_Oct_3_11(10)_e0161225.txt
2.4.1.1,...N43448	Chicken wings	California (USA)	2013	152	15	2.4.1.1,128,55,PLoS_One_2016_Oct_3_11(10)_e0161225.txt
6.18.4.665,...ci . 2006 ;18 (4 ):665 –79 . doi: 10.1162/jocn.2006.18.4.665,234,211,PLoS_One_2016_Oct_6_11(10)_e0158446.txt
6.18.7.113,...ci . 2006 ;18 : 1133 –1146 . doi: 10.1162/jocn.2006.18.7.1133,307,181,PLoS_One_2016_Oct_6_11(10)_e0164024.txt
1.29.1.1,"...Cognition , 29 (1 ), 1 –14 . doi: 10.1521/soco.2011.29.1.1",352,210,PLoS_One_2016_Oct_6_11(10)_e0160747.txt
4.53.1.1,...stica . 2007 ;53 (1 ):1 –2 . doi: 10.1026/0012-1924.53.1.1,275,148,PLoS_One_2016_Oct_20_11(10)_e0163101.txt
6.18.8.138,...i . 2006 ;18 (8 ):1380 –93 . doi: 10.1162/jocn.2006.18.8.1380,368,236,PLoS_One_2016_Oct_31_11(10)_e0163938.txt
EC 2.3.1.74,Os07g0526400	Chalcone synthase (EC 2.3.1.74).		OsCHS,135,33,PLoS_One_2016_Nov_7_11(11)_e0165732.txt
5.29.4.441,...alia . 1965 ;29 : 441 –445 . doi: 10.1515/mamm.1965.29.4.441,140,117,PLoS_One_2016_Nov_8_11(11)_e0166024.txt
4.91.1.154,...chol . 2006 ;91 : 154 –170 . doi: 10.1037/0022-3514.91.1.154,221,204,PLoS_One_2016_Nov_15_11(11)_e0166116.txt
5.30.3.263,"...ul, Korea) . 30 (3 ):263 –9 . doi: 10.3803/EnM.2015.30.3.263 26435131",169,117,PLoS_One_2016_Nov_18_11(11)_e0166597.txt
2.17.1.179,doi: 10.1359/jbmr.2002.17.1.179,239,22,PLoS_One_2016_Nov_28_11(11)_e0165462.txt
3.2.1.23,"...ases are classified by the Enzyme Commission as EC3.2.1.23/108. They hydrolyze terminal, non-reducin...",34,63,PLoS_One_2016_Dec_8_11(12)_e0168035.txt
2.3.3.239,...otion . 2003 ;3 : 239 –253 . doi: 10.1037/1528-3542.3.3.239,280,172,PMC5207701.txt
5.22.3.383,...logy . 2008 ;22 : 383 –389 . doi: 10.1037/0894-4105.22.3.383,284,200,PMC5207728.txt
3.7.2.122,...ng . 2013 ;7 (2 ):122 –131 . doi: 10.5626/JCSE.2013.7.2.122,350,223,PMC5218471.txt
2.2.2.501,...ducible measurements (Aperio ImageScope program v12.2.2.5015) of tissue markers were obtained includ...,71,740,PMC5224992.txt
3.1.9.2,"...mple size calculation was performed using G*power 3.1.9.2, with α set at 0.05, power at 0.80 and eff...",74,53,PMC5249240.txt
4.4.1.89,...ines . 2005 ;4 (1 ):89 –101 . doi: 10.1586/14760584.4.1.89,264,151,PMC5279777.txt
2.5.1.1,...ellipsoidea)	Dimethylallyltranstransferase	2.5.1; 2.5.1.1,108,153,PMC5289490.txt
5.17.1.31,...troke . 2015 ;17 (1 ):31 –7 . doi: 10.5853/jos.2015.17.1.31,249,135,PMC5289565.txt
2.10.7.110,10 : 1103 –1111 . doi: 10.1200/jco.1992.10.7.1103,299,39,PMC5293254.txt
4.23.3.22,...3 (3 ):377 –84 .PM:25164447 doi: 10.6133/apjcn.2014.23.3.22,282,58,PMC5312963.txt
EC 2.7.1.4,...vely catabolized in the liver where fructokinase (EC 2.7.1.4) and aldolase (EC 4.1.2.13) split fruct...,172,640,PMC5313224.txt
4.6.1.3,"...aplotype network was also constructed in NETWORK v4.6.1.3 [61], using the TCS algorithm and the MP o...",103,221,PMC5336229.txt
3.1.3.11,"3.1.3.11	fructose-1,6-bisphosphate	fructose-1,6-bi...",84,1,PLoS_ONE_2007_May_23_2(5)_e456.txt
1.1.1.2,1.1.1.2. Eliminate all potential cross-hybridizati...,221,1,PLoS_ONE_2007_Oct_3_2(10)_e988.txt
EC 4.2.1.12,"...les S4, S5). Edd (6-phosphogluconate dehydratase, EC 4.2.1.12) is involved in the carbon flow from g...",220,480,PLoS_ONE_2008_Feb_27_3(2)_e1685.txt
EC 3.6.5.5,DNM1L_MOUSE (Q8K1M6)	Dynamin-1-like protein (EC 3.6.5.5) (Dynamin-related protein 1) (Dynamin f...,240,46,PLoS_ONE_2008_Jul_23_3(7)_e2750.txt
1.2.4.1,Pyruvate dehydrogenase E1 alpha subunit	acoA	1.2.4.1	Pro1362,86,46,PLoS_ONE_2008_Oct_20_3(10)_e3416.txt
EC 2.3.1.-,"... 1.14.13.-, EC 4.1.3.39, EC 4.2.1.17, EC 1.1.1.-, EC 2.3.1.-) are also implicated in other conserved...",44,143,PLoS_ONE_2009_Apr_23_4(4)_e5276.txt
EC 1.15.1.1,...se reactive oxygen species. Superoxide dismutase (EC 1.15.1.1) converts superoxide to molecular oxyg...,8,554,PLoS_ONE_2006_Dec_20_1(1)_e70.txt
2.9.3.2,...ested using permutation test implemented in FSTAT 2.9.3.2. The nominal P-value of 0.05 was adjusted ...,158,483,PLoS_Pathog_2010_Dec_16_6(12)_e1001229.txt
2.2.1.2,"...etected in both avian and human isolates in clade 2.2.1.2 and clade 2.2.1-B, respectively. All clade...",103,645,PLoS_Pathog_2016_Apr_20_12(4)_e1005583.txt
1.5.1.62,...(Roche LightCycler 480 software; Software release 1.5.1.62). Reference genes and external standards ...,180,954,PLoS_Pathog_2016_Jun_14_12(6)_e1005660.txt
3.18.4.280,...iety of Food Science and Nutrition 10.3746/pnf.2013.18.4.280pnf018-04-09ArticlesAssociation between ...,3,156,Prev_Nutr_Food_Sci_2013_Dec_18(4)_280-286.txt
6.21.2.110,...iety of Food Science and Nutrition 10.3746/pnf.2016.21.2.110pnfs-21-110ArticlesAntioxidant Contents ...,3,156,Prev_Nutr_Food_Sci_2016_Jun_30_21(2)_110-116.txt
2.17.4.239,...Food Science and Nutrition 2447109110.3746/pnf.2012.17.4.239e1fsa3_2012_v17n4_239ArticlesHypoglycemi...,3,182,Prev_Nutr_Food_Sci_2012_Dec_17(4)_239-244.txt
5.20.2.110,...iety of Food Science and Nutrition 10.3746/pnf.2015.20.2.110pnfs-20-110ArticlesPhysicochemical Prope...,3,156,Prev_Nutr_Food_Sci_2015_Jun_30_20(2)_110-118.txt
5.20.2.88,...iety of Food Science and Nutrition 10.3746/pnf.2015.20.2.88pnfs-20-88ArticlesHypoglycemic Effect of ...,3,156,Prev_Nutr_Food_Sci_2015_Jun_30_20(2)_88-93.txt
3.33.3.705,"33 , 705 –715 10.1037/0096-1523.33.3.705  (doi:10.1037/0096-1523.33.3.705",152,31,Proc_Biol_Sci_2013_Aug_7_280(1764)_20131049.txt
EC 1.3.5.1,...functions as succinate-ubiquinone reductase (SQR; EC 1.3.5.1) and is also an important enzyme in the...,12,291,Proc_Jpn_Acad_Ser_B_Phys_Biol_Sci_2009_Jul_85(7)_258-265.txt
3.74.3.391,...on J Periodontol 2003 15 3 391 401 10.1902/jop.2003.74.3.391 12710761,161,162,Prog_Orthod_2014_Apr_1_15(1)_30.txt
1.41.3.200,...hy Korean J Orthod 2011 41 200 10 10.4041/kjod.2011.41.3.200,191,244,Prog_Orthod_2016_Jan_8_17_1.txt
EC 4.2.2.2,Pectate lyases (EC 4.2.2.2),86,17,PMC5217362.txt
2.7.7.23,"...34), UDP-N-acetyl-glucosamine pyrophosphorylase (E2.7.7.23; Spot 20), UDP-glucose pyrophosphorylase ...",57,448,Proteome_Sci_2009_Mar_28_7_13.txt
EC 1.2.1.5,"...	Aldehyde dehydrogenase, Dimeric NADP-preferring (EC 1.2.1.5) (ALDH class 3)	RED	58.04	40.10	38.77",165,52,Proteome_Sci_2010_Jun_17_8_34.txt
EC 1.15.1.1,"..., which is induced by various stresses [45]. SOD (EC 1.15.1.1) is believed to be among the first lin...",70,914,Proteome_Sci_2013_Sep_26_11_41.txt
1.8.3.262,...Korean Neuropsychiatric Association 10.4306/pi.2011.8.3.262Original ArticleGenetic Polymorphisms in ...,3,114,Psychiatry_Investig_2011_Sep_26_8(3)_262-268.txt
2.9.2.174,...Korean Neuropsychiatric Association 10.4306/pi.2012.9.2.174Original ArticleRash in Psychiatric and N...,3,133,Psychiatry_Investig_2012_Jun_30_9(2)_174-179.txt
2.9.4.408,...Korean Neuropsychiatric Association 10.4306/pi.2012.9.4.408Original ArticleOrbito-Frontal Cortex Vol...,3,133,Psychiatry_Investig_2012_Dec_12_9(4)_408-412.txt
3.10.1.47,...Korean Neuropsychiatric Association 10.4306/pi.2013.10.1.47Original ArticleAn fMRI Study Investigati...,3,133,Psychiatry_Investig_2013_Mar_8_10(1)_47-55.txt
4.11.3.223,...Korean Neuropsychiatric Association 10.4306/pi.2014.11.3.223Original ArticleMotor Function in School...,3,133,Psychiatry_Investig_2014_Jul_21_11(3)_223-227.txt
5.12.1.152,...Korean Neuropsychiatric Association 10.4306/pi.2015.12.1.152Case ReportNew-Onset Mania Following Bar...,3,133,Psychiatry_Investig_2015_Jan_12_12(1)_152-154.txt
5.12.3.417,...Korean Neuropsychiatric Association 10.4306/pi.2015.12.3.417Letter to the EditorWhy Systematic Revie...,3,133,Psychiatry_Investig_2015_Jul_6_12(3)_417-419.txt
6.13.2.174,...Korean Neuropsychiatric Association 10.4306/pi.2016.13.2.174Original ArticlePlasma Oxytocin in Child...,3,133,Psychiatry_Investig_2016_Mar_23_13(2)_174-183.txt
4.83.2.284,"... Psychology , 83 , 284 –299 . doi:10.1037/0022-3514.83.2.284 12150228",261,219,Psychol_Public_Policy_Law_2015_Feb_17_21(1)_35-49.txt
3.21.4.837,"...n and Performance 1995 21 837 854 10.1037/0096-1523.21.4.837 Eimer, M. (1995). Stimulus-response com...",156,221,Psychol_Res_2008_May_10_72(3)_261-272.txt
3.27.1.229,"...ion & Performance 2001 27 229 240 10.1037/0096-1523.27.1.229 Elsner, B., & Hommel, B. (2001). Effect...",184,158,Psychol_Res_2009_Sep_3_73(5)_674-684.txt
3.31.1.100,...y and Cognition 2005 31 1 100 107 10.1037/0278-7393.31.1.100,250,247,Psychol_Res_2010_Mar_27_74(2)_219-236.txt
4.87.5.586,...Social Psychology 2004 87 586 598 10.1037/0022-3514.87.5.586 15535773,114,191,Psychol_Res_2010_Nov_31_74(6)_586-592.txt
3.31.5.880,...n and Performance 2005 31 880 888 10.1037/0096-1523.31.5.880 16262485,166,204,Psychol_Res_2012_Jul_9_76(4)_467-475.txt
3.26.6.174,"...rformance , 26 , 1746 –1759 . doi:10.1037/0096-1523.26.6.174611129371",401,244,Psychol_Rev_2012_Apr_27_119(2)_388-407.txt
5.16.4.577,"...y Neuropsychology 2002 16 577 590 10.1037/0894-4105.16.4.577 Bublak P, Müller U, Grön G, Reuter M, v...",162,221,Psychopharmacology_(Berl)_2009_Nov_12_207(1)_35-45.txt
2.6.4.675,...ual masking Emotion 2006 6 675 80 10.1037/1528-3542.6.4.675 17144759,227,83,Psychopharmacology_(Berl)_2011_Feb_2_213(2-3)_603-613.txt
4.85.5.909,...Available from: http://dx.doi.org/10.1037/0022-3514.85.5.909 14599253,129,264,Psychosoc_Med_2009_Nov_5_6_Doc06.txt
4.46.1.38,...vailable from: http://dx.doi.org/10.1026//0012-1924.46.1.38,138,193,Psychosoc_Med_2009_Nov_5_6_Doc06.txt
5.2.6.4,5.2.6.4 Resistance to the deletion of the traumati...,360,1,Psychosoc_Med_2013_Dec_18_10_Doc09.txt
3.6.2.174,...uman Learning and Memory  174 215 10.1037/0278-7393.6.2.174 7373248,275,240,Q_J_Exp_Psychol_(Hove)_2015_Sep_2_68(9)_187112-1894.txt
2.30.2.53,...ean Society for Radiation Oncology 10.3857/roj.2012.30.2.53Original ArticleClinical InvestigationCli...,3,139,Radiation_Oncol_J_2012_Jun_30_30(2)_53-61.txt
4.19.6.879,... J Korean Med Sci 2004 19 879 886 10.3346/jkms.2004.19.6.879 15608402,164,189,Radiat_Oncol_2011_Sep_30_6_128.txt
3.11.6.111,...noma J Clin Oncol 1993 11 6 1112 7 10.1200/JCO.1993.11.6.1112 8501497,317,167,PMC5341372.txt
3.31.3.171,...ean Society for Radiation Oncology 10.3857/roj.2013.31.3.171Case ReportSorafenib-triggered radiation...,3,133,Radiat_Oncol_J_2013_Sep_30_31(3)_171-174.txt
5.33.3.226,...ean Society for Radiation Oncology 10.3857/roj.2015.33.3.226Original ArticlePhysics ContributionFeas...,3,133,Radiat_Oncol_J_2015_Sep_30_33(3)_226-232.txt
5.33.4.301,...ean Society for Radiation Oncology 10.3857/roj.2015.33.4.301Original ArticleClinical InvestigationPr...,3,133,Radiat_Oncol_J_2015_Dec_30_33(4)_301-309.txt
6.2.1.1,6.2.1.1 Propagating a single edge with one labe,862,1,PMC5324709.txt
3.91.1.29,...ucational Psychology 1999 9 29 43 10.1037/0022-0663.91.1.29,250,213,Read_Writ_2010_Mar_13_23(3-4)_415-434.txt
3.19.5.106,...y and Cognition 1993 19 1061 1070 10.1037/0278-7393.19.5.1061,212,192,Read_Writ_2012_Aug_18_25(7)_1665-1690.txt
3.96.1.31,"...nal Psychology, 96(1), 31–42. doi:10.1037/0022-0663.96.1.3",847,235,Read_Writ_2015_May_22_28(8)_1203-1232.txt
EC 2.7.1.40,"...l kinase (GyK; EC 2.7.1.30), pyruvate kinase (PK, EC 2.7.1.40), lactate dehydrogenase (LDH, EC 1.1.1...",53,109,PMC5294721.txt
4.4.5.645,...v Vaccines 2005 4 645 656 16221066 10.1586/14760584.4.5.645,142,153,Respir_Res_2007_Aug_5_8(1)_57.txt
2.4.5.290,...thma Immunol Res 2012 4 5 290 294 10.4168/aair.2012.4.5.290 22950035,226,198,Respir_Res_2012_Nov_24_13(1)_108.txt
3.5.1.3,...uted on the basis of FST and RST with Arlequin v. 3.5.1.3 [35]. Two fixation indices were considered...,35,1568,R_Soc_Open_Sci_2015_May_6_2(5)_140493.txt
1.56.4.141,"56 , 1411 –1428 . (doi:10.4319/lo.2011.56.4.1411",229,38,R_Soc_Open_Sci_2014_Nov_19_1(3)_140294.txt
3.29.2.363,"29 , 363 –378 . (doi:10.1037/0096-1523.29.2.363)12760621",169,38,R_Soc_Open_Sci_2016_May_4_3(5)_160096.txt
1.7.2.4,K00376 nosZ: nitric oxide reductase (EC: 1.7.2.4)	N2O→N2	r7	s7: nosZ,43,43,PMC5319346.txt
1.18.6.1,...trogenase molybdenum-iron protein beta chain (EC: 1.18.6.1),47,67,PMC5319346.txt
1.2.4.336,...ety and Health Research Institute 10.5491/SHAW.2011.2.4.336Original ArticleThe Risk Rating System fo...,3,144,Saf_Health_Work_2011_Dec_5_2(4)_336-347.txt
1.2.4.336,...ety and Health Research Institute 10.5491/SHAW.2011.2.4.336Original ArticleThe Risk Rating System fo...,3,144,Saf_Health_Work_2011_Dec_5_2(4)_336-347.txt
4.2.1.7,4.2.1.7. Patients with a compromised lumen (does n...,167,1,Saudi_Med_J_2014_35(12)_1538-1544.txt
4.3.2.3,4.3.2.3.3. FOLFOX + panitumumab31 (EL-1,262,1,Saudi_Med_J_2014_35(12)_1538-1544.txt
3.2.2.1,3.2.2.1 Preserved insight vs poor insight patient,81,1,Schizophr_Res_2014_Jan_152(1)_201-209.txt
2.38.3.145,...ial Surgeons  2012 38 3 145 151 10.5125/jkaoms.2012.38.3.145,180,222,Scientifica_(Cairo)_2015_Oct_8_2015_135298.txt
1.54.1.29,...nal of Pediatrics  2011 54 1 29 35 10.3345/kjp.2011.54.1.29 2-s2.0-79951574229 21359058,155,235,Scientifica_(Cairo)_2016_Mar_20_2016_8013431.txt
3.4.1.1,...and Health at Work  2013 4 1 1 11 10.5491/shaw.2013.4.1.1 2-s2.0-84879018645 23515885,315,168,Scientifica_(Cairo)_2016_May_23_2016_9269210.txt
EC 1.13.11.12,...h TM  Laakso S   [53] Lipoxygenase from soybeans. EC 1.13.11.12 Linoleate:oxygen oxidoreductase Meth...,232,75,ScientificWorldJournal_2014_Jan_28_2014_501392.txt
3.18.1.80,... Medical Science  2003 18 1 80 87 10.3346/jkms.2003.18.1.80 2-s2.0-0141889609 12589092,211,341,ScientificWorldJournal_2014_Nov_6_2014_460194.txt
1.3.2.48,...1981 3 2 48 56 2-s2.0-0019850178 10.2519/jospt.1981.3.2.48 18810137,280,215,ScientificWorldJournal_2014_Nov_16_2014_473281.txt
1.1.1.42,"...pyruvate, and another enzyme encoded by K00031 (EC1.1.1.42) consumes 2-oxoglutarate (also part of rT...",34,175,Sci_Rep_2013_Apr_29_3_1748.txt
1.2.7.3,"...in CO2 fixation via the rTCA and rACA pathways. EC1.2.7.3 and EC1.2.7.1 displayed 228 cORFs in DBP, ...",36,377,Sci_Rep_2013_Apr_29_3_1748.txt
2.1.1.4,"...d X-ray powder diffraction software (PDXL Version 2.1.1.4, Rigaku)",48,823,Sci_Rep_2014_Jan_13_4_3650.txt
1.11.1.16,"..., E.C. 1.11.1.13), versatile peroxidase (VP, E.C. 1.11.1.16), and dye-decolorizing peroxidase (DyP, ...",7,206,Sci_Rep_2015_Feb_4_5_8245.txt
EC 1.14.19.1,"...FPKM, three fatty acid delta 9 desaturase (FADS9, EC 1.14.19.1) ~200, 500 and 600 FPKM, fatty acid d...",24,514,Sci_Rep_2015_Jun_10_5_11247.txt
EC 2.3.3.8,"...e, MDH (EC 1.1.1.37): Malate dehydrogenase, ACLY (EC 2.3.3.8): ATP-citric lyase, ACS (EC 6.2.1.1): A...",97,1255,Sci_Rep_2015_Jun_10_5_11247.txt
EC 2.7.1.1,"...ach isozyme were as follows55:(I) Hexokinase (HK, EC 2.7.1.1): 50 ml of a 0.1 M Tris-HCl (pH 7.8) so...",66,708,Sci_Rep_2015_Aug_25_5_11391.txt
1.2.1.12,"...yceraldehyde-3-phosphate dehydrogenase, type I(EC:1.2.1.12)",234,77,Sci_Rep_2015_Sep_4_5_13517.txt
4.1.2.22,"BBIF_00286	5,645	3,686	2478	Phosphoketolase(EC:4.1.2.22)",258,48,Sci_Rep_2015_Sep_4_5_13517.txt
4.1.1.49,"... are phosphoenolpyruvate carboxykinase (ATP) (EC: 4.1.1.49, SS1G_02281), malate dehydrogenase (EC: 1...",18,1439,Sci_Rep_2015_Aug_11_5_12952.txt
4.1.2.9,...and SS1G_06790) encoding the phosphoketolase (EC: 4.1.2.9) which play roles in carbon fixation of so...,18,1967,Sci_Rep_2015_Aug_11_5_12952.txt
2.6.1.1,"...tolase (EC: 4.1.2.9), aspartate transaminase (EC: 2.6.1.1), malate dehydrogenase (EC: 1.1.1.37) and ...",31,233,Sci_Rep_2015_Aug_11_5_12952.txt
2.7.1.40,"...(8E-67), AT3G52990 (6E-65), AT3G49160 (1E-26)	EC: 2.7.1.40	pyruvate kinase",123,288,Sci_Rep_2015_Aug_11_5_12952.txt
1.5.3.8,"Raw files were analyzed by MaxQuant version 1.5.3.8 using protein, peptide and site FDRs of 0....",48,45,Sci_Rep_2015_Dec_16_5_18271.txt
1.2.1.12,Monosaccharide	EC:1.2.1.12	D-Glyceraldehyde	Glyceraldehyde-3-phospha...,124,19,Sci_Rep_2016_Jan_4_6_18408.txt
2.4.1.227,EC:2.4.1.227	Undecaprenyldiphospho-muramoylpentapepti...,136,4,Sci_Rep_2016_Jan_4_6_18408.txt
2.5.1.7,EC:2.5.1.7	UDP-N-acetylglucosamine 1-carboxyvinyltran...,137,4,Sci_Rep_2016_Jan_4_6_18408.txt
2.9.3.241,...rium between genotypes for all loci we used FSTAT 2.9.3.241. Significance levels were adjusted using...,56,440,Sci_Rep_2016_Jan_6_6_18788.txt
2.28.64.70,"...oute for extracting glowing antioxidant. http://172.28.64.70:8080/jspui/handle/123456789/15296, Ph.D...",169,77,Sci_Rep_2016_Feb_24_6_21915.txt
3.5.1.292,"...y-Weinberg equilibrium were tested using ARLEQUIN 3.5.1.292 (10,000 dememorizations, 100,000 Markov ...",55,443,Sci_Rep_2016_Mar_8_6_22291.txt
3.5.1.354,...d heterozygosity (He) were calculated in ARLEQUIN 3.5.1.354. Departure from Hardy-Weinberg Equilibri...,57,113,Sci_Rep_2016_Mar_17_6_23246.txt
3.33.6.131,"33 , 1311 –1321 , 10.1037/0096-1523.33.6.1311  (2007 ).18085945",199,35,Sci_Rep_2016_May_18_6_26188.txt
3.6.1.66,"...roteins involved in thiamine metabolism (xtp1, EC:3.6.1.66; thiE, EC:2.5.1.3; thiM, EC:2.7.1.50; and...",23,4457,Sci_Rep_2016_Jun_7_6_27392.txt
EC 2.4.1.129,...division protein FtsI [Peptidoglycan synthetase] (EC 2.4.1.129),155,88,Sci_Rep_2016_Jun_14_6_27930.txt
1.5.3.12,Raw data was processed using MaxQuant62 (v1.5.3.12) searched with Andromeda (v1.5.3.8) again...,95,43,Sci_Rep_2016_Jun_21_6_28321.txt
EC 1.5.1.2,... E. coli pyrroline-5-carboxylate (P5C) reductase (EC 1.5.1.2) (encoded by proC gene) acted efficient...,33,76,Sci_Rep_2016_Aug_1_6_30760.txt
3.4.21.4,"...r to incubation with 1 μg of porcine trypsin (EC: 3.4.21.4, Promega) in 50 mM ammonium bicarbonate, ...",112,462,Sci_Rep_2016_Sep_8_6_32956.txt
3.15.2.109,"15 , 109 –114 , 10.5853/jos.2013.15.2.109  (2013 ).24324946",165,32,Sci_Rep_2016_Sep_30_6_34570.txt
3.30.2.104,"30 , 104 –117 , doi: 10.1037/0097-7403.30.2.104  (2004 ).15078120",204,38,Sci_Rep_2016_Nov_4_6_36295.txt
2.53.5.886,"53 , 886 –893 , doi: 10.3349/ymj.2012.53.5.886  (2012 ).22869469",230,37,PMC5233958.txt
3.1.9.2,"...error, a preliminary power analysis using G*power 3.1.9.2 computer program, based on a One-way analy...",45,71,PMC5133546.txt
4.2.1.92,"... enzymes, both hydroperoxide dehydratase (AOS [EC:4.2.1.92]) and OPC-8:0 CoA ligase1 (OPCL1 [EC:6.2....",40,475,PMC5278365.txt
EC 3.2.1.176,...se; the exocellulases act from the reducing ends (EC 3.2.1.176) or non-reducing ends (EC 3.2.1.91) o...,7,1394,PMC5309792.txt
EC 2.3.1.191,...-hydroxymyristoyl] glucosamine N-acyltransferase (EC 2.3.1.191) (jhp_0182)	30	29	32	26.9	KX119204,133,155,PMC5311958.txt
EC 1.2.1.88,"...mic semialdehyde (GSA). P5C dehydrogenase (P5CDH, EC 1.2.1.88) oxidises GSA to L-glutamate. ProDH an...",17,262,PMC5335563.txt
4.2.1.47,"...ted to the metabolism of fructose and mannose (EC:4.2.1.47–4,6-dehydratase and EC:1.1.1.271-synthase...",38,82,PMC5339828.txt
4.2.1.33,"... enzymes (e.g., EC:3.5.3.1-arginine amidinase, EC:4.2.1.33-dehydratase), were up-regulated. It has b...",48,292,PMC5339828.txt
6.4.1.2,...C:2.3.1.85-synthase ↓ EC:6.4.1.2-carboxylase ↓	EC:6.4.1.2-carboxylase ↓,129,76,PMC5339828.txt
3.45.2.117,"...t. Chemother . 45 , 117 –136 , doi: 10.3947/ic.2013.45.2.117  (2013 ).24265961",199,126,PMC5341023.txt
2.11.9.264,... J. Wound Care 11 335 341 335–41 10.12968/jowc.2002.11.9.26438 12430368,158,145,Sci_Technol_Adv_Mater_2015_May_20_16(3)_034606.txt
2.1.1.3,2.1.1.3.  Positio,120,1,Sci_Technol_Adv_Mater_2016_Jul_29_17(1)_41045-430.txt
2.1.5.1,2.1.5.1.  NumberDefectType,274,1,Sci_Technol_Adv_Mater_2016_Jul_29_17(1)_41045-430.txt
4.70.2.395,...Social Psychology 1996 70 395 407 10.1037/0022-3514.70.2.395 8636891,183,198,Self_Identity_2014_Sep_25_13(5)_594-612.txt
3.2.2.2,3.2.2.2. Support Vector Machine (SVM,76,1,Sensors_(Basel)_2012_Nov_9_12(11)_15542-15557.txt
EC 1.13.11.12,...  Formation of aroma compounds and lipoxygenase. (EC 1.13.11.12) activity in unblanched leek (Allium...,155,89,Sensors_(Basel)_2012_Nov_22_12(12)_16060-16076.txt
4.2.4.2,...r β0 between the optical axis obtained in Section 4.2.4.2 and the true optical axis of the lens. Max...,206,425,Sensors_(Basel)_2013_Apr_8_13(4)_4598-4623.txt
4.2.4.2,"(4) As described in Section 4.2.4.2—(3), we can obtain the distortion values Δ...",226,29,Sensors_(Basel)_2013_Apr_8_13(4)_4598-4623.txt
EC 1.1.99.17,...is used in glucose sensors. The quinoprotein GDH (EC 1.1.99.17) uses pyrroloquinoline quinone (PQQ) ...,97,83,Sensors_(Basel)_2008_Mar_27_8(4)_2043-2081.txt
5.98.78.94,12. Openni  Available online: http://75.98.78.94/default.aspx  accessed on 22 February 2...,112,39,Sensors_(Basel)_2012_Mar_26_12(4)_3868-3878.txt
2.2.2.2,2.2.2.2. Developing of the goal progra,51,1,Sensors_(Basel)_2008_Sep_17_8(9)_5745-5758.txt
2.3.1.1,"2.3.1.1	   R = R + G[j] [Ij,k]",156,1,Sensors_(Basel)_2013_Jul_23_13(7)_9483-9512.txt
3.2.2.8,3.2.2.8. PH-based syste,144,1,Sensors_(Basel)_2006_Oct_1_6(10)_1161-1186.txt
5.3.1.94,...et Social Cognition 1985 3 94 120 10.1521/soco.1985.3.1.94,199,149,Sex_Roles_2011_Jul_30_65(1-2)_35-46.txt
2.49.1.11,...pulations Soc Probl 2002 49 1 11 34 10.1525/sp.2002.49.1.11,218,175,Shanghai_Arch_Psychiatry_2015_Feb_25_27(1)_27-35.txt
3.1.1.205,"Using EV Insite version 3.1.1.205 and AquariusNet Viewer V4.8.85 software,...",44,25,SICOT_J_2_2.txt
5.1.3.592,...Threatening Behavior 2005 35 1 3 13 10.1521/suli.35.1.3.59263 2-s2.0-15044351321 15843320,329,256,Sleep_Disord_2016_Mar_3_2016_8737654.txt
5.41.12.937,...Drugs Today (Barc) 2005 12 773 784 10.1358/dot.2005.41.12.937959 16474853,139,166,Springerplus_2015_Feb_28_4_102.txt
6.11.12.224,...ommunity Nurs 2006 11 12 532 536 10.12968/bjcn.2006.11.12.22424 17170677,215,147,Springerplus_2016_Mar_3_5_270.txt
6.10.5.575,...pert Opin Ther Pat 2000 10 575 600 10.1517/13543776.10.5.575,402,142,Springerplus_2016_Jun_24_5(1)_887.txt
2.3.5.7,None	211	2.3.5.7	None,161,11,Springerplus_2016_Jul_19_5(1)_1128.txt
EC 1.10.3.2,Entcl_3603	     LO1	      putative laccase (EC 1.10.3.2),216,45,Stand_Genomic_Sci_2011_Sep_23_5(1)_69-85.txt
6.5.4.433,... 5 433 8 PubMed [http://dx.doi.org/10.1517/14622416.5.4.433] 10.1517/14622416.5.4.433 15165179,196,93,Stand_Genomic_Sci_2014_Dec_8_9_3.txt
4.1.99.17,....7]: 1-deoxy-D-xylulose-5-phosphate synthase; [EC:4.1.99.17]: phosphomethylpyrimidine synthase; [EC:...,282,628,Stand_Genomic_Sci_2015_Aug_5_10_50.txt
3.5.1.3,3.5.1.3	Registries of specific patient populations...,138,1,Stem_Cell_Reports_2016_May_12_6(6)_787-797.txt
1.1.5.709,... heading? Regen Med 2006 1 709 714 10.2217/17460751.1.5.709 17465739,28,155,Stem_Cell_Res_Ther_2010_Dec_14_1(5)_40.txt
1.1.4.2,...ssion’s Seventh Framework Programme FP7-HEALTH.2011.1.4.2 under grant agreement No. 278152 “InnovaLi...,302,96,Stem_Cell_Res_Ther_2015_Dec_12_6_246.txt
1.2.7.4,"...bel-free quantification we used MaxQuant (Version 1.2.7.4) associated with Andromeda [19, 20]. MS/MS...",58,107,Stem_Cells_Int_2013_Mar_26_2013_245695.txt
3.6.1.55,...al of Stem Cells  2013 6 1 55 66 10.15283/ijsc.2013.6.1.55 2-s2.0-84886242731 24298374,257,283,Stem_Cells_Int_2016_Mar_16_2016_9618480.txt
EC 4.2.1.19,...e imidazoleglycerol-phosphate dehydratase (IGPD) (EC 4.2.1.19) has been identified as a potential he...,27,67,Structure_2015_Jul_7_23(7)_1236-1245.txt
3.46.5.373,... Cardiovasc Surg 2013 46 5 373 6 10.5090/kjtcs.2013.46.5.373 24175275,90,198,Surg_Case_Rep_2015_Apr_10_1_35.txt
1.11.2.122,...t J Gastric Cancer 2011 11 122 125 10.5230/jgc.2011.11.2.122 22076213,96,149,Surg_Case_Rep_2016_Nov_15_2_133.txt
1.5.4.454,...led trial Gut Liver 2011 5 454 459 10.5009/gnl.2011.5.4.454 22195243,114,281,Surg_Endosc_2015_Jul_23_29_500-504.txt
3.9.12.119,...J Palliat Nurs 2003 9 12 521 527 10.12968/ijpn.2003.9.12.11987 14765008,166,182,Syst_Rev_2014_May_24_3_49.txt
3.33.2.467,... ; PMID:4760830; http://dx.doi.org/10.2466/pr0.1973.33.2.467 4760830,172,69,Temperature_(Austin)_2015_Oct_27_2(4)_54319-553.txt
2.86.7.736,...rulence Plant Dis 2002 86 736 740 10.1094/PDIS.2002.86.7.736,206,172,Theor_Appl_Genet_2010_Nov_11_121(8)_1633-1644.txt
1.1.1.1,"...tain (11%) corresponding to profiles −1.-1.-1.-1, 1.1.1.1 and 0.0.0.0 respectively. We observed that...",59,260,Theor_Biol_Med_Model_2013_May_31_10_37.txt
2.13.11.562,(A) doi:10.7314/APJCP.2012.13.11.562723317228,730,26,Tob_Control_2015_Mar_24_24(Suppl_1)_i13-i21.txt
3.29.3.173,... Society of Toxicology toxicr-29-17310.5487/TR.2013.29.3.173ArticlesGastrointestinal Tract Abnormali...,3,127,Toxicol_Res_2013_Sep_29(3)_173-179.txt
1.3.4.1,1.3.4.1. Hookworm Platelet Inhibitor (HPI,149,1,Toxins_(Basel)_2012_Apr_26_4(5)_296-322.txt
5.7.11.159,.... Rev. Neurother. 2007 7 1597 1612 10.1586/14737175.7.11.1597 17997706,92,162,Toxins_(Basel)_2014_Aug_13_6(8)_2363-2378.txt
EC 3.4.21.4,...itory activity against bovine pancreatic trypsin (EC 3.4.21.4) using the substrate N-benzoyl-arginin...,77,304,Toxins_(Basel)_2016_Apr_13_8(4)_110.txt
5.31.2.151,...cells Toxicol. Res. 2015 31 151 156 10.5487/TR.2015.31.2.151 26191381,194,221,Toxins_(Basel)_2016_May_24_8(6)_162.txt
6.7.1.1,... Physiol. Pharmacol. 1996 7 1 10 10.1515/JBCPP.1996.7.1.1 8983332,582,210,Toxins_(Basel)_2016_Sep_26_8(10)_279.txt
3.27.3.379,...ns Health Psychol 2008 27 379 387 10.1037/0278-6133.27.3.379 18624603,197,137,Transl_Behav_Med_2016_Sep_13_6(3)_418-427.txt
3.20.2.112,...ts Health Psychol 2001 20 112 119 10.1037/0278-6133.20.2.112 11315728,181,192,Trials_2014_Aug_12_15_320.txt
5.8.5.799,...pert Rev Neurother. 2008 8 799 808 10.1586/14737175.8.5.799 18457536,140,141,Trials_2015_Apr_23_16_186.txt
3.27.3.379,...ntions Health Psychol 2008 27 379 10.1037/0278-6133.27.3.379 18624603,269,132,Trials_2015_Apr_16_16_165.txt
4.84.4.822,...Pers Soc Psychol 2003 84 4 822 48 10.1037/0022-3514.84.4.822 12703651,222,161,Trials_2016_Jun_2_17_273.txt
2.72.3.261,...erculosis and Respiratory Diseases 10.4046/trd.2012.72.3.261ReviewPercutaneous Dilatational Tracheos...,3,184,Tuberc_Respir_Dis_(Seoul)_2012_Mar_31_72(3)_261-274.txt
2.72.4.360,...erculosis and Respiratory Diseases 10.4046/trd.2012.72.4.360Original ArticleFour Year Trend of Carba...,3,184,Tuberc_Respir_Dis_(Seoul)_2012_Apr_30_72(4)_360-366.txt
3.74.1.1,...erculosis and Respiratory Diseases 10.4046/trd.2013.74.1.1ReviewRecent Advances in Idiopathic Pulmon...,3,184,Tuberc_Respir_Dis_(Seoul)_2013_Jan_31_74(1)_1-6.txt
3.75.2.47,...erculosis and Respiratory Diseases 10.4046/trd.2013.75.2.47ReviewInterstitial Lung Diseases: Respira...,3,184,Tuberc_Respir_Dis_(Seoul)_2013_Aug_30_75(2)_47-51.txt
6.79.2.104,...erculosis and Respiratory Diseases 10.4046/trd.2016.79.2.104ErratumErratum: Spontaneous Pulmonary He...,3,184,Tuberc_Respir_Dis_(Seoul)_2016_Apr_31_79(2)_104.txt
6.79.3.143,...erculosis and Respiratory Diseases 10.4046/trd.2016.79.3.143Original ArticleApolipoprotein A1 Inhibi...,3,184,Tuberc_Respir_Dis_(Seoul)_2016_Jul_1_79(3)_143-152.txt
3.14.1.453,...c J Cancer Prev. 2013 14 453 456 10.7314/APJCP.2013.14.1.453 23534772,127,208,Tumour_Biol_2014_Feb_9_35(6)_5199-5203.txt
3.2.2.2,3.2.2.2.5.	Patients with CRPC who were on LHRH ago...,151,1,Urol_Ann_2011_Mar_3(Suppl)_S10-S16.txt
4.1.5.1,4.1.5.1. If size <3 cm and normal markers: Surveil...,152,1,Urol_Ann_2014_Oct-Dec_6(4)_290-295.txt
4.1.6.2,"4.1.6.2. Four cycles of paclitaxel, ifosfamide and...",184,1,Urol_Ann_2014_Oct-Dec_6(4)_290-295.txt
4.1.3.2,4.1.3.2. CIS,110,1,Urol_Ann_2014_Oct-Dec_6(4)_273-277.txt
5.4.1.4,5.4.1.4. Patients should not have received neo-adj...,266,1,Urol_Ann_2014_Oct-Dec_6(4)_273-277.txt
4.2.1.1,4.2.1.1.3.2. pN1: Surveillance in compliant patien...,166,1,Urol_Ann_2016_Apr-Jun_8(2)_141-145.txt
4.6.5.821,...xpert Rev. Vaccines 2007 6 821 834 10.1586/14760584.6.5.821 17931161,191,219,Vaccines_(Basel)_2015_Mar_5_3(1)_148-171.txt
2.4.1.4,2.4.1.4. 2009 Pandemic H1N1 and Its Reassortant,92,1,Vaccines_(Basel)_2015_Jan_30_3(1)_22-73.txt
EC 3.2.1.17,"...dies (Dako, Polyclonal Rabbit Anti-Human Lysozyme EC 3.2.1.17, ref A0099), T and B cells were detect...",90,373,Vet_Res_2014_Aug_28_45(1)_85.txt
2.3.4.6,"... subtype virus was initially clustered into clade 2.3.4.6 when published in Ref. [17], the provision...",341,67,PMC5294818.txt
1.44.4.318,...rdiovasc Surg 44(4):318–320. doi:10.5090/kjtcs.2011.44.4.31,323,168,Virchows_Arch_2015_Sep_10_467(5)_487-500.txt
3.3.5.539,... C Future Microbiol 2008 3 539 545 10.2217/17460913.3.5.539 18811238,119,152,Virol_J_2014_Jan_23_11_10.txt
5.30.8.120,... Korean Med Sci 2015 30 1207 1208 10.3346/jkms.2015.30.8.1207 26240502,349,199,Virol_J_2015_Dec_22_12_222.txt
2.2.1.2,a The Bayseian skyride analysis of the 2.2.1.2 cluster from 2009 to 2014 showing changes ...,86,40,Virol_J_2016_Mar_22_13_49.txt
2.3.4.4,"... N, Bodenstein B, White CL, Ip HS. Novel H5 Clade 2.3.4.4 Reassortant (H5N1) Virus from a Green-Wing...",127,109,Virol_J_2016_Aug_30_13(1)_147.txt
2.2.1.2,"...nated subclade A, B and C. TK16 belonged to clade 2.2.1.2a clustering with gene sequences from recen...",95,357,PMC5343302.txt
1.14.10.114,... Microbe Interact 2001 14 1149 57 10.1094/MPMI.2001.14.10.1149 11605954,204,276,Virulence_2012_Mar_1_3(2)_109-121.txt
4.6.2.255,... Expet Rev. Vaccine 2007 6 255 266 10.1586/14760584.6.2.255,479,143,Viruses_2012_Sep_3_4(9)_1438-1476.txt
1.52.4.13,... research J. Apic. Res. 2013 52 1 24 10.3896/IBRA.1.52.4.13,198,135,Viruses_2015_Jun_23_7(6)_3285-3309.txt
EC 1.10.3.2,"...zyme laccase (benzenediol: oxygen oxidoreductase, EC 1.10.3.2) is widely used for the oxidative poly...",12,57,Viruses_2015_Oct_15_7(10)_5343-5360.txt
6.1.1.111,...se Expert Rev. Hematol. 2008 1 111 10.1586/17474086.1.1.111 20151032,373,148,Viruses_2016_Mar_22_8(3)_85.txt
3.87.1.33,...us (BSV) Plant Dis. 2003 87 33 38 10.1094/PDIS.2003.87.1.33,296,198,Viruses_2016_Jun_22_8(6)_177.txt
6.21.2.279,... Korean Med. Sci. 2006 21 279 283 10.3346/jkms.2006.21.2.279 16614514,253,316,PMC5294990.txt
1.46.6.140,...nd Oceanography 2001 46 6 1400 1405 10.4319/lo.2001.46.6.1400,198,180,Water_Air_Soil_Pollut_2015_Jul_11_226(8)_254.txt
2.30.3.153,...for Sexual Medicine and Andrology 10.5534/wjmh.2012.30.3.153Review ArticleAntipsychotic-Induced Sexu...,3,159,World_J_Mens_Health_2012_Dec_27_30(3)_153-159.txt
5.33.1.36,...for Sexual Medicine and Andrology 10.5534/wjmh.2015.33.1.36Case ReportSpontaneous Corpus Cavernosum ...,3,159,World_J_Mens_Health_2015_Apr_23_33(1)_36-38.txt
EC 1.10.3.2,"...atile peroxidase (VP, EC 1.11.1.16), and laccase (EC 1.10.3.2). In the various species of white rot ...",16,637,World_J_Microbiol_Biotechnol_2014_Jan_11_30(6)_1725-1736.txt
2.9.3.272,...Surg Oncol 2002 9 272 277 11923134 10.1245/aso.2002.9.3.272,109,404,World_J_Surg_Oncol_2007_Jan_29_5_10.txt
4.3.3.263,...ture Oncol 2007 3 263 271 17547520 10.2217/14796694.3.3.263,184,128,World_J_Surg_Oncol_2008_Jun_20_6_65.txt
6.47.6.811,...atients Yonsei Med J 2006 47 811 6 10.3349/ymj.2006.47.6.811 17191310,407,222,World_J_Surg_Oncol_2011_Sep_21_9_108.txt
4.2.6.743,...ssion Future Oncol 2006 11 743 763 10.2217/14796694.2.6.743 17155901,193,140,World_J_Surg_Oncol_2013_Sep_13_11_226.txt
1.52.6.961,... cancer Yonsei Med J 2011 52 961 6 10.3349/ymj.2011.52.6.961 22028160,202,195,World_J_Surg_Oncol_2015_Nov_4_13_309.txt
3.31.3.162,...cer Radiat Oncol J 2013 31 162 170 10.3857/roj.2013.31.3.162 24137562,111,199,World_J_Surg_Oncol_2016_Mar_31_14_94.txt
5.46.3.372,...sei University College of Medicine 10.3349/ymj.2005.46.3.37215988809Original ArticleCortical Margini...,3,109,Yonsei_Med_J_2005_Jun_30_46(3)_372-378.txt
5.46.4.526,...sei University College of Medicine 10.3349/ymj.2005.46.4.52616127778Original ArticleA Phase II Study...,3,109,Yonsei_Med_J_2005_Aug_31_46(4)_526-531.txt
6.47.5.715,...sei University College of Medicine 10.3349/ymj.2006.47.5.71517066516Original ArticleTransurethral Re...,3,109,Yonsei_Med_J_2006_Oct_31_47(5)_715-720.txt
1.52.3.454,...ersity College of Medicine 2148818810.3349/ymj.2011.52.3.454Original ArticleOncologyClinical Charact...,3,117,Yonsei_Med_J_2011_May_1_52(3)_454-462.txt
1.52.5.803,...ersity College of Medicine 2178644610.3349/ymj.2011.52.5.803Original ArticleSurgeryResults from Over...,3,117,Yonsei_Med_J_2011_Sep_1_52(5)_803-808.txt
2.53.1.198,...ersity College of Medicine 2218725310.3349/ymj.2012.53.1.198Original ArticleAnesthesiologyLipid-Emul...,3,117,Yonsei_Med_J_2012_Jan_1_53(1)_198-203.txt
2.53.1.53,...ersity College of Medicine 2218723210.3349/ymj.2012.53.1.53Original ArticleNeurology & Neurosciences...,3,117,Yonsei_Med_J_2012_Jan_1_53(1)_53-57.txt
2.53.5.901,...ersity College of Medicine 2286947110.3349/ymj.2012.53.5.901Original ArticlePsychiatricsThe Impact o...,3,130,Yonsei_Med_J_2012_Sep_1_53(5)_901-905.txt
3.54.3.626,...ersity College of Medicine 2354980710.3349/ymj.2013.54.3.626Original ArticleEndocrinology & Metaboli...,3,130,Yonsei_Med_J_2013_May_1_54(3)_626-636.txt
5.56.1.53,...ersity College of Medicine 2551074710.3349/ymj.2015.56.1.53Original ArticleCardiac & Cardiovascular ...,3,130,Yonsei_Med_J_2015_Jan_1_56(1)_53-61.txt
4.55.6.174,...ersity College of Medicine 2532391510.3349/ymj.2014.55.6.1743Case ReportRehabilitationUsefulness of ...,3,130,Yonsei_Med_J_2014_Nov_1_55(6)_1743-1746.txt
6.57.1.111,...ersity College of Medicine 2663239010.3349/ymj.2016.57.1.111Original ArticleInfectious DiseasesAssoc...,3,130,Yonsei_Med_J_2016_Jan_1_57(1)_111-117.txt
6.57.2.399,...sei University College of Medicine 10.3349/ymj.2016.57.2.399Original ArticleAllergyStandardization o...,3,122,Yonsei_Med_J_2016_Mar_1_57(2)_399-406.txt
6.57.2.536,...sei University College of Medicine 10.3349/ymj.2016.57.2.536Letter to the EditorSuccessful Applicati...,3,122,Yonsei_Med_J_2016_Mar_1_57(2)_536-537.txt
6.12.13.49,"...P.-Cambridge, 1896), female holotype, NHM (BMNH1896.12.13.49), Santarem, lower Amazonas, Brazil. Dip...",40,99,Zookeys_2011_Jun_24_(112)_89-96.txt
1.7.1.1,...e]. Comment: family-group name unavailable (Art. 11.7.1.1): not based on an available genus name,33789,320,Zookeys_2011_Apr_4_(88)_1-972.txt
4.2.23.8,"... images of Dendy’s (1905) non-type slides BMNH 1954.2.23.8 (A–E) and Cyamon quadriradiatum Carter, 1...",688,98,Zookeys_2012_Nov_8_(239)_1-70.txt
1.9.1.2,"...ural (e.g., musculorum) (see ICZN 1999: Articles 11.9.1.2 and 11.9.1.3). All authors seen, starting ...",41779,635,Zookeys_2012_Nov_28_(245)_1-1722.txt
1.9.1.3,"...usculorum) (see ICZN 1999: Articles 11.9.1.2 and 11.9.1.3). All authors seen, starting with LeConte ...",41779,648,Zookeys_2012_Nov_28_(245)_1-1722.txt
1.7.1.3,"...ithocheiridae Seeley, 1870 following the article 11.7.1.3 of the ICZN",410,162,Zookeys_2013_Jun_12_(308)_1-112.txt
2.2.4.33,"NHMUK 1922.2.4.33, lectotype (ex Rolle)",10352,10,Zookeys_2014_Mar_21_(392)_1-367.txt
4.12.4.152,"NHMUK 1854.12.4.152–157, 53 paralectotypes (d’Orbigny coll....",10879,10,Zookeys_2014_Mar_21_(392)_1-367.txt
3.2.4.204,"...ryx serotinus (Morelet, 1860), lectotype NHMUK 1893.2.4.204 (H = 25.5)",15169,55,Zookeys_2014_Mar_21_(392)_1-367.txt
1.6.22.451,"...us) championi (Martens, 1893), lectotype NHMUK 1901.6.22.451 (H = 27.0) G–",15234,70,Zookeys_2014_Mar_21_(392)_1-367.txt
5.12.1.161,".... Perinereis atlantica (McIntosh, 1885) (NHMUK.1885.12.1.161): A anterior end, dorsal view B anterio...",368,59,Zookeys_2014_Jul_22_(427)_75-108.txt
1.3.17.724,"...ble syntypes: Formosa, coll. Hungerford (NHMUK 1891.3.17.724–726, 3 shells), 2.76–3.29 × 1.66–1.76 m...",219,56,Zookeys_2014_Jul_23_(428)_1-28.txt
3.28.6.119,...Oceanography 28 : 1199 –1213 . doi: 10.4319/lo.1983.28.6.119,301,105,Zookeys_2014_Oct_8_(444)_95-118.txt
6.6.13.18,"Lectotype NHMUK 1896.6.13.18 (Fig. 5I; H=35.4 mm, W=17.8 mm)",568,20,Zookeys_2015_Mar_30_(492)_49-105.txt
3.7.1.312,"oakesi (Gude, 1915), NHMUK 1903.7.1.3125. (syntype)",1064,31,Zookeys_2015_Oct_26_(529)_1-70.txt
3.7.1.773,"...a); Shillong, Khasi, “animal dissected”, NHMUK 1903.7.1.773/1 (with long lower plica); Teria Ghat, c...",1562,762,Zookeys_2015_Oct_26_(529)_1-70.txt
6.1.14.43,"PANAMÁ: BM 1946.1.14.43, off Taboguilla, 9 m, C. Crossland, 22 N...",1417,15,Zookeys_2016_Apr_14_(581)_1-69.txt
6.10.4.4,"subspinipes I (typical form)”. NHMUK 1916.10.4.4-8, one spm., unknown locality. NHMUK, one...",1775,41,Zookeys_2016_May_17_(590)_1-124.txt
